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ABSTRACT 
 
 
Consumer awareness of the link between dietary fats and health outcomes has led 
to increased demand for food products enriched with bioactive fatty acids (FA). Ruminant-
derived fats, such as dairy fats, contribute significantly to the American diet and contain 
many unique beneficial FA, such as short- and medium-chain FA, n-3 FA, conjugated 
linoleic acids (CLA), vaccenic acid (VA), as well as odd-and branched-chain FA 
(OBCFA). Increasing these FA in dairy products by altering farm management practices, 
such as breed, lactation stage, and nutrition, may improve human health without a change 
to the diet. The overarching goal of this dissertation was to evaluate on-farm strategies to 
increase the content of bioactive FA in bovine milk. 
 
The first objective was to enrich milk fat with bioactive FA via supplementation 
with echium oil, a terrestrial oil rich in n-3 FA. Treatments were 1.5% and 3.0% dry matter 
as lipid encapsulated echium oil (EEO) which were compared to a control (no EEO). Milk 
fat contents of n-3 FA increased with EEO supplementation but the transfer of n-3 FA from 
EEO into milk fat was rather low (< 5%). In a subsequent trial, ruminal protection of EEO 
and post-ruminal release of EEO-derived FA was examined. EEO-derived FA were 
preferentially incorporated into plasma lipid fractions unavailable to the mammary gland. 
Moreover, fecal excretion of EEO-derived FA ranged from 7-14% of intake, and VA and 
CLA, the biohydrogenation and metabolism products of n-3 FA, increased in milk and 
feces with EEO supplementation. Therefore, lipid-encapsulation provided inadequate 
digestibility and low transfer efficiency of n-3 FA into milk. The second objective was to 
compare the bacterial community structure and unique bioactive FA in bacterial 
membranes and milk fat between Holstein (HO), Jersey (JE), and HO x JE crossbreeds 
(CB) across a lactation. Lactation stage had a prominent effect on rumen bacterial taxa, 
with Firmicutes being most abundant during early lactation. The FA composition of 
bacterial cells was affected by both lactation stage and genetics, and OBCFA in bacterial 
cells were positively correlated with several bacteria of the Firmicutes phylum. HO and 
CB exhibited greater contents of various bioactive FA in milk than JE. The highest content 
of all bioactive FA occurred at early lactation, while OBCFA were highest at late lactation. 
The third objective was to determine the effects of grazing a monoculture vs. a diverse 
pasture on rumen bacterial and protozoal taxa, their membrane FA composition, and milk 
FA. Microbial communities shifted in response to grazing regime accompanied with 
changes in their membrane FA profiles. Rumen microbiota from cows grazing a diverse 
pasture had higher contents of n-3 FA and VA, but lower contents of OBCFA. Microbial 
membrane FA correlated with microbial taxa, the contents of ALA and n-3 FA were 
positively correlated with the bacterial genus Butyrivibrio and the protozoal genus 
Eudioplodinium. Milk contents of CLA and n-3 FA increased when cows grazed a diverse 
pasture, while grazing a monoculture led to greater milk contents of OBCFA. 
 
In conclusion, grazing cows on a diverse pasture, when compared to genetic 
effects and lipid supplementation, was the most efficacious strategy to increase the 
content of bioactive FA in milk.   
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CHAPTER 1 : LITERATURE REVIEW 
1.1. Research Significance 
To date, there have been over 150 diseases and conditions linked to dietary lipids, 
ranging from high blood pressure and obesity, to Alzheimer’s disease, cancer, diabetes, 
stroke, and cardiovascular diseases (CVD). Both the direct and indirect healthcare costs of 
obesity have been estimated at $147 billion in 2008 (Finkelstein et al., 2009), the cost of 
CVD and stroke in 2010 was $315 billion (Go et al., 2014), and the total estimated cost of 
diagnosed diabetes in 2012 was $245 billion (Yang et al., 2013). Furthermore, public health 
organizations have recommended a population-wide decrease in the consumption of 
saturated and trans fatty acids (FA), and higher intakes of polyunsaturated FA (PUFA). 
Milk and dairy products are the single major source of fat in the diets of Western countries, 
representing 31% of the total fat intake (National Center for Health Statistics, 2006). 
Altering the FA composition of widely consumed foods, such as dairy products, may prove 
to be a successful strategy to reduce the incidence of chronic diseases and maintain human 
health. Milk with an improved FA profile also presents an opportunity for dairy producers 
to increase their income by marketing dairy products with added value (i.e., functional 
foods). 
1.2. Bioactive Fatty Acids in Milk 
Bovine milk contains approximately 3 to 5% fat by volume, which is mainly comprised 
(98%) of triacylglycerols (TAG) (Jensen, 2002). TAG consist of three FA esterified to a 
glycerol backbone. More than 400 different FA have been identified in milk fat, making it 
one of the most diverse fats in nature (Jensen, 2002). Yet, most of these FA occur only in 
trace amounts, with about twelve FA present in concentrations greater than 1% of milk fat 
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(Jensen, 2002). The FA composition of milk is important to consider as it is directly related 
to the nutritional value and physical properties of fat-based dairy products (Walstra et al., 
2006). Milk fat is comprised of numerous bioactive FA, or FA that have bioactivity beyond 
that of providing nutritional value (Kris-Etherton et al., 2004). A complete review of the 
biochemical mechanism of these FA is beyond the scope of this literature review, and the 
review herein concentrates on providing a better understanding of the researched biological 
effects that these FA provide. 
1.2.1. Conjugated Linoleic Acids 
Conjugated linoleic acids (CLA) are a class of positional and geometric isomers 
of octadecadienoic acid. The primary isomer in milk fat is 18:2 c9,t11 (rumenic acid; RA) 
which has potential as a functional food ingredient (Lock and Bauman, 2004). Therefore, 
the discussions of this literature review will focus on the bioactive effects of the CLA 
isomer, RA. There is a vast body of research utilizing animal models and cell lines to 
demonstrate the potential health benefits of RA. In brief, RA has been shown to attenuate 
pro-inflammatory markers associated with insulin resistance in adipose tissue (Moloney et 
al., 2007), exert anti-inflammatory effects (Lee et al., 2009; Lee and Vanden Heuvel, 2010; 
Mollica et al., 2014), suppress tumorigenesis in several different forms of cancer (El Roz 
et al., 2013; Huang et al., 2007; Huot et al., 2010; Wang et al., 2013), and lower risk 
markers for CVD (Nicod et al., 2015; LeDoux et al., 2007; Arbonés-Mainar et al., 2006; 
Kritchevsky et al., 2004). The link between RA and health effects in humans, however, is 
less conclusive. Although the evidence is unclear as to whether RA affects plasma 
lipoprotein concentrations and risk for atherosclerosis (Ritzenthaler et al., 2001; Mele et 
al., 2013; Tricon et al., 2004; Pintus et al., 2013; Sluijs et al., 2010; Sofi et al., 2010), two 
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recent reviews concluded that there are potentially beneficial effects of RA on mechanisms 
that contribute to the progression of atherosclerosis, such as monocyte migration, 
inflammation mediators, and foam cell formation (Mooney et al., 2012; Bruen et al., 2016). 
RA has also been shown to have modest anti-inflammatory effects in allergic subjects 
(Jaudszus et al., 2016; Turpeinen et al., 2008) and to induce positive changes in immune 
modulators associated with inflammation (Penedo et al., 2013). There is also some 
evidence that suggests RA improves bone mineral density in men (Deguire et al., 2012) 
and cognitive function (Jenkins et al., 2016). Currently, the primary evidence of the anti-
cancer activity of RA is limited to that from epidemiological and observational studies 
based on estimated consumption of RA. Case-control studies revealed a reduction in breast 
cancer tumorigenesis with the highest levels of RA intake (McCann et al., 2004; Aro et al., 
2000), while other studies concluded no association between RA intake and risk for breast 
cancer (Larsson et al., 2009; Voorrips et al., 2002). A prospective evaluation of the 
relationship between consumption of dairy products and colorectal cancer showed that 
women who consumed ≥4 servings of high-fat dairy per day had a lower risk for colorectal 
cancer than those who consumed ≤1 serving per day (Larsson et al., 2005). The authors 
concluded that this may be due to the higher level of RA intake. Although these studies 
offer important information, there are limitations, including dietary intake and report bias, 
sample size, and confounding factors, such as physical activity, family genetic history, and 
other dietary habits. There has only been one clinical trial evaluating the effect of a 50:50 
mixture of RA and 18:2 t10,c12 supplemented at 7.5g per day to 24 women with breast 
cancer (McGowan et al., 2013). After 12 days of supplementation a reduction in tumor 
proliferation was observed without any toxicity. The health benefits of RA are well 
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demonstrated in animal models and cell lines, and there is some evidence to support the 
health benefits of RA, especially from dairy, in humans. However, more research needs to 
be conducted with controlled dietary intervention trials to further elucidate the role of RA 
in human health. 
1.2.2. n-3 Fatty Acids 
n-3 FA are a class of PUFA possessing a double bond at the third carbon from the 
methyl end. As with CLA, there are various FA within the n-3 class that have differing 
effects on the body. α-linolenic acid (ALA; 18:3 c9,c12,c15) is the essential dietary n-3 
FA that is the substrate for elongation and desaturation to eicosapentaenoic acid (EPA; 
20:5 c5,c8,c11,c14,c17) and docosahexaenoic acid (DHA; 22:6 c4,c7,c10,c13,c16,c19) 
(Figure 1.1.). There is a large body of evidence to demonstrate that EPA and DHA are 
crucial in the prevention and treatment of CVD. A recent review, considering all clinical 
trials and previous meta-analyses, concluded that n-3 FA reduce the incidence of sudden 
death due to cardiac arrhythmias and all-cause mortality in CVD patients (Jain et al., 2015). 
Increased consumption of EPA and DHA is also linked to decreased risk for cancer (Zheng 
et al., 2013), inflammatory diseases (Lorente-Cebrián et al., 2015), allergies (Miyata and 
Arita, 2015), and several neurological disorders, as n-3 FA are important components of 
neuronal cell membranes (Sublette et al., 2011; Sarris et al., 2012; Bloch and Qawasmi, 
2011; van Elst et al., 2014; Gajos and Beaver, 2016; Zhang et al., 2016). The anti-
inflammatory properties of n-3 FA have been generally attributed to their ability to interfere 
with the pro-inflammatory signaling cascades and to their ability to produce several anti-
inflammatory signaling molecules, such as cytokines, prostaglandins (PG), and 
leukotrienes (Calder, 2012). 
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Figure 1.1. The synthesis, elongation, and desaturation of n-6 and n-3 fatty acids.  
LA: Linoleic Acid, ALA: α-Linolenic Acid, SDA: Stearidonic Acid, AA: Arachidonic Acid, EPA: 
Eicosapentaenoic Acid, DHA: Docosahexaenoic Acid, TX: Thromboxanes, PG: Prostaglandins, 
LT: Leukotrienes. Adapted from Liu and Ma (2014b). 
Milk fat typically contains low levels of n-3 FA (<1% total FA), and is primarily 
composed of ALA, with ~5% of total milk n-3 FA being EPA, and DHA being rarely 
detected in milk (O’Donnell et al., 2010). Furthermore, the conversion of ALA to EPA in 
the human body is very low (~8%) (Spilker et al., 2006), and the conversion of ALA to 
DHA is negligible (<0.05%) (Burdge and Calder, 2005). EPA and DHA are primarily 
derived from marine sources, and there is growing concern of overfishing, the health of 
oceanic ecosystems, heavy metal and chemical contamination, and lack of palatability 
(especially in children) (Kuhnt et al., 2014; Delgado et al., 2003). Therefore, there is an 
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emerging interest in establishing ALA, which is derived from terrestrial sources, as an 
alternative source to the marine-derived EPA and DHA. Although ALA has been less 
widely researched than EPA and DHA, studies suggest that ALA possesses health benefits 
beyond just conversion to EPA and DHA (Fleming and Kris-Etherton, 2014). Research 
demonstrates that ALA and steariodonic acid (SDA; 18:4 c6,c9,c12,c15) have equivalent 
biological effects to EPA (Baker et al., 2016; Walker et al., 2013). In addition, a recent 
review concluded that the synthesis of DHA from ALA is sufficient enough to supply DHA 
levels to the brain (Domenichiello et al., 2015). ALA has some of the same anti-cancer 
(Liu and Ma, 2014a; Carayol et al., 2010; Kim et al., 2014), cardiovascular-protective 
(Fleming and Kris-Etherton, 2014; Pan et al., 2012a), neuro-protective (Pan et al., 2012b), 
anti-inflammatory (Reifen et al., 2015; Egert et al., 2014), anti-obesogenic (Bhaswant et 
al., 2015; Perng et al., 2015), anti-osteoporotic (Kim and Ilich, 2011), and anti-diabetic 
properties (Heskey et al., 2016; Rajaram, 2014) possessed by EPA and DHA. Overall, it 
has been proposed that ALA should be included in food sources that have other bioactive 
constituents to act synergistically to reduce chronic disease risk factors (Rajaram, 2014). 
When considering the health effects of n-3 FA, it is imperative to also consider 
the amount of n-6 FA in a diet, as ALA and linoleic acid (LA; 18:2 c9,c12) compete for 
the same enzymes in elongation and desaturation to long-chain n-3 and n-6 PUFA, 
respectively (Figure 1.2.). Thus, absolute levels of ALA and LA in the diet can affect 
metabolic outcomes for each FA. For example, a high LA intake interferes with the 
conversion of ALA to EPA and produces a series of pro-inflammatory signaling molecules 
synthesized from the long-chain n-6 FA, arachidonic acid (AA; 20:4 c5,c8,c11,c14), while 
the series of molecules produced from EPA are anti-inflammatory (Simopoulos, 2016). For 
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this reason, and because n-3 and n-6 FA cannot be interconverted by mammals, the dietary 
ratio n-6/n-3 ratio is an important factor to consider for health outcomes (Barceló-Coblijn 
and Murphy, 2009).  
1.2.3. Odd and Branched-Chain Fatty Acids 
Branched-chain fatty acids (BCFA) are a class of bioactive fatty acids that appear 
most commonly as saturated fatty acids (SFA) with one or more methyl branches on the 
carbon chain (although branches other than methyl groups can be present). Their main 
function within membranes is to add fluidity, similarly to unsaturated FA (UFA), except, 
BCFA are not susceptible to oxidation as is in the case of UFA (Christie, 2012). In mono-
methylated BCFA (those with one methyl branch) the branching occurs predominately at 
the terminal end, and are either referred to as iso, having the branch point on the 
penultimate carbon (one carbon from the terminal end) or anteiso, having the branch point 
at the ante-penultimate carbon (two carbons from the terminal end) (Christie, 2012). BCFA 
are derived primarily from bacterial membranes and are found in dairy products at a content 
of ~2% total FA (Ran-Ressler et al., 2011b). Although present in the human diet, BCFA 
are rarely found in significant proportions in internal human tissues, they are however, 
found at elevated levels in skin tissue and in skin and gut tissue of term infants (Ran-Ressler 
et al., 2008). As a result of this property, Ran-Ressler et al. (2011a) confirmed their 
hypothesis that BCFA reduce the incidence of necrotizing enterocolitis in the neonatal rat, 
a disease that causes inflammation and infection of the intestinal wall in newborns. BCFA 
have been shown to inhibit tumor growth in several cell lines (Wongtangtintharn et al., 
2004; Yang et al., 2003; Cai et al., 2013; Lin et al., 2012 ), and in vivo, iso 15:0 reduces 
tumor growth (Yang et al., 2000). The cytotoxicity of BCFA has been shown to be similar 
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to CLA, and the mechanism of action is thought to be through inhibition of FA synthesis 
(Wongtangtintharn et al., 2004).  
Odd-chain FA (OCFA) are also of microbial origin, consisting of odd-numbered 
chains of saturated carbons. The two main odd-chain FA found in milk fat are 15:0 and 
17:0 and there have been two recent reviews to highlight the health benefits of these two 
FA (Jenkins et al., 2015; Pfeuffer and Jaudszus, 2016). In contrast to BCFA, these FA are 
found in almost all human tissues. The content of 15:0 and 17:0 in plasma phospholipids 
(PL) and erythrocytes is inversely associated with incidence of CVD (Pfeuffer and 
Jaudszus, 2016; Sun et al., 2007; de Oliveira Otto et al., 2013). There has also been an 
inverse association between type 2 diabetes and tissue levels of 15:0 and 17:0 reported 
(Forouhi et al., 2014; Hodge et al., 2007; Santaren et al., 2014; Krachler et al., 2008; 
Kröger et al., 2015; Patel et al., 2010), which was significant for all studies, except for one 
(Mozaffarian et al., 2009). OCFA are found in lower concentrations in cerebrospinal fluid 
of Alzheimer’s patients when compared to healthy individuals (Fonteh et al., 2014). As a 
result, the authors hypothesized that OCFA may impart more membrane fluidity than 
PUFA, and thus lead to improved neurological function (Jenkins et al., 2015).  
1.2.4. Other Bioactive Fatty Acids 
The scientific evidence to support the link between trans FA and heart diseases 
has become substantial, and accordingly, the Food and Drug Administration has trans FA 
no longer listed as “Generally Recognized as Safe” (also called GRAS) as of 2015, giving 
food companies a three-year period to phase out the use of industrially-produced trans FA 
(Food and Administration, 2015). Milk fat contains trans FA, however, the profile and 
content of trans FA in dairy products differs from that of products with industrially-
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produced trans FA, with milk-derived trans FA not demonstrating the same deteriorative 
health effects (Rice et al., 2010). In fact, the main trans FA in milk fat, vaccenic acid (VA; 
18:1 t11), imparts several health benefits (Blewett et al., 2009). VA can be converted to 
RA via the action of delta-9 desaturase, this conversion occurs at a rate of ~19% in humans 
and is dependent on VA intake, supplementation period, and gender (Kuhnt et al., 2006; 
Turpeinen et al., 2002). Thus, the main benefits from this FA are presumed to be from its 
contribution to tissue levels of RA, although, other research has shown that VA imparts 
health benefits beyond that of being a substrate for RA (Miller et al., 2003; Sauer et al., 
2004). Data are limited, but animal studies show VA to reduce risk of CVD (Lock et al., 
2005; Bassett et al., 2010), cancer (Banni et al., 2001; Corl et al., 2003), metabolic 
syndrome (Wang et al., 2009), and favorably alter immune function (Blewett et al., 2009).  
Oleic acid (OA; 18:1 c9) is the principal monounsaturated FA (MUFA) found in 
milk fat, typically at contents between 20% and 25% of total FA (O’Donnell et al., 2010). 
A limited number of studies evaluated OA in animal studies and cell lines, and have shown 
OA to possess beneficial health effects, such as, improved glucose homeostasis and 
prevention of type 2 diabetes (Obici et al., 2002; Vassiliou et al., 2009), decreased 
development of colorectal cancer (Llor et al., 2003), and reduced risk of breast cancer 
(Menendez et al., 2005). In addition, OA-rich diets reduce insulin resistance in type 2 
diabetes patients (Ryan et al., 2000) and plasma OA levels have been shown to be inversely 
associated with risk of stroke in humans (Samieri et al., 2011).  
Short-chain FA (SCFA) are SFA with 2-6 carbons in length (Nobel, 1978). They 
are present in milk at 6-7% of total FA and may reduce the risk of gastrointestinal disorders, 
cancer, and CVD (Hijova, 2007; Tan et al., 2014) along with improving immunity, 
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reducing inflammation (Meijer et al., 2010; Roy et al., 2006b), controlling obesity, and 
improving glucose homeostasis (Canfora et al., 2015; Byrne et al., 2015). Yet, all of these 
positive health outcomes are due to increased SCFA production in the colon and not from 
consuming an increased amount of SCFA. While research on dietary butyrate (4:0) is 
scarce, studies suggest that ingested butyrate can exhibit biological effects on tissues other 
than the colon, such as the ability to reduce mammary tumerogenesis (Belobrajdic and 
McIntosh, 2000; Yanagi et al., 1993). 
Medium-chain fatty acids (MCFA) contain 8-12 carbons and are saturated 
constituents of milk fat that have been associated with beneficial effects linked with 
metabolic function (Nagao and Yanagita, 2010). It has been postulated that MCFA may 
reduce the risk of developing attributes of metabolic syndrome (Pfeuffer and Schrezenmeir, 
2007), as early studies suggest that dietary substitutions of MCFA for long-chain FA can 
affect energy balance (Dulloo et al., 1996; Hill et al., 1989) and therefore may improve 
body fat mass. This was confirmed by Tsuji et al. (2001), demonstrating that 
supplementation with 10g/day of MCFA over 12-weeks reduced body fat, abdominal 
subcutaneous fat, and improved plasma lipids  in subjects with a body mass index (BMI) 
≥23 (Kasai et al., 2003). The link between MCFA intake and prevention of obesity was 
further corroborated by additional research (St-Onge and Jones, 2002; St-Onge et al., 
2003). 
1.3. Metabolic Origins of Milk Fatty Acids 
In the pursuit of developing effective strategies that enhance the content of 
specific bioactive FA in milk, the metabolic origins of these FA must first be considered. 
In the following sections, a brief overview of ruminal lipid metabolism, FA transport, and 
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mammary FA synthesis is provided. A more detailed discussion of the biochemical and 
genetic regulation of lipid metabolism and milk fat synthesis in ruminants can be found in 
the other reviews (Harfoot and Hazlewood, 1997; Bauman et al., 2011; Palmquist, 2006; 
Bauman et al., 2006; Arrigoni et al., 2016). 
1.3.1. Lipid Metabolism in the Rumen 
In non-ruminant animals, FA are hydrolyzed and absorbed directly in the small 
intestine, resulting in a close relationship between dietary and absorbed FA (Wood et al., 
2008). However, in ruminants, FA are first subject to microbial digestion in the rumen, 
resulting in a vastly different profile between dietary and duodenal FA to be absorbed 
(Pappritz et al., 2011). Dairy cattle diets are typically low in fat, containing around 4-5% 
lipids as dry matter (DM) (van Soest, 1995). The lipids in forages are primarily TAG and 
glycolipids, with minor amounts of mono- and diacylglycerides, PL, and free FA (FFA) 
(Harfoot and Hazlewood, 1997). The FA composition of forages is highly unsaturated, with 
the majority of FA being PUFA (45-65% ALA and 12-20% LA) (Glasser et al., 2013). 
ALA is typically higher in fresh forages (i.e., pastures), while LA is generally higher in 
concentrates (i.e., grains). FA metabolism in the rumen significantly alters the composition 
of these dietary lipids, and thus, has a profound effect on the composition of bovine milk.  
When lipids enter the rumen they are subject to the action of the 109 to 1011 
bacteria residing within in the rumen in a symbiotic relationship with the host animal 
(Wright and Klieve, 2011). The first step in the breakdown of dietary lipids (i.e., TAG, 
glycolipids, and PL) is lipolysis, defined as the hydrolysis of ester linkages between the 
glycerol backbone and the FA, which is performed extracellularly by the hydrolase 
enzymes of rumen bacteria (Jenkins, 1993). Following lipolysis, the FFA are subject to the 
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process of biohydrogenation (BH), the action of adding hydrogens to double bonds, 
ultimately leading to a saturated FA product (Figure 1.2.). This reaction is carried out by 
the rumen bacteria as a protective mechanism to mitigate the bacteriostatic effects of PUFA 
(Jenkins et al., 2008). Certain species of bacteria have the ability to biohydrogenate UFA, 
and most bacteria only play a role in one step of the process (Kemp and Lander, 1984). As 
a result of the excess hydrogen in the rumen from anaerobic fermentation, BH is rapid and 
extensive, often exceeding 85% of dietary UFA (Jenkins et al., 2008). Yet, incomplete BH 
does allow for accumulation and escape of BH intermediates from the rumen. Thus, BH of 
dietary FA by rumen bacteria is both the origin of unique rumen-derived bioactive FA (e.g., 
VA and CLA) and the cause of the low content of PUFA in milk fat.  
 
Figure 1.2. The primary biohydrogenation pathways of linoleic acid (LA) and α-linolenic acid 
(ALA) in the rumen and subsequent desaturation of biohydrogenation intermediates in the 
mammary gland.  
RA: Rumenic Acid, VA: Vaccenic Acid, OA: Oleic Acid, CLA: Conjugated Linoleic Acids. 
Adapted from Kramer et al. (2004).  
Ruminal BH plays a crucial role in modifying dietary FA to those available for 
milk fat synthesis. As dietary factors change, rumen BH shifts, resulting in an altered FA 
profile available to the mammary gland for incorporation into milk fat (Shingfield et al., 
2006; Roy et al., 2006a; Loor et al., 2004). Several factors affect the relative proportions 
of FA produced during BH within the rumen, including dietary FA and dietary chemical 
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composition, feed particle size, inclusion of ionophores, forage secondary metabolites 
(e.g., condensed tannins), as well as the microbial ecosystem and their enzymatic processes 
(Jenkins et al., 2008). Diets that are excessively rich in unprotected PUFA and highly 
fermentable starches can cause a shift in the BH pathway, resulting in the production of 
BH FA intermediates that may cause milk fat depression and reduced DM intake (DMI) 
(Figure 1.2.) (Bauman et al., 2011; Allen, 2000).  
1.3.2. Fatty Acid Absorption and Transport 
Any remaining esterified FA that escape the rumen are hydrolyzed by pancreatic 
lipases in the duodenum, and then absorbed as FFA in the enterocyctes (Doreau and Ferlay, 
1994). The FFA are then re-esterified and packaged into chylomicrons and very low-
density lipoproteins (VLDL) to be transported to peripheral tissues (Palmquist, 2009). 
These plasma transport lipoproteins are made up of lipid fractions, cholesterol esters (CE), 
TAG, PL, and FFA in differing proportions, with TAG and FFA fractions being available 
to the mammary gland for milk fat synthesis. During the re-esterification process, n-3 FA 
are preferentially incorporated into CE and PL to prevent these PUFA from being utilized 
for energy (Offer et al., 2001). Preferential incorporation of n-3 FA into these polar lipid 
fractions also influences their tissue site of uptake, making them less available to the 
mammary gland (Rymer et al., 2003). Circulating lipids are hydrolyzed by the mammary 
enzyme, mammary lipoprotein lipase (LPL), which acts primarily on TAG in plasma 
chylomicrons and VLDL (Askew et al., 1970). In ruminants, the FA composition and 
secretion rate of lipoproteins are the primary factors that dictate lipid utilization by the 
mammary gland (Bauchart, 1993). Thus, one of the challenges in enhancing the content of 
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n-3 FA in milk fat is overcoming the preferential incorporation of n-3 FA into plasma lipid 
fractions unavailable to the mammary gland. 
1.3.4. Mammary Fatty Acid Synthesis and Modification 
Bovine milk FA come from primarily two sources; those that are synthesized de 
novo in the mammary epithelial cells, and those that are referred to as preformed, 
originating from FA absorbed in the small intestine or mobilized from adipose tissue. de 
novo synthesized FA account for 40% of milk FA by weight and are comprised of FA from 
4-16 carbon atoms (Gross et al., 2011). The preformed FA account for 60% of FA in milk 
and are comprised of FA that consist of 16 carbon atoms or greater (Chilliard et al., 2000). 
Within the preformed FA are those FA derived from the diet such as ALA, LA, and OA, 
and those which were synthesized within the rumen, for instance CLA, VA, and OBCFA. 
FA that are 16 carbons in length are derived from both sources and are therefore referred 
to as mixed FA.  
de novo synthesized FA are produced by mammary epithelial cells using acetate 
and β-hydroxybutyrate, the end products of carbohydrate fermentation in the rumen. The 
two key enzymes involved in this process are acetyl-CoA carboxylase and FA synthase 
(Palmquist, 2006). Acetyl-CoA carboxylase is the rate limiting enzyme that catalyzes the 
formation of malonyl-CoA from acetyl-CoA. FA synthase is a large, complex enzyme 
responsible for elongation of malonyl-CoA through condensation with acetyl-CoA 
(Palmquist, 2006). Genetics and dietary factors, such as energy intake and dietary fat level, 
can influence expression of these enzymes, leading to differing contents of de novo 
synthesized FA in milk fat (Marchitelli et al., 2013; Matsumoto et al., 2012).  
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A key discovery within the last two decades was the observation that delta-9 
desaturase is the primary source of RA in milk (Griinari et al., 2000) (Figure 1.2.). Delta-
9 desaturase, otherwise known as stearoyl-CoA desaturase, inserts a cis double bond at the 
9th carbon atom from the carboxyl end. Therefore, OA can also be synthesized through the 
action of delta-9 desaturase on stearic acid. More than 50% of the OA and between 64-
91% of RA are synthesized in the mammary gland from stearic acid and VA, respectively 
(Griinari et al., 2000; Corl et al., 2001; Kay et al., 2004). Accordingly, differences in delta-
9 desaturase expression due to genetic factors could affect the content of OA and RA in 
milk. It has been reported that between animals delta-9 desaturase expression can vary 3-
fold (Kelsey et al., 2003), and because of this variation, there exists the potential for 
increasing the bioactive FA in milk through genetic selection (Bilal et al., 2012; Bastin et 
al., 2013).  
1.4. Strategies to Improve the Bioactive Fatty Acid Content of Milk 
The milk FA profile and content can be altered through farm management 
practices, such as dietary regime and breeding, offering the opportunity to respond to 
recommendations of health organizations and create functional food products for human 
health promotion and disease prevention. The following is a review of the relevant 
literature of the most current and prevailing strategies to improve the bioactive FA content 
of milk.  
1.4.1. Genetic and Physiological Variation 
The genetics of dairy cattle mainly affect the de novo synthesized FA and those 
modified in the mammary gland via delta-9-desaturase (Arnould and Soyeurt, 2009). 
Genetic selection for overall milk fat percentage typically increases the content of de novo 
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synthesized FA and decreases the content of UFA with >18-carbons (Arnould and Soyeurt, 
2009). The two most common dairy cattle breeds in the United States, Jerseys and 
Holsteins, have been selected for different production traits. Jerseys have been selected to 
produce a higher milk fat percentage, while Holstein are selected for milk production, 
leading to differences in milk FA composition and content between these two breeds. Three 
studies have evaluated the difference in milk FA profile among Holsteins and Jerseys on a 
pasture-based diet. Palladino et al. (2010) demonstrated Holstein milk to contain greater 
contents of OA and total n-6 FA than Jersey milk, whereas Jersey milk had higher SFA 
contents than Holstein milk. No difference was discerned in the content of total CLA and 
n-3 FA between milk of the two breeds. White et al. (2001) showed Holstein’s milk to have 
a higher content of total 18:1 FA and CLA, while Jersey milk contained higher SFA. In 
contrast, an evaluation of Holstein and Jersey cattle across a lactation demonstrated no 
differences between the SFA content of Holstein and Jersey milk (Nantapo et al., 2014). 
Another common dairy breed, Brown Swiss, was observed to have no difference in milk 
contents of bioactive FA when compared to Holstein and Jersey breeds (Carroll et al., 
2006).  
Feed intake varies with lactation stage, affecting rumen fill, energy balance and 
rumen microbial activity, leading to altered rates of rumen passage, BH, and activity of 
delta-9 desaturase in the mammary gland (Kay et al., 2005; Stoop et al., 2009). There is 
evidence that the milk FA profile may shift across the lactation stage (Craninx et al., 2008), 
however, the composition of the diet in that study was not consistent (e.g., adjustment of 
concentrate), and therefore, changes in the milk FA profile could not be directly attributed 
to the effect of lactation stage.  
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Parity has been shown to affect the milk FA profile. Bilal et al. (2014) 
demonstrated that milk fat from primiparous cows contained greater proportions of OA, 
ALA, VA, and RA and lower proportions of 12:0, 14:0, and 16:0 when compared to milk 
from multiparous cows. The lower proportion of these SFA may be explained by the lower 
enzymatic activity in the mammary gland of primiparous cows, as Miller et al. (2003) 
showed a decreased expression of FA synthase in first-lactation cows. This effect of parity 
on the milk FA profile has been confirmed by Kelsey et al. (2003), demonstrating that 
parity accounts for 32-45% of the variation of OA in milk, however, no differences in ALA, 
VA, and RA were observed between primiparous and multiparous cattle (Kelsey et al., 
2003). 
1.4.2. Lipid Supplementation 
The milk FA profile is highly influenced by lipid supplementation, which has been 
the focus of much research over the past decades. The extent to which FA derived from 
dietary supplements are incorporated into milk fat depends, in part, on the magnitude of 
BH in the rumen and the transfer efficiency of FA from the small intestine into milk fat. 
Abomasal or duodenal infusions of oils or FA mixtures have demonstrated the potential 
for high transfer efficiencies of FA into milk fat when BH in the rumen is bypassed. 
Infusion of ALA into the abomasum typically results in a transfer efficiency into milk fat 
of 40-60% (Chilliard et al., 2000; Moallem et al., 2012); this transfer efficiency is lower 
for the longer chain n-3 FA, EPA and DHA, ranging from 20-30% (Lock and Bauman, 
2004; Chilliard et al., 2001). When these FA are supplemented to the dairy cow without 
rumen protection, the transfer efficiency is drastically reduced as a result of BH, being 
5.0% for ALA, 2.6% for EPA, and 4.1% for DHA (Khiaosa-ard et al., 2015; Chilliard et 
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al., 2001). In addition, supplementation of these FA can result in the altered BH pathway, 
creating BH intermediates, such as 18:2 t10,c12 (Figure 1.2.), which down regulate 
enzymes in the mammary gland causing milk fat depression (Bauman et al., 2011). Thus, 
several nutritional and technological strategies have been designed to bypass rumen BH of 
n-3 FA and therefore increase the transfer of UFA to milk fat while maintaining rumen 
health. Rumen-protected (or also termed rumen-bypass) fats are designed to resist the BH 
processes in the rumen, and be available in the small intestine for digestion and subsequent 
incorporation into milk fat (Papas and Wu, 1997).  
A natural form of rumen-protection is supplementing whole seeds, as seed hulls 
restrict bacterial access to the seed lipids, resulting in reduced BH of the seed-derived FA 
(Chilliard et al., 2007). The extent of this reduction is dependent on the density of the hull 
and on the seed processing per se (whole-grain vs. rolled, extruded, or ground) (Tripathi, 
2015). Seed hulls, however, also reduce the availability of the FA in the small intestine, 
and thus, oilseeds are commonly processed to enhance their digestibility, which in turn 
increases the extent of ruminal BH. Supplementation of whole flaxseeds and processing 
flaxseeds with micronization increased the content of ALA in milk fat (Petit, 2002; 
Caroprese et al., 2010; Soita et al., 2003) while heat processing, such as extrusion, leads to 
smaller increases in the content of ALA in milk fat (Gonthier et al., 2005). Yet transfer 
efficiencies from all forms of flaxseed supplementation are low (~2%), with extruded 
flaxseed yielding the lowest transfer efficiency (0.9%) (Gonthier et al., 2005). Grinding 
whole flaxseed resulted in higher amounts of ALA in milk in comparison to whole 
flaxseed, but resulted in decreased DMI, possibly due to altered BH (Petit and Côrtes, 
2010). 
19 
 
One of the most prominent methods of rumen-protection is to encapsulate an 
emulsified oil in a matrix of formaldehyde-treated proteins. The protein encapsulation 
protects the FA from bacterial enzymes in the rumen, and allows for a 89-92% digestibility 
of the protected FA in the small intestine (Gulati et al., 2005). Moderate success (i.e., 
increases in transfer efficiency) with this rumen-protection technology has been 
demonstrated with protected tuna oil (Kitessa et al., 2004), fish oil (Gulati et al., 2003), 
and flax oil (Goodridge et al., 2001; Hawkins et al., 2013). Limitations to this protection 
technology are production costs and the controversial use of formaldehyde. 
Calcium salts of FA are rumen inert and are formed by binding calcium to the 
carboxyl end of the FA, making the carboxyl group unavailable to bacterial isomerases, 
and thus preventing BH (Jenkins and Bridges, 2007). The drawback of calcium salts is due 
to the dissociation of the FA from calcium below a pH of 6.5, consequently, only partial 
protection from ruminal BH is provided (Sukhija and Palmquist, 1990). Therefore, calcium 
salts result in a much lower transfer efficiency compared to their formaldehyde-treated 
counter parts (de Veth et al., 2005), providing only marginal increases in milk n-3 FA with 
supplementation of calcium salts of either flax oil (Cortes et al., 2011) or fish oil (Allred 
et al., 2006). Notably, milk fat content of n-3 FA was not different when cows were 
supplemented with calcium salts of fish oil compared to unprotected fish oil (Castañeda-
Gutiérrez et al., 2007).  
Protecting UFA through encapsulation in a matrix of SFA with a high-melting 
point is another method of rumen-protection known as lipid-encapsulation. Data on the 
efficacy of the lipid-encapsulation rumen-protection method are limited, however, one 
study has shown that these fats may provide similar protection to formaldehyde-treated 
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proteins (Perfield et al., 2004). Thus, this protection method shows promise for providing 
an increased transfer efficiency of UFA to milk fat. 
1.4.3. Dietary Forages 
The modification of milk FA composition has generally been achieved through 
lipid supplementation, and not through forage management. Hence, less research has been 
conducted examining the effect of forage composition on the milk FA profile. Forages 
provide a low-cost approach to modifying milk lipids in comparison with diet 
supplementation strategies, such as seeds or rumen-protected oils. Furthermore, forage-
derived FA do not induce large increases in trans 18:1 isomers other than VA (Dewhurst 
et al., 2006). Plants have the unique ability, over mammals, to endogenously synthesize 
ALA and LA (Figure 1.1.). In temperate climates, fresh forages contain 55–65% of total 
FA as ALA (Chilliard et al., 2001). The extent to which forages can alter the content of 
milk bioactive FA is dependent on two processes, i) increasing the ALA supply in the 
forage crop and ii) minimizing the extent of BH of forage-derived ALA in the rumen. There 
are several factors that affect these two processes, which need to be considered when 
utilizing forages to optimize milks’ FA profile. The FA composition of forages is primarily 
affected by forage species and plant maturity (Dewhurst et al., 2006; Chilliard et al., 2007). 
For example, FA profiles have been used to differentiate ryegrass species from other grass 
species at the same vegetative stage (Dewhurst et al., 2001), and clover silages contain a 
higher content of n-3 FA in comparison to grass silages (Dewhurst et al., 2003; Al-Mabruk 
et al., 2004). Overall, legumes were shown to have a higher content of ALA compared to 
grasses, which have very similar ALA contents among species (Clapham et al., 2005). 
Forbs are broad-leaf plants that have variable contents of ALA, with some species, such as 
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chicory, exhibiting ALA contents similar to legumes (35-42mg/g DM), while others, such 
as turnip, having very low contents of ALA (11-22mg/g DM) (Clapham et al., 2005). The 
content of ALA and total FA in forages consistently declines with increasing plant maturity 
(Glasser et al., 2013). The common basis for these effects is related to the leaf to stem ratio, 
with lower concentrations of ALA in forages having a low leaf to stem ratio and higher 
concentrations of ALA in species having a high leaf to stem ratio (Rugoho et al., 2014). 
Other factors affecting the ALA content in fresh forages include seasonality (i.e., 
temperature), soil quality, and nitrogen fertilization. Forages have the highest contents of 
ALA during the colder months of spring and autumn in temperate zones of the northern 
hemisphere and a positive linear relationship has been observed between ALA in forages 
and nitrogen application (Glasser et al., 2013).  
Feeding cows conserved forage in comparison to fresh forage consistently results 
in a lower content of n-3 FA in milk (White et al., 2001; Whiting et al., 2004; Schroeder 
et al., 2003). This is due primarily to the lipoxygenase system, the plant defense mechanism 
that causes plant lipases to release FFA from damaged plant tissues, resulting in oxidation 
of unsaturated FFA to hydroperoxides, and therefore loss of n-3 FA content (Feussner and 
Wasternack, 2002). Oxidative losses of n-3 FA can also occur during field wilting and 
ensiling at a rate of between 2-35%, with haymaking practices resulting in the most 
substantial losses when compared to ensiling (Glasser et al., 2013; Dewhurst et al., 2006). 
Therefore, the pursuit to enhance milks’ bioactive FA profile should focus on grazing fresh 
forages, where possible, and minimizing n-3 FA losses during harvesting and storage.  
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1.4.4. Rumen Microorganism Modification 
Modifying rumen microbial metabolism of FA through dietary alterations is a 
novel way to enhance the content of bioactive FA in ruminant products. This strategy 
requires an understanding of the complex relationship between several factors, such as 
dietary components and rumen microbial metabolism. Rumen microorganisms modify the 
milk FA content and profile through shifting BH and by supplying lipids from their own 
cellular membranes (Kaneda, 1991). The general focus of research in this field has been to 
elucidate the microbial ecology of lipolysis and BH and to discover methods to modify 
rumen microorganisms to increase the flow of PUFA, CLA, VA, and OBCFA to the 
duodenum for incorporation into ruminant products. 
Bacteria biohydrogenate dietary LA and ALA to various CLA isomers and trans 
18:1 isomers, including VA and 18:0 (Figure 1.2.). No single bacterium can perform all 
processes of the BH pathway, thus, bacteria have been divided into two groups (Kemp and 
Lander, 1984). Group A biohydrogenates PUFA to trans 18:1 isomers, and Group B 
biohydrogenates trans 18:1 isomers to 18:0 (Kemp and Lander, 1984). Butyrivibrio species 
belong to group A and are one of the most well understood bacteria in the BH process. 
They are a diverse group of Gram-positive bacteria that metabolize LA at a much faster 
rate than other rumen bacteria species (Maia et al., 2007). The two main BH products of 
LA by Butyrivibrio species are VA and RA. The specific roles of other rumen bacteria 
species in the process of BH are lesser known.  
The other method by which bacteria can modify the milk FA profile is as a source 
of OBCFA when bacterial cells pass with rumen digesta into the abomasum. Bacteria are 
the primary source of OBCFA in milk fat, as they use BCFA to regulate the fluidity of their 
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cell membranes (Suutari and Laakso, 1992). Factors that affect the composition of OBCFA 
in bacterial membranes include i) the bacteria-specific activity of bacterial enzymes 
involved in FA synthesis and ii) the environment-specific availability of substrates and 
nutrients for FA synthesis (Kaneda, 1991). The FA composition of specific bacterial 
species has been evaluated, demonstrating that cellulolytic bacteria, such as Ruminococcus 
albus and Butyrivibrio fibrosolvens, contain increased amounts of iso BCFA (Minato et 
al., 1988). While amylolytic bacteria, such as Prevotella, contain more anteiso BCFA, 
especially anteiso 15:0, and OCFA (Minato et al., 1988). In addition, Saluzzi et al. (1993) 
concluded that minor changes in the OBCFA profile of bacteria resulted from culture 
conditions (i.e., increased volatile FA and vitamins) relative to differences among bacterial 
species. Hence, the difference in OBCFA profiles of rumen bacteria appears to be species-
specific. This demonstrates the potential to alter the OBCFA content and profile of milk 
by shifting the relative abundance of specific bacterial populations in the rumen.  
Diet is the main factor that induces shifts in the rumen bacterial populations. For 
example, increasing the proportion of forage in the diet resulted in an increase in OBCFA 
in milk, presumably due to a shift to a more cellulolytic population (Vlaeminck et al., 
2006b). Dietary starch also negatively correlates with the content of milk iso BCFA, such 
as  iso 14:0, iso 15:0, and iso 16:0, and positively correlates with OCFA (Vlaeminck et al., 
2006a). It is not only the proportion of forage, but also the type of forage that affects 
bacterial populations and therefore the milk OBCFA content. Several studies have shown 
that feeding corn silage, as opposed to grass silage, increases the contents of iso 17:0 and 
anteiso 17:0 in milk fat (Shingfield et al., 2005; Nielsen et al., 2004). A correlation analysis 
between the OBCFA profile of milk and dietary nutrient composition revealed that overall, 
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OBCFA are positively correlated with the neutral detergent fiber (NDF) content of the diet, 
and negatively correlated with crude protein content. The total FA content of the diet is 
negatively correlated with all OBCFA except for iso 17:0 (Vlaeminck et al., 2006a; Loor 
et al., 2004; Collomb et al., 2004). Yet, dietary fish oil or marine algae increased the milk 
OBCFA content (Shingfield et al., 2003; Loor et al., 2005). This discrepancy could be due 
to the property of fish oil to increase fiber digestion and therefore alter the bacterial 
communities to those that are cellulolytic (Vlaeminck et al., 2005). Research has shown 
that the OCFA 15:0 and 17:0 are not only of microbial origin but can also be endogenously 
synthesized in the mammary gland from propionate, although the contribution of this 
source to milk contents is low (<2% of labeled proprionate is converted to OCFA) 
(Massart-Leën et al., 1983; Masoro and Porter, 1961). 
Protozoa are less numerous than bacteria in the rumen (104–106 cells/mL rumen 
digesta vs. 1010–1011 cells/mL rumen digesta, respectively) (Wright and Klieve, 2011), but 
as a result of their larger size, protozoa make up half of the microbial biomass in the rumen, 
and thus, supply a large proportion of microbial-derived FA leaving the rumen (Jouany, 
1996). Protozoa consist of primarily UFA in their cellular membranes, as they accumulate 
UFA by engulfing chloroplasts, which are comprised of approximately 60% n-3 FA 
(Devillard et al., 2006; Huws et al., 2009). It has been hypothesized that this preferential 
incorporation of UFA into the protozoa membranes is to maintain cell fluidity and function 
(Devillard et al., 2006). Protozoa, unlike bacteria, do not produce the FA intermediates 
formed during the BH process, however, they can incorporate BH intermediates formed by 
bacteria into their membranes. Notably, protozoa account for 20-34% of the total VA and 
35-43% of RA leaving the rumen (Yáñez-Ruiz et al., 2006) and defaunation resulted in a 
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13% and 10% reduction of the flow of MUFA and PUFA, respectively, to the duodenum 
(Newbold et al., 2015).  
1.5. Hypotheses and Objectives 
Although considerable research has been performed concerning the optimization 
of bioactive FA in milk, there are still substantial gaps in our knowledge. The overarching 
goal of this dissertation is to narrow these gaps and evaluate novel strategies to enhance 
the content of bioactive FA in milk for human health promotion and disease prevention. 
There have been no studies to evaluate the effects of breed and lactation stage on the milk 
content of bioactive FA, with emphasis on OBCFA, from cows on a consistent, 
conventional diet. We hypothesized that genetic effects and lactation stage influence the 
content and composition of bioactive FA, especially OBCFA, in milk fat. The specific 
objective for chapter 2 was to compare the milk bioactive FA, milk production, and milk 
components at four time points, 5, 95, 185, and 275 days in milk (DIM) between 
primiparous Holstein, Jersey, and Holstein x Jersey crossbreeds fed the same diet across 
the lactation.  
Next, we hypothesized that genetics and lactation stage result in characteristic 
rumen bacterial communities producing a distinct quantity and profile of OBCFA. There 
has been no research to correlate bacterial FA with rumen bacterial genera, and elucidating 
these relationships would allow for modification of rumen bacterial communities to 
increase the flow of OBCFA to the mammary gland for milk fat synthesis. The objectives 
of the study in chapter 3 were to i) identify and quantify the rumen bacterial populations 
of Holstein, Jersey, and Holstein x Jersey crossbreeds over a lactation, and ii) compare and 
correlate the content of OBCFA in rumen bacterial cells membranes with bacterial genera. 
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There has been little research to evaluate the effects of n-3 FA derived from 
terrestrial sources (e.g. SDA) on the content of bioactive FA in milk. In addition, ALA and 
SDA present in echium oil (EO) may be preferentially incorporated into plasma lipid 
fractions available to the mammary gland at higher contents than EPA and DHA, 
improving the transfer efficiency of these FA to milk fat. We hypothesized that inclusion 
of a rumen protected lipid-encapsulated EO in the diet of dairy cattle would substantially 
increase the content of EO-derived FA in milk fat. The specific objectives of chapter 4 
were to i) determine the transfer efficiency of EO-derived FA to milk fat and ii) assess the 
incorporation of EO-derived FA into plasma lipid fractions. As a result of low transfer 
efficiencies of EO-derived FA to milk fat in chapter 4, we hypothesized that lipid-
encapsulation allowed for biohydrogenation and/or excretion of EO-derived FA. In a 
subsequent study (chapter 5), we aimed to investigate the ruminal protection and post-
ruminal release of FA derived from lipid-encapsulated EO and assess the bioavailability 
and metabolism of EO-derived FA through measuring FA composition of plasma, feces, 
and milk. 
There is a lack of research into the effects of fresh forages on the bioactive FA 
content of milk. In addition, pasture-based dairies are increasing the inclusion of summer 
annuals in pastures as they grow well in the hot summer months when cool-season pastures 
experience less growth. We hypothesized that inclusion of the summer annual, pearl millet, 
would result in lower contents of bioactive FA in milk in comparison to cool-season 
pastures. The objective of chapter 6 was to compare the effects of grazing pearl millet on 
forage quality, animal performance, and bioactive FA in milk with a cool-season pasture. 
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As demonstrated in chapter 3, rumen microorganisms may provide a novel way 
to improve the bioactive FA content of milk, and there has been no research to correlate 
microbial genera and microbial FA with FA in milk. We hypothesized that dairy cows 
grazing on the summer annual, pearl millet, in comparison to a cool-season pasture, will 
result in a shift of the rumen microbial communities (i.e., bacteria and protozoa) and 
modify their cellular membrane FA composition, resulting in an altered milk FA profile. 
The objectives in chapter 7 were to i) identify and quantify the rumen bacteria and protozoa 
when cows graze pearl millet in comparison to a cool-season pasture, ii) determine the 
microbial membrane FA, and iii) correlate the microbial genera with cellular FA 
composition and FA in milk.  
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2.1. Abstract 
Dairy products contain bioactive fatty acids (FA) and are a unique dietary source 
of an emerging class of bioactive FA, branched-chain fatty acids (BCFA). The objective 
of this study was to compare the content and profile of bioactive FA in milk, with emphasis 
on BCFA, among Holstein (HO), Jersey (JE), and first generation HO x JE crossbreeds 
(CB) across a lactation to better understand the impact of these factors on FA of interest to 
human health. Twenty-two primiparous cows (n=7 HO, n=7 CB, n=8 JE) were followed 
across a lactation. All cows were fed a consistent total mixed ration (TMR) at a 70:30 
forage to concentrate ratio. Time points were defined as 5 days in milk (DIM), 95 DIM, 
185 DIM, and 275 DIM. HO and CB had a higher content of n-3 FA at 5 DIM than JE and 
a lower n-6:n-3 ratio. Time point had an effect on the n-6:n-3 ratio, with the lowest value 
observed at 5 DIM and the highest at 185 DIM. The content of vaccenic acid was highest 
at 5 DIM, yet rumenic acid was unaffected by time point or breed. Total odd and BCFA 
(OBCFA) were higher in JE than HO and CB at 185 and 275 DIM. Breed affected the 
content of individual BCFA. The content of iso-14:0 and iso-16:0 in milk was higher in JE 
than HO and CB from 95 to 275 DIM. Total OBCFA were affected by time point, with the 
highest content in milk at 275 DIM. In conclusion, HO and CB exhibited a higher content 
of several bioactive FA in milk than JE. Across a lactation the greatest content of bioactive 
FA in milk occurred at 5 DIM and OBCFA were highest at 275 DIM. 
2.2. Introduction 
There is growing awareness of the physiological and metabolic health properties 
of bioactive fatty acids (FA) derived from milk and dairy products. Bioactive FA in dairy 
products, such as α-linolenic acid (ALA; 18:3 c9,c12,c15), conjugated linoleic acids 
30 
 
(CLA), and vaccenic acid (VA; 18:1 t11), are typically present in low percentages in milk 
(<5%), but exert a significant biological impact on human health [1]. CLA have been 
shown to have anti-carcinogenic effects [2], and research suggests VA can reduce tumor 
growth and the risk of cardiovascular diseases (CVD) [3], while ALA has demonstrated 
protective effects against inflammation [4], neurological disorders [5], and CVD [6]. This 
is supported by several observational studies and diet-intervention trials that associated 
milk consumption with a lower risk for CVD and type 2 diabetes [6–10]. Much of the 
research over the past decades has focused on maximizing these specific bioactive FA in 
milk, however, other unique bioactive lipids and FA have rarely been considered. For 
example, branched-chain FA (BCFA) are an emerging class of bioactive FA that exert 
cytotoxic effects on breast cancer cells [11], reduce the incidence of necrotizing 
enterocolitis in newborns [12], have anti-tumor effects on lymphomas [13], and improve 
pancreatic β-cell function [14]. Because BCFA originate from the cell membranes of rumen 
bacteria, dairy and meat products from ruminants are a unique source of these FA. This 
allows for BCFA to be used as biomarkers of dairy intake in humans and also as biomarkers 
of rumen function in cattle [15]. 
The content and composition of bioactive FA in milk fat is not constant, but varies 
markedly [16]. Composition of bioactive FA can be modified through several factors, such 
as animal genetics, environment, lactation stage, and diet [17]. Moreover, the content and 
profile of BCFA in milk fat varies depending on the activity and composition of the 
microbial populations (i.e., bacteria and protozoa) in the rumen, which are highly 
responsive to factors like diet [15,18] and host genetics (i.e., breed) [19]. Craninix et al. 
[20] examined the effect of lactation stage on milk odd and BCFA (OBCFA) in twenty 
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primiparous and multiparous Holstein (HO) dairy cows throughout the first forty weeks of 
lactation. They determined that the content of iso-14:0, anteiso-15:0, and 15:0 increased 
with lactation stage, whereas 17:0 decreased from early to late-lactation. The composition 
of the diet was not consistent (e.g., adjustment of concentrate) and thus, caution must be 
taken when interpreting these results. 
HO and Jersey (JE) dairy cattle are the two most prominent breeds in the U.S. 
[21].  HO cows are known for their high milk production, while JE cows are known for 
having a high fat and protein content in their milk [22]. Many dairy producers cross these 
two breeds to maintain elevated milk components and high milk production. Research 
shows that HO exhibit a greater content of CLA in milk fat when compared to other breeds, 
such as JE and Brown Swiss dairy cattle [23, 24]. Palladino et al. [25] examined the FA 
profile of milk in HO and JE on a pasture-based diet and showed HO to have a lower 
content of saturated FA (SFA). 
To the authors’ knowledge, no studies have quantified the effect of breed on the 
content and composition of BCFA in milk fat. The objectives of this study were to compare 
milk bioactive FA (with emphasis on BCFA), milk production, and milk components at 
four time points (5, 95, 185, and 275 DIM) between primiparous HO, JE, and first 
generation HO x JE crossbreeds (CB) fed the same diet across the lactation. 
 
2.3. Materials and Methods 
2.3.1 Experimental Design 
All procedures using animals were approved by the University of Vermont 
(UVM) Institutional Animal Care and Use Committee under protocol # 14-034. Twenty-
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two primiparous cows of three breeds, HO (n=7), JE (n=8), and first generation CB (n=7) 
were followed across a lactation. All cows calved within a two-month period and were co-
housed at the UVM Paul Miller Research Facility from May of 2013 to May of 2014. Prior 
to calving, cows were fed a pre-partum total mixed ration (TMR; 70:30 forage to 
concentrate ratio; Table 2.1.). Within 24 hours post-partum, cows were switched to a TMR 
formulated for lactating cows (70:30 forage to concentrate ratio; Table 2.1.). Cows were 
fed twice daily, at 0600h and 1500h, for ad libitum intake (5-10% refusals) and had 
continuous access to water. Milking occurred twice daily at 0600h and 1700h and milk 
weights were recorded at each milking. 
2.3.2 Data and Sample Collection 
At the first time point, milk weights and samples were taken from 2 to 7 DIM 
(defined as time point 5 DIM) and composited by weight for each individual day. Cows 
were not sampled until colostrum excretion ceased. Every 90 days (after 5 DIM) samples 
were taken on days -2 to 2 relative to the sample time point and the five days of milk 
samples were composited by weight; these time points were denoted as 95, 185, and 275 
DIM. An aliquot of each milk sample was preserved in 2-bromo-2-nitropropane-1,3-diol 
(Bronopol) and analyzed by mid-infrared spectroscopy for fat, crude protein, and organic 
solids by Lancaster Dairy Herd Improvement Association (Manheim, PA). A second 
aliquot was centrifuged at 3,434 x g for 30 minutes at 8°C and the cream layer was collected 
and stored at -20°C for FA analysis. Feed samples were taken three times per week, 
composited per time point, dried in a forced air oven at 65°C for 48 hours, and analyzed 
by Cumberland Valley Analytical Services (Hagerstown, MD) for chemical composition. 
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2.3.3 Milk and Forage FA Analysis 
FA composition of feed and milk samples was determined as described by 
Bainbridge et al. [26]. The content (g/kg) of individual FA in milk was calculated as 
follows, assuming milk fat to be 93.3% of FA [27]: 
Total milk FA yield (g/d) = [Milk fat yield (kg/d) x 1000] x 0.933 
FA yield (g/d) = Total milk FA yield (g/d) x [FA proportion (g/100g)/ 100] 
Content of FA (g/kg milk) = FA yield (g/d)/ Milk yield (kg/d) 
The content (mg) of individual FA in a serving of whole milk (3.25% milk fat; 
244g [28]) was calculated as follows: 
Total FA per serving (mg) = 7.93g fat/serving x 0.933 x 1000 
FA per serving (mg) = Total FA per serving (mg) x [FA proportion (g/100g) / 100] 
2.3.4 Statistical Analysis 
Data were analyzed by repeated measures ANOVA using the PROC MIXED 
procedure in SAS 9.4 (SAS Institute, Cary, NC). Data were not obtained from one Jersey 
cow at 5 DIM due to illness, thus, data for that time point were considered missing in the 
model. The statistical model included the random effect of cow, fixed effect of breed, fixed 
effect of time point, the interaction of breed and time point, and residual error. The 
Kenward-Roger approximation was used for computing the denominator degrees of 
freedom for the tests of fixed effects resulting from the model. Least-squares (LS) means 
were generated using the LSMEANS/DIFF option to display the results. Data were 
adjusted for multiple comparisons using Bonferroni’s method. Significance was declared 
at P<0.05 and trends at 0.05≤P<0.10. P-values listed in the text refer to the main effects of 
either breed or lactation stage. Standard errors (SE) presented are averaged over all LS 
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means. The small sample size in this study may have led to insufficient data to detect minor 
effects. 
2.4. Results 
2.4.1. Animal Parameters 
Overall, cows produced the most milk at 95 DIM (26.0 kg/d) and the least at 5 
and 275 DIM (19.9 and 20.0 kg/d, respectively; P<0.001). Crude protein and organic solids 
yield was highest at 95 and 185 DIM (0.87 and 0.83 kg protein/d; 1.52 and 1.31 kg organic 
solids/d, respectively; P<0.001). Fat production differed in response to lactation stage, with 
cows producing less fat at 5 DIM than at all other time points (0.78, 1.15, 1.07, and 0.98 
kg/d for 5, 95, 185, and 275 DIM, respectively; P<0.001). The significant interaction 
between breed and stage of lactation for milk fat and crude protein percentage (P<0.001) 
prohibits the comparison of main effects, but individual breeds across the lactation were 
considered. HO milk fat percentage did not vary across the lactation. In contrast, fat 
percentage in CB was higher at 275 DIM than at 5 DIM (Table 2.2.) and the percentage of 
milk fat in JE increased at each time point until 185 DIM. HO had a higher percentage of 
milk crude protein at 5 DIM when compared to the subsequent time points. Milk crude 
protein percentage was highest in CB at 5 DIM and at 275 DIM and lowest at 95 DIM. In 
JE, milk crude protein percentage was highest at 185 and 275 DIM and lowest at 95 DIM. 
Milk yield, 3.5% fat-corrected milk (FCM), and energy-corrected milk (ECM) 
differed by breed (Table 2.2.); HO cows exhibited the highest milk yield across the 
lactation (25.9 kg/d), followed by CB (22.0 kg/d), and then JE (18.7 kg/d; P<0.001). FCM 
and ECM were higher in HO than JE and CB. Crude protein production differed between 
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breeds; protein yield was overall highest in HO (0.90 vs. 0.73 and 0.77 kg/d for HO, JE, 
and CB, respectively; P=0.01). 
2.4.2. Milk FA Composition 
 
The complete FA profile of milk, in g/100g FA, is presented in Table A.1. The 
milk FA profile was affected by lactation stage, with only two of the forty reported FA 
being unaffected by lactation stage (Tables 2.3. and 2.4.). De novo synthesized FA (<16 
carbon atoms) were lowest at 5 DIM then increased at each subsequent time point (7.61, 
11.36, 12.60, and 13.32 g/kg milk for 5, 95, 185, and 275 DIM, respectively; P<0.001; 
Table 2.3.). Conversely, preformed FA (>16 carbon atoms) were higher at 5 DIM (18.40 
g/kg milk) when compared to the rest of lactation (14.43, 14.35, and 14.87 g/kg milk for 
95, 185, and 275 DIM, respectively; P<0.001). Stage of lactation affected SFA; cows had 
the lowest content of SFA at 5 DIM, increasing at each subsequent time point (22.70, 29.62, 
31.99, and 34.17 g/kg milk for 5, 95, 185, and 275 DIM, respectively; P<0.001). 
Total OBCFA, BCFA, iso-14:0, 15:0, iso-15:0, anteiso-15:0, iso-16:0, 17:0, and 
iso-17:0 differed across the lactation, however, the significant interaction between breed 
and time point prohibits the examination of main effects (Table 2.4.). The content of 
OBCFA and BCFA in milk fat from JE increased at each time point. CB had the highest 
content of OBCFA and BCFA in milk fat at 275 DIM. The content of OBCFA in HO did 
not differ across the lactation, although BCFA were lower at 95 DIM when compared to 
all other time points. The content of iso-14:0 in JE milk increased at each time point from 
5 to 275 DIM. HO had the lowest content of iso-14:0 at 5 and 95 DIM and the highest 
content at 275 DIM. CB also had the lowest content of iso-14:0 at 5 DIM and highest at 
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275 DIM. HO and CB had a lower content of 15:0 in milk at 5 DIM when compared to the 
subsequent time points. Similarly, JE had the lowest content of 15:0 at 5 DIM and the 
highest at 185 and 275 DIM. The content of iso-15:0 in HO and CB was highest at 275 
DIM. In JE, the content of iso-15:0 increased at each time point from 5 DIM. HO and CB 
had the lowest content of anteiso-15:0 at 5 DIM and highest at 275 DIM. Comparably, the 
content of anteiso-15:0 in JE was lowest at 5 DIM and increased at each subsequent time 
point. The content of iso-16:0 was highest in all breeds at 275 DIM. In JE, iso-16:0 
increased at each time point, while HO had the lowest content of iso-16:0 at 95 DIM. 
Across the lactation, the content of 17:0 in milk from CB did not vary. HO had a higher 
content of 17:0 at 5 DIM, whereas JE had a lower content of 17:0 at 5 DIM when compared 
to 185 and 275 DIM. In JE cows the content of iso-17:0 was highest at 275 DIM, while in 
HO the content of iso-17:0 was highest at 5 DIM. Similar to HO, the content of iso-17:0 in 
milk of CB was higher at 5 DIM than at 95 and 185 DIM. In all breeds, the proportion of 
anteiso-17:0 was highest at 5 DIM and lowest at 95 and 275 DIM (0.15, 0.04, 0.06, and 
0.04 g/kg milk for 5, 95, 185, and 275 DIM, respectively; P<0.001). 
As a result of the significant interaction between breed and time point, total 18:1 
t, VA, n-3 FA, n-6:n-3 ratio, ALA, and eicosapentaenoic acid (20:5 c5,c8,c11,c14,c17; 
EPA) will be compared across a lactation by individual breed (Table 2.3.). The content of 
total 18:1 t, VA, and n-3 FA in milk fat from JE did not vary across the lactation. Contrary, 
HO and CB had a higher content of total 18:1t, VA, and n-3 FA at 5 DIM when compared 
to the subsequent time points. ALA was the main driver of the increased n-3 FA, with HO 
and CB having a higher content of ALA at 5 DIM than all other time points, while the 
content of ALA in milk fat of JE did not differ across the lactation. EPA followed the same 
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pattern, with HO and CB having a higher content of EPA in milk at 5 DIM and JE showing 
no change across the lactation. The n-6:n-3 ratio of JE milk did not differ across the 
lactation. Milk fat from HO and CB had a lower n-6:n-3 ratio at 5 DIM than the remainder 
of lactation. In all breeds, docosapentaenoic acid (22:5 c7,c10,c13,c16,c19) was higher at 
5 DIM when compared to later time points (0.06, 0.03, 0.03, and 0.02 g/kg milk for 5, 95, 
185 and 275 DIM, respectively; P<0.001). Docosahexaenoic acid (22:6 
c4,c7,c10,c13,c16,c19) was only present in contents greater than 0.01 g/kg milk at 5 DIM. 
Total PUFA, n-6 FA, and total CLA were unaffected by lactation stage. 
Across the lactation there were marked differences in the milk FA profile between 
breeds (Table 2.3. and 2.4.). The significant interaction between breed and lactation stage 
for de novo FA and SFA is due to the effect of breed being non-significant at 5 DIM, 
although, from 95 to 275 DIM, production of de novo FA was higher in JE than HO and 
CB (15.12 vs. 10.70 and 11.46 g/kg milk, respectively; P<0.001). Similarly, the proportion 
SFA was greater in JE than HO and CB from 95 to 275 DIM (38.61 vs. 27.87 and 29.31 
g/kg milk, respectively; P<0.001). 
JE had a higher content of total OBCFA in milk fat at 185 and 275 DIM than HO 
and CB (Table 2.4.). At 275 DIM JE also had a higher content of total BCFA. The contents 
of iso-14:0 and iso-16:0 were higher in JE at 95 and 275 DIM. At 185 and 275 DIM 15:0, 
iso-15:0, and anteiso-15:0 were higher in JE than in CB and HO. Content of 17:0 in milk 
was higher in HO than in JE and CB at 5 DIM, yet by 275 DIM the content of 17:0 was 
highest in JE. Similarly, the content of iso-17:0 at 5 DIM was higher in HO than JE, while 
at 275 DIM the content of iso-17:0 was higher in JE than HO. MUFA, PUFA, CLA, total 
iso FA, total anteiso FA, anteiso-17:0, and 18:1 t were unaffected by breed. At 5 DIM, HO 
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and CB had a higher content of n-3 FA than JE (Table 2.3.). Overall, milk from JE had a 
greater content of n-6 FA than HO and CB (0.81 vs. 0.70 and 0.70 g/kg milk, respectively; 
P<0.05) resulting in higher n-6:n-3 ratio when compared to HO and CB at 5 DIM. 
2.5. Discussion 
The main objective of this study was to compare bioactive milk FA, with 
emphasis on BCFA, between HO, JE, and CB fed the same diet across a lactation. The 
three breeds were chosen because of their high prevalence on U.S. dairy farms and 
primiparous cows were used to eliminate the effect of parity on FA content in milk. Diet is 
acknowledged as a major factor affecting the FA profile of milk fat [16]. The diet of the 
dairy cattle changed at parturition from a TMR formulated for pre-partum cows to a TMR 
formulated for lactating cows to meet the energy and nutrient demands of the animal, which 
is typical practice on dairy farms. The data at the 5 DIM time point are a reflection of the 
transition between the two diets, and thus, changes between this time point and other time 
points in lactation may reflect both the effect of diet and the effect of lactation stage. The 
FA contents were reported in g/kg milk to show the impact of breed and lactation (i.e., 
production). These units also eliminate the difficulty in determining whether a change in 
the proportion (g/100g FA) of a FA occurred because of an actual change in the amount of 
that FA, or a change in the total amount of FA [29]. Results discussed from other studies 
were converted to g/kg milk for comparison when data were available, if data were 
unavailable (data presented in figures only, or production data not presented) then results 
were compared in g/100g FA. The authors would also like to note that the small sample 
size in this study may have resulted in insufficient power, thus some non-significant results 
may reach significance in a study with more observations. 
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2.5.1. Animal Production Parameters 
As expected, HO cows produced more 3.5% FCM and ECM than JE and CB, 
agreeing with research conducted at the herd level [30], and in both pasture and TMR 
systems [23]. The observation of higher milk fat and crude protein concentrations from 95 
to 275 DIM in JE than HO and CB is consistent with previous research between HO and 
JE [23.31], while Palladino et al. [25] found CB to have an intermediate concentration of 
milk fat and crude protein that was different from both HO and JE. In addition, no 
difference between the fat yield of HO and JE was observed by Palladino et al. [25], 
however, they found fat yield to be higher in CB than JE, while no difference was observed 
in the current study. 
2.5.2 Milk OBCFA 
The predominant OBCFA detected in milk fat in this study were 15:0, 17:0, 
anteiso-15:0, iso-17:0, iso-16:0, iso-15:0, anteiso-17:0, and iso-14:0, which is in agreement 
with other research [18,32]. Ruminant products are a unique source of OBCFA in the 
human diet, as OBCFA are synthesized by rumen bacteria and protozoa [33]. Small 
amounts of 15:0 and 17:0 can also be synthesized de novo from propionate in the mammary 
gland and adipose tissue of ruminants [18,34]. In addition, research suggests some capacity 
for the mammary gland to elongate iso-15:0 and anteiso-15:0 to iso-17:0 and anteiso-17:0, 
respectively [35]. Hence, levels of 15:0 and 17:0 have been used as markers for dairy and 
ruminant fat intake in humans and to identify correlations between intake of ruminant 
products [36] and risk for disease, such as metabolic syndrome [37,38]. Palladino et al. 
[25] examined mid-lactation HO, JE, and CB, demonstrating the content of 15:0 to be 
higher in JE than HO and CB (0.56 vs. 0.45 and 0.52 g/kg milk) and no difference among 
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breeds in the content of 17:0, agreeing with our findings during the mid-lactation time 
points (95 and 185 DIM). Craninx et al. [20] followed HO dairy cows over 40 weeks of 
lactation and observed the lowest proportion (g/100g FA) of 15:0 in milk during early-
lactation, matching our observations in HO cows at 5 DIM. They also noted a higher 
proportion (g/100g FA) of 17:0 in milk fat of early-lactation cattle and attributed this to a 
higher content of 17:0 in adipose tissue [20]. Thus, mobilization of non-esterified FA from 
adipose tissue in early-lactation would increase the supply of this FA to the mammary 
gland. The FA profile of adipose tissue was not determined in the present study, although, 
plasma non-esterified FA (data not shown) and 17:0 in milk were higher at 5 DIM than all 
other time points. In the current study, the content of 17:0 was higher in a serving of whole 
milk from cows at 5 DIM when compared to all subsequent time points (Figure 2.1.), while 
the content of 15:0 in a serving of whole milk was lowest at 5 DIM (57 vs. 98, 95, and 93 
mg/serving; P<0.001). These results need to be taken into consideration when using these 
FA as biomarkers for ruminant product consumption in humans. 
BCFA may function to lower the melting point of butter, creating a more desirable 
product as these FA generally function to maintain the fluidity of bacterial cell membranes 
[39], and anteiso BCFA in particular, have a low melting point relative to chain length 
[18,40]. BCFA have been proposed as a potential biomarker for rumen function [35,41]. 
Vlaeminck et al. [42] developed regression equations showing milk iso-14:0 and iso-15:0 
to be positively related to rumen concentrations of acetate. The total BCFA content (g/kg 
milk and g/100g FA) was affected by stage of lactation, which agrees with research done 
by Craninx et al. [20]. The shift in the BCFA across the lactation, however, does not match 
the pattern of the present study. Craninx et al. [20] observed an increase in BCFA (g/100g 
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FA) until week 12 of lactation (approx. 84 DIM) when the content plateaued. The present 
study demonstrated a higher proportion of BCFA (g/100g; Table A.1.) at 5 DIM and at 
275 DIM, with a lower proportion at 95 and 185 DIM. Discrepancies could be a result of 
the experimental design, such as the inclusion of multiparous cows, basal diet composition, 
or the adjustment of concentrate fed across the lactation according to the animal’s 
requirements by Craninx et al. [20]. 
Research demonstrates that BCFA possess anticarcinogenic properties [11,43]. 
Wongtangtintharn et al. [11] observed anti-tumor activity with iso-16:0, and the content of 
this FA was highest in a serving of whole milk from cows at 275 DIM (27.0 mg/serving). 
The inhibitory effect of iso-15:0 on several malignant tumor cell lines was tested by Yang 
et al. [43]. The results showed that iso-15:0 could inhibit tumor growth at a dosage of 35 
mg/kg body weight in mice. A serving of whole milk in this study provided 16 mg of iso-
15:0, thus, more research needs to be done to show if the average content of iso-15:0 in 
milk fat exhibits bioactivity in humans. Additionally, when examining the total content of 
BCFA known to have anticarcinogenic properties, the contribution of milk fat to the 
bioactive dose is more significant. The content of iso-15:0 in a single serving of whole milk 
was unaffected by breed, but was higher in a serving of whole milk from cows at 275 DIM 
when compared to the other time points (Figure 2.1.). This is consistent with research done 
by Baumann et al. [44] who examined the OBCFA composition (mg/g) of milk fat from 
seven HO cows across five time points in lactation and found iso-15:0 to be highest from 
120 to 310 DIM. anteiso-15:0 has been shown to have similar toxicity in tumor cells to iso-
15:0 [11]. The content of this BCFA was overall higher per serving of whole milk from 
HO than from JE (32.7 vs. 28.8 mg/serving), and CB were not different from the other 
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breeds (31.5 mg/serving, P<0.05). Despite the statistical significance, a 4 mg difference in 
BCFA content per serving is negligible for human nutrition. Similarly to iso-15:0, content 
of anteiso-15:0 in a serving of whole milk was highest in milk from cows at 275 DIM (35.3 
mg/serving) and lowest in milk from cows at 5 DIM (24.3 mg/serving), agreeing with 
results from Baumann et al. [44]. Overall, a serving of whole milk from cows at 5 DIM 
provided the highest content of iso-17:0 (Figure 2.1.), comparable to results by Baumann 
et al. [44] who observed the highest content of iso-17:0 in milk from HO cows at 5-15 
DIM. HO consistently had a higher content of iso-17:0 per serving of whole milk than JE 
(Figure 2.1.). BCFA are a substantial component of the gastrointestinal tract of newborns 
[45], and have been shown to prevent necrotizing enterocolitis in a neonatal rat model [12]. 
A serving of whole milk contains on average 121 mg of BCFA, but only 42 mg of total n-
3 FA (Figures 2.1. and 2.2.). This content is lower, but similar, to that observed by Ran-
Ressler et al. [32] who examined the BCFA content of retail milk, approximating 158 mg 
BCFA/per serving of whole milk. 
2.5.3 Other Milk FA of Importance to Human Health 
Individual SFA can have varied effects on disease outcomes. Palmitic acid (16:0) 
has been correlated with decreased insulin sensitivity [46] whereas, stearic acid (18:0) may 
have a protective effect against cardiovascular disease [47], and very-long-chain SFA (>22 
carbon atoms) have been associated with a lower risk for diabetes[48]. Opposing effects 
on plasma lipids have been shown for myristic acid (14:0), depending on dietary intake, 
with a moderate intake leading to a higher plasma high-density lipoprotein level [49,50]. 
Thus, when considering the contributions of SFA in a food product to human health, not 
only the overall SFA content but also the composition of SFA needs to be considered. In 
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accordance with other research, the content of total SFA in milk fat was higher in JE 
compared with HO, which is often associated with a greater de novo synthesis of FA in JE 
[51,52]. Myristic acid and palmitic acid were lowest at 5 DIM, then increased at each 
subsequent time point. Nantapo et al. [53] observed HO, JE, and CB in a pasture system at 
three stages of lactation, and also found myristic acid to be highest at late-lactation (291 
DIM). However, unlike in the current study, they observed the lowest content of myristic 
acid at 135 and 174 DIM, not at 5 DIM. Palladino et al. [25] examined milk FA of mid-
lactation (approx. 120 DIM) HO, JE, and CB on a pasture-based diet during June and July, 
demonstrating palmitic acid to be higher in JE and CB than HO (12.1 and 10.6 vs. 8.4 g/kg 
milk). Our research also showed the content of palmitic acid to be highest in JE, although 
it was lower in CB than JE, and more consistent with the content of palmitic acid in milk 
from HO. Overall, stearic acid was highest at 5 DIM. These results are similar to Kay et 
al. [54] who examined the milk FA profile of HO cows at 1, 8, and 16 weeks of lactation 
and observed a higher proportion of stearic acid during the first week of lactation when 
compared to week 16 (approximately 112 DIM). Stearic acid comprises 12-18% of total 
FA in adipose tissue of ruminants [55,56]. The mobilization of FA during early lactation 
to meet the energy demands of the animal [57] may have led to the observed higher content 
of this FA in milk at 5 DIM. 
VA is the precursor to rumenic acid (RA; 18:2 c9,t11), the predominant CLA 
isomer in milk fat. VA reduces the risk for atherosclerosis [58], as well as contributes to 
the levels of RA in tissues by conversion via Δ-9 desaturase [59]. VA was highest in a 
serving of whole milk from cows at 5 DIM (Figure 2.2.). Breed did not affect the content 
of VA, which agrees with data published by Pallidino et al. [25]. Notably, although 
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differences were observed in the content of VA across the lactation, RA was not affected 
by lactation stage. Neither Pallidino et al. [25] nor Nantapo et al. [53] observed breed 
differences when comparing RA between HO, JE, and CB, agreeing with results presented 
in the current study. Yet, the content of RA in a serving of whole milk was affected by 
breed (Figure 2.2.), with milk from HO providing approximately 10 mg more RA per 
serving than milk from JE. This demonstrates the importance in comparing results in 
equivalent units. Kelsey et al. [24] has also shown the proportion (g/100g FA) of CLA in 
milk fat to be higher in HO than JE. This could be due to lower Δ-9 desaturase activity in 
JE vs. HO cattle [60]. Both the 18:0 [18:1 c9/(18:0 + 18:1 c9)] and 18:1 t11 [18:2 c9,t11 
/(18:1 t11 + 18:2 c9,t11)] Δ-9-desaturase indices were lower in JE than HO and CB, 
agreeing with research by Pallidino et al. [25] who observed lower desaturase indices in 
JE than HO dairy cattle. 
Content of total n-3 FA and ALA in a single serving of whole milk was lower in 
JE than HO and CB at 5 DIM (Figure 2.2.). At all other time points, the content of total n-
3 FA and ALA in a serving of whole milk was not different between breeds. At 5 DIM, the 
content of n-3 FA in a serving of whole milk was highest for HO and CB breeds when 
compared to the subsequent time points. ALA content (g/kg milk) in milk decreased from 
5 to 275 DIM, agreeing with results presented by Nantapo et al. [53]. The breed difference 
in the content (g/kg milk) of ALA at 5 DIM, however, was not observed by Nantapo et al. 
[53]. This may be due to the difference in sampling days (5 DIM in this study vs. 28 DIM 
[53]). The current recommendation of adequate intake of n-3 FA by the Institute of 
Medicine of the National Academies is 1.6 g/day for men and 1.1 g/day for women, or 0.6–
1.2% of energy intake, with up to 10% of this value from EPA and DHA [61]. In the current 
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study a serving of whole milk provides an average of 41.6 mg of n-3 FA and 130.5 mg n-
6 FA. These values are consistent with the content of n-3 (40.7 mg) and n-6 (153.1 mg) FA 
in retail milk of conventional farms in northeast England [62]. Moreover, dairy 
cooperatives are moving towards paying farmers based on the content of bioactive FA in 
their milk (personal communication), thus, these data could be used by farmers to improve 
their profitability and the healthfulness of their product. The n-6:n-3 ratio was lower in HO 
and CB than JE at 5 DIM. Overall, this ratio was lowest in milk at 5 DIM, and highest in 
milk fat at 185 DIM, the ratio in milk fat was consistently at or below 4:1, which is 
considered to be the upper limit of the optimal ratio (1:1 to 4:1) [63]. 
2.6. Conclusion 
U.S. American nutrition guidelines state that most dairy product choices should 
be fat-free or reduced-fat, based on the potentially detrimental health effects of SFA [64]. 
Nonetheless, there is no conclusive evidence that whole milk consumption is harmful to 
human health [7]. The reduced intake of milk fat in response to these guidelines may result 
in consumers lacking in various bioactive FA provided by whole-fat dairy products. The 
profile and content of bioactive FA in milk varies with stage of lactation and breed. A 
serving of whole milk from HO cows has a higher content of RA, anteiso-15:0, iso-17:0, 
and n-3 FA (at 5 DIM) than milk from JE cows. Overall, milk from cows at 5 DIM had a 
higher content of n-3 FA, VA, CLA, iso-17:0, and 17:0. This research suggests that HO 
cows have a more desirable FA profile from a human health standpoint on a per serving 
basis, although the numeric difference in total bioactive FA (n-3, VA, CLA, and OBCFA) 
is modest (281 vs. 253 mg per serving for HO and JE cows, respectively). Regardless of 
breed, stage of lactation was the predominant factor affecting bioactive FA, with milk from 
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cows at 5 DIM containing a higher amount of bioactive FA than cows at 275 DIM on a per 
serving basis (340 vs. 240 and 253 mg/serving for 5, 185, and 275 DIM, respectively). 
Additional research is needed to elucidate the mechanism of the shifts in the milk OBCFA 
to in order to develop dairy products with an enhanced profile. 
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2.10. Figures 
 
 
Figure 2.1. Content of total branched-chain fatty acids (BCFA) [A], iso-15:0 [B], iso-17:0 [C], 
and 17:0 [D] per serving of whole milk (3.25% milk fat). 
Means are presented as least-squares (LS) means (n = 7 Holstein (HO), n = 8 Jersey (JE), and n = 
7 HO x JE crossbreeds (CB)) and standard error. LS means without a common letter differ 
significantly (P<0.05). DIM = Days in milk.   
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Figure 2.2. Content of n-3 FA [A], n-6 FA [B], vaccenic acid (VA) [C], and rumenic acid (RA) 
[D] per serving of whole milk (3.25% milk fat).  
Means are presented as least-squares (LS) means (n = 7 Holstein (HO), n = 8 Jersey (JE), and n = 
7 HO x JE crossbreeds (CB)) and standard error. LS means without a common letter differ 
significantly (P<0.05). DIM = Days in milk.  
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2.11. Tables 
Table 2.1.: Ingredient and chemical composition (mean ± 
standard deviation) of the pre-partum and post-partum diets.  
 
Diet 
Pre-partum Post-partum 
    %DM 36.8 ± 1.2 40.8 ± 1.1 
Ingredient, TMR, % DM   
    Corn silage 51.2 52.3 
    Haylage 8.3 15.9 
    Hay 13.3  
    Concentratea 27.2 31.8 
Chemical composition, % DM   
    aNDFomb 35.0 ± 2.1 27.8 ± 1.1 
    CP (N x 6.25)c 14.1 ± 0.3 15.2 ± 0.7 
    NFCd 31.9 ± 4.8 39.7 ± 2.2 
    NEL
e Mcal/kg 1.44 ± 0.04 1.56 ± 0.02 
Total fatty acids, % DM 1.97 ± 0.22 2.35 ± 0.07 
Fatty acid compsition (mg/g DM)   
16:0 4.18 ± 0.50 3.94 ± 0.21 
18:0 0.62 ± 0.05 0.58 ± 0.04 
18:1 c9 4.16 ± 0.81 4.99 ± 0.25 
18:2 c9,c12 7.08 ± 1.22 9.64 ± 0.22 
18:3 c9,c12,c15 2.07 ± 0.25 2.70 ± 0.28 
Ʃ otherf 1.62 ± 0.05 1.67 ± 0.05 
Total SFAg 5.65 ± 0.53 5.25 ± 0.29 
Total MUFAh 4.89 ± 0.92 5.87 ± 0.28 
Total PUFAi 9.19 ± 1.04 12.40 ± 0.32 
Total n-3 FA 2.07 ± 0.25 2.70 ± 0.28 
Total n-6 FA 7.12 ± 1.21 9.70 ± 0.22 
aThe concentrate of the pre-partum diet contained (on DM basis): 16.1% 
ground soybean hulls, 16.9% Pasturechlor, 12.5% Soychlor, 15.7% 
canola meal, 18.8% amino max, 12.5% soybean meal, 4.4% calcium 
carbonate, 1.3% magnesium sulfate, 0.5% magnesium oxide, 0.5% 
sodium chloride, 0.7% trace minerals and vitamins, and 0.1% rumensin®. 
The concentrate of the post-partum diet contained (on DM basis): 16.4% 
soybean meal, 10.9% canola meal, 24.6% corn grain, 19.1% citrus pulp, 
16.4% amino max, 5.5% PGI amino enhancer, 2.2% sodium sesquinate, 
2.5% calcium carbonate, 1.2% sodium chloride, 0.43% trace minerals and 
vitamins, 0.05% zinc methionine, 0.65% magnesium oxide, 0.02% 
rumensin®. baNDFom = Ash-corrected neutral detergent fiber.  cCP = 
Crude protein. dNFC = Non-fiber carbohydrate = 100 - (NDF + CP + ether 
extract + ash). eNEL: Net energy lactation. fƩ other: 12:0; 14:0; 15:0; 16:1 
t9; 16:1 c9; 17:0; 18:1 t9; 18:1 c11; 20:0; 18:3 c6,c9,c12; 20:1 c8; 21:0; 
20:2 c11,c14; 22:0; 22:1 c13; 20:4 c5,c8,c11,c14; 23:0; 24:0; 24:1 c15. 
gSFA = Saturated fatty acids. hMUFA = Monounsaturated fatty acids. 
iPUFA = Polyunsaturated fatty acids. 
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Table 2.2. Milk yield and components of three breeds of dairy cowa over four time points; 5 days in milk (DIM), 95 DIM, 185 DIM, 275 
DIM. 
 
Time Point 
SE 
P value 
5 DIM  95 DIM  185 DIM  275 DIM 
Bd Te BxTf HO JE CB  HO JE CB  HO JE CB  HO JE CB 
Milk yield 
(kg/day) 
22.81 17.31 19.49  30.07 21.77 26.24  27.27 19.16 22.19  23.28 16.38 20.22 1.30 *** *** NS 
3.5% FCMb 25.57 17.93 20.27  32.95 27.13 29.67  30.92 25.93 24.63  26.69 23.04 24.02 1.71 * *** NS 
ECMc 26.05 18.66 20.84  32.48 26.62 28.98  30.54 25.79 24.53  26.35 22.75 23.95 1.62 * *** NS 
Milk components 
(kg/day) 
                    
    Fat 0.97 0.65 0.73  1.23 1.09 1.13  1.18 1.09 0.93  1.03 0.98 0.94 0.07 NS *** NS 
    Crude protein 0.88 0.67 0.73  0.98 0.78 0.84  0.93 0.79 0.77  0.80 0.68 0.75 0.05 * *** NS 
    Organic solids 1.27 0.94 1.09  1.77 1.25 1.56  1.56 1.07 1.29  1.33 0.91 1.16 0.07 *** *** NS 
Milk components 
(%)  
                   
    Fat 4.24 3.79 3.82  4.07 4.96 4.29  4.30 5.66 4.21  4.40 5.97 4.69 0.22 ** *** *** 
    Crude protein 3.86 3.88 3.72  3.26 3.56 3.21  3.41 4.14 3.47  3.43 4.15 3.72 0.08 *** *** *** 
    Organic solids  5.55 5.42 5.60  5.87 5.73 5.93  5.71 5.60 5.80  5.72 5.57 5.71 0.05 ** *** NS 
aLeast-squares (LS) means are based on n = 7 Holstein (HO), n = 8 Jersey (JE), and n = 7 HO x JE crossbreeds (CB). b3.5% Fat-corrected milk = [0.4324 x 
milk yield (kg/d)] + [16.216 x fat yield (kg/d)]. cEnergy-corrected milk = [12.82 x fat yield (kg/d)] + [7.13 x protein yield (kg/d)] + [0.323 x milk yield 
(kg/d)]. dBreed effect. eTime point effect. fBreed x time point interaction. *P<0.05; **P<0.01; ***P<0.001, NS = Not significant
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Table 2.3. Contenta (g/kg milk) of major fatty acids in milk from three breeds of dairy cow over four time points; 5 days in milk (DIM), 95 
DIM, 185 DIM, 275 DIM. 
 Time Point  P Values 
  5 DIM  95 DIM 185 DIM 275 DIM SE  
Fatty acid HO JE CB HO JE CB HO JE CB HO JE CB  Bg Th B x Ti 
4:0 1.95 1.86 1.67 1.11 1.50 1.24 1.19 1.62 1.18 1.22 1.70 1.27 0.08 *** *** * 
6:0 0.77 0.70 0.69 0.70 1.04 0.81 0.79 1.14 0.80 0.79 1.17 0.85 0.05 *** *** *** 
8:0 0.32 0.30 0.31 0.41 0.63 0.48 0.48 0.71 0.48 0.47 0.72 0.52 0.03 *** *** *** 
10:0 0.58 0.54 0.57 0.97 1.57 1.16 1.15 1.75 1.19 1.15 1.77 1.29 0.08 *** *** *** 
12:0 0.61 0.54 0.62 1.18 1.92 1.42 1.45 2.22 1.50 1.48 2.26 1.66 0.10 *** *** *** 
14:0  3.45 2.96 2.99 4.19 5.70 4.65 4.85 6.54 4.80 5.09 6.97 5.50 0.25 *** *** *** 
14:1 c9 0.14 0.09 0.12 0.30 0.34 0.35 0.39 0.51 0.42 0.42 0.52 0.49 0.03 NS *** ** 
16:0 10.41 8.90 9.51 12.57 16.32 13.76 14.00 19.09 13.81 14.52 20.42 15.75 0.85 ** *** *** 
16:1 c9 0.64 0.45 0.56 0.61 0.58 0.63 0.61 0.83 0.66 0.68 0.89 0.80 0.07 NS *** ** 
18:0 5.12 5.58 4.82 3.59 4.73 3.58 3.39 4.70 3.26 3.40 5.08 3.47 0.27 *** *** NS 
18:1 t9 0.06 0.05 0.05 0.08 0.09 0.08 0.07 0.09 0.07 0.06 0.08 0.07 0.00 ** *** ƚ 
18:1 t10 0.19 0.15 0.16 0.12 0.12 0.12 0.10 0.13 0.10 0.09 0.11 0.09 0.02 NS *** NS 
18:1 t11 0.57 0.47 0.63 0.39 0.44 0.37 0.34 0.41 0.29 0.35 0.44 0.31 0.04 NS *** ** 
18:1 t12 0.10 0.08 0.09 0.13 0.14 0.12 0.11 0.14 0.11 0.10 0.13 0.10 0.01 * *** * 
18:1 t13/t14 3.90 3.86 3.32 0.16 0.24 0.18 0.16 0.23 0.16 0.17 0.22 0.15 0.28 NS *** NS 
18:1 c9 6.21 5.17 5.41 7.15 6.25 6.68 6.80 7.53 6.43 6.75 7.82 7.02 0.48 ** * NS 
18:2 c9,c12 0.59 0.65 0.58 0.60 0.64 0.60 0.61 0.72 0.59 0.56 0.71 0.61 0.05 * NS NS 
18:3 c9,c12,c15 0.21 0.14 0.27 0.15 0.15 0.16 0.15 0.17 0.14 0.17 0.19 0.16 0.02 NS ** * 
18:2 c9,t11 0.21 0.14 0.21 0.19 0.16 0.18 0.17 0.17 0.15 0.18 0.18 0.17 0.02 NS NS NS 
20:5 c5,c8,c11,c14,c17 0.03 0.02 0.04 0.01 0.01 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.00 ƚ *** *** 
22:5 c7,c10,c13,c16,c19 0.06 0.04 0.06 0.03 0.03 0.04 0.03 0.02 0.03 0.02 0.02 0.02 0.00 NS *** NS 
22:6 
c4,c7,c10,c13,c16,c19 
0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 * *** ** 
Unknown 0.22 0.15 0.21 0.26 0.27 0.24 0.18 0.23 0.19 0.21 0.28 0.20 0.02 NS *** *** 
De novo 8.22 7.28 7.32 9.61 13.59 10.88 11.09 15.57 11.13 11.40 16.20 12.37 0.61 *** *** *** 
Mixed 11.23 9.49 10.22 13.28 17.00 14.49 14.71 20.02 14.55 15.29 21.42 16.65 0.89 ** *** *** 
Preformed 19.47 18.20 17.54 14.44 14.92 13.93 13.66 16.39 12.98 13.59 17.10 13.92 1.07 ƚ *** NS 
Total SFAb 24.09 22.08 21.94 25.85 34.76 28.26 28.47 39.36 28.15 29.29 41.71 31.52 1.48 *** *** *** 
Total MUFAc 13.03 11.35 11.36 9.94 9.16 9.48 9.44 10.87 9.06 9.45 11.20 9.88 0.83 NS ** NS 
Total PUFA 1.44 1.26 1.48 1.32 1.35 1.34 1.30 1.49 1.23 1.31 1.54 1.32 0.10 NS NS NS 
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Total 18:1 trans 1.01 0.83 1.02 0.82 0.91 0.80 0.72 0.89 0.67 0.69 0.86 0.66 0.06 NS *** * 
Total n-6 FAd 0.69 0.78 0.67 0.69 0.75 0.70 0.73 0.86 0.70 0.68 0.86 0.73 0.05 * NS NS 
Total n-3 FAe 0.33 0.21 0.38 0.20 0.20 0.22 0.19 0.22 0.18 0.22 0.24 0.21 0.03 NS *** ** 
n-6:n-3 ratio 2.19 3.75 1.98 3.51 3.69 3.23 3.78 4.03 3.79 3.15 3.74 3.47 0.19 *** *** * 
Total CLAf 0.23 0.15 0.22 0.20 0.16 0.19 0.18 0.18 0.16 0.19 0.19 0.18 0.02 NS NS NS 
aLeast-sqaures (LS) means are based on n = 7 Holstein (HO), n = 8 Jersey (JE), and n = 7 HO x JE crossbreeds (CB). bTotal SFA: all saturated fatty acid (4:0 to 
26:0). cTotal MUFA: all monounsaturated fatty acids (14:1 to 24:1). dTotal n-6 FA: all n-6 fatty acids; 18:2 c9,c12; 18:3 c6,c8,c12; 20:2 c11,c14; 20:3 c8,c11,c14; 
20:4 c5,c8,c11,c14; and 22:4 c7,c10,c13,c16. eTotal n-3 FA: all n-3 fatty acids; 18:3 c9,c12,c15; 20:3 c11,c14,c17; 20:5 c5,c8,c11,c14,c17; 22:5 c7,c10,c13,c16,c19; 
and 22:6 c4,c7,c10,c13,c16,c19. fTotal CLA: all detected conjugated linoleic acid isomers: 18:2 c9,t11, 18:2 t11,t13, and 18:2 t7,t9/18:2 t10,t12. gBreed effect. 
hTime point effect. iBreed x time point interaction. ƚ 0.05≤P<0.10; *P<0.05; **P<0.01; ***P<0.001, NS = Not significant. 
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Table 2.4. Contenta (g/kg milk) of odd and branched-chain fatty acids (OBCFA) in milk from three breeds of dairy cow over four time 
points; 5 days in milk (DIM), 95 DIM, 185 DIM, 275 DIM. 
 
Time Point  P Value 
 5 DIM   95 DIM  185 DIM  275 DIM SE  
Fatty acid HO JE CB  HO JE CB  HO JE CB  HO JE CB  Bf Tg B x Th 
5:0 0.02 0.01 0.01  0.02 0.01 0.02  0.03 0.04 0.03  0.02 0.03 0.02 0.00 NS *** * 
7:0 0.01 0.00 0.01  0.01 0.02 0.02  0.01 0.02 0.01  0.01 0.02 0.01 0.00 NS *** * 
9:0 0.01 0.00 0.01  0.02 0.02 0.02  0.02 0.03 0.02  0.02 0.02 0.01 0.00 * *** NS 
11:0 0.03 0.02 0.03  0.09 0.12 0.10  0.11 0.16 0.12  0.12 0.17 0.13 0.01 *** *** ** 
13:0 0.03 0.02 0.02  0.08 0.11 0.09  0.09 0.13 0.09  0.09 0.13 0.10 0.01 ** *** ** 
iso-13:0 0.01 0.01 0.01  0.01 0.01 0.01  0.01 0.01 0.01  0.02 0.02 0.02 0.00 NS *** NS 
anteiso-13:0  0.01 0.01 0.01  0.02 0.04 0.03  0.04 0.05 0.04  0.04 0.06 0.05 0.00 ** *** * 
iso-14:0 0.03 0.03 0.03  0.03 0.06 0.05  0.04 0.07 0.05  0.06 0.08 0.07 0.00 *** *** *** 
15:0 0.32 0.25 0.28  0.52 0.59 0.52  0.52 0.68 0.50  0.53 0.72 0.53 0.03 ** *** ** 
iso-15:0 0.09 0.07 0.07  0.08 0.09 0.08  0.08 0.10 0.08  0.10 0.13 0.10 0.00 ** *** *** 
anteiso-15:0 0.13 0.11 0.12  0.18 0.18 0.17  0.18 0.21 0.17  0.20 0.25 0.21 0.00 ƚ *** ** 
iso-16:0 0.11 0.09 0.09  0.08 0.13 0.10  0.11 0.18 0.11  0.14 0.21 0.17 0.01 *** *** *** 
17:0 0.38 0.31 0.32  0.29 0.32 0.29  0.28 0.37 0.28  0.29 0.39 0.31 0.02 * * ** 
iso-17:0 0.15 0.12 0.14  0.13 0.12 0.12  0.11 0.13 0.11  0.12 0.14 0.13 0.01 NS ** * 
anteiso-17:0 0.17 0.15 0.13  0.04 0.05 0.04  0.06 0.06 0.04  0.03 0.04 0.04 0.01 NS *** NS 
17:1 c9 0.18 0.12 0.13  0.09 0.07 0.08  0.08 0.09 0.07  0.08 0.09 0.08 0.01 NS *** * 
iso-18:0 0.00 0.00 0.00  0.01 0.01 0.00  0.00 0.00 0.01  0.01 0.01 0.00 0.00 NS * NS 
Total OBCFA 2.28 1.82 1.92  2.19 2.50 2.24  2.32 2.96 2.22  2.42 3.21 2.55 0.11 ** *** *** 
Total BCFAb 0.70 0.58 0.59  0.57 0.69 0.61  0.65 0.82 0.62  0.71 0.94 0.78 0.03 ** *** *** 
Total OCFAc 1.59 1.24 1.33  1.62 1.81 1.63  1.67 2.14 1.60  1.71 2.27 1.77 0.09 ** *** *** 
Total iso BCFAd 0.39 0.32 0.34  0.33 0.42 0.37  0.36 0.50 0.37  0.43 0.59 0.48 0.02 ** *** *** 
Total anteiso BCFAe 0.31 0.26 0.25  0.24 0.27 0.24  0.29 0.32 0.26  0.28 0.35 0.30 0.02 * *** ** 
aLeast-sqaures (LS) means are based on n = 7 Holstein (HO), n = 8 Jersey (JE), and n = 7 HO x JE crossbreeds (CB). bTotal BCFA: all branched-chain fatty acids 
(iso-13:0 to iso-18:0 and anteiso-13:0 to anteiso-17:0). cTotal OCFA: all odd-chain fatty acids (5:0 to 17:0). dTotal iso BCFA: all iso branched-chain fatty acids 
(iso-13:0 to iso-18:0). eTotal anteiso BCFA: all anteiso branched-chain fatty acids (anteiso-13:0 to anteiso17:0). fBreed effect. gTime point effect. hBreed x time 
point interaction. ƚ 0.05≤P<0.10; *P<0.05; **P<0.01; ***P<0.001, NS = Not significant
 58 
 
CHAPTER 3 : RUMEN BACTERIAL COMMUNITIES SHIFT ACROSS A 
LACTATION IN HOLSTEIN, JERSEY, AND HOLSTEIN X JERSEY DAIRY 
COWS AND CORRELATE TO RUMEN FUNCTION, BACTERIAL FATTY 
ACID COMPOSITION, AND PRODUCTION PARAMETERS. 
Melissa L. Bainbridge1, Laura M. Cersosimo1, André-Denis G. Wright2, and Jana Kraft1* 
1The University of Vermont, Department of Animal and Veterinary Sciences, Burlington, 
VT, USA 
2University of Arizona, School of Animal and Comparative Biomedical Sciences, 
Tucson, AZ, USA 
 
*Corresponding Author 
E-mail: Jana.Kraft@uvm.edu (JK) 
 
Conflict of Interest 
The Authors declare no conflicts of interest. 
 
Key words: Branched-chain fatty acids, Holstein, Illumina MiSeq, Jersey, volatile fatty 
acids 
 59 
 
3.1. Abstract 
Rumen bacteria form a dynamic, complex symbiotic relationship with their host, 
degrading forages to provide volatile fatty acids (VFA) and other substrates as energy to 
the animal. The objectives were to characterize rumen bacteria in three genetic lines of 
primiparous dairy cattle, Holstein (HO, n=7), Jersey (JE, n=8), and HO x JE crossbreeds 
(CB, n=7) across a lactation (3, 93, 183, and 273 days in milk (DIM)) and correlate these 
factors with VFA, bacterial cell membrane fatty acids (FA), and animal production (i.e., 
milk yield). This study employed Illumina MiSeq (v. 3) to investigate rumen bacterial 
communities and gas chromatography/mass spectroscopy to identify bacterial membrane 
FA. Lactation stage had a prominent effect on rumen bacterial communities, whereas 
genetics had a lesser effect on rumen bacteria. The FA composition of bacterial cell 
membranes was affected by both lactation stage and genetics.  Few correlations existed 
between VFA and bacterial communities, however, moderate correlations occurred 
between milk yield, protein percentage, fat yield, and rumen bacterial communities. 
Positive correlations were found between branched-chain FA (BCFA) in bacterial cell 
membranes and bacteria genera. In conclusion, bacterial communities and their FA 
compositions are more affected by stage of lactation than by genetics of dairy cow. 
3.2. Introduction 
The rumen of cattle is inhabited by a symbiotic microbial ecosystem, constituted 
of anaerobic bacteria (1010-1011 cells/mL), ciliate protozoa (104-106 cells/mL), archaea 
(107-109 cells/mL), fungi (103-106 zoospores/mL), and phages (109-1010 cells/mL) (Wright 
and Klieve 2011). These microorganisms are crucial to the digestion of forages and 
performance of dairy cattle. The symbiotic host-microorganism relationship, in pre-gastric 
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fermentation, facilitates the effective utilization of forage components otherwise 
unavailable to dairy cattle. Forage components are converted into fermentation products, 
such as volatile fatty acids (VFA) and microbial protein, thereby providing the host with 
the majority of its energy and protein requirements (Storm and Orskov 1983, Bergman 
1990). The amount and composition of fermentation products synthesized has a direct 
impact on the performance of the lactating animal (i.e., milk production and milk fat and 
protein synthesis) (Seymour, Campbell and Johnson 2005). Jami, White and Mizrahi 
(2014) provided evidence that various physiological processes in the host animal are 
correlated with specific rumen bacteria. For example, their study demonstrated for the first 
time that the ratio of Firmicutes-to-Bacteroidetes is positively associated with milk-fat 
yield.   
Research has shown there is a high inter-animal variation and a low intra-animal 
variation among rumen bacterial communities (Mullins et al., 2013), but the reason for this 
variation is still not completely elucidated. It has been suggested that differences in the 
bacterial communities between animals may be caused by factors such as individual feed 
selection/sorting, feeding and drinking behavior, and rumination time (McCann, 
Wickersham and Loor 2014). Weimer et al. (2010) demonstrated the host-specific nature 
of rumen bacterial communities by exchanging the rumen contents of two cows. The rumen 
bacterial community returned to its original composition within 14 days for one cow and 
within 61 days for the other cow. Hernandez-Sanabria et al. (2013) discovered differences 
in the rumen bacterial populations between three breeds of beef cattle, suggesting that host 
genetics may impact the community structure and diversity of rumen bacteria. Little is 
known, however, about the effect of host-genetics on rumen bacteria in dairy cattle and as 
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to whether the populations shift in response to factors like days in milk (DIM). Therefore, 
there is a need to characterize the relationship between dairy cattle genetics and rumen 
bacteria community structure observed during the lactation period to better understand the 
role of specific rumen bacteria in animal performance.  
Microbial cells that escape the rumen and flow to the duodenum are an important 
source of fatty acids (FA) for absorption by the animal. Cellular membranes of rumen 
bacteria are unique as they are composed of odd and branched-chain fatty acids (OBCFA) 
(Harfoot 1978) and thus, these FA can be used as a biomarker for rumen function. For 
instance, OBCFA serve as a biomarker of microbial protein flow from the rumen 
(Dewhurst, Davies and Merry 2000) and the composition of OBCFA in milk fat can be 
used to predict the production of molar proportions of ruminal VFA (Vlaeminck et al. 
2006c). 
To our knowledge, no previous work has been conducted to correlate the OBCFA 
of cellular bacteria membranes with bacterial populations in rumen digesta. Therefore, 
identifying rumen bacterial populations and the FA contained in their membranes could 
provide insight about the relationship between rumen bacteria, rumen function, and animal 
performance. We hypothesized that genetics and lactational stage of dairy cattle result in a 
characteristic rumen bacterial community producing a distinct quantity and profile of 
OBCFA. The objectives of this study were to 1) identify and quantify the rumen bacterial 
populations between Holstein (HO), Jersey (JE), and HO x JE crossbreeds (CB) fed the 
same diet over a lactation period, 2) correlate bacterial genera with milk production and 
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rumen fermentation parameters, and 3) compare and correlate the concentration and 
composition of OBCFA in rumen bacteria cell membranes.    
3.3. Materials and Methods 
3.3.1. Experimental Design 
All procedures using animals were approved by the University of Vermont 
(UVM) Animal Care and Use Committee. Twenty-two primiparous dairy cows of three 
genetic lines, HO (n=7), JE (n=8), and F1 CB (n=7) were followed across a lactation. All 
cows calved within a two-month period and were kept in the same pen throughout the study 
at the UVM Paul Miller Research Facility from May of 2013 to May of 2014. Prior to 
calving, cows were fed a total mixed ration (TMR) formulated for pre-fresh cows. After 
calving, cows were switched to a TMR formulated for lactating cows (70:30 forage to 
concentrate ratio; Table 3.1.). Cows were fed twice daily at 0600h and 1500h for ad libitum 
intake (5-10% refusals) and had continuous access to water. Milking occurred twice daily 
at 0600h and 1700h and milk weights were recorded at each milking.  
3.3.2. Sample and Data Collection 
Milk samples were taken from 2 to 7 days in milk (DIM; defined as time point 3 
DIM) and composited by weight for each individual day. At time points 93, 183, and 273 
DIM milk samples were taken on days -2 to 2 relative to the sample time point then 
composited by weight. An aliquot of each milk sample was preserved with 2-bromo-2-
nitropropane-1,3-diol (bronopol) and analyzed by mid-infrared spectroscopy for fat, 
protein, and lactose by Lancaster Dairy Herd Improvement Association (Manheim, PA). 
Feed samples were taken three times per week and composited by time point, dried in a 
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forced air oven (VWR 1630, VWR, Radnor, PA) at 65°C for 48 h and sent to Cumberland 
Valley Analytical Services (Hagerstown, MD) for chemical composition analysis.  
At each time point, cows were cut off from feed at 0600h and whole rumen digesta 
(500 mL) was collected via esophageal intubation at 0900h. The pH was immediately 
recorded (Fisher Scientific Accumet Portable Laboratory pH meter, model AP110, 
Pittsburgh, PA), samples were thoroughly mixed, and two aliquots were taken for VFA 
analysis and microbial identification/quantification and stored at -20°C, until further 
analysis (no longer than 6 months). The remaining rumen digesta (~400 mL) was used to 
fractionate rumen bacteria based on modified methods of Or-Rashid, Alzahal and McBride 
(2011) and Lee, Ha and Cheng (2000). First, rumen digesta was combined with 100 mL of 
MB9 buffer (2.8 g NaCl/L, 0.1 g CaCl2·2H2O/L, 0.1 g MgSO4·7H2O/L, 2.0 g KH2PO4/L, 
and 6.0 g Na2HPO4/L; Or-Rashid, Alzahal and McBride 2011) and 1.5 mL of 1% 
methylcellulose, then homogenized using an electric mixer (Bella Rocket Blender, Bella 
Housewares, Montreal, Canada) to detach particle-associated bacteria. The sample was 
incubated at 4°C for 1 h, then strained through two layers of cheese cloth. The fluid was 
centrifuged at 500 x g for 5 min. at 4°C; the supernatant containing the bacteria was poured 
off into a new bottle and centrifuged again at 12,000 x g for 30 min. at 4°C. The resultant 
supernatant was discarded and the bacterial pellet re-suspended in MB9 buffer, confirmed 
under a microscope to be free of protozoa and feed particulates, lyophilized (FreeZone Plus 
2.5, Labconoco, Kansas City, MO), and stored at -20°C. 
3.3.3. FA Analyses 
VFA samples were centrifuged at 14,000 x g for 20 min. at 8°C. The supernatant 
was filtered through a 25 mm hardened ashless filter (Whatman 540, GE Healthcare Bio-
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Science, Pittsburgh, PA) and mixed with an equal amount of internal standard (0.06 M 
oxalic acid containing 50 µM/mL trimethyl acetic acid). Samples were analyzed on a 
Varian CP3800 gas chromatograph (GC) (Agilent Technologies, Santa Clara, CA) 
equipped with a flame ionization detector (FID) and an 80/120 Carbopac B-DA/4% 
carbowax packed glass column (2 m x 2 mm ID; Supelco, Sigma-Aldrich, St. Louis, MO). 
One µL of the VFA and internal standard mixture were flash injected onto the column. 
Nitrogen was used as the carrier gas at a flow rate of 15 mL/min. The make-up gas, purified 
air, was set at 300 mL/min. For the FID, hydrogen gas was set at 30 mL/min. Injector and 
detector temperatures were kept at 200°C. The oven temperature was isothermal at 175°C 
for 25 min. Peaks were integrated using the Star Chromatography software (version 6; 
Agilent Technologies, Santa Clara, CA). Molar concentrations were determined with a 
standard calibration curve prepared for each individual VFA (Fisher Chemical, Waltham, 
MA). First, 1.0 N standard solutions were calculated using formula weight and adjusted for 
purity and density. Next, concentrations ranging from 10 µM to 100 µM were created using 
the 1.0 N standard solutions and double distilled H2O and mixed in equal proportions with 
the internal standard. Peaks were identified using individual VFA standards (Supelco, 
Sigma-Aldrich, St. Louis, MO).  
FA composition of feed samples was determined as described by Bainbridge, 
Lock and Kraft (2015). Bacteria cell membrane FA transesterification was based on the 
method of Vlaeminck et al. (2006b). Bacterial fatty acid methyl esters (FAME) were 
identified using GC with mass spectrometry (GC/MS) in electron ionization mode. 
Samples were analyzed on a GCMS-QP2010 Plus (Shimadzu, Kyoto, Japan) equipped with 
a split/splitless injector using a Rtx-2330 (90% biscyanopropyl/10% phenylcyanopropyl 
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polysiloxane; 105 m x 0.25 mm x 0.1 µm; Restex, Bellefonte, PA) column. Helium was 
used as the carrier gas at a flow rate of 1.0 mL/min. The temperatures of the injector, ion 
source, and interface were 260°C, 200°C, and 240°C, respectively. The GC oven program 
was set as follows: initial temperature of 45°C, held for 4 min, programmed at 13°C/min 
to 150°C, held for 27 min, then programmed at 3°C/min to 215°C, and held for 35 min. 
GC/MS analyses were performed in full scan mode (m/z 45-500). The injection volume 
was 1 µL of the FAME mixture at a 1:40 split ratio. Integration and quantification were 
performed with GCMS Solutions software (version 2.72; Shimadzu, Kyoto, Japan). FAME 
were identified by comparison with known standards (Nu-Check Prep 463 and 674 
(NuCheck Prep, Inc., Elysian, MN), individual iso and anteiso FA from 10 to 20 carbons 
(Larodan Fine Chemicals AB, Malrnö, Sweden) and comparison of spectra averaged over 
the width of the GC peak, with background subtraction, to the National Institute of 
Standards and Technology mass spectral library. These were based on a similarity factor 
of at least 95% between the unknown and the library spectra.  
3.3.4. DNA Extraction, PCR Amplification, and Bioinformatics Analyses 
 Microbial DNA was extracted following the method of Yu and Morrison (2004), 
modified by Cersosimo et al. (2014). PCR amplification was performed following the 
method of Cersosimo et al. (2014). The V1-V3 region of the 16S rRNA gene was amplified 
using the bacteria-specific primer pair 27F (5’ AGAGTTTGATCCTGGCTCAG) and 
519R (5’ GWATTACCG CGGCKGCTG). Negative controls were run with all reactions 
and amplicons were not used if nucleic acid contamination was noted. Purified samples 
were sent to Molecular Research DNA Laboratories (Shallowater, TX) for sequencing 
using the Illumina MiSeq (v.3) platform.  Molecular Research DNA laboratories assembled 
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reads using USEARCH (Edgar 2010). A total of 8,528,373 raw sequence reads were 
obtained for 87 samples. 
 Real-time PCR amplification was performed in triplicate on a BioRad C1000 Touch 
Thermocycler (BioRad, Hercules, CA). Negative controls were included with all reactions. 
Each real-time PCR reaction contained 12.5 μL of SYBR Green Mix, 6.5 μL of double 
distilled water, 2.5 μL of primer pair 1114F and 1275R for the 16S rRNA gene (Denman 
and McSweeney 2006), and 1 μL of template DNA (10 ng/μL) or 1 μL of double distilled 
water (negative control). The amplification conditions were as follows: hot start of 98°C 
for 15s followed by 40 cycles of 95°C for 30s, 60°C for 30s, and 72°C for 30s, with a final 
melting curve analysis of the fluorescence performed between 60°C and 95°C, with 
increments of 0.5°C every 10s. The 16S rRNA gene standards were created by serial 
dilution of purified PCR product (10 ng/μL). All standard curves had an R2 value greater 
or equal to 0.997 and amplification efficiencies were > 85%. An optimal amplification 
efficiency is between 90-105%, low amplification efficiency could be due to presence of 
PCR inhibitors, or poor PCR primer and/or probe design. Individual densities were 
calculated using a previously established method; copy number/μL = (measured DNA 
concentration (ng/μL)/ PCR amplicon length (bp/copy)) × 0.912 × 1012 (Huo, Zhu and 
Mao 2013).  
 All bioinformatics analyses were done in-house. First, Perl scripts (courtesy of 
Benoit St. Pierre, available upon request) were used to bin sequence reads by barcode, trim 
the reverse primer, screen for quality score (>Q20), and change read names. Sequences 
without a complete forward or reverse primer were removed. MOTHUR version 1.33.3 
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was used to determine the unique sequences (Schloss et al. 2009). Alignment of the 
conserved regions was performed using Perl scripts and manually checked. Chimeric 
sequences were detected using the chimera-slayer and UCHIME commands in MOTHUR 
and removed from the data set. Bacterial sequences were classified down to genus level 
using the “classify.seqs” command with method=wang at an 80% confidence threshold 
(Wang et al. 2007). A subsample of 124,000 sequences (using equal size per sample, which 
was based on computing power) was taken by the “sub.sample” command and used for 
genetic distance calculation. The “dist.seqs” command was used to determine genetic 
distance between sequences at 5%, and the cluster command grouped the unique sequences 
into operational taxonomical units (OTUs). A phylogenetic tree was created in NEWICK 
format using FastTree (Price, Dehal and Arkin 2009) and used in the principal coordinates 
analysis (PCoA) performed with Fast UniFrac (Hamady, Lozupone and Knight 2010).  
3.3.5. Statistical Analysis 
The data were analyzed by repeated measures ANOVA using the PROC MIXED 
procedure in SAS 9.4 (SAS Institute, Cary, NC). The statistical model included the factors 
of cow, genetics, and time point, the interaction of genetics and time point, and residual 
error. The Kenward-Roger method was used for computing the denominator degrees of 
freedom for the tests of fixed effects resulting from the model. Least-squares (LS) means 
were generated using the LSMEANS/DIFF option and data were adjusted for multiple 
comparisons using Bonferroni’s method. P-values listed in the text refer to the main effects 
of either genetics or lactation stage. Due to illness, data were not obtained from one Jersey 
cow at 3 DIM and were considered missing in the model. Significance was declared at P ≤ 
0.05 and trends at 0.05 ≤ P ≤ 0.10. 
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3.4. Results 
3.4.1. Rumen Parameters 
There was no difference in rumen pH between genetic lines or time points (Table 
3.2.). Lactic acid, as percent of total VFA, tended to be lower in HO than JE (3.32 vs. 
3.77%, respectively; P=0.07). There were no other genetic effects on the concentrations of 
rumen VFA. Rumen VFA shifted over the lactation; total molar concentration of VFA was 
higher at 3 DIM than for the remainder of lactation (144.4 vs. 112.8, 118.7, and 105.2 mM 
for 3, 93, 183, and 273 DIM, respectively; P<0.001). Overall, acetic acid (% total VFA) 
was lowest at 3 DIM and highest at 273 DIM (65.3, 66.7, 67.8, and 68.5% for 3, 93, 183, 
and 273 DIM, respectively, P<0.001). The percentage of propionic acid was highest at 3 
and 93 DIM (18.5 and 18.0%, respectively), intermediate at 183 DIM (16.1%), and lowest 
at 273 DIM (14.7%; P<0.001). Thus, the acetic acid-to-propionic acid ratio was lowest at 
3 and 93 DIM and highest at 273 DIM (3.59, 3.80, 4.26, and 4.69 for 3, 93, 183, and 273 
DIM, respectively; P<0.001). Lactic acid concentrations were highest at 273 DIM (3.57, 
3.29, and 3.38 vs. 4.12% for 3, 93, 183, and 273 DIM, respectively, P<0.001). Butyric acid 
was unaffected by stage of lactation. 
3.4.2. Rumen Bacterial Communities 
Rumen bacterial densities did not differ with genetics or lactation stage. Bacterial 
densities averaged 9.39, 9.37, and 9.31 log copies/mL of rumen digesta for HO, JE, and 
CB, respectively (P=0.57). Across the lactation, bacterial densities averaged 9.35, 9.23, 
9.39, and 9.45 log copies/mL rumen digesta for 3, 93, 183, and 273 DIM, respectively 
(P=0.11). A signal was not detected in the negative controls. 
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After quality and chimera checking, a total of 390,990 sequences with an average 
length of 484 base pairs (range of 454-492) were used for downstream analysis. Sequence 
data sets are publically available through NCBI’s Sequence Read Archive, under accession 
number SRP065952. The mean and standard deviation of sequence reads per sample were 
4466 ± 1827. Greater than 99% of sequences were classified to the phylum level and a total 
of 16 bacterial phyla were detected (Table 3.3.). For all samples, sequences representing 
the phyla Bacteroidetes and Firmicutes predominated, accounting for 28-90% and 8-70% 
of total bacteria, respectively, followed by the phyla Proteobacteria (<1-10%) and the 
undescribed group TM7 (0-8%; Table 3.3.). The remaining phyla Acidobacteria, 
Actinobacteria, Chloroflexi, Cyanobacteria, Fusobacteria, Lentisphaerae, Planctomycetes, 
Spirochaetes, Synergistetes, Tenericutes, Verrucomicrobia and the group SR1, represented 
<1% of total sequences. Genetics had no effect on bacteria belonging to the phyla 
Bacteroidetes and Firmicutes, nor the group TM7. However, genetics affected bacteria 
belonging to the phylum Proteobacteria, with HO and JE having a lower abundance than 
CB at 3 DIM (P<0.05; Table 3.3.). Lactation stage affected the three most predominant 
phyla (Bacteroidetes, Firmicutes, and Proteobacteria) and the group TM7. In all genetic 
lines, Bacteroidetes were lowest at 3 DIM when compared to the rest of lactation (57.2 vs. 
72.6, 72.7, and 70.2% abundance for 3, 93, 183, and 273 DIM, respectively; P<0.001). In 
contrast, Firmicutes were more abundant at 3 DIM than at all other time points (38.5 vs. 
25.0, 25.6, and 28.2% abundance for 3, 93, 183, and 273 DIM, respectively; P<0.001). The 
highest abundance of bacteria belonging to the group TM7 was observed at 93 DIM and 
was lowest at 3 DIM (0.34, 1.74, 0.93, and 0.54% abundance for 3, 93, 183, and 273 DIM, 
respectively; P<0.001). In HO and CB, bacteria belonging to the phylum Proteobacteria 
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were higher in abundance at 3 DIM than at the rest of lactation (2.41, 0.37, 0.33, and 0.41% 
abundance for 3, 93, 183, and 273 DIM, respectively; P<0.001). 
Approximately 75% of sequences could be classified to the genus level, bacteria 
that could not be classified to genus level, but occurred at an average abundance >1% in 
all samples, are presented at the lowest taxonomic level that could be assigned to them 
(Table 3.4.). Bacteria belonging to the genus Prevotella were the most abundant of all 
rumen bacterial genera, being lower at 3 DIM when compared to the rest of lactation (49.8, 
67.3, 62.2 and 60.9% abundance for 3, 93, 183, and 273 DIM, respectively; P<0.001). For 
the first half of lactation (3 and 93 DIM; 1.54, 1.82% abundance) bacteria belonging to the 
genus Ruminococcus were less abundant than at the second half of lactation (183 and 273 
DIM; 2.69 and 2.83% abundance; P<0.001). There was a trend for Ruminococcus bacteria 
to be more abundant in HO than JE, however, CB were not different from the other genetic 
lines (2.59, 1.95, and 2.13, for HO, JE, and CB, respectively, P=0.053). Bacteria of the 
genus Butyrivibrio were more abundant at 3 DIM than the rest of lactation (1.32, 0.30, 
0.33, and 0.34% abundance for 3, 93, 183, and 273 DIM, respectively; P<0.001). JE tended 
to have a higher abundance (0.65%) of bacteria from the genus Butyrivibrio than HO 
(0.51%), and CB (0.56%) were not different from the other genetic lines (P=0.080). Only 
lactation stage affected bacteria belonging to the genus Coprococcus, being higher at 3 
DIM than at the subsequent time points (1.74, 0.26, 0.17, and 0.23% abundance for 3, 93, 
183, and 273 DIM, respectively; P<0.001). The abundance of bacteria in the genus 
Acetivibrio were highest at 93 DIM (2.31%) and lowest at 3 DIM (1.27%; P<0.001).  
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Sequences were clustered into OTUs and diversity was assessed using the 
Shannon Diversity Index and Inverse Simpson Index presented in Table 3.5. JE tended to 
have a higher number of OTU than JE across the lactation (370 vs. 312, respectively; 
P=0.09). The highest number of OTU was observed at 3 and 273 DIM, followed by 183 
DIM, then 93 DIM (431, 414, 302, and 210, respectively; P<0.001). The Shannon Diversity 
Index followed the same pattern being highest at 3 and 273 DIM, intermediate at 183 DIM, 
and lowest at 93 DIM (3.5, 3.2, 2.7, and 2.1, respectively; P<0.001). While, the Inverse 
Simpson Index was higher at 3 DIM than at all other time points (6.7 vs. 2.8, 3.3, and 4.0 
for 3, 93, 183, and 273 DIM, respectively; P<0.01). The diversity indices were unaffected 
by genetics.  
PCoA did not demonstrate clustering of bacterial communities by genetic lines, 
however, rumen bacterial communities clustered at each time point (Figure 3.1.). There 
were three individual animals at 273 DIM that did not cluster with that time point.  
3.4.3. FA Composition of Rumen Bacteria 
 The FA composition of rumen bacteria was highly affected by lactation stage, and 
less notably by genetics (Table 3.6.). Saturated FA (SFA) made up the highest proportion 
of FA in bacterial membranes. SFA were lower in bacterial membranes of JE at 183 DIM 
than 93 and 273 DIM, but not 3 DIM. In HO and CB, SFA were lower at 3 DIM than at 
the subsequent time points. Contrary, trans-18:1 FA were lowest in bacteria at 273 DIM 
(8.24, 7.36, and 7.11 vs. 5.88 g/100g FA for 3, 93, 183, and 273 DIM, respectively; 
P<0.001). Rumenic acid (18:2 c9,t11; RA), the predominant isomer of conjugated linoleic 
acids (CLA), was higher in rumen bacteria of JE and CB than of HO (0.64 and 0.59 vs. 
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0.30 g/100g FA, respectively; P=0.02). Across the lactation, RA was lower at 3 and 273 
DIM than at 93 and 183 DIM (0.37 and 0.17 vs. 0.82 and 0.69 g/100g, respectively; 
P<0.001). OBCFA in rumen bacteria were highest at 3 DIM (11.07 g/100g FA) then 
decreased to a lower proportion at 93 and 183 DIM (7.34 and 7.61 g/100g FA, respectively) 
and increased at 273 DIM (8.68 g/100g FA; P<0.001), but to a proportion not higher than 
3 DIM. Bacteria in HO tended to have a higher proportion of anteiso FA than JE, and CB 
were not different from the other genetic lines (3.70, 3.10, and 3.65 g/100g FA for HO, JE, 
and CB, respectively; P=0.065). The majority of individual BCFA in rumen bacteria; iso 
13:0, iso 14:0, iso 15:0, anteiso 15:0, and iso 16:0, were at the highest proportion at 3 DIM 
(Table 3.6.). Rumen bacteria tended to have a higher proportion of anteiso 15:0 in HO than 
JE (3.26 vs. 2.70 g/100g FA, respectively; P=0.075). The proportion of 15:0 was higher at 
3 and 273 DIM (2.31 and 2.14, respectively) than at 93 and 183 DIM (1.78 and 1.83, 
respectively; P<0.001).  
3.4.4. Correlations between Bacterial Communities, VFA, Production Parameters, 
and Bacterial FA 
 Only bacterial genera that averaged >1% abundance in all cows at each time point 
were included in the correlation analyses. There were several significant correlations 
between bacterial genera and the VFA concentrations in the rumen (Figure 3.2.), although, 
only one had an R value > 0.4. Ruminoccocus bacteria were positively correlated with the 
concentration of acetic acid (R=0.43; P<0.01; Figure 3.2.). Weaker significant correlations 
included a negative relationship between the abundance of unclassified bacteria from the 
family Porphyromonadaceae and the concentration of propionic acid (R=0.35; P<0.05); a 
positive relationship between unclassified bacteria of the order Bacteroidales and the 
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concentration of lactic acid in the rumen (R=0.36; P<0.05); and a negative relationship 
between unclassified bacteria of the family Lachnospiraceae and Butyrivibrio species, with 
concentration of acetic acid in the rumen (R=0.34 and 0.33, respectively; P<0.05).  
 The bacterial genera Coprococcus (R=0.47; P<0.01) and Butyrivibrio (R=0.34; 
P<0.05), as well as unclassified bacteria belonging to the family Lachnospiraceae (R=0.38; 
P<0.05) and the order Clostridiales (R=0.37; P<0.05) were positively correlated with the 
FA iso 13:0 (Figure 3.3.). The FA iso 15:0 was also positively correlated with the bacterial 
genera Coprococcus (R=0.53; P<0.01) and Butyrivibrio (R=0.48; P<0.01), as well as 
unclassified bacteria belonging to the family Lachnospiraceae (R=0.42; P<0.01) and total 
bacteria from the phylum Proteobacteria (R=0.40; P<0.05). In addition, bacteria 
representing the phylum Proteobacteria were positively correlated with total iso FA 
(R=0.36; P<0.05). Coprococcus species were positively correlated with the FA anteiso 
15:0 (R=0.37; P<0.05). Bacteria belonging to the phylum Proteobacteria and the genus 
Coprococcus were also positively correlated with total anteiso FA and OBCFA (Figure 
3.3.). Total trans-18:1 were positively correlated with bacteria of the Acetivibrio species 
(R=0.52; P<0.01) and bacteria from the phylum Proteobacteria (R=0.44; P<0.01), along 
with Butyrivibrio species (R=0.38; P<0.05) and bacteria of the family Lachnospiraceae 
family (R=0.36; P<0.05). Ruminoccocus species were negatively correlates with trans-
18:1 FA (R= -0.41; P<0.01). 
 Milk yield was moderately negatively correlated with unclassified bacteria from 
the order Bacteroidales (R= -0.40; P<0.05), unclassified bacteria of the order Clostridiales 
(R= -0.42; P<0.01), and unclassified bacteria of the class Colstridia (R= -0.46; P<0.01, 
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Figure 3.4.). Milk yield was positively correlated with the abundance of Prevotella species 
(R=0.34; P<0.05). Fat yield (kg/d) was positively correlated with Prevotella species 
(R=0.33; P<0.05) and the abundance of total Bacteroidetes bacteria (R=0.34; P<0.05). A 
negative relationship was present between fat yield (kg/d) and Butyrivibrio species (R= -
0.51; P<0.01) and Coprococcus species (R= -0.45; P<0.01) as well as unclassified bacteria 
from the family Lachnospiraceae (R= -0.41; P<0.05). 
3.5. Discussion 
The objectives of this study were to identify and quantify rumen bacterial 
communities in three genetic lines of dairy cattle across a lactation, and then to correlate 
these bacterial genera with rumen VFA, milk production, and bacterial membrane FA. 
Because there are limitations in cannulating a large number of dairy cows, rumen digesta 
samples were collected via esophageal intubation. Research demonstrated no statistical 
difference in bacterial diversity or VFA concentrations between samples collected by 
esophageal intubation or rumen cannula (Lodge-Ivey, Browne-Silva and Horvath 2009). 
However, bacteria associated with the rumen wall will be under-represented in this study. 
Diet is a known driver of bacterial communities (Fernando et al. 2010; Ghaffari et al. 2014; 
Zhang et al. 2014) and the diet of the dairy cows in the present study was changed within 
24 h of parturition from a diet formulated for pre-fresh cows to one formulated for lactating 
cows (Table 3.1.). Thus, the 3 DIM time point likely reflects both the effects of stage of 
lactation and change of diet. 
 VFA supply the majority of the energy to the ruminant animal, and are the main 
end product of carbohydrate fermentation by the rumen microorganisms. The 
concentrations of rumen VFA are directly related to the rumen bacterial community 
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structure and rumen epithelial absorption by the host (Brockman 2005). The higher molar 
concentration of total VFA at 3 DIM suggests increased microbial fermentation and 
metabolism during the first week post-partum, which could be due to the increased energy 
demand of the animal at this time point, or a result of the diet transition. Propionic acid is 
a precursor to glucose and 45 to 60% of the glucose in lactating animals is derived from 
propionic acid (Wiltrout and Satter 1972). Indeed, propionic acid concentration was highest 
at 3 and 93 DIM, when the demand for glucose by the mammary gland is high, and 
propionic acid decreased from 183 to 273 DIM as demand for glucose recedes. Acetic acid 
is the main fermentation product of cellulose and polysaccharide degradation, and thus, the 
primary VFA in the rumen (Lynd et al. 2002). Correlation of Ruminococcus with the molar 
percentage of acetic acid indicates a fibrolytic capacity for this genus (Sawanon, Koike and 
Kobayashi 2011). Sandri et al. (2014) correlated rumen VFA with bacterial genera and 
observed a greater number of strong correlations between rumen VFA and bacterial genera 
than in the current study. The few number of strong correlations in the current study could 
be due to the varied sampling (i.e., over a 273-day lactation and among three genetic lines 
of dairy cow) diluting any direct effects that might be seen in a more controlled study.  
Bacteria are the most abundant and diverse population of rumen microorganisms, 
making up about 95% of the total microbiota (Zhou, Chen and Guan 2015). Diet is the 
main driver of shifts in rumen bacterial communities and this effect has been extensively 
studied (Kong, Teather and Forster 2010; Pitta et al. 2010; de Menezes et al. 2011), 
however, much less in known about the shifts in rumen bacteria within the same animal 
across a lactation or over time. Although changes may be observed in the composition of 
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bacterial genera in response to diet or other environmental factors, the bacterial density in 
the rumen often remains the same (Fernando et al. 2010), as was observed in this study.  
Bacteria of the phylum Bacteroidetes are typically the most predominant bacteria 
in the rumen of dairy cattle, followed by bacteria of the phylum Firmicutes (Kong, Teather 
and Forster 2010; Pitta et al. 2010; Peng et al. 2015). There is a diverse array of biological 
functions associated with bacteria from the phylum Bacteroidetes; the most prevailing 
function being polysaccharide degradation (Thomas et al. 2011). Bacteria of the phylum 
Firmicutes have a lower ability for polysaccharide degradation (Kaoutari et al. 2013) and 
are more known for their production of butyric acid (Louis et al. 2010) and particle-
association within the rumen (Firkins and Yu 2006). The abundance of these bacteria were 
found to be highly variable between animals in this study (28-90% for Bacteroidetes and 
8-70% for Firmicutes). This observation agrees with results by (Jami and Mizrahi 2012) 
who examined the similarity of rumen microbiota among 16 Holstein cows, under the same 
management system, and found Bacteroidetes to vary 26-70% of all sequence reads. 
Moreover, only four OTUs were shared among the genetic lines across time points, the few 
number of shared OTUs and variable bacterial populations suggests that the rumen 
environment is highly dynamic and specific to the particular host (Fernando et al. 2010). 
Herdnandez-Sanabria et al. (2013) observed the host-specific nature of rumen bacteria 
between three genetic lines of beef cattle, demonstrating specific bacterial phylotypes for 
Angus and Charolais breeds, but not for the Angus x Charolais crossbreeds. Our research 
also showed differences in the bacterial communities between genetic lines, however, stage 
of lactation had a much more pronounced effect on rumen bacteria. To the authors’ best 
knowledge, no other studies have examined the shift in bacterial populations across a 
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lactation, although Pitta et al. (2010) described the temporal dynamics of rumen bacteria 
during the transition period. In their study, five primiparous and five multiparous HO dairy 
cows were sampled 21 days before parturition, one to three days after parturition, and at 
28 and 56 DIM. An increase in the abundance of bacteria in the phylum Bacteroidetes and 
a decrease in bacteria from the phylum Firmicutes was observed between pre and post-
partum periods in primiparous cows. Pitta et al.’s (2010) results are similar to the shift in 
bacteria belonging to the phyla Bacteroidetes and Firmicutes observed in the present study 
from 3 to 93 DIM. However, Pitta et al. (2010) did not note differences in bacterial phyla 
between the post-partum periods of 1-3 and 56 DIM. Discrepancies could be a result of 
their post-partum diet being higher in concentrate (50:50 forage to concentrate ratio) than 
during the pre-partum period (80:20 forage to concentrate ratio). This would lead to 
increased availability of substrate for bacterial proliferation to occur more rapidly, as 
Fernando et al. (2010) demonstrated the ability of rumen bacterial communities to change 
in seven days when switching from an 80:20 to 60:40 forage to concentrate ratio. In the 
current study, the forage to concentrate ratio remained the same (70:30) between the pre 
and post-partum periods.  
OBCFA are synthesized by rumen bacteria via i) elongation of propionic acid and 
valeric acid, and ii) conversion and elongation of α-keto acids derived from branched-chain 
amino acids (Kaneda 1977, 1991). Rumen bacteria use these FA to modulate the fluidity 
of their membranes as BCFA have lower melting points than their straight-chain 
counterparts (Suutari and Laakso 1992; Poger, Caron and Mark 2014). Across genetic lines 
and lactation stage, the most predominant OBCFA found in rumen bacterial cell 
membranes were iso 15:0, anteiso 15:0, and 15:0 agreeing with previous research (Bas et 
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al. 2003). The FA composition of rumen bacterial cell membranes is dependent on 
substrates available to rumen bacteria for synthesis (Magnuson et al. 1993). Despite this, 
Saluzzi et al. (1993) showed that differences in the FA profile are more pronounced 
between bacterial species than between bacterial cultures with varying substrates. Based 
on these data, Valeminck et al. (2006a) concluded that bacterial FA profiles are more 
dependent on the FA synthases of the species than on the environmental conditions. Thus, 
the OBCFA profile of ruminal bacteria may reflect the abundance of bacterial populations. 
Several other studies have demonstrated the ability to distinguish bacterial species based 
on their FA profile (Minato, Ishibashi and Hamaoka 1988; Brondz and Olsen 1991). Strains 
of Prevotella and Butyrivibrio can be distinguished based on their FA ratios (Logar, Zorec 
and Kopecný 2001) and cellulytic bacteria tend to be enriched with iso 15:0 (Vlaeminck et 
al. 2006a). Indeed, we showed a positive correlation between Butyrivibrio species and iso 
15:0. Cellulolytic ability has also been reported in bacteria belonging to the family 
Lachnospiraceae, and these bacteria were also positively correlated with iso 15:0. No 
correlation was found, however, for bacteria from the cellulolytic genus Ruminococcus. 
Total trans-18:1 FA, intermediates of PUFA biohydrogenation, were correlated with the 
bacteria from the genera Butyrivibrio and Acetobacter.  Butyrivibrio fibrisolvens was 
identified several decades ago as possessing biohydrogenation activity (Polan, McNeil and 
Tove 1964) and more recently several species of the Butyrivibro were shown to accumulate 
trans 18:1 FA in the rumen (Boeckaert et al. 2008). There has been no research so far 
examining the biohydrogenation ability of Acetobacter species. Yet, the correlation 
between Acetobacter species and trans-18:1 FA in the current study suggests they may 
possess some capacity to biohydrogenate unsaturated FA. Ifkovits and Ragheb (1968) 
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examined the cellular FA composition of rumen bacteria and found limited correlation 
between bacterial FA composition and taxonomy, except for at the species level, explaining 
the few number of moderate correlations observed in this study. Future studies need to 
employ full genome sequencing to identify potential stronger correlations between mixed 
bacterial species in rumen digesta and cellular FA. 
In general, production traits are discussed without the consideration of the rumen 
bacteria, however, these bacteria are an important, yet overlooked component of the dairy 
cow that offers a great opportunity to better understand digestion and host physiology. 
Rumen bacteria convert feed stuffs to compounds usable by the host for milk production, 
such as VFA, proteins, and FA (e.g., OBCFA). A weak negative correlation existed 
between milk fat yield and the Firmicutes/Bacteroidetes ratio (R= -0.30). Jami, White and 
Mizrahi (2014) also compared bacterial communities with production parameters of 15 
primiparous HO cows and found a strong negative correlation between Prevotella species 
and milk fat yield (R= -0.69), and subsequently, a positive correlation between milk fat 
yield and the Firmicutes/Bacteroidetes ratio (R=0.72). They observed genera belonging to 
the phylum Firmicutes that were not found in the present study, such as Dialister, 
Lactobacillus, Eubacterium, Moryella, Bulleidia, and Mitsuokella that were also positively 
correlated with milk fat production and thus these bacteria may be the driver of this 
observation. Lima et al. (2014) were also unable to corroborate the correlation between 
milk fat yield and the Firmicutes/Bacteroidetes ratio when examining the relationship 
between rumen bacteria and productions traits in 115 HO dairy cows (48 primiparous and 
67 multiparous) during the first twelve weeks post-partum. They found a modest negative 
correlation (R=0.24-0.48) between Butyrivibrio and milk yield, similar to our results. 
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However, the majority of correlations shown by Lima et al. were not confirmed in the 
current study. This suggests that milk production and microbial populations may be 
strongly influenced by multiple other factors, and that correlation does not imply causation, 
per se,  as bacterial taxon can fill multiple functional niches (Weimer 2015).  
3.6. Conclusion 
This study examined rumen bacterial communities across a lactation within three 
genetic lines of dairy cattle and related these communities to bacterial cell membrane FA 
as well as physiological parameters of rumen function and milk production. Rumen 
bacterial communities and the FA in their cell membranes were affected by lactation stage, 
but less notably by genetics. There were few correlations between bacterial populations 
and rumen VFA, though several moderate correlations existed between bacterial genera 
and the FA composition of bacterial cells. This suggests the ability to identify some 
bacterial genera by their FA composition, as well as to identify the biohydrogenation 
capacity of bacterial genera by their trans-18:1 FA composition. Bacterial communities 
showed moderate correlations with milk production parameters (i.e., milk yield, protein %, 
and fat yield), however, few correlations were in agreement with the literature 
demonstrating that several other factors affect these parameters. Further research with 
isolated bacterial species are needed to elucidate these relationships between bacterial 
communities and membrane FA. 
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3.10. Figures 
 
Figure 3.1. Principal coordinate analysis of rumen bacteria from three genetic lines of dairy 
cow over four time points; 3 days in milk (DIM); 93 DIM; 183 DIM; 273 DIM.  
Principal coordinate 1 (PC1) plotted against principal coordinate 2 (PC2) explained the largest 
variance between samples. 
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Figure 3.2. A Pearson correlation matrix between VFA and bacterial taxa (>1% abundance) 
of three genetic lines of dairy cow over four time points; 3 days in milk (DIM); 93 DIM; 183 
DIM; 273 DIM.  
The scale of the colors is denoted as follows: the more positive the correlation (closer to 1), the 
darker the shade of blue; the more negative the correlation (closer to -1), the darker the shade of 
red. 
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Figure 3.3. A Pearson correlation matrix between bacterial taxa (>1% abundance) and 
bacterial FA of three genetic lines of dairy cow over four time points; 3 days in milk (DIM); 
93 DIM; 183 DIM; 273 DIM.  
The scale of the colors is denoted as follows: the more positive the correlation (closer to 1), the 
darker the shade of blue; the more negative the correlation (closer to -1), the darker the shade of 
red. CLA = Conjugated linoleic acids. OBCFA = Odd and branched-chain fatty acids. 
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Figure 3.4. A Pearson correlation matrix between production parameters and bacterial taxa 
(>1% abundance) of three genetic lines of dairy cow over four time points; 3 days in milk 
(DIM); 93 DIM; 183 DIM; 273 DIM. 
The scale of the colors is denoted as follows: the more positive the correlation (closer to 1), the 
darker the shade of blue; the more negative the correlation (closer to -1), the darker the shade of 
red. 
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3.11. Tables 
Table 3.1. Ingredient and chemical composition (mean ± standard 
deviation) of the diets. 
 Pre-partum Post-partum 
Ingredient, TMR, % of DM   
   Corn silage 51.2 52.3 
   Haylage 8.3 15.9 
   Hay 13.4  
   Concentratea 27.2 31.8 
Chemical composition   
   %DM 36.8 ± 3.3 40.8 ± 1.1 
   aNDFb 35.0 ± 2.1 27.8 ± 1.1 
   CP (N x 6.25)c 14.1 ± 0.7 15.2 ± 0.7 
   Lignin 4.8 ± 0.2   4.5 ± 0.2 
   Starch 13.9 ± 4.0 22.7 ± 0.9 
   Sugar  3.1 ± 1.1   4.6 ± 0.3 
Total fatty acids 2.0 ± 0.2 2.4 ± 0.1 
Fatty acid composition (mg/g)   
   16:0 4.18 ± 0.50 3.94 ± 0.21 
   18:0 0.62 ± 0.05 0.58 ± 0.04 
   18:1 c9 4.16 ± 0.81 4.99 ± 0.25 
   18:2 c9,c12 7.08 ± 1.22 9.64 ± 0.22 
   18:3 c9,c12,c15 2.07 ± 0.25 2.70 ± 0.28 
   Ʃ otherd 1.62 ± 0.05 1.67 ± 0.05 
   Total SFAe 5.65 ± 0.53 5.25 ± 0.29 
   Total MUFAf 4.89 ± 0.92 5.87 ± 0.28 
   Total PUFAg 9.19 ± 1.04 12.40 ± 0.32 
   Total n-3 2.07 ± 0.25 2.70 ± 0.28 
   Total n-6 7.12 ± 1.21 9.70 ± 0.22 
aThe pre-partum concentrate contained (on DM basis): 16.1% ground soybean 
hulls, 16.9% Pasturechlor, 12.5% Soychlor, 15.7% canola meal, 18.8% amino 
max, 12.5% soybean meal, 4.4% calcium carbonate, 1.3% magnesium sulfate, 
0.5% magnesium oxide, 0.5% sodium chloride, 0.7% trace minerals and 
vitamins, and 0.1% rumensin®. The post-partum concentrate contained (on DM 
basis): 16.4% soybean meal, 10.9% canola meal, 24.6% corn grain, 19.1% 
citrus pulp, 16.4% amino max, 5.5% PGI amino enhancer, 2.2% sodium 
sesquinate, 2.5% calcium carbonate, 1.2% sodium chloride, 0.43% trace 
minerals and vitamins, 0.05% zinc methionine, 0.65% magnesium oxide, 
0.02% rumensin®.  bNDF = Neutral detergent fiber.  cCP = Crude protein. dƩ 
other: 12:0; 14:0; 15:0; 16:1 t9; 16:1 c9; 17:0; 18:1 t9; 18:1 c11; 20:0; 18:3 
c6,c9,c12; 20:1 c8, 21:0, 20:2 c11,c14; 22:0, 22:1 c11, 20:4 c5,c8,c11,c14, 23:0, 
24:0, 24:1 c15, 22:5 c4,c7,c10,c13,c16. eSFA = Saturated Fatty acids. fMUFA 
= Monounsaturated fatty acids. gPUFA = Polyunsaturated fatty acids
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Table 3.2. Volatile fatty acid (VFA) content of three genetic lines of dairy cowa over four time points; 3 days in milk (DIM); 93 DIM; 183 
DIM; 273 DIM 
 
Time Point 
SE 
P value 
3 DIM  93 DIM  183 DIM  273 DIM 
Gc Td G x Te HO JE CB  HO JE CB  HO JE CB  HO JE CB 
Total VFA (mM) 146.5 132.9 154.0  114.7 106.4 117.3  116.7 115.1 124.3  109.9 100.8 104.9 11.3 NS *** NS 
VFA, % total                    
Acetate 65.54 66.66 63.69  66.33 67.56 66.24  68.40 67.93 66.91  68.61 68.29 68.69 0.88 NS *** NS 
Propionate 19.50 17.49 18.65  19.27 16.29 18.47  15.64 15.77 16.79  14.84 14.73 14.55 0.69 NS *** NS 
Butyrate 9.21 9.78 10.96  8.83 10.05 9.68  10.07 10.21 10.37  10.34 9.89 9.79 0.45 NS NS NS 
Isobutryate 0.80 0.84 0.84  0.84 0.92 0.83  0.94 0.83 0.85  1.00 1.11 1.08 0.06 NS *** NS 
Valerate 0.95 0.82 1.01  0.93 0.95 1.08  0.86 1.11 1.06  0.78 0.87 0.80 0.07 NS ** NS 
Isovalerate 0.71 0.80 1.00  0.87 0.64 0.66  0.73 0.66 0.72  0.75 0.71 0.82 0.08 NS NS NS 
Lactate 3.29 3.60 3.83  2.94 3.59 3.33  3.37 3.48 3.30  3.68 4.41 4.26 0.25 0.07 *** NS 
A:P ratiob 3.43 3.91 3.44  3.51 4.24 3.64  4.38 4.39 4.02  4.64 4.68 4.75 0.21 NS *** NS 
Rumen pH 6.84 6.91 6.66  6.94 6.84 6.97  6.91 6.85 6.60  6.82 6.86 6.68 0.10 NS NS NS 
aMeans are based on n =7 Holstein(HO), n=8 Jersey(JE), and n=7 HO x JE crossbreeds(CB). bAcetate:Propionate ratio. cGenetics interaction. dTime point 
interaction. eGenetics x time point interaction. **P<0.01; ***P<0.001; NS= non-significant. 
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Table 3.3. Bacterial Phyla (% of total sequences) of three genetic lines of dairy cowa over four time points; 3 days in milk (DIM); 93 DIM; 
183 DIM; 273 DIM 
Taxa 
 Time Point 
SE 
P value 
 3 DIM  93 DIM  183 DIM  273 DIM 
Gb Tc G x Td  HO JE CB  HO JE CB  HO JE CB  HO JE CB 
Bacteroidetes  54.21 63.83 53.63  78.09 67.88 71.87  78.10 67.46 72.55  69.12 68.78 72.62 4.08 NS *** NS 
Firmicutes  41.98 34.23 39.31  19.43 29.35 26.13  20.35 30.52 25.78  29.48 29.36 25.89 4.01 NS *** NS 
Proteobacteria  1.65 1.14 4.44  0.42 0.54 0.16  0.39 0.36 0.25  0.24 0.61 0.39 0.34 * *** *** 
TM7  0.40 0.23 0.38  1.84 1.81 1.58  0.65 1.15 0.99  0.65 0.48 0.50 0.32 NS *** NS 
<1% abundance  1.75 0.59 2.24  0.22 0.42 0.27  0.52 0.51 0.43  0.49 0.78 0.60 0.22 NS *** *** 
aMeans are based on n =7 Holsteins (HO), n=8 Jerseys (JE), and n=7 Holstein-Jersey Crossbreeds (CB). bGenetics interaction. cTime point interaction. dGenetics 
x time point interaction. *P<0.05; **P<0.01; ***P<0.001; NS= non-significant. 
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Table 3.4. Bacterial taxa (% of total sequences) of three genetic lines of dairy cowa over four time points; 3 days in milk 
(DIM); 93 DIM; 183 DIM; 273 DIM 
Taxa 
Time Point 
SE 
P value 
3 DIM 93 DIM 183 DIM 273 DIM 
Gc Td G x Te HO JE CB HO JE CB HO JE CB HO JE CB 
Prevotella 45.49 54.86 48.91 74.99 59.08 67.70 67.00 56.40 63.30 60.91 58.41 62.51 4.31 NS *** NS 
Un-Porphyromonadaceae 0.29 2.01 0.38 1.03 2.47 0.88 6.44 4.50 3.73 2.24 3.50 3.92 1.00 NS *** NS 
Un-Bacteroidales 4.35 3.49 1.87 0.89 3.57 1.59 1.80 3.12 2.12 2.69 3.83 2.44 0.59 * * * 
Bacteroidetes <1%  4.08 3.52 2.48 1.18 2.76 1.70 2.87 3.44 3.41 3.25 3.03 2.76 0.51 NS *** NS 
Un-Lachnospiraceae 7.52 7.85 8.79 1.44 2.40 2.16 1.26 1.67 1.25 2.00 1.88 1.51 0.79 NS *** NS 
Ruminococcus 2.15 0.76 1.71 2.40 1.75 1.32 2.99 2.50 2.60 2.82 2.79 2.89 0.34 ƚ *** NS 
Un-Ruminococcaceae 10.79 6.43 7.54 7.53 10.47 9.99 6.30 11.98 11.41 10.38 9.39 11.41 1.52 NS NS NS 
Butyrivibrio 1.06 1.56 1.35 0.23 0.35 0.31 0.37 0.37 0.26 0.39 0.31 0.32 0.08 ƚ *** NS 
Coprococcus 1.55 1.80 1.88 0.25 0.27 0.27 0.16 0.19 0.14 0.26 0.23 0.19 0.12 NS *** NS 
Acetivibrio 1.28 0.90 1.64 1.61 2.92 2.39 1.77 1.76 1.88 1.73 1.62 1.32 0.31 NS *** NS 
Un-Clostridiales 6.49 5.17 5.72 1.26 2.91 2.15 2.15 3.68 2.23 3.81 4.17 3.11 0.65 NS *** NS 
Mogibacterium  0.26 0.76 0.80 0.90 1.76 1.65 0.49 0.70 0.58 0.42 0.42 0.27 0.22 * *** NS 
Un-Clostridia 4.03 2.32 2.80 0.48 1.94 1.30 1.34 3.15 1.60 2.91 3.49 2.45 0.58 NS ** NS 
Firmicutes <1% 6.84 6.68 7.07 3.32 4.60 4.58 3.51 4.52 3.83 4.83 5.05 4.03 0.70 NS *** NS 
Un-TM7 0.40 0.23 0.38 1.84 1.81 1.58 0.65 1.15 0.99 0.65 0.48 0.50 0.32 NS *** NS 
Acetobacter 0.54 0.31 2.24 0.01 0.01 0.01 0.01 0.03 0.03 0.02 0.06 0.03 0.30 ƚ ** * 
Proteobacteria <1% 1.11 0.84 2.20 0.42 0.52 0.16 0.37 0.35 0.23 0.22 0.55 0.36 0.20 NS *** NS 
Otherb 1.20 0.53 1.27 0.22 0.42 0.26 0.51 0.50 0.41 0.49 0.74 0.57 0.13 NS *** NS 
aMeans are based on n =7 Holsteins (HO), n=8 Jerseys (JE), and n=7 Holstein-Jersey Crossbreeds (CB). bOther = all bacterial genera <1% abundance. cGenetics 
interaction. dTime point interaction. eGenetics x time point interaction. Un = Unclassified.  ƚ0.05≥P<0.10; *P<0.05; **P<0.01; ***P<0.001; NS= non-significant.  
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Table 3.5. Diversity indicesa of three genetic lines of dairy cow over four time points; 3 days in milk (DIM); 93 DIM; 183 DIM; 273 
DIM 
 
 Time Point 
SE 
P value 
 3 DIM 93 DIM 183 DIM 273 DIM 
Gb Tc G x Td  HO JE CB HO JE CB HO JE CB HO JE CB 
OTU  441.0 404.5 447.0 161.3 260.1 209.0 232.8 358.1 314.0 411.0 455.3 374.3 31.0 ƚ *** NS 
Coverage (%)  0.73 0.73 0.72 0.91 0.85 0.88 0.86 0.78 0.81 0.73 0.70 0.76 0.02 * *** NS 
Shannon Diversity  3.75 3.28 3.60 1.65 2.55 2.06 2.28 3.06 2.67 3.17 3.49 2.99 0.22 NS *** NS 
Inverse Simpson  6.34 7.54 6.15 1.88 3.61 2.96 2.56 4.14 3.06 3.73 4.67 3.56 1.27 NS ** NS 
aMeans are based on n =7 Holsteins (HO), n=8 Jerseys (JE), and n=7 Holstein-Jersey Crossbreeds (CB). bGenetics interaction. cTime point interaction. 
dGenetics x time point interaction. ƚ0.05≥P<0.10; *P<0.05; **P<0.01; ***P<0.001; NS= non-significant. 
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Table 3.6. Fatty acid concentrationa (g/100g FA) of bacteria from three genetic lines of dairy cattle over four time points; 3 days in milk 
(DIM), 93 DIM, 183 DIM, 273 DIM. 
 
Time Point 
SE 
P Value 
3 DIM  93 DIM 183 DIM 273 DIM  
Fatty Acid HO JE CB HO JE CB HO JE CB HO JE CB Gi Tj G x Tk 
12:0 0.87 0.49 0.60 0.45 0.40 0.47 0.36 0.38 0.48 0.37 0.37 0.36 0.07 NS *** * 
iso 13:0 0.38 0.27 0.26 0.14 0.14 0.17 0.16 0.18 0.17 0.18 0.21 0.21 0.03 NS *** NS 
anteiso 13:0  0.00 0.01 0.00 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.00 NS *** NS 
iso 14:0 0.62 0.59 0.52 0.32 0.45 0.44 0.39 0.46 0.38 0.41 0.54 0.48 0.05 NS *** NS 
14:0  2.71 1.73 2.05 1.90 1.40 1.57 1.39 1.31 1.43 1.32 1.49 1.41 0.16 † *** NS 
iso 15:0 1.99 1.52 1.66 0.88 0.84 0.89 0.85 0.95 0.87 0.97 1.09 1.06 0.15 NS *** NS 
anteiso 15:0 4.70 3.11 4.09 2.88 2.39 2.88 2.76 2.46 2.73 2.69 2.85 3.10 0.30 † *** NS 
15:0 2.68 2.02 2.22 1.78 1.74 1.82 2.00 1.67 1.81 2.00 2.20 2.20 0.16 NS ** NS 
iso 16:0 0.91 0.90 0.71 0.38 0.48 0.44 0.42 0.62 0.48 0.57 0.67 0.65 0.11 NS *** NS 
16:0 23.19 20.41 21.98 17.96 18.89 19.60 18.04 18.93 19.47 19.99 19.86 20.30 0.59 NS *** * 
cis-9 16:1  0.14 0.04 0.07 0.05 0.06 0.06 0.01 0.05 0.06 0.04 0.04 0.05 0.02 NS NS NS 
iso 17:0 0.32 0.19 0.26 0.20 0.18 0.19 0.23 0.23 0.22 0.28 0.22 0.27 0.02 * ** NS 
anteiso 17:0 0.55 0.38 0.51 0.32 0.32 0.34 0.37 0.41 0.41 0.45 0.38 0.47 0.04 NS *** NS 
17:0 0.73 0.46 0.62 0.43 0.46 0.45 0.53 0.48 0.51 0.59 0.56 0.60 0.05 † *** NS 
iso 18:0 0.01 0.01 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.02 0.00 0.01 0.00 NS *** *** 
18:0 36.62 48.31 40.36 51.70 51.68 48.98 53.58 49.03 49.98 50.39 50.48 48.33 1.75 NS *** ** 
18:1 t6-8 0.30 0.25 0.37 0.34 0.33 0.31 0.28 0.33 0.28 0.22 0.23 0.24 0.04 NS * NS 
18:1 t9 0.21 0.18 0.26 0.23 0.25 0.24 0.21 0.25 0.21 0.17 0.16 0.17 0.03 NS * NS 
18:1 t10 0.84 0.48 0.86 0.70 0.64 0.69 0.57 0.70 0.61 0.44 0.44 0.48 0.08 NS *** * 
18:1 t11 4.80 4.27 4.17 2.94 2.97 2.74 2.72 2.84 2.26 2.70 2.61 2.31 0.34 NS *** NS 
18:1 t12 3.29 2.85 3.49 2.93 3.18 3.61 2.71 4.08 3.33 2.30 2.43 2.77 0.27 † ** † 
18:1 t13-14/c6-8 1.34 1.07 1.43 1.63 1.68 1.55 1.42 1.58 1.50 1.33 1.29 1.31 0.10 NS ** NS 
18:1 c9 1.59 1.04 1.21 1.33 0.85 1.15 0.75 0.97 1.04 0.74 0.70 0.74 0.16 NS ** NS 
18:1 c11 0.48 0.38 0.52 0.64 0.62 0.55 0.53 0.55 0.69 0.53 0.49 0.50 0.06 NS ** NS 
18:1 c12 0.56 0.31 0.49 0.49 0.60 0.63 0.40 0.65 0.46 0.39 0.42 0.47 0.07 NS * * 
18:1 c13 0.56 0.44 0.61 0.73 0.73 0.65 0.62 0.66 0.66 0.66 0.62 0.62 0.04 NS ** NS 
11:0 cyclohexyl-11 0.69 0.53 0.44 0.60 0.34 0.45 0.39 0.35 0.42 0.43 0.34 0.41 0.09 NS NS NS 
18:2 c9,c12 3.15 1.95 3.08 1.83 2.22 2.45 2.43 3.06 3.30 2.94 2.88 3.62 0.26 * *** * 
19:1 t10 0.12 0.07 0.11 0.06 0.07 0.06 0.04 0.06 0.06 0.05 0.06 0.07 0.01 NS *** † 
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18:3 c9,c12,c15 0.31 0.23 0.42 0.19 0.25 0.23 0.30 0.31 0.34 0.43 0.40 0.40 0.05 NS *** NS 
20:0 0.38 0.44 0.50 0.45 0.49 0.42 0.50 0.50 0.47 0.52 0.49 0.52 0.03 NS * † 
18:2 c9,t11 0.26 0.36 0.51 0.57 0.81 1.07 0.25 1.21 0.59 0.14 0.19 0.19 0.19 * *** NS 
21:0 0.00 0.01 0.00 0.01 0.00 0.03 0.00 0.04 0.00 0.00 0.00 0.00 0.01 NS NS NS 
22:0 0.21 0.26 0.34 0.26 0.29 0.24 0.27 0.28 0.27 0.27 0.29 0.27 0.02 NS NS NS 
24:0 0.25 0.28 0.29 0.27 0.30 0.25 0.28 0.30 0.28 0.29 0.29 0.28 0.02 NS NS NS 
Total dimethyl acetal 4.74 2.66 3.71 3.15 2.64 3.20 2.97 2.97 3.12 3.51 3.08 3.39 0.27 ** ** * 
Unknown 1.37 1.47 1.28 1.26 1.27 1.18 1.24 1.12 1.12 1.63 1.61 1.69 0.14 NS *** NS 
Total SFAb 67.61 74.41 68.97 75.20 75.66 73.83 76.95 72.93 74.71 75.75 76.02 74.28 1.15 NS *** ** 
Total MUFAc 12.63 11.77 14.09 12.63 12.79 13.29 10.47 13.93 11.70 9.69 9.68 9.92 0.99 NS *** NS 
Total trans 18:1d 7.57 8.01 9.14 7.14 7.36 7.58 6.46 8.20 6.69 5.82 5.87 5.96 0.60 NS *** NS 
Total PUFAe 3.46 2.19 3.50 2.02 2.47 2.68 2.73 3.37 3.65 3.37 3.28 4.02 0.28 * *** *    
Total OBCFAf 12.89 9.49 10.85 7.35 7.03 7.65 7.73 7.48 7.60 8.21 8.75 9.09 0.73 NS *** NS 
Total isog 4.24 3.46 3.41 1.92 2.09 2.13 2.04 2.43 2.12 2.44 2.73 2.68 0.29 NS *** NS 
Total anteisoh 5.25 3.51 4.60 3.22 2.74 3.25 3.16 2.90 3.16 3.18 3.26 3.61 0.30 † *** NS 
aMeans are based on n =7 Holsteins (HO), n=8 Jerseys (JE), and n=7 Holstein-Jersey Crossbreeds (CB). bTotal SFA: all saturated fatty acid (12:0 to 24:0). cTotal 
MUFA: all monounsaturated fatty acids (16:1 to 20:1). dTotal trans 18:1: all trans 18:1 isomers. eTotal PUFA: all polyunsaturated fatty acids (18:2 n-6 and 18:3 
n-3). fTotal OBCFA: all odd and branched-chain fatty acids (iso 13:0 to iso 18:0). gTotal iso: all iso fatty acids (iso 13:0 to iso 18:0). hTotal anteiso: all anteiso fatty 
acids (anteiso 13:0 to anteiso 17:0). iGenetics interaction. jTime point interaction. kGenetics x time point interaction. ƚ0.05≥P<0.10; *P<0.05; **P<0.01; 
***P<0.001; NS= non-significant. 
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4.1. Abstract 
The objective of this study was to evaluate the impact of feeding lipid-encapsulated 
echium oil (EEO) on animal performance and milk fatty acid profile. Twelve Holstein dairy 
cows were used in a 3×3 Latin Square design with 14 day periods. Treatments were a 
control diet (no supplemental fat), 1.5%, dry matter (DM) as EEO and 3.0% DM as EEO. 
Treatments had no negative effect on animal performance (dry matter intake, milk yield, 
and fat yield). The milk fat content of total n-3 fatty acids, and SDA increased with EEO 
supplementation (P<0.001). The proportion of SDA increased in all plasma lipid fractions 
with EEO supplementation (P<0.001). Transfer of SDA from EEO into milk fat was 3.4% 
and 3.2% for the 1.5% and 3% EEO treatments, respectively. In conclusion, EEO increases 
the content of n-3 fatty acids in milk fat, however the apparent transfer efficiency was low.  
4.2. Introduction 
The increased understanding of the relationship between nutrition and health has 
led to a growing interest in promoting functional foods enriched with bioactive compounds. 
One class of bioactive compounds is n-3 fatty acids (n-3 FA) which are known for their 
protective effects against inflammation1, neurological disorders2 and cardiovascular 
diseases3,4, as well as their importance to growth and development5. Current dietary sources 
do not meet the requirements for n-3 FA in the human diet6, driving the pursuit to develop 
functional foods enriched with n-3 FA.  
The FA profile of milk is predominantly influenced by the diet of dairy cows7, and 
research has demonstrated that FA derived from supplemental oils can be incorporated into 
milk fat8,9. There are several challenges, however, when supplementing dairy cows with 
oils rich in polyunsaturated FA (PUFA). One is the extensive biohydrogenation of dietary 
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unsaturated FA by rumen bacteria, which often exceeds 85%10. This produces trans-FA 
isomers that decrease lipogenesis in the mammary gland, leading to milk fat depression, 
and reduce the amount of unsaturated FA available to the mammary gland for milk fat 
synthesis10. Various protection methods have been developed to try to minimize ruminal 
biohydrogenation of feed-derived unsaturated FA, such as chemical treatment, calcium 
salt, protein aldehyde matrix, and encapsulation with saturated lipid. Hence, protecting n-
3 FA from bacterial degradation in the rumen is essential in order to increase the amount 
of n-3 FA in milk while maintaining animal performance11. 
Docosahexaenoic acid (DHA; 22:6 4c,7c,10c,13c,16c,19c) and eicosapentaenoic 
acid (EPA; 20:5 5c,8c,11c,14c,17c) are long chain, highly unsaturated n-3 FA that are 
preferentially incorporated into plasma cholesterol esters and phospholipids12. Both plasma 
lipid fractions are unavailable to the mammary gland for production of milk fat13 resulting 
in a low transfer efficiency of EPA and DHA into milk14. Recent research demonstrates 
the two shorter carbon chain n-3 FA, α-linolenic acid (ALA; 18:3 9c,12c,15c) and 
stearidonic acid (SDA; 18:4 6c,9c,12c,15c) show similar health benefits to EPA and 
DHA15,16. SDA bypasses the initial rate-limiting step of delta-6-desaturase in the 
biosynthesis of EPA and DHA and thus, is converted 4-to 5-fold more efficiently to EPA, 
than ALA17. Moreover, recent research suggests that uptake of FA by the mammary gland 
is based on the FA composition of plasma triacylglyceride (TAG), as an intravenous-
infusion of a TAG emulsion of ALA exhibited a higher transfer efficiency (28%) to milk 
fat when compared to DHA (11%)18.  
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Echium oil (EO) from the seed of Echium plantagineum, a member of the 
Boraginaceae family, is a plant-based, source of SDA (13% of total FA), ALA (31% of 
total FA), and γ-linolenic acid (GLA; 18:3 6c,9c,12c; 9% of total FA). GLA has been 
shown to possess anti-carcinogenic and anti-inflammatory properties19,20, and several 
studies have shown the health benefits of echium oil, as well as its promise as an alternative 
to fish oils21,22. Kitessa and Young23 demonstrated an increase in the n-3 FA content of 
milk with inclusion of a formaldehyde-treated EO on a pasture-based diet using five dairy 
cows. Lipid protection may provide more resilience against rumen biohydrogenation and 
thus may result in higher incorporation into milk fat11. There can also be considerable 
variation in response to supplementation depending upon basal diet and inclusion level24, 
thus an evaluation of EO fed at incremental levels on conserved forages is needed to 
determine the optimal inclusion rate for commercial feasibility. It is necessary to determine 
which plasma lipid fractions EO-derived FA are preferentially incorporated into and hence 
to what extent they can be incorporated into milk fat. We hypothesized that the inclusion 
of lipid-encapsulated echium oil (EEO) in the diet of dairy cows fed a total mixed ration 
(TMR) would increase the ALA, SDA, EPA, DHA and GLA content of milk fat. Our 
objectives were to 1) evaluate the effects of feeding an EEO supplement on milk production 
parameters, 2) determine the transfer efficiency of EO-derived FA to milk fat by 
supplementing incremental levels of EEO, and 3) assess the incorporation of EO-derived 
FA into plasma lipid fractions.  
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4.3. Materials and Methods 
4.3.1. Experimental Design 
All experimental procedures were approved by the Michigan State Institutional 
Animal Care and Use Committee. Twelve multiparous Holstein dairy cows in late-lactation 
(229 ± 62 DIM) were used in a 3x3 Latin square design with 14 day experimental periods. 
Cows averaged body weights of 749 ± 69 kg and body condition scores of 3.56 ± 0.39 (1 
to 5 in 0.25 increments25) at the start of the study. Diets were formulated to meet NRC 
(2001) nutrient requirements (Table 4.1.) and fed as total mixed rations (TMR). Treatments 
were diets containing no supplemental fat [Control; CON], diets supplemented with EEO 
at 1.5% of DM [Low EEO; LEO], and EEO at 3% of DM [High EEO; HEO]. EEO 
replaced soy hulls in the diet. EO was purchased from Technology Crops International 
(Winston-Salem, NC) and lipid-encapsulated with hydrogenated-vegetable oil by Jefo 
(Saint-Hyacinthe, Canada) using the spray cooling method with a prilling atomizer. Lipid 
encapsulation technology is based on the inherent property of saturated lipids being 
resistant to enzymes in the rumen, yet susceptible to enzymatic digestion in the small 
intestine11. EO contained 35% ALA, 15% 18:1 9c, 15% SDA, 10% 18:2 9c,12c, 10% GLA, 
and 3% 18:0. The lipid-encapsulated supplement contained 25% EO, and the FA profile of 
the supplement is presented in Table 4.2. A ten-day period before the start of the trial 
served as a preliminary period. Milk samples were collected during the last three days of 
this period and cows were subsequently blocked by fat-corrected milk (FCM) yield and 
assigned to treatments. Cows were housed in individual tie stalls, blocked from feed at 
0800h, fed once daily at 1000h, and milked twice daily at 0400h and 1500h. Corn silage 
and alfalfa silage DM were determined twice weekly and TMR was adjusted accordingly. 
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Diets were fed ad libitum (12-17% orts) throughout the experiment. Fresh drinking water 
was available continuously. 
4.3.2. Sample and Data Collection 
Milk weights and samples were taken at each milking during the last four days of 
each period; an aliquot was preserved with 2-bromo-2-nitropropane-1,3-diol and analyzed 
for fat, protein, lactose, and milk urea nitrogen (MUN) by mid-infrared spectroscopy by 
the Michigan Herd Improvement Association (Universal Lab Services, Lansing, MI). 
Another aliquot was stored at -20°C without preservative for FA analysis. Feed offered and 
refusals were weighed and recorded daily. Feed ingredients and TMR were sampled during 
the last four days of each period and stored at -20°C until further analysis. Blood was 
collected from coccygeal vessels into evacuated tubes containing K2EDTA (Becton 
Dickenson, Franklin Lakes, NJ) at 0900h on the last day of each period. Blood samples 
were placed immediately on ice and plasma was obtained within 2 hours of blood collection 
by centrifugation at 900 x g for 15 min at 4°C, and stored at -20°C.   
4.3.3. Feed and Orts Samples 
Samples for each period were composited and dried in a forced air oven at 65°C for 
48h. Dried samples were weighed to determine dry matter and ground with a Wiley mill 
using a 1 mm screen (Arthur H. Thomas, Philadelphia, PA). Individual feed ingredients 
and orts were analyzed for NDF with heat-stable α-amylase and sodium sulfite26, crude 
protein (CP)27, and starch composition28 (Cumberland Valley Analytical Services Inc., 
Hagerstown, MD). Reported NDF values are inclusive of ash. FA composition of feed 
samples was determined by a modified method of Sukhija and Palmquist29. Glyceryl 
tridecanoate (Nu-Check Prep; Elysian, MN) was used as an internal standard (1mg/mL in 
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acetone). Two mL of toluene and 2mL of 5% methanolic sulfuric acid (Sigma Aldrich, St. 
Louis, MO) were added to 500mg of ground sample and shaken overnight at 50°C. Samples 
were cooled to room temperature and 5mL of 5% sodium chloride solution and 2mL of n-
hexane were added. The extraction procedure was repeated twice with 1mL of n-hexane 
each. The samples were washed with 4mL of saturated potassium bicarbonate solution; the 
n-hexane phase removed, dried over 1g of anhydrous sodium sulfate, and purified using 
silica gel and activated charcoal. A 1% FA methyl ester (FAME) solution was prepared in 
n-hexane, and samples were stored -20°C until gas-liquid chromatography (GLC) analysis. 
4.3.4. Milk FA Analysis 
Milk samples from the last four days of each period were composited by fat yield 
and an aliquot was centrifuged at 17,800 x g for 30 min at 8°C to collect the cream. Milk 
lipids were extracted using the method of Hara and Radin,30 and FAME were prepared by 
base-catalyzed transmethylation. Briefly, a total of 25 mg of lipid extract was solubilized 
in 2.5 mL n-n-hexane and 0.5 mL of 0.5 M sodium methoxide was added to the lipid 
solution and subsequently vortexed for 5 min.  Following, enough sodium bisulfate 
monohydrate was added to the vial to cover the lower layer.  The supernatant containing 
the FAME was transferred into a 2 mL vial and directly used for GLC analysis. 
4.3.5. Plasma Lipid Fraction FA Analysis 
Plasma lipids were extracted by the method of Folch et al.,31 using 
chloroform/methanol in a 2:1 ratio (v/v). The chloroform layer, containing the lipids, was 
dried down under nitrogen gas and the lipids resuspended in 1 mL of n-n-hexane/methyl 
tert-butyl ether/acetic acid (100:3:0.3; v/v) and stored at -20°C.  Lipid classes were 
separated by solid-phase extraction (SPE) using aminopropyl (N2) cartridges (Fisher 
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scientific, Waltham, MA).  The columns (100 mg matrix) were preconditioned with 1.2 
mL acetone/water (7:1; v/v) and 4 mL of n-hexane prior to use.  The lipid solution was 
loaded onto the column and 14 mL of n-hexane were added to elute CE at a flow rate of 
0.3 mL/min. TAG were extracted with 8 mL of n-hexane/chloroform/ethyl acetate 
(100:5:5; v/v). The column was then washed with 6 mL of chloroform/isopropanol (2:1; 
v/v) and this solution was discarded. Free fatty acids (FFA) were eluted in 8 mL of 
chloroform/methanol/acetic acid (100:2:2; v/v) and PL were eluted by adding 10 mL 
methanol/chloroform/water (10:5:4; v/v) to the column. All fractions except for the PL 
were dried down under nitrogen gas, redissolved in chloroform and then stored at -20°C 
until transesterification.  PL were washed with 5% sodium chloride before being dried 
down under nitrogen gas and re-dissolved in chloroform and stored at -20°C for further 
analysis.  The TAG fraction was methylated with sodium methoxide as described above.  
PL, CE, and FFA fractions were methylated with 1 mL of sodium hydroxide at 100°C for 
10 min. 1mL of 10% (w/w) boron trifluoride-methanol solution (Sigma Aldrich, St. Louis, 
MO) was added, and incubated at 100° for 10 min.  Once cooled to room temperature 2 
mL of saturated potassium bicarbonate and 2mL of n-hexane were added.  The extraction 
step was repeated twice with 2mL of n-hexane each then transferred over anhydrous 
sodium sulfate.  The samples were dried under nitrogen gas and re-suspended in n-hexane 
to achieve a 0.1% FAME solution and stored at -20°C for GC analysis.  
4.3.6. Gas Chromatography 
The total FA composition covering circa 110 FA in the range C4:0 to C24:0, 
including branched-chain FA and isomers of octadecenoic acid (18:1) and conjugated 
linoleic acids (CLA), were determined by GC analysis of the FAME on a GC-2010 gas 
  
104 
 
chromatograph (Shimadzu, Kyoto, Japan) equipped with a split injector (1:100 split ratio) 
and a flame-ionization detector (FID) using a SP-2560 fused-silica capillary column (100m 
x 0.25m x0.2µm). Hydrogen was used as the carrier gas at a flow rate of 1 mL/min and for 
the FID at 40 mL/min. The other gases were purified air at 400 mL/min and nitrogen 
makeup gas at 30 mL/min. Injector and detector temperature were kept at 250°C. The oven 
program was: initial temperature of 45°C and held for 4 min, programmed at 13°C/min to 
175°C and held for 27 min, then programmed at 4°C/min to 215°C held for 35 min32. The 
injection volume was 1 μL of the FAME mixture containing about 1-2 μg/μL. Integration 
and quantitation was accomplished with GCsolution software (version 2.30.00) and based 
on the FID response. FAME were identified by comparison of retention times with known 
FAME standards (Nu-Check Prep #463, # 674, CLA mixture; Supelco PUFA-3 mixture 
and Linoleic and Linolenic acid mixture). The short chain FAME were corrected for mass 
discrepancy using the correction factors published by Wolff et al.33. 
4.3.7. Plasma Metabolite Quantification 
Commercially available kits were used to analyze the plasma concentrations of 
FFA (Serum/Plasma Fatty Acid Detection Kit, ZenBio; Research Triangle Park, NC), beta-
hydroxy butyrate (BHBA) (β-Hydroxybutyrate assay kit, Sigma Aldrich; St. Louis, MO), 
and glucose (Glucose (GO) Assay Kit, Sigma Aldrich; St. Louis, MO) according to 
manufacturer’s instructions. Samples were analyzed in duplicate and all coefficients of 
variance were < 5%. 
4.3.8. Calculations 
Apparent transfer efficiency was determined as: 
100 𝑥 [
𝑀𝐹𝐴(𝑡)−𝑀𝐹𝐴(𝑐)
𝐸𝑂𝐹𝐴(𝑡)
 ]     
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Where MFA is/are the FA yield(s) (g/day) in milk, EOFA is the amount (g/day) of FA 
supplied by the EEO supplement, t is treatment (i.e. LEO and HEO), and c is control 
[CON]. 
4.3.9. Statistical Analyses 
Data were analyzed using the fit model program of JMP Pro (version 11; SAS 
Institute, Cary, NC). The following model was used for all data: Yijk = μ + Si  + C(S)ij + Pk 
+ Tl  + eijkl where Yijk = the dependent variable, μ = the overall mean, Si = fixed effect of 
square (i = 1 to 4),  C(S)ij = random effect of cow nested within square (j = 1 to 12), Pk = 
fixed effect of period (k = 1 to 3), Tl  = fixed effect of treatment (l = 1 to 3), and eijk = the 
residual error. Treatment by period interactions were evaluated and removed because P > 
0.15. A post-hoc Tukey’s Honestly Significantly Different (HSD) test was used to 
determine differences between dietary treatments. Differences between plasma lipid 
fractions were determined by an unpaired t-test. Reported values are least squares means 
and standard error. Significance was declared at P ≤ 0.05 and trends at 0.05 ≤ P ≤ 0.10. 
4.4. Results 
4.4.1. Animal Performance 
FA intakes are shown in Table 4.3. CON, LEO, and HEO treatments provided 50.4, 
84.5, and 116.4 g/day of ALA respectively (Table 4.3.; P<0.001).  The intakes of SDA 
were 0.0, 10.6, and 21.7 g/day for CON, LEO, and HEO treatments, respectively 
(P<0.001). Treatments had no effect on DMI which averaged 26.6 kg/day (Table 4.4.). 
Milk yield (30.7 kg/day), energy-corrected milk (34.0 kg/day), and feed efficiency (1.3) 
were unaffected by EEO supplementation (Table 4.4.). There was a trend towards 
increased 3.5% fat-corrected milk in the HEO treatment (P=0.09; Table 4.4.). The 
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percentage of milk fat (4.1 vs. 4.3%; P=0.03) and fat yield (1.25 vs. 1.32 kg/day; P=0.04) 
was higher in the HEO treatment compared to CON. Milk protein percentage decreased 
between CON and HEO treatments (3.56 and 3.47 %, respectively; P=0.002; Table 4.4.), 
however, protein yield did not differ among treatments and averaged 1.1 kg/day. Milk urea 
nitrogen was lower in the HEO treatment when compared to CON (10.1 and 10.9 mg/dl, 
respectively; P=0.01). Percentage of milk lactose and lactose yield were unaffected by 
treatment. There was no difference between treatments for plasma glucose (74.0 mg/dL), 
FFA (0.12 mmol/L), or BHBA (0.67 mmol/L) (Table 4.5.). 
4.4.2. Milk FA Composition 
Supplementation with EEO altered milk FA profile (Table 4.6. and Table B.1.).  
LEO and HEO treatments decreased the content of de novo synthesized FA (<16 carbon 
atoms) by 5% and 12%, respectively, relative to CON (P<0.001). The EEO treatments 
increased preformed FA (≥ 18 carbon atoms) content in milk fat by 9% (LEO) and 16% 
(HEO) when compared to CON (P<0.001). Total saturated fatty acid (SFA) content of milk 
fat was reduced in LEO and HEO relative to CON (Table 4.6.; P<0.001). The content of 
MUFA in milk fat increased from CON to LEO treatment (by 6%) and from CON to HEO 
treatment (by 12%; P<0.001). The largest change in MUFA was seen in the trans-18:1 
isomers; increasing 18% (LEO) and 37% (HEO), respectively, relative to CON (P<0.001; 
Table 4.6.). Total PUFA content increased in milk fat with increasing EEO 
supplementation (P<0.001). Total n-3 FA showed the largest percentage change of all 
PUFA when compared to CON; increasing by 34% for the LEO treatment and by 66% for 
the HEO treatment (P<0.001), compared to CON. The content of n-6 FA decreased in LEO 
(by 5%) and HEO (by 7%), compared to CON (P<0.001). Similarly, the n-6/n-3 ratio 
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decreased from 5.9 in CON to 4.1 and 3.3 for LEO and HEO treatments, respectively 
(P<0.001). Both LEO and HEO treatments increased the content of FA derived from EO 
in milk fat.  Compared with CON, the ALA content in milk fat increased 25% and 53% for 
LEO and HEO (P<0.001), respectively. GLA increased, relative to CON, in LEO (by 80%) 
and HEO (by 145%) treatments (P<0.001). The SDA content of milk fat increased 3.4-fold 
in the LEO treatment and 5.4-fold in the HEO treatment when compared to CON 
(P<0.001). Milk fat from EEO treated cows had a higher content of EPA than CON, 
increasing 43% and 61% for LEO and HEO, respectively (P<0.001).  DHA was not 
detected in milk fat. Total CLA increased 14% in the LEO treatment and 36% in the HEO 
treatment compared to CON (P<0.001). Branched-chain FA decreased, relative to CON, 
by 6% and by 12% for LEO and HEO, respectively (P<0.001). 
 The apparent transfer efficiency of ALA from the EEO supplement to milk fat 
was 3.4% and 3.9% for LEO and HEO treatments, respectively (Table 4.7.). SDA showed 
a similar transfer efficiency of 3.2% for LEO and 3.4% for HEO.  The apparent transfer 
efficiency of GLA was 3.0% and 2.8% for LEO and HEO, respectively. 
4.4.3. Plasma Lipid Fraction FA Composition 
The FA composition of plasma lipid fractions, TAG, FFA, CE, and PL, are 
presented in Figure 4.1. and Tables B.2.-B.5. Overall, 18:0 and 16:0 made up the 
predominant proportion of TAG and FFA fractions (Table B.2. and B.3.), whereas 18:2 
n-6 was the most abundant FA in the CE and PL fractions (Table B.4. and B.5.). The ALA 
(P=0.02) content increased in plasma TAG in response to LEO (18%) and HEO (33%) 
treatment. SDA was not detected in CON plasma TAG and increased (P<0.001) in response 
to LEO and HEO treatments. The GLA content of plasma TAG increased from CON to 
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HEO (48%; P<0.01) but not between CON and LEO (Figure 4.1.). There was no increase 
of EPA in plasma TAG. Changes in the composition of most plasma FFA were negligible, 
however, there was a 41% increase in GLA (P<0.05) between CON and HEO treatments, 
a 13-fold increase in SDA from CON to LEO, and a 39-fold increase from CON to HEO 
(P<0.001). Plasma CE had the highest proportion of ALA, GLA, and SDA of all plasma 
lipid fractions. ALA was 30% higher in plasma CE of LEO than CON and 55% higher in 
plasma CE of HEO than CON (P<0.001). GLA increased 15% and 34% from CON to LEO 
and HEO treatments, respectively (P<0.001). There was a 2.4-fold increase in SDA of 
plasma CE from CON to LEO and a 3.9-fold increase from CON to HEO (P<0.001). EPA 
increased 20% and 44% in plasma CE from CON for LEO and HEO treatments, 
respectively (P<0.01). Plasma PL showed a similar pattern of incorporation with 
significant increases in ALA, GLA, SDA, and EPA with increasing EEO inclusion in the 
diet (P<0.001). There was a 56% (LEO) and 111% (HEO) increase in the content of GLA 
in plasma PL from CON (P<0.001). ALA increased 30% in plasma PL from CON to LEO 
and 56% from CON to HEO (P<0.001). EPA content of plasma PL increased 55% and 
92% from CON to LEO and HEO, respectively (P<0.001).  
4.5. Discussion 
4.5.1. Animal Performance 
Increasing the inclusion of EEO in the diet increased the intake of EO-derived FA 
(ALA, SDA, GLA) in the LEO and HEO treatment groups. Intakes of 18:0 and 16:0 also 
increased due to the lipid-encapsulation of the EEO supplement. A primary consideration 
when supplementing dietary FA to dairy cows is their effect on production and 
performance. Inclusion of EEO in the diet of dairy cows at 1.5% and 3% of DM increased 
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milk fat concentration and yield. These results are consistent with some experiments 
supplementing oil containing SFA or n-3 FA34,35, however, others have shown no change 
or a decrease in milk fat with n-3 FA supplementation9,15. This observation can be 
explained by the increase in fat content of the treatment diets. There was a slight decrease 
in milk protein percentage, but no change in the protein yield. 
4.5.2. Milk FA Profile 
Milk fat from cows supplemented with EEO contained less de novo synthesized FA 
and more preformed FA, which is similar to results observed with linseed oil or fish oil in 
the diet8,9. Unsaturated FA are known to inhibit de novo synthesis of milk fat resulting in 
a greater uptake of preformed FA by the mammary gland36. A decrease in total SFA was 
observed despite the increase in SFA intake supplied by the lipid-encapsulated product.  
This can also be attributed to a reduction in de novo synthesized FA as they are composed 
primarily of SFA. The MUFA content of milk fat increased, mainly due to an increase in 
trans 18:1 isomers and a greater content of cis-9 18:1. The 18:0 delta-9-desaturase index 
(cis-9 18:1/(18:0 + cis-9 18:1)) decreased due to treatments, thus the higher proportion of 
cis-9 18:1 in milk fat is explained by the increased supply of its precursor, 18:0, from the 
diet. 
As expected, supplementation with EEO enhanced the content of PUFA in milk fat, 
particularly GLA, ALA, SDA, and their down-stream metabolites: cis-8,cis-11,cis-14,cis-
17 20:4, EPA, and cis-7,cis-10,cis-13,cis-16,cis-19 22:5 (Docosapentaenoic acid; DPA). 
Similar results were seen by Kitessa et al.23 when supplementing formaldehyde-treated EO 
for 10 days on a pasture-based diet. They noted, however, a decrease in milk production 
that was not observed in the present study. DHA was not detected in milk fat, despite the 
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increase in DPA, which is consistent with Kitessa et al.23 Bernal-Santos et al.37 also saw 
no change in the content of DHA in milk with abomasal infusion of SDA-rich soybean oil, 
containing 27.1% SDA. Delta-6-desaturase acts in both the pathway of converting ALA to 
SDA and EPA to DHA, and thus increasing ALA in the diet could saturate delta-6-
desaturase in the conversion of ALA to SDA and cause a lower activity of this enzyme in 
the conversion of EPA to DHA38. Angulo et al.39 demonstrated the ability to increase DHA 
in milk fat by supplementing DHA-rich marine algae at 0.4% of DM for 10 weeks. 
4.5.3. Apparent Transfer Efficiency and Plasma Lipid Fraction Incorporation of 
EO-Derived FA 
Apparent transfer efficiencies of dietary FA to milk fat vary with, individual FA, 
diet, length of supplementation, protection method, and stage of lactation40,41. The apparent 
transfer efficiency of ALA from the EEO supplement into milk fat was 3.4% and 3.9% for 
LEO and HEO treatments, respectively. This is similar to reports using formaldehyde-
treated flax oil42 and extruded or micronized flaxseed43. The apparent transfer efficiency 
of SDA to milk fat was 3.4% for the LEO treatment and 3.2% for the HEO treatment. The 
metabolism of SDA to EPA, however, is not accounted for in this model, thus, when 
including the increase in EPA from CON to treatments in the apparent transfer efficiency 
equation of SDA values were 4.7 and 4.1% for LEO and HEO, respectively. Bernal-Santos 
et al.37 infused SDA-enriched soybean oil into the abomasum of dairy cows and reported 
an apparent transfer efficiency for SDA of 39.3%, whereas ruminal infusion of SDA-
enriched oil resulted in a 1.7% apparent transfer efficiency to milk fat. Therefore, there is 
potential for a greater transfer efficiency if the FA successfully bypasses the rumen, as with 
abomasal infusion. The apparent transfer efficiency of GLA was similar to ALA and SDA, 
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being 3.0% and 2.8% for LEO and HEO, respectively, indicating consistent transfer 
efficiencies among n-6 and n-3 PUFA.  
The overall low transfer of FA from EEO to milk may be due to 1) partial ruminal 
biohydrogenation of the n-3 FA in the supplement, 2) low release and/or decreased 
absorption of EO-derived FA in the intestine, or 3) incorporation of FA into plasma lipid 
fractions unavailable to the mammary gland. Our data support a combination of these 
factors. trans 18:1 isomers, a marker of incomplete biohydrogenation, were significantly 
increased from LEO to HEO but no difference was observed between CON and LEO 
suggesting biohydrogenation of the unsaturated FA in the HEO treatment despite the lipid-
encapsulation. The release of encapsulated oil and absorption of EO-derived FA in the 
small intestine could not be assessed in this study, however, others have noted that lipid-
protected oils may have lower digestibility14. 
 Mammary lipoprotein lipase utilizes TAG from circulating chylomicrons and 
LDL, thus TAG are the main source of preformed FA for milk fat synthesis44. 
Supplementing n-3 FA in the diet of dairy cows can saturate the normal esterification 
capacity of the small intestine and cause an increased uptake of n-3 FA into plasma TAG44. 
In our study ALA, SDA, and GLA content increased in plasma TAG demonstrating 
potential for these FA to be incorporated into milk fat. This increase, however, was small, 
compared to the increase in the CE and FFA fractions, suggesting not enough of these FA 
were available to substantially increase enterocyte esterification of n-3 FA into TAG.  
Plasma CE had the highest contents of SDA, GLA, and total n-3 FA, demonstrating 
preferential incorporation of SDA and GLA into plasma CE, which are unavailable to the 
mammary gland for milk fat synthesis12,13. Plasma FFA are also available to the mammary 
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gland for milk fat synthesis.45 The only n-3 FA to show a significant increase in 
incorporation into plasma FFA was SDA, however the concentration of FFA available to 
the mammary gland of mid-late lactation dairy cows in positive energy balance is 
negligible.46 To our knowledge, there are no studies delineating the incorporation of SDA 
into plasma lipid fractions and only few studies evaluated the incorporation of other n-3 
FA. Stamey et al.14 supplemented mid-lactation Holstein dairy cows with a lipid-
encapsulated algal oil and algal biomass for 7 days and showed that DHA was 
preferentially incorporated into plasma PL, with very little DHA found in plasma TAG. 
Sterk et al.35 supplied 1.6% DM as ALA to early lactation dairy cows via a formaldehyde-
treated linseed oil and demonstrated a two-fold higher content of ALA in plasma TAG than 
the HEO treatment in the current study that supplied 0.4% DM as ALA. The increased 
incorporation of ALA into plasma TAG coincided with a 13% apparent transfer efficiency 
of ALA to milk fat35, differences could be due to supplementation level, oil-protection 
method or the use of early lactation dairy cows, as previous research has demonstrated an 
increased availability of preformed FA to the mammary gland in early lactation.47 
4.5.4. Human Health Considerations 
The increase of n-3 FA in the diet of dairy cows led to a decrease in the n-6/n-3 
ratio in milk fat of the LEO and HEO treatments when compared to CON.  The n-6/n-3 
balance is critical as dietary n-6 and n-3 FA compete for the same enzymes in the 
production of eicosanoids, and in general n-6 FA produce inflammatory signaling 
molecules while eicosanoids derived from n-3 FA have anti-inflammatory properties48. A 
lower n-6/n-3 FA ratio in the diet of humans is associated with improved health and 
reduced risk of disease49. The mg of n-3 FA per g milk fat was estimated by mass correcting 
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FA values to triglyceride equivalents using a correction factor of 0.87, one serving of EO-
FA enriched whole milk (1 cup (244g) of 3.25% milk fat) would provide 56 mg of n-3 FA. 
The amount of n-3 FA provided in EO-FA enriched milk is comparable to levels of n-3 FA 
supplied by commercially available whole-milk products with added marine oils (50 mg 
EPA/DHA per serving; Organic Valley Omega-3 Milk, Organic Valley, La Farge, WI; 
32mg DHA per serving; Horizon Organic DHA Omega-3 Milk, Horizon Organic, 
Broomfield, CO). Supplementing dairy cows with EEO increased the milk fat content of 
GLA but did not increase the content of its downstream pro-inflammatory metabolite 
arachidonic acid. Human studies have demonstrated that consuming GLA leads to 
increased serum arachidonic acid, however because EO also contains SDA this conversion 
is inhibited, allowing for the accumulation of the anti-inflammatory GLA50. Moreover, 
research shows that consuming GLA along with EPA and DHA reduces risk of heart attack 
and lowers blood TAG levels more effectively than EPA and DHA alone51. Milk fat from 
cows supplemented with EEO had an increased proportion of trans18:1 FA in milk. Trans 
18:1 FA have been generally associated with increased risk of cardiovascular disease in 
humans by increasing low-density lipoprotein (LDL) and decreasing high-density 
lipoprotein (HDL)52. However, the majority of these trials were conducted with trans FA 
from partially hydrogenated vegetable oils (PHVO).  Ruminant-derived trans FA do not 
show the same negative health effects as trans FA from PHVO due to the difference in the 
composition of trans 18:1 isomers53. The predominant trans 18:1 in milk fat is vaccenic 
acid and epidemiological studies suggest that consumption of vaccenic acid may impart 
health benefits54. Thus, the increase in the content of trans FA in the EO enriched milk 
does not influence the healthfulness of the product.  
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4.6. Conclusion 
Developing functional food products enriched with n-3 FA is a challenging 
endeavor in ruminants. The n-3 FA must be both protected from ruminal biohydrogenation, 
and released in the small intestine, then subsequently incorporated into plasma TAG to be 
available to the mammary gland for milk fat synthesis. Supplementing an EEO at 1.5% and 
3% of DM increased the content of n-3 FA in milk fat, while percentage increases of n-3 
FA were high, the actual content of these FA in milk is still relatively low.  ALA, and SDA, 
showed the highest incorporation into plasma TAG and milk, while EPA also increased in 
milk but not in plasma TAG. The greatest increase in content of n-3 FA occurred in the 
plasma PL and CE, explaining the low apparent transfer efficiency of ALA and SDA to 
milk fat.  High transfer efficiencies are feasible only if rumen protection and post-rumen 
absorption are optimized, thus further research is needed to assess the protection of the 
EEO supplement in the rumen, digestibly in the small intestine, and whether longer-term 
supplementation or increasing the SDA content of the oil would increase the apparent 
transfer efficiency to milk fat.  
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4.9. Figures 
 
Figure 4.1. Content (g/100g within plasma lipid fraction) of gamma-linoleic acid [A], alpha-
linolenic acid [B], stearidonic acid [C], and eicosapentaenoic acid [D] in plasma lipid fractions 
of dairy cows supplemented 0% DM as lipid-encapsulated echium oil (EO) [CON], 1.5% DM 
as EO [LEO], and 3% DM as EO [HEO]. 
TAG: Triacylglycerols, CE: Cholesterol Esters, PL: Phospholipids, FFA: Free Fatty Acids. Data 
are presented as least square means (n=12) and standard error. LS means within fatty acids without 
a common letter differ significantly (P < 0.05). 
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4.10. Tables 
Table 4.1. Ingredient and nutrient composition of the treatment 
diets. 
 Treatment 
 
CONa LEOb HEOc 
ingredient, % of DM    
   corn silage 33.9 33.9 33.9 
   alfalfa silage 17.0 17.0 17.0 
   dry ground corn 23.8 23.8 23.8 
   soybean meal 12.7 12.7 12.7 
   soyhulls 9.2 7.7 6.2 
   vitamin-mineral mixd 3.5 3.5 3.5 
   echium oil supplement 0.0 1.5 3.0 
nutrient composition    
   DM, % 48.8 47.7 47.4 
   NDFe, % of DM 27.2 26.2 25.3 
   CPf,% of DM 17.0 15.9 16.3 
   starch, % of DM 28.5 28.4 28.5 
   total fatty acids, % of DM 2.72 3.71 4.94 
      cis-9,cis-12 18:2 1.33 1.25 1.31 
      cis-6,cis-9,cis-12 18:3 0.00 0.03 0.06 
      cis-9,cis-12,cis-15 18:3 0.20 0.31 0.43 
      cis-6,cis-9,cis-12,cis-15 18:4 0.0 0.04 0.08 
      total SFA 0.58 1.49 2.39 
      total MUFA 0.59 0.59 0.65 
      total PUFA 1.54 1.63 1.89 
      total n-3 0.20 0.35 0.51 
      total n-6 1.34 1.28 1.37 
   n-6/n-3 ratio 6.61 3.63 2.69 
aCON: control (0% of DM as lipid-encapsulated echium oil), bLEO: 
1.5% of DM as lipid-encapsulated echium oil, cHEO: 3% of DM as 
lipid-encapsulated echium oil.  dVitamin-mineral mix contained 
(DM basis) 30.1% limestone, 25.3% sodium bicarbonate, 10.1% 
salt, 7.07% urea, 6.00% potassium chloride, 5.98% dicalcium 
phosphate, 5.68% magnesium sulfate, 5.68% animal fat, 3.94% 
trace mineral premix and vitamins, 0.21% selenium yeast 600 (600 
mg of Se/kg). eNDF: Neutral detergent fiber.  fCP: Crude protein.  
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Table 4.2. Fatty acid composition (g/kg) of lipid-
encapsulated echium oil (EEO). 
fatty acids (g/100g) EEO
 
  12:0 0.12 
  14:0  0.81 
  16:0 41.53 
  18:0 33.37 
  cis-9 18:1 4.33 
  cis-11 18:1 0.14 
  cis-9,cis-12 18:2 3.96 
  20:0 0.39 
  cis-6,cis-9,cis-12 18:3 2.65 
  cis-9,cis-12,cis-15 18:3 9.03 
  cis-6,cis-9,cis-12,cis-15 18:4 3.40 
  22:0 0.06 
  cis-11,cis-14,cis-17 20:3  0.12 
  24:0 0.06 
  cis-15 24:1 0.04 
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Table 4.3.  Fatty acid intake (g/day) of treatments. 
 Treatment 
SE P value 
 
CONa LEOb HEOc 
total fatty acids 726a 1000b 1329c 27.0 <0.001 
   16:0 114a 250b 382c 7.54 
<0.001 
   18:0 21.5a 125b 228c 4.48 
<0.001 
   cis-9 18:1 145a 146a 162b 3.94 
<0.001 
   cis-9,cis-12 18:2  358a 338b 356a 8.24 
<0.001 
   cis-9,cis-12,cis-15 18:3 50.4a 84.5b 116c 2.34 
<0.001 
   cis-6,cis-9,cis-12 18:3  0.30a 8.50b 17.1c 0.32 
<0.001 
   cis-6,cis-9,cis-12,cis-15 18:4 0.04a 10.6b 21.7c 0.40 
<0.001 
   Ʃ otherd 35.7a 34.8a 44.5b 1.02 
<0.001 
   total SFAe 157a 400b 641c 12.6 <0.001 
   total MUFAf 156a 158a 176b 3.91 
<0.001 
   total PUFAg 413a 442b 512c 11.1 
<0.001 
   total n-3 54.9a 95.6b 138c 2.75 
<0.001 
   total n-6 358a 347b 373c 8.51 
<0.001 
aCON: control (0% of DM as lipid-encapsulated echium oil),bLEO: 1.5% of DM as lipid-
encapsulated echium oil, cHEO: 3% of DM as lipid-encapsulated echium oil. dƩ Other: 12:0, 
14:0, 15:0, cis-9 16:1, 17:0, cis-11 18:1, 20:0, 20:1 n-9, 21:0, 20:2 n-6, 22:0,22:1 n-9, 20:4 n-
6, 23:0, 24:0 eTotal SFA: sum of saturated fatty acids (4:0 to 26:0). fTotal MUFA: sum of 
monounsaturated fatty acids (14:1 to 24:1).  gTotal PUFA: sum of polyunsaturated fatty acids 
(18:2 to 22:5). 
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Table 4.4. Daily dry matter intake (DMI), milk yield, milk components, and feed efficiency 
of dairy cowsa in response to dietary treatment of CONb, LEOc, and HEOd. 
 
 
Treatment 
SE P value 
CON LEO HEO 
DMI (kg/day) 26.4 26.5 26.8 0.58 ns 
milk yield (kg/day) 30.6 30.3 31.1 0.92 ns 
3.5% fat-corrected milk (FCM)e 33.5 33.8 35.5 0.75 0.09 
energy-corrected milk (ECM)f 33.6 33.8 34.6 0.85 ns 
milk components yield (kg/day)      
fat  1.25a 1.27ab 1.32b 0.03 0.04 
protein 1.08 1.07 1.08 0.03 ns 
lactose 1.39 1.38 1.43 0.05 ns 
milk components (%)      
fat  4.10a 4.22ab 4.25b 0.10 0.03 
protein 3.56a 3.54ab 3.47b 0.04 0.002 
lactose 4.53 4.54 4.55 0.06 ns 
feed efficiencyg 1.28 1.28 1.31 0.04 ns 
milk urea nitrogen (mg/dl) 10.9a 10.4ab 10.1b 0.44 0.01 
 aLS means are based on 12 dairy cows per treatment. LS means without a common letter differ 
significantly (P < 0.05). bCON: control (0% of DM as lipid-encapsulated echium oil), cLEO: 
1.5% of DM as lipid-encapsulated echium oil, dHEO: 3% of DM as lipid-encapsulated echium 
oil. e3.5% FCM = [0.43 x milk yield (kg/d)] + [16.22 x fat yield (kg/d)]. fECM = [12.82 x fat 
yield (kg/d)] + [7.13 x protein yield (kg/d)] + [0.32 x milk yield (kg/d). gFeed efficiency = kg of 
3.5% FCM/kg DMI. 
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Table 4.5. Plasma metabolitesa of dairy cows in response to dietary treatment of CONb, 
LEOc, and HEOd. 
 
Treatment 
SE P value 
CON LEO HEO 
    FFA (mmol/L) 0.11 0.12 0.12 0.01 ns 
    Glucose (mg/dL) 75.8 74.5 71.7 1.20 0.07 
    BHBA (mmol/L) 0.71 0.69 0.61 0.06 ns 
aLS means are based on 12 dairy cows per treatment. LS means without a common letter differ 
significantly (P < 0.05).  bCON: control (0% of DM as lipid-encapsulated echium oil), cLEO: 1.5% 
of DM as lipid-encapsulated echium oil, dHEO: 3% of DM as lipid-encapsulated echium oil. 
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Table 4.6. Milk fat contenta of select fatty acids (g/100g FA) in response to dietary treatments 
of CONb, LEOc, and HEOd. 
fatty acid 
Treatment 
SE 
P 
value CON LEO HEO 
16:0 34.8a 34.1b 34.5ab 0.62 0.04 
18:0 6.80a 7.99b 8.58c 0.21 <0.001 
trans-11 18:1 0.54a 0.62a 0.77b 0.08 <0.001 
cis-9 18:1 14.8a 15.9b 16.7c 0.28 <0.001 
cis-9,cis-12 18:2  2.46a 2.29b 2.24b 0.07 <0.001 
cis-6,cis-9,cis-12 18:3  0.03a 0.06b 0.08c 0.00 <0.001 
cis-9,cis-12,cis-15 18:3 0.38c 0.47c 0.58c 0.02 <0.001 
cis-9,trans-11 18:2 0.29a 0.30a 0.37b 0.03 <0.001 
cis-6,cis-9,cis-12,cis-15 18:4 0.02a 0.06b 0.09c 0.00 <0.001 
cis-5,cis-8,cis-11,cis-14 20:4  0.16a 0.15b 0.15b 0.00 <0.001 
cis-8,cis-11,cis-14,cis-17 20:4 0.02a 0.03b 0.04c 0.00 <0.001 
cis-5,cis-8,cis-11,cis-14,cis-17 20:5 0.03a 0.05b 0.05b 0.00 <0.001 
cis-7,cis-10,cis-13,cis-16,cis-19 22:5 0.06a 0.07b 0.06ab 0.00 0.03 
unknown 0.29a 0.30a 0.32b 0.01 <0.001 
de novoe 29.8a 28.7b 26.6c 0.53 <0.001 
Mixedf 36.4a 35.6ab 35.9b 0.65 0.03 
Preformedg 29.0a 31.5b 33.6c 0.70 <0.001 
total SFAh 73.7a 72.4b 71.1c 0.53 <0.001 
total MUFAi 20.5a 21.6b 22.6c 0.42 <0.001 
total PUFAj 3.98a 4.05a 4.37b 0.12 <0.001 
total n-6 PUFAk 2.85a 2.69b 2.64b 0.07 <0.001 
total n-3 PUFAl 0.49a 0.65b 0.81c 0.02 <0.001 
n-6:n-3 ratio 5.88a 4.11b 3.28c 0.07 <0.001 
total trans 18:1 1.75a 1.91a 2.22b 0.17 <0.001 
total CLAm 0.31a 0.33a 0.39b 0.03 <0.001 
total odd and branched-chain FA 3.85a 3.41b 3.15c 0.11 <0.001 
18:0 delta-9-desaturase indexn 0.69a 0.67b 0.66b 0.01 <0.01 
aLS means are based on 12 dairy cows per treatment. LS means without a common letter differ 
significantly (P<0.05). bCON: control (0% of DM as lipid-encapsulated echium oil), cLEO: 1.5% of DM 
as lipid-encapsulated echium oil, dHEO: 3% of DM as lipid-encapsulated echium oil. eDe novo: sum of 
fatty acids < 16 carbons. fMixed: sum of 16:0 and cis-9 16:1. gPreformed: sum of fatty acids >16 carbons.  
hTotal SFA: sum of saturated fatty acids (4:0 to 26:0). iTotal MUFA: sum of monounsaturated fatty acids 
(14:1 to 24:1). jTotal PUFA: sum of polyunsaturated fatty acids (18:2 to 22:5).  kTotal n-6 PUFA: sum of 
n-6 PUFA: cis-9,cis-12 18:2, cis-6,cis-9,cis-12 18:3, cis-11,cis-14 20:2, cis-8,cis-11,cis-14 20:3, cis-5,cis-
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8,cis-11,cis-14 20:4, and cis-7,cis-10,cis-13,cis-16 22:4. lTotal n-3 PUFA: sum of n-3 PUFA: cis-9,cis-
12,cis-15 18:3, cis-6,cis-9,cis-12,cis-15 18:4, cis-11,cis-14,cis-17 20:3, cis-8,cis-11,cis-14,cis-17 20:4, 
cis-5,cis-8,cis-11,cis-14,cis-17 20:5, and cis-7,cis-10,cis-13,cis-16,cis-19 22:5. mTotal CLA: sum of 
conjugated linoleic acids: cis-9,trans-11-CLA, cis-9,cis-11-CLA, trans-7,trans-9-CLA, and trans-
10,trans-12-CLA. n18:0 delta-9-desaturase index: (cis-9 18:1/(18:0 + cis-9 18:1)).   
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Table 4.7. Transfer efficienciesa of FA from the echium oil supplement to milk fat. 
 
Treatment 
SE P value 
LEOb HEOc 
cis-6,cis-9,cis-12 18:3, % 3.0 2.8 0.32 ns 
cis-9,cis-12,cis-15 18:3, % 3.4 3.9 0.59 ns 
cis-6,cis-9,cis-12,cis-15 18:4, % 3.4 3.2 0.23 ns 
cis-6,cis-9,cis-12,cis-15 18:4 plus cis-5,cis-8,cis-
11,cis-14,cis-17 20:5, %d 
4.7 4.1 0.38 ns 
aLS means are based on 12 dairy cows per treatment. LS means without a common letter differ 
significantly (P < 0.05). bLEO: 1.5% of DM as lipid-encapsulated echium oil, cHEO: 3% of DM 
as lipid-encapsulated echium oil. dcis-6,cis-9,cis-12,cis-15 18:4 (SDA) plus cis-5,cis-8,cis-11,cis-
14,cis-17 20:5 (EPA): [((SDA + EPA in milk fat of treatment) – (SDA + EPA in milk fat of 
control))/ SDA in diet]*100. 
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5.1. Abstract 
Transfer efficiencies of rumen-protected n-3 fatty acids (FA) to milk are low, thus 
we hypothesized that rumen-protection technologies allow for biohydrogenation and 
excretion of n-3 FA. The objectives of this study were to i) investigate the ruminal 
protection and post-ruminal release of the FA derived from the lipid-encapsulated echium 
oil (EEO), and ii) assess the bioavailability and metabolism of the EEO-derived FA through 
measuring the FA content in plasma lipid fractions, feces, and milk. The EEO was tested 
for rumen stability using the in situ nylon bag technique, then the apparent total-tract 
digestibility was assessed in vivo using six Holstein dairy cattle. Diets consisted of a control 
(no EEO); 1.5% of dry matter (DM) as EEO and 1.5% DM as encapsulation matrix; and 
3% DM as EEO. The EEO was rumen-stable and had no effect on animal production. EEO-
derived FA were incorporated into all plasma lipid fractions, with the highest proportion 
of n-3 FA observed in cholesterol esters. Fecal excretion of EEO-derived FA ranged from 
7-14%. Biohydrogenation products increased in milk, plasma, and feces with EEO 
supplementation. In conclusion, lipid-encapsulation provides inadequate digestibility to 
achieve an optimal transfer efficiency of n-3 FA to milk.  
5.2. Introduction 
Over the past two decades, consumers have become increasingly conscious about 
the nutritional value of foods and their components with respect to health maintenance and 
disease prevention. Animal foods make a significant contribution to the daily diet in 
Western societies and dietary guidelines advise limiting the intake of animal fats, 
particularly ruminant-derived, since their higher content of saturated fatty acids (SFA) has 
been linked to various chronic diseases [1]. Although the purported link between SFA, 
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derived from ruminant fats (i.e., meat and dairy), and the incidence of chronic diseases 
continues to be debated, there has been heightened research interest in modifying ruminant 
fats to meet consumer preferences and align with recommendations by public health 
authorities, nutritionists, and health-care providers. Ruminant dairy fats are comprised of 
approximately 65-70% SFA and only 2-4% polyunsaturated fatty acids (PUFA) [2] 
because of the extensive microbial biohydrogenation of feed-derived unsaturated fatty 
acids (UFA) in the rumen [3]. Thus, efforts to alter the fatty acid (FA) composition of dairy 
lipids include the reduction of SFA while increasing the content of UFA, especially PUFA 
and n-3 FA. Various vegetable and marine oils, but also oilseeds, have been used to 
supplement the dairy cows’ ration as a means to increase the concentration of UFA in milk 
fat. However, when unprotected oils are fed to cows, ruminal bacteria extensively 
hydrolyze and biohydrogenate the dietary lipids, resulting in marginal increases in passage 
to the small intestine [4,5]. Moreover, detrimental side effects, such as altered rumen 
biohydrogenation pathways associated with decreased fiber digestion, dry matter intake 
(DMI), and milk fat depression, have been observed [6,7]. Bypassing ruminal 
biohydrogenation and degradation of UFA may be achieved through the utilization of 
rumen-inert (i.e., calcium salts) or rumen-protected (i.e., fatty acid amides, formaldehyde-
treated, lipid-encapsulated) oils [8] that may represent an opportunity to achieve a desired 
consistent milk fatty acid composition. Yet, these products have produced wide-ranging 
and inconsistent results [9]. We previously supplemented a total-mixed ration diet of mid-
lactating Holstein cows with lipid-encapsulated echium oil (EEO) at 1.5 and 3.0% of dry 
matter (DM) to enhance the content of bioactive fatty acids (FA) in milk fat [10]. The 
protected supplement contained 25% of echium oil rich in α-linolenic acid (18:3 
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c9,c12,c15, ALA), stearidonic acid (18:4 c6,c9,c12,c15, SDA), and γ-linolenic acid (18:3 
c6,c9,c12, GLA). Although the content of ALA, SDA, and GLA in milk fat increased, 
relatively low transfer efficiencies into milk fat were observed (ALA: 3.4 -3.9%; SDA: 
4.1-4.7%; and GLA: 2.8-3.0%). We hypothesize that either i) the EEO was not rumen 
stable and FA losses occurred as result of bacterial biohydrogenation, ii) EEO did not 
become available for absorption and utilization in the small intestine, or iii) EEO-derived 
FA were incorporated into plasma lipid fractions that are less available to the mammary 
gland. The objectives of this study were to i) investigate the ruminal protection and post-
ruminal release of the FA derived from the EEO, and ii) assess the bioavailability and 
metabolism of the EEO-derived FA through measuring the FA content in plasma lipid 
fractions, feces, and milk. 
5.3. Materials and Methods 
5.3.1. Experiment 1: In situ Nylon Bag Procedure 
All procedures involving animals were approved under the University of Vermont 
Institutional Animal Care and Use Committee (Protocol # 12-036). EEO was first evaluated 
for rumen stability using the in situ nylon bag technique. Echium oil (Echium 
plantagineum) was purchased from Technology Crops International (Winston-Salem, NC, 
USA) and micro-encapsulated with a hydrogenated vegetable oil by Jefo (Saint-Hyacinthe, 
QC, Canada) using a spray cooling method with a prilling atomizer. The final encapsulated 
product contained 25% echium oil.  
EEO and a wheat straw (i.e., control) were incubated in the rumen of two rumen-
cannulated non-lactating dairy cattle in a repeated measures design (x3). Five g of EEO 
and 2.5 g of wheat straw were weighed into individual nylon bags measuring 10 x 20 cm, 
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with a pore size of 50 m (ANKOM Technology; Macedon, NY). Three replicates of each 
sample were performed per time point per cow. Bags were heat sealed and distributed 
among three mesh retaining bags (Household Essentials, Hazelwood, MO) attached to a 
weight to control the location within the rumen. Samples were removed at time points 2, 
4, 8, 16, 48, and 72 hours, and machine-rinsed, using the cold water cycle, until there was 
no color remaining in the rinse water. Zero-hour bags did not enter the rumen, but were 
subjected to the same procedures as the other bags (i.e., washing). The bags were dried at 
65°C, placed in a desiccator until cool, and weighed to determine percent dry matter 
disappearance. 
5.3.2. Experiment 2: Animals and Experimental Design 
Six lactating Holstein dairy cattle at 188 ± 43 days in milk (DIM) were used to 
assess the digestibility and incorporation of EEO-derived FA into milk fat. Cows were 
housed in individual tie-stalls at the UVM Paul Miller Research Facility, milked twice daily 
at 0400h and 1600h, and fed twice daily at 0600h and 1800h. Individual feed intakes were 
recorded and adjusted to achieve 10-15% refusals daily. Cows had continuous access to 
water. The four days prior to the start of the experiment served as the baseline period 
(control; CON), during which cows were fed the standard herd diet consisting of a mixed 
ration and top-dressed grain (Table 5.1.). The two consecutive experimental periods were 
seven days each, and experimental diets were formulated for equal fat intake, consisting of 
1.5% of DM as EEO plus 1.5% of DM as encapsulation matrix (Low-EEO; LEO) and 3% 
of DM as EEO (High-EEO; HEO). These percentages were applied to the DM intake (DMI) 
of the cows during the baseline period resulting in 380g each (190g at each feeding) of EEO 
plus encapsulation matrix being supplemented daily for the LEO treatment and 760g of EEO 
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supplemented daily (380g at each feeding) for the HEO treatment. The supplements were 
thoroughly mixed with the top-dress grain and each cow was observed until the entirety of 
the supplement was consumed. EEO replaced an equal percentage of the top-dressed grain 
in the diets (Table 5.1.). All diets were formulated to meet NRC 2001 requirements [11]. 
5.3.3. Data Sample Collection 
Milk weights were recorded and a 100 mL milk sample was taken at each milking. 
Milk samples were composited based on milk weight for each day and cow. An aliquot 
was preserved with 2-bromo-2-nitropropane-1,3-diol and analyzed for fat, protein, and 
lactose by Lancaster Dairy Herd Improvement Association (Manheim, PA). The cream 
layer was collected from a second aliquot by centrifugation at 3434 x g for 30 min at 8°C, 
and kept at -20°C until FA analysis. Feed and refusals were weighed and sampled daily. 
Both feed and refusal samples were composited per period for each cow, dried in a forced-
air oven (VWR 1630, VWR, Radnor, PA) at 65°C for 48 h, and sent to Cumberland Valley 
Analytical Services Inc. (Hagerstown, MD) for chemical analysis of crude protein (CP) 
[12], neutral detergent fiber (NDF) [13], and ash [14]. Blood was collected into evacuated 
tubes containing K2EDTA (Becton Dickenson, Franklin Lakes, NJ) from the coccygeal 
vein at 0800 h (2 hours after feeding) on day -1 of the CON period and on day 2, 3, 4, and 
7 of each experimental period. Blood samples were placed immediately on ice and plasma 
was obtained within 1 h of collection by centrifugation at 900 x g for 15 min at 4°C. Fecal 
matter was collected from each cow quantitatively for a 24 h period starting at 0830h on 
the last day of each period. Each fecal event was weighed, mixed thoroughly using an 
electric hand mixer, and subsampled. Fecal events were composited per cow and one 
aliquot was dried in a forced-air oven at 65°C for 48 h to determine DM. A second aliquot 
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was lyophilized (FreeZone Plus 2.5, Labconco, Kansas City, MO) and stored at -20°C until 
subsequent FA analysis. 
5.3.4. Forage, Fecal, Milk, and Plasma FA Analyses 
Milk lipids were extracted using the method of Hara and Radin [15] and fatty acid 
methyl esters (FAME) were generated in a base-catalyzed transmethylation reported by 
Bainbrigde et al. [10]. Forage FAME were prepared as described by Sukhija and Palmquist 
[16] with the modifications by Bainbridge et al. [10] of using glyceryl tridecanoate (Nu-
Check Prep, Elysian, MN, USA) as an internal standard (1 mg/mL in acetone). Plasma 
lipids were extracted using chloroform/methanol (2:1) as detailed by Folche et al. [17], 
isolated using solid-phase extraction, and methylated by the methods of Bainbridge et al. 
[10]. FAME from dried and ground forage samples, cream, and plasma were prepared and 
analyzed by gas-liquid chromatography (GLC) using the methods of Bainbridge et al. [10]. 
Fecal FAME were prepared and analyzed using the same procedure as for forage FA. 
5.3.5. Statistical Analysis 
Data were analyzed by repeated measures ANOVA using the PROC MIXED 
procedure in SAS (v. 9.4; SAS Institute, Cary, NC). The model included the fixed effect 
of diet, the fixed effect of period and sample day nested within period, the random effect 
of cow, and residual error. The interaction of period and diet was originally included in the 
model but removed because of P>0.15. For milk production and milk FA data, the last 4 
days of each period were used to assess treatment effects. Differences between least-
squares (LS) means were determined using the LSmeans/Diff option. Data were adjusted 
for multiple comparisons using Bonferroni’s method. Differences between FA intakes and 
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fecal outputs were generated using the TTEST procedure with the PAIRED statement. 
Significance was declared at P<0.05 and trends at 0.05≤P<0.10. 
5.4. Results 
5.4.1. Experiment 1 
The EEO supplement lost 1.5% of DM after 16 h of rumen incubation and 3.3% 
DM after 48 h. Less than 5% DM disappearance was observed after 72 h of rumen 
incubation (Figure 5.1.). The control (wheat straw) lost 28% of DM after 16 h and 39% 
after 72 h of incubation in the rumen. 
5.4.2. Experiment 2: Animal Intake and Performance 
The encapsulation matrix consisted of exclusively SFA (Table 5.2.) and hence, the 
EEO supplement was comprised of primarily SFA (66.6% of total FA) and only 17% of 
PUFA. Accordingly, the daily intake of SFA was highest on the LEO treatment, 
intermediate during HEO, and lowest during CON. The diets supplemented with either LEO 
or HEO provided more total FA than the CON diet (P<0.001, Table 5.3.). Total PUFA, 
ALA, GLA, SDA, and total n-3 FA intakes increased in each experimental diet.  
The inclusion of EEO in the diet at 1.5% and 3% of DM did not affect milk 
components (Table C.1.). DMI tended to be higher on the HEO treatment when compared 
to the CON treatment (30.4 vs. 27.3 kg/day, respectively; P=0.09, Table 5.3.). This 
coincided with a trend of increased total fecal weight during the HEO treatment when 
compared to CON (8.6 vs. 7.4 kg DM/day, respectively; P=0.06). Milk production tended 
to be higher in the LEO and HEO treatments when compared to CON (44.8 vs. 41.4 kg/day, 
respectively; P=0.07).  
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5.4.3. Milk FA Profile 
The milk fat content of total SFA was lower during the HEO treatment (68.2 
g/100g FA) when compared to CON (69.6 g/100g FA; P=0.007; Table 5.4.), while total 
PUFA were higher during HEO than during CON and LEO (4.52 vs. 3.96, and 4.06 g/100g 
FA, respectively; P<0.001). Total milk n-3 FA increased with increasing EEO 
supplementation (0.41, 0.59, 0.77 g/100g FA for CON, LEO, and HEO, respectively; 
P<0.001). This was driven by the increase of ALA in milk fat with each addition of EEO to 
the diet (0.33, 0.47, 0.59 g/100g for CON, LEO, and HEO, respectively; P<0.001). SDA 
increased in response to EEO supplementation from undetectable in CON to 0.05 and 0.08 
g/100g FA during the LEO and HEO treatments, respectively (P<0.001). The milk fat 
content of eicosapentaenoic acid (20:5 c5,c8,c11,c14,c17; EPA) was higher in HEO-fed 
cows than in CON (0.04 vs. 0.03 g/100g FA; P<0.001). GLA increased with increasing EEO 
supplementation (0.02, 0.04, 0.07 g/100g FA, respectively; P<0.001). Milk fat of HEO-fed 
cows contained a higher content of trans-18:1 FA than LEO- and CON-fed cows (2.56 vs. 
2.03 and 2.23 g/100g FA, respectively; P<0.001). Rumenic acid (18:2 c9,t11), the 
predominant CLA isomer, was highest in HEO (0.58 vs. 0.52, and 0.44 for HEO, LEO, and 
CON, respectively; P<0.001). 
5.4.4. Temporal Incorporation of FA into Milk and Plasma 
The temporal incorporation of EO-derived FA into milk fat is presented in Figure 
5.2. There were no differences in the transfer efficiencies of EEO-derived FA into milk fat 
between LEO and HEO treatments (Table 5.5.). The temporal incorporation of GLA, ALA, 
SDA, and EPA into plasma cholesterol esters (CE), free fatty acids (FFA), phospholipids 
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(PL), and triacylglycerols (TAG) is presented in Figures 5.3.-5.6.  Full FA profiles of all 
plasma lipid fractions are available in Tables C.3.-C.6. 
5.4.5. Fecal FA Output 
The EEO and encapsulation matrix were visually evident in the feces (Figure 
C.1.). Palmitic acid (16:0; PA) made up 52% of the encapsulation matrix, this FA was 
excreted in the feces at a rate of 43% and 39% on the LEO and HEO treatments, 
respectively, vs. 19% on CON (P<0.001; Figure 5.7.). Since ALA was not solely derived 
from the EEO supplement, we only accounted for ALA derived from EEO and normalized 
for the amount of ALA excreted in feces during CON. LEO-fed cows excreted 7% of EEO-
derived ALA while HEO-fed cows excreted 8% of EEO-derived ALA. For both GLA and 
SDA, 12% and 14% of EEO-derived FA remained unabsorbed by LEO- and HEO-fed cows.  
5.5. Discussion 
The objectives of this study were to evaluate the ruminal protection and apparent 
total-tract digestibility of echium oil, using lipid-encapsulation as the encapsulate 
technology, and the incorporation of EO-derived FA into plasma lipid fractions and milk 
fat. Rumen-protection of UFA by lipid encapsulation with hydrogenated oil makes the UFA 
unavailable to bacterial enzymes by increasing the melting point of the fat supplement, 
while decreasing solubility. Hence, the calculation of DM disappearance using the in situ 
nylon bag technique assumes that physical losses are due to the dissociation of FA from the 
supplement, and that biohydrogenation of non-dissociated FA is minimal. To the authors’ 
knowledge, no study has evaluated rumen-stability of lipid-encapsulated oils, although a 
lipid-encapsulated lysine product showed rumen stability at 92-95% of DM after 24 h [18]. 
The negligible loss of DM from the EEO supplement after 72 h of rumen incubation 
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suggests that the product is rumen stable, as average retention time within the rumen is 8-
30 hours depending on particle size, with smaller particles moving more rapidly through the 
rumen than larger particles [19]. 
5.5.1. Milk FA Composition 
The milk FA profile was altered following the inclusion of EEO in the diet, as 
demonstrated previously [10], and contents of ALA, SDA, EPA, total n-3, and GLA were 
similar among studies. The time-course incorporation of EO-derived FA and their 
downstream metabolites into milk fat was evaluated in this study, and, in accordance with 
other studies, incorporation of dietary FA occurred within 2-5 days [20–22]. Incorporation 
of EPA, however, was slower, potentially due to the 25% bioconversion rate of SDA to 
EPA [23]. Bernal-Santos et al. [21] demonstrated that EPA levels in milk plateaued after 
day 3 of ruminal infusion of SDA-rich soybean oil, however, if treatments in the current 
study had been longer, EPA levels in milk and plasma may have increased.  
Total trans 18:1 and CLA were increased in milk fat of the HEO treatment 
suggesting some EEO-derived PUFA were released from the supplement and 
biohydrogenated, which could explain, in part, the lower transfer efficiency of ALA, SDA, 
and GLA into milk fat. However, these increases were negligible, and the increase in 
biohydrogenation intermediates in the HEO vs. LEO treatment did not produce a difference 
in transfer efficiencies between the treatments. In the current study, transfer efficiencies 
were higher than previously shown [10]. This could be due to the method of 
supplementation (top dressed vs. tumble-mixed) as the current study did not allow for EEO 
in refusals. Overall, the transfer efficiencies of ALA, SDA, and GLA in the current study 
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are comparable to other research using rumen-protected flax oil [24] or above the transfer 
efficiencies for EPA and docosahexaenoic acid (DHA) described by Chillard et al. [25]. 
5.5.2 Temporal Incorporation of EO-Derived FA into Plasma Lipid Fractions 
 
When cows are in positive energy balance, only small amounts of PUFA are used 
for energy; instead, these FA are protected from degradation through preferential 
incorporation into plasma PL and CE [26,27], as validated in the current study. n-3 FA are 
preferentially transported in plasma PL and CE so that they can be used as precursors for 
signaling molecules, such as prostaglandins, leukotrienes, eicosanoids, and thromboxanes. 
Stamey et al. [22] also observed a preferential incorporation of the n-3 FA, DHA, into 
plasma PL when supplementing dairy cows with rumen-protected algal oil and algal 
biomass for 7 days.  
Plasma TAG are the primary source of FA to the mammary gland for milk fat 
synthesis, whereas plasma FFA are available for direct uptake, and the utilization of FFA 
is dependent on their plasma concentration [28]. Incorporation of GLA, ALA, and SDA 
into plasma TAG and milk fat both occurred by day 3, demonstrating that a portion of these 
FA were readily available in the small intestine. It is noteworthy that content of EPA in 
plasma TAG was increased on day 4, yet, higher contents in milk fat were not observed 
until day 9. This finding supports the hypothesis by Stamey et al. [29] that the action of 
lipoprotein lipase in the mammary gland is dependent on the FA composition of 
chylomicrons. GLA, ALA, and SDA in plasma TAG did not increase with the additional 
intake of EEO from the LEO to HEO treatment. This suggests that i) increased 
supplementation did not result in increased bioavailability in the small intestine, ii) the 
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metabolism and/or catabolism of these FA increased, or iii) incorporation into tissues 
and/or removal from plasma increased with the additional intake of EEO. 
5.5.3. Apparent Total-Tract Digestibility of EEO 
While consuming the LEO- and HEO-supplemented diets, cows excreted more 
than two-fold ALA (6.7 and 8.2%, respectively) when compared to CON (3.2%), suggesting 
that the lipid encapsulation matrix (hydrogenated vegetable oil) likely inhibited the 
digestibility of PUFA. SFA have been shown to be less digestible than unsaturated fats [30] 
and PA excretion in feces was two-fold higher on LEO and HEO treatments (43 and 39%, 
respectively) in comparison to CON (19%). These data are corroborated by the visual 
evidence of the EEO supplement and encapsulation matrix in the feces of the dairy cows, 
indicating that a large proportion of the supplement passed through the cow unchanged. 
Pappritz et al. [31] examined the digestibility of CLA encapsulated in hydrogenated fat fed 
at 50 and 100 g/day and demonstrated a similar excretion of PA (39.5% and 42.8%, 
respectively) compared to the current study. Digestibility may also be reduced in particular 
with hydrogenated fat supplements which have a higher melting point and lower solubility 
than UFA. A meta-analysis of FA digestibility in ruminants showed that inclusion of 
hydrogenated tallow decreases the intestinal absorption of FA by 23-53% [32]. Moreover, 
Weiss and Wyatt [33] demonstrated a decreased digestibility of a hydrogenated fat source 
(38.1% digestibility) when compared to calcium salts of palm FA (87.5% digestibility). 
Lastly, silica was used as a binder in the encapsulation matrix and hence occurred in the 
EEO supplement. This could have affected the absorption of EO-derived FA as forages 
containing silica have been shown to decrease FA digestibly [34]. 
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Once released, the EO-derived FA may also undergo biohydrogenation in the large 
intestine, leading to heightened fecal output of biohydrogenation intermediates [35]. The 
increased proportions of the biohydrogenation intermediates, such as CLA and trans-18:1 
isomers, as well as the biohydrogenation end product 18:0, in fecal matter during the LEO 
and HEO treatments suggests that EEO-derived PUFA became partly available in the 
animals’ hindgut resulting in microbial biohydrogenation processes. Demeyer et al. [36] 
demonstrated the site of microbial FA modification shifts to the large intestine when high-
fat diets are fed. Similar results were observed by Côrtes et al. [37] who supplemented 19 
g/kg DM as calcium salts of flaxseed oil, resulting in an increased proportion of fecal 18:0, 
causing a negative apparent total-tract digestibility. Fecal CLA and trans-18:1 FA, however, 
were not reported. The time-course adaption of hindgut bacteria to lipid supplementation is 
unknown, thus the authors acknowledge that the short periods in the current study may not 
fully account for the shifting bacterial populations in the hindgut.  
During the HEO treatment, 5% of SDA was incorporated into milk fat and 14% 
was excreted in the feces, resulting in 81% of dietary SDA being unaccounted for. This 
rather large proportion of SDA may have been i) incorporated into tissues, which is 
supported by our observation of increased SDA in plasma PL and CE, ii) biohydrogenatated 
by rumen and/or hindgut microbes, or iii) metabolized (i.e., elongation, desaturation, or β-
oxidation). The increase in CLA and trans-18:1 in milk, plasma lipids, and feces of HEO-
fed cows suggests some SDA may have been biohydrogenated [38]. However, the net 
biohydrogenation of SDA cannot be estimated, as biohydrogenation of SDA follows the 
same pathway of other 18-carbon UFA [39]. SDA that was metabolized into EPA and 
incorporated into milk accounts for an additional 1% of dietary SDA, and fecal excretion of 
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EPA accounts for an additional 3%. EPA was increased in all plasma lipid fractions, yet, 
this study could not assess the percentage of dietary SDA that was converted into EPA and 
transported in plasma, nor the amount of dietary SDA that was subject to β-oxidation or 
converted into signaling molecules. Research shows that transfer efficiencies of SDA into 
milk fat can reach as high as 47% (accounting for down-stream metabolites) when this FA 
is infused into the abomasum [21]. This higher transfer efficiency of PUFA into milk fat in 
comparison to the current rumen-protection technologies suggests future research should 
focus on improving rumen-protection methods to achieve optimal transfer efficiencies of 
PUFA into milk fat. 
5.6. Conclusion 
The successful protection of PUFA from biohydrogenation in the rumen is difficult 
to achieve, with most rumen-protection technologies allowing for some modification of 
PUFA in the rumen. Moreover, if a product is rumen stable, it must subsequently release 
the FA for absorption in the small intestine. This study has demonstrated that the same 
technology that imparts rumen-protection also significantly inhibits the FA availability for 
intestinal absorption, resulting in large proportions being excreted into the feces. In addition, 
EEO-derived PUFA were not incorporated in sufficient proportions into plasma lipid 
fractions available to the mammary gland, leading to an overall low transfer efficiency of 
EEO-derived PUFA into milk fat. Overall, lipid-encapsulation appears to be an inadequate 
rumen-protection method to provide optimal transfer of PUFA into milk fat.    
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5.10. Figures 
 
Figure 5.1. In situ ruminal dry matter (DM) disappearance (%) of EEO and wheat straw 
(control). 
Data are presented as LS means (n=6) and standard error of the mean. 
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Figure 5.2. Temporal pattern of milk fatty acid yield (g/day) of γ-linoleic acid (GLA) [A], α-
linolenic acid (ALA) [B], stearidonic acid (SDA) [C], and eicosapentaenoic acid (EPA) [D] 
from cows on baseline diet (CON: ●), supplemented with 1.5% of DM as encapsulated echium 
oil (EEO) and 1.5% of DM as encapsulation matrix (LEO: ▲), and 3% DM as EEO (HEO:∎).  
Data are presented as LSmeans (n=6) and standard error. *= days significantly different from CON, 
‡= days significantly different from CON and LEO (P<0.05). 
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Figure 5.3. Temporal incorporation (g/100g) of γ-linolenic acid (GLA) [A], α-linolenic acid 
(ALA) [B], stearidonic acid (SDA) [C], and eicosapentaenoic acid (EPA) [D] into plasma 
cholesterol esters of cows on baseline diet (CON), supplemented with 1.5% of DM as 
encapsulated echium oil (EEO) and 1.5% of DM as encapsulation matrix (LEO), and 3% DM 
as EEO (HEO). 
Data are presented as LSmeans (n=6) and standard error. *= days significantly different 
from CON, ‡= days significantly different from CON and LEO (P<0.05). 
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Figure 5.4. Temporal incorporation (g/100g) of γ-linolenic acid (GLA) [A], α-linolenic acid 
(ALA) [B], stearidonic acid (SDA) [C], and eicosapentaenoic acid (EPA) [D] in plasma free 
fatty acids of cows on baseline diet (CON), supplemented with 1.5% of DM as encapsulated 
echium oil (EEO) and 1.5% of DM as encapsulation matrix (LEO), and 3% DM as EEO 
(HEO). 
Data are presented as LSmeans (n=6) and standard error. *= days significantly different 
from CON, ‡= days significantly different from CON and LEO (P<0.05). 
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Figure 5.5. Temporal incorporation (g/100g) of γ-linolenic acid (GLA) [A], α-linolenic acid 
(ALA) [B], stearidonic acid (SDA) [C], and eicosapentaenoic acid (EPA) [D] in plasma 
phospholipids of cows on baseline diet (CON), supplemented with 1.5% of DM as 
encapsulated echium oil (EEO) and 1.5% of DM as encapsulation matrix (LEO), and 3% DM 
as EEO (HEO). 
Data are presented as LSmeans (n=6) and standard error. *= days significantly different 
from CON, ‡= days significantly different from CON and LEO (P<0.05). 
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Figure 5.6. Temporal incorporation (g/100g) of γ-linolenic acid (GLA) [A], α-linolenic acid 
(ALA) [B], stearidonic acid (SDA) [C], and eicosapentaenoic acid (EPA) [D] in plasma 
triacylglycerides of cows on baseline diet (CON), supplemented with 1.5% of DM as 
encapsulated echium oil (EEO) and 1.5% of DM as encapsulation matrix (LEO), and 3% DM 
as EEO (HEO). 
Data are presented as LSmeans (n=6) and standard error. *= days significantly different 
from CON, ‡= days significantly different from CON and LEO (P<0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
152 
 
 
Figure 5.7. Fecal output of EEO-derived FA; palmitic acid (PA) [A], γ-linolenic acid (GLA) 
[B], α-linolenic acid (ALA) [C], stearidonic acid (SDA) [D] in comparison to intake of cows 
on baseline diet (CON), supplemented with 1.5% of DM as encapsulated echium oil (EEO) 
and 1.5% of DM as encapsulation matrix (LEO), and 3% DM as EEO (HEO). 
LSmeans (n=6) and standard error. Means without a common letter differ significantly, 
P<0.05. 
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5.11. Tables 
Table 5.1. Ingredient and nutrient composition of the diets. 
 Treatment 
 CON
a LEOb HEOc 
Ingredient, % of DM    
   Corn silage 28.3 28.3 28.3 
   3rd cut mixed haylage 19.4 19.4 19.4 
   Concentrated 37.2 37.2 37.2 
   Graine 15.2 12.2 12.2 
   Lipid-encapsulated echium 
oil 
 1.5 3.0 
   Encapsulation matrix  1.5  
Nutrient composition    
   DM, % 41.0 40.6 48.0 
   CPf, % DM 15.2 14.4 14.2 
   aNDFomg, % DM 27.6 25.6 26.4 
   NFCh, % DM 38.7 38.7 38.6 
   NEL
i, Mcal/kg 1.6 1.6 1.6 
   Fatty acids, % DM 3.0 5.5 5.3 
aCON: control (0% of DM as encapsulated echium oil), bLEO: 1.5% of DM as 
encapsulated echium oil, 1.5% DM as encapsulation matrix, cHEO: 3% of DM 
as encapsulated echium oil. dConcentrate contained (DM basis) 43.1% ground 
corn, 21.6% amino max, 16.2% citrus pulp, 8.6% canola meal, 5.4% soybean 
meal, 1.9% sodium sesquinate, 1.2% calcium carbonate, 1.0% salt, 0.5% 
magnesium oxide, 0.2% trace minerals, 0.1% vitamin mix, 0.1% Zinpro 
Availa®Plus, and 0.01% rumensin®. eGrain contained (DM basis) 32.6% wheat 
midds, 20.0% steamed flaked corn, 16.1% soybean meal, 8.8% distiller’s 
grains, 6.5% fine corn meal, 4.8% heat-treated soy, 4% cane molasses, 2.2% 
calcium carbonate, 1.5% tallow, 1.4% bakery meal, 1.0% sodium 
sequicarbonate, 0.8% salt, 0.3% trace vitamins, 0.3% magnesium oxide.  fCP: 
Crude protein. gaNDFom: Ash-corrected neutral detergent fiber. hNFC: Non-
fiber carbohydrates. iNEL: Net energy lactation 
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Table 5.2. Fatty acid composition (mg/g DM) of the diet components. 
 
Mixed-rationa Grain EEOb 
Encapsulation 
Matrix 
   Total fatty acids 24.38 51.99 880.3 958.0 
      16:0 3.84 10.13 390.8 520.2 
      18:0 0.56 3.41 254.4 417.5 
      18:1 c9  5.85 12.89 39.61  
      18:2 c9,c12 10.20 21.99 36.05  
      18:3 c6,c9,c12    23.99  
      18:3 c9,c12,c15  2.22 1.53 81.56  
      18:4 c6,c9,c12,c15    31.14  
      ∑ otherc 1.70 2.03 16.54 20.31 
      Total SFAd 4.97 14.30 666.1 958.0 
      Total MUFAe 6.97 14.14 41.41  
      Total PUFAf 12.44 23.55 172.7  
      Total n-3 2.22 1.53 112.7  
      Total n-6 10.22 22.02 60.04  
      n-6/n-3 ratio 4.70 14.38 0.53  
aThe mixed-ration contained: 33.3% corn silage, 22.8% haylage, and 43.8% concentrate, bEEO: encapsulated 
echium oil. cƩ Other: 10:0, 12:0, 14:0, 16:1 c9, 16:1 c8, 16:1 c11, 18:1 c11, 20:0, 20:1 c11, 20:2 c11,c14, 
22:0, 22:1 c13, 20:4 c5,c8,c11,c14, 24:0, 24:1 c15.  dTotal SFA: sum of saturated fatty acids (4:0 to 26:0). 
eTotal MUFA: sum of monounsaturated fatty acids (14:1 to 24:1).  fTotal PUFA: sum of polyunsaturated 
fatty acids (18:2 to 22:5). 
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Table 5.3. Dry matter (kg/day) and fatty acid intake (g/day) of dairy cowsa on CONb, LEOc, 
and HEOd diets. 
 Treatment 
SE P-value 
 CON
b LEOc HEOd 
Dry matter intake, kg/d 27.3 28.0 30.4 1.6 0.09 
Total fatty acids 808.1a 1538.6b 1596.9b 68.20 <0.001 
   16:0 132.6a 508.1b 486.2b 21.26 <0.001 
   18:0 26.94a 312.4c 260.4b 12.07 0.003 
   18:1 c9 197.0a 202.5a 229.3b 9.85 0.016 
   18:2 c9,c12  332.7 341.2 372.9 16.32 0.071 
   18:3 c9,c12,c15  68.77a 84.53b 133.2c 4.96 <0.001 
   18:3 c6,c9,c12  0.00a 10.29b 21.38c 0.72 <0.001 
   18:4 c6,c9,c12,c15 0.00a 13.33b 27.79c 0.94 <0.001 
   Ʃ othere 50.18a 62.40b 64.96b 2.85 0.003 
   Total SFAf 176.6a 854.5c 778.5b 34.61 <0.001 
   Total MUFAg 229.6a 234.2a 262.7b 11.35 0.029 
   Total PUFAh 401.9a 449.9b 555.7c 22.76 <0.001 
   Total n-3 68.77a 97.87b 161.0c 5.88 <0.001 
   Total n-6 333.2a 352.0a 394.8b 16.99 0.013 
aLS means are based on 6 dairy cows per treatment. bCON: control (0% of DM as encapsulated echium 
oil).cLEO: 1.5% of DM as encapsulated echium oil, and 1.5% of DM as encapsulation matrix, dHEO: 3% 
of DM as encapsulated echium oil. eƩ Other: 10:0, 12:0, 14:0, 16:1 c9, 16:1 c8, 16:1 c11, 18:1 c11, 20:0, 
20:1 c11, 20:2 c11,c14, 22:0, 22:1 c13, 20:4 c5,c8,c11,c14, 24:0, 24:1 c15.  fTotal SFA: sum of saturated 
fatty acids (4:0 to 26:0). gTotal MUFA: sum of monounsaturated fatty acids (14:1 to 24:1).  hTotal PUFA: 
sum of polyunsaturated fatty acids (18:2 to 22:5). 
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Table 5.4. Content of selected fatty acids (g/100g FA) in milk fat of dairy cowsa on CONb, 
LEOc, and HEOd diets. 
Fatty acid 
Treatment 
SE P-value 
CON LEO HEO 
16:0 32.66a 33.19a 31.47b 0.77 0.009 
18:0 9.52ab 8.92b 9.80a 0.27 0.025 
18:1 t11 0.95a 1.04a 1.23b 0.08 <0.001 
18:1 c9 17.67 17.53 17.58 0.71 ns 
18:2 c9,c12 1.96 1.95 2.06 0.10 ns 
18:3 c6,c9,c12 0.02a 0.04b 0.07c 0.00 <0.001 
18:3 c9,c12,c15 0.33a 0.47b 0.59c 0.02 <0.001 
18:2 c9,t11 0.44b 0.52b 0.58a 0.03 <0.001 
18:4 c6,c9,c12,c15 0.00c 0.05b 0.08a 0.00 <0.001 
20:4 c5,c8,c11,c14 0.13 0.13 0.12 0.00 ns 
20:5 c5,c8,c11,c14,c17 0.03b 0.03b 0.04a 0.00 <0.001 
22:5 c7,c10,c13,c16,c19 0.04 0.04 0.04 0.00 ns 
de novoe 27.58 27.35 27.03 0.39 ns 
Mixedf 34.98a 35.47a 33.54b 0.85 0.003 
Preformedg 35.07b 34.99b 37.05a 1.11 0.004 
Total SFAh 69.55a 69.12ab 68.18b 0.93 0.007 
Total MUFAi 24.62 24.88 25.14 0.76 ns 
Total PUFAj 3.69b 4.06b 4.52a 0.17 <0.001 
Total n-6k 2.30 2.30 2.37 0.09 ns 
Total n-3l 0.41c 0.59b 0.77a 0.02 <0.001 
n-6:n-3 ratio 5.63a 3.85b 3.10c 0.03 <0.001 
Total trans 18:1 2.03b 2.23b 2.56a 0.14 <0.001 
Total CLAm 0.48b 0.55ab 0.61a 0.04 <0.001 
Total odd and branched-chain FA 1.62a 1.48b 1.49b 0.04 0.003 
aLS means are based on 6 dairy cows per treatment. LS means without a common letter differ 
significantly (P<0.05). bCON: control (0% of DM as encapsulated echium oil). cLEO: 1.5% of DM as 
encapsulated echium oil, and 1.5% of DM as encapsulation matrix, dHEO: 3% of DM as encapsulated 
echium oil. ede novo: sum of fatty acids <16 carbons. fMixed: sum of 16:0 and 16:1 c9. gPreformed: sum 
of fatty acids >16 carbons.  hTotal SFA: sum of saturated fatty acids (4:0 to 26:0). iTotal MUFA: sum of 
monounsaturated fatty acids (14:1 to 24:1). jTotal PUFA: sum of polyunsaturated fatty acids (18:2 to 
22:5).  kTotal n-6: sum of n-6 PUFA: 18:2 c9,c12, 18:3 c6,c9,c12, 20:2 c11,c14, 20:3 c8,c11,c14, 20:4 
c5,c8,c11,c14, and 22:4 c7,c10,c13,c16. lTotal n-3: sum of n-3 PUFA: 18:3 c9,c12,c15, 18:4 
c6,c9,c12,c15, 20:3 c11,c14,c17, 20:4 c8,c11,c14,c17, 20:5 c5,c8,c11,c14,c17, and 22:5 
c7,c10,c13,c16,c19. mTotal CLA: sum of conjugated linoleic acid isomers: 18:2 c9,t11, 18:2 c9,c11, 18:2 
t7,t9, and 18:2 t10,t12. 
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Table 5.5. Transfer efficienciesa (%) of fatty acids derived from encapsulated-echium 
oil into milk fat. 
 Treatment 
SE P-Value 
 LEOb HEOc 
18:3 c6,c9,c12 4.74 4.36 0.86 ns  
18:3 c9,c12,c15 9.01 7.46 0.78 ns  
18:4 c6,c9,c12,c15 5.92 5.19 0.48 ns  
18:4 c6,c9,c12,c15 plus 20:5 
c5,c8,c11,c14,c17d 
6.98 6.30 0.65 ns 
 
aLS means are based on 6 dairy cows per treatment. bLEO: 1.5% of DM as encapsulated echium 
oil, and 1.5% of DM as encapsulation. cHEO: 3% of DM as encapsulated echium oil. d18:4 
c6,c9,c12,c15 (SDA) plus 20:5 c5,c8,c11,c14,c17 (EPA): [((SDA + EPA (g/day) in milk fat of 
treatment) – (SDA + EPA (g/day) in milk fat of control))/ SDA (g/day) in diet]*100. 
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CHAPTER 6 : MILK FROM COWS GRAZING ON COOL-SEASON 
PASTURES PROVIDES AN ENHANCED PROFILE OF BIOACTIVE FATTY 
ACIDS COMPARED TO THOSE GRAZED ON A MONOCULTURE OF PEARL 
MILLET. 
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6.1. Abstract 
The demand for grass-fed dairy products is driven, in part, by their more desirable 
fatty acid (FA) profile, containing more n-3 FA and conjugated linoleic acids (CLA) than 
conventionally produced dairy products.  This study investigated the effects of pearl millet 
(PM) vs. cool-season pasture (CSP) on animal performance and milk FA in a grazing 
system. Eight Holstein dairy cows were used in a repeated measures design with four-week 
periods. Forage type had no effect on animal performance (estimated dry matter intake, 
milk production, fat, or protein). The contents of CLA and n-3 FA in a serving of whole 
milk (3.25% fat) increased when cows grazed a CSP compared to PM. A serving of whole 
milk from cows grazing PM had a higher content of saturated FA and branched-chain FA. 
In conclusion, the contents of various bioactive FA were higher in milk fat of cows grazing 
a CSP compared to PM. 
Highlights 
 Evaluated effect of millet vs. pasture on milk production and bioactive fatty acids. 
 Milk production, milk fat and protein yield did not differ between grazing regimes. 
 CLA were increased in a serving of whole milk when cows grazed cool-season 
pasture 
 Milk from cows grazed on pasture had a 2-fold greater n-3 fatty acid content.  
6.3. Introduction 
The demand for organic food in the United States (U.S.) is primarily driven by 
the favorable view of its nutritional content and the ecological benefits of its production 
(Lee & Yun, 2015). Organic milk, for example, contains higher amounts of the bioactive 
compounds, n-3 fatty acids (FA) and conjugated linoleic acids (CLA), than conventionally 
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produced milk (Butler, Stergiadis, Seal, Eyre, & Leifert, 2011). This demand for foods with 
added nutritional value is reflected by the 25% increase in organic whole-milk sales from 
2014 to 2015, in comparison to a <1% increase for low-fat and fat-free versions (Maltby, 
2016). It is not the effect of the management system (organic vs. conventional) per se, but 
the consequence of the dietary feeding regime associated with the management system that 
leads to the improved milk FA profile of organic milk (Butler et al., 2008). The feeding 
regimen on any particular dairy farm is driven by economic, philosophic, and regulatory 
factors (McBride & Greene, 2009). For example, the U.S. Department of Agriculture 
(USDA), requires organic dairy producers to have 30% of their cows’ dry matter intake 
(DMI) come from pasture for a 120-day grazing season (U.S. Department of Agriculture, 
2010). While the inclusion of fresh forage in the diet of dairy cows leads to an improved 
milk FA profile, not all forage species affect the milk FA profile in the same way. Turner 
et al. observed a higher content of n-3 FA in milk when cows grazed birdsfoot trefoil (Lotus 
corniculatus L.) in comparison to ryegrass (Turner, Waghorn, Woodward, & Thompson, 
2005), and Soder et al. demonstrated an increased content of CLA in milk with additional 
forage species in the pasture (3, 6, and 9 species mixtures vs. 2 species mix) (Soder, 
Sanderson, Stack, & Muller, 2006). There has been no evaluation, however, of the 
influence of summer annual species on the milk FA profile. Summer annuals are C4 plants 
that grow rapidly and are more productive during the hot-summer months when cool-
season (C3) perennial plants experience reduced growth and productivity. Therefore, C4 
plants contribute to the dry matter needed to meet the energy demands of the animal and 
the regulations of the USDA, making them increasingly popular on Northeastern U.S. 
grass-based dairies. Thus, the objective of this study was to compare the effects of grazing 
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a warm-season annual, pearl millet (Pennisetum glaucum L.), on forage quality, animal 
performance, and bioactive FA in milk with a cool-season diverse pasture. 
6.4. Material and Methods 
6.4.1. Experimental Design 
All procedures involving animals were approved under the University of Vermont 
Institutional Animal Care and Use Committee. Eight multiparous (parity: 2.9 ± 0.6 
lactations) mid-lactation (179 ± 20 days in milk) Holstein cows were used in a repeated 
measures design on a commercial organic dairy farm in northwest Vermont. The treatments 
consisted of two grazing regimes; a diverse cool-season pasture (CSP) and a warm-season 
monoculture of pearl millet (PM) (Table 6.1.). PM was chosen because it can be grazed 
directly as soon as it reaches 60 cm, is palatable and produces high yields, is drought 
tolerant, is adapted to low pH soils, and lacks prussic acid. Cows were grazed on CSP or 
PM for four-week periods from the months of July to September 2014 in the following 
sequence: PM, CSP, and PM (the final grazing period was intended to account for the effect 
of growing month on PM). A 0.5 ha paddock of previously established CSP was chosen 
based for its uniform composition of forage species and proximate location to the pearl 
millet on the farm. The CSP consisted of more than 15 species; orchard grass (Dactylis 
glomerata L.), timothy grass (Phleum pretense L.), perennial ryegrass (Lolium perenne L.), 
junegrass (Koeleria macrantha (Ledeb.) Schult.), meadow fescue (Festuca pratensis 
Huds.), smooth bromegrass (Bromus inermis L.), creeping bentgrass (Agrostis palustris 
Huds.), quack rass (Elymus repens (L.) Gould.), kentucky bluegrass (Poa pratensis L.), 
white clover (Trifolium repens L.), red clover (Trifolium pretense L.), common vetch 
(Vicia sativa L.), dandelion (Taraxacum officinale H.F. Wigg), burdock (Arctium minus 
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Bernh.), milk weed (Asclepias syriaca L.), and bull thistle (Cirsium vulgare (savi) Ten.) 
consistently made up the majority. Two 0.25 ha paddocks were tilled and seeded at 22.4 
kg/ha with PM in two-week successions to eliminate the effect of maturity on forage 
composition. The paddocks were re-seeded in the same manner for the second grazing of 
PM. The average mean daily temperatures for each treatment period were 20.0 for PM, 
18.9 for CSP, and 17.3°C for the second grazing of PM. Cows received grain at 2.42 kg/day 
(DM basis) during each treatment. The cows were milked twice daily at 0630h and 1730h 
and after each milking cows were rotated to a new paddock. 
6.4.2. Data and Sample Collection 
Dry matter intake was estimated using an electronic rising plate meter (Jenquip; 
Feilding, New Zealand) three times per week by taking sixty measurements each in both 
pre-grazed and post-grazed paddocks. The rising plate meter was calibrated weekly by 
taking ten 0.2m2 quadrats, cut to ground level, in both pre and post-grazed paddocks for a 
total of twenty measurements per week. Samples were dried at 65°C for 48 hours to 
determine dry matter content (DM). DM (kg) of these samples was plotted against the 
pasture height/density to obtain an equation with an R2 > 0.8. Rising plate meter values 
were used in the equation derived from the calibration to obtain kg of DM consumed by 
the eight dairy cattle per ha. Estimated DMI per cow was then calculated from measured 
pasture areas and the number of cows grazing the pasture. Forage samples for quality 
measurements were collected weekly from the next paddock in the pasture rotation. Thirty 
samples, clipped to the height of the post-grazed paddock, were composited then divided 
into forage classes; grasses, legumes, broad-leaf weeds, and dead matter. Each fraction was 
dried at 65°C to determine DM and ground through a Wiley Mill (Arthur H. Thomas, 
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Philadelphia, PA) with a 2mm screen and then through an Udy Mill (UDY Corporation; 
Fort Collins, CO) with 1mm screen. Ground forage samples were analyzed by near-infrared 
reflectance spectroscopy (NIRS) for forage quality. Milk weights and samples were 
collected during weeks 3 and 4 of each period from both AM and PM milking. Samples 
were composited by weight and one aliquot was frozen at -20°C for FA analysis. A second 
aliquot was preserved with 2-bromo-2-nitropropane-1,3 diol and analyzed by mid-infrared 
spectroscopy by Lancaster DHIA (Manheim, PA) for total fat, protein, ands organic solids.  
6.4.3. Milk and Forage FA Analysis 
Forage and milk FA compositions were determined by the method of Bainbridge 
et al. (Bainbridge, Lock, & Kraft, 2015). A typical chromatograph produced by this method 
is presented in Figure D.1. The content (mg) of individual FA in a serving (244g) of whole 
milk (3.25% milk fat (U.S. Department of Agriculture Agricultural Research Service, 
2008)) was calculated as follows, assuming milk fat to be 93.3% of FA (Glasser, Doreau, 
Ferlay, & Chilliard, 2007): 
 Total FA per serving (mg) = 7.93g fat/serving x 0.933 x 1000 
 FA per serving (mg) = Total FA per serving (mg) x [FA proportion (g/100g) / 
100] 
6.4.4. Statistical Analyses 
Data were analyzed by a repeated-measures ANOVA using the PROC MIXED 
procedure in SAS 9.4 (SAS Institute, Cary, NC). All statistical analyses were performed 
considering the guidelines presented by Granato et al. (Granato, de Araújo Calado, & 
Jarvis, 2014). The statistical model included the random effect of cow, fixed effect of 
treatment and residual error. The REPEATED statement included week within period with 
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the SUBJECT=cow option. The effect of treatment x period was originally included in the 
model and then removed because P>0.15. The Kenward-Roger approximation was used 
for computing the denominator degrees of freedom for the tests of fixed effects resulting 
from the model. Least-squares (LS) means were generated for treatments using the 
LSMEANS/DIFF option to display the results. Significance was declared at P<0.05 and 
trends at 0.05≤P<0.10. 
6.5. Results and Discussion 
6.5.1. Diet Composition 
PM contained a higher amount of neutral-detergent fiber (NDF) and acid-
detergent fiber (ADF), while CSP provided more starch, protein, and non-fiber 
carbohydrates (NFC) (Table 6.1.). These findings are comparable to previous studies 
demonstrating that warm-season grasses, like PM, have lower digestibility and crude 
protein levels than cool-season grasses (Ball et al., 2001). Cool-season grasses have been 
shown to contain greater amounts of unsaturated FA (UFA) to resist cold temperatures, 
while warm-season grasses, such as PM, contain less UFA to minimize lipid peroxidation 
caused by high temperatures (Bell, 2011). Accordingly, the PM in this study, contained 
less monounsaturated FA (MUFA), polyunsaturated FA (PUFA), and total n-3 FA, and n-
6 FA than CSP (Table 6.1.). The lower PUFA content could also be due to PM being 
grazed at a mature stage (between boot and milk stages; 37 to 51 days of maturity), as 
PUFA content has been shown to decrease as forages mature (Glasser et al., 2013). The 
FA profile of CSP was similar to that of cool-season pasture species evaluated by Dewhurst 
et al. (n-3 FA range: 10.33 – 15.28 g/kg DM) (Dewhurst et al., 2001). This study is the 
first to characterize the FA profile of PM. 
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6.5.2. Animal production parameters 
DMI, milk yield, energy-corrected milk, fat-corrected milk, and milk components 
did not differ between treatments of CSP and PM (Table 6.2.) and thus, producers would 
not gain any additional production premiums from grazing PM. No studies have compared 
the effects of cool-season and warm-season forages on dairy cow performance; however, 
studies have examined the effects of increasing the number of forage species. Muir et al. 
observed no differences in production parameters between cows grazing a monoculture of 
perennial rye grass and a mixture of perennial ryegrass and chicory (Muir, Ward, & Jacobs, 
2014), and Soder et al. showed no benefit to production when cows grazed forage mixtures 
of two-to-nine species (Soder et al., 2006). 
6.5.3. FA content in a serving of whole milk (3.25% fat) 
Grazing regime had a significant effect on the FA composition of milk that would 
be available to the consumer. A serving of whole milk from cows on the CSP treatment 
provided more MUFA (2289 vs. 2131 mg/serving 3.25% milk; P<0.01) and PUFA (433 
vs. 319 mg/serving 3.25% milk; P<0.001) than a serving of whole milk from cows on PM. 
The health benefits of increasing these FA classes in the diet have been widely reported, 
including decreased risk for cardiovascular disease and protection against metabolic 
disease (Dolecek, 1992; Gillingham, Harris-Janz, & Jones, 2011; Mensink & Katan, 1989), 
however, the numerically small increases in this study may not impart biological effects. 
Although no studies have described the effects of warm-season annuals on milk FA 
composition, Varnold et al. evaluated the effects of warm-season annuals on beef FA 
composition. The results showed a decrease in UFA, MUFA, and PUFA in steaks of cows 
grazing warm-season grasses in comparison to a cool-season pasture (Varnold et al., 2014). 
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Our study suggests that warm-season grasses, such as PM, show a similar decrease in fatty 
acids—and that future studies should examine whether this distinction is the result of 
reduced diversity or warm-season vs. cool-season pastures.  
Bovine milk fat contains many unique rumen-derived FA such as BCFA, CLA, 
and trans 18:1 isomers. Total trans 18:1 FA were higher in a serving of whole milk from 
cows grazing CSP than those grazing on PM (403 vs. 273 mg/serving 3.25% milk; 
P<0.001). Ruminant-derived trans-FA do not impart the same deteriorative health effects 
as industrially produced trans-FA (Rice, Kraft, Bauman, & Lock, 2010). In fact, the main 
trans-FA isomer in milk fat, vaccenic acid (VA; trans-11 18:1), has been shown to have 
health benefits, such as reducing tumor growth and the risk for atherosclerosis (Field, 
Blewett, Proctor, & Vine, 2009; Lock, Horne, Bauman, & Salter, 2005). A serving of whole 
milk from CSP-fed cows provided an additional 125 mg of VA per serving than milk from 
cows grazing PM (327 vs. 202 mg/serving 3.25% milk; P<0.001). VA is converted to 
rumenic acid (RA; cis-9, trans-11 18:2) through the action of delta-9 desaturase at an 
average rate of 19% in the human body (Turpeinen et al., 2002). The content of RA was 
higher in cows fed CSP (150 vs. 105 mg/serving 3.25% milk for CSP and PM treatments, 
respectively; P<0.01). A serving of whole milk from cows grazing CSP also had a higher 
content of total CLA when compared to PM (163 vs. 116 mg/serving 3.25% milk; P<0.01). 
Ritzenthaler et al. estimated dietary CLA intakes of men and women and found on average 
men consume 212 mg of CLA/d and women to consume 151 mg/day (Ritzenthaler et al., 
2001). Three servings of whole milk from CSP-fed cows would provide 489 mg/d of CLA 
and three servings of milk from cows on PM would provide 348 mg/d of CLA. Both are 
over the intakes presented by Ritzenthaler et al., but lower than the amount of CLA 
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supplemented to observe decreased tumor proliferation in women with breast cancer (7.5 
g/day) and improved blood lipid profile in healthy adults (19.6 g/day) (McGowan et al., 
2013; Wanders, Brouwer, Siebelink, & Katan, 2010). However, Aro et al. observed a 60% 
reduction in risk of breast cancer for postmenopausal women who consumed the highest 
quantile of CLA per day (203 mg CLA/d) (Aro et al., 2001). Branched-chain FA (BCFA) 
are an emerging class of bioactive FA, unique to dairy products, that have been shown to 
improve pancreatic β-cell function and have an anti-tumor effect (Kraft, Jetton, Satish, & 
Gupta, 2015; Wongtangtintharn, Oku, Iwasaki, & Toda, 2004). Contents of individual 
BCFA; iso-14:0, iso-15:0, and iso-16:0, were higher in a serving of whole milk from cows 
grazing PM when compared to CSP (Table 6.3.). BCFA are derived from the membranes 
of rumen bacteria, and therefore the increase in the content of these FA in milk from PM-
fed cows is likely due to the change or increase in the bacterial populations (Vlaeminck, 
Fievez, Cabrita, Fonseca, & Dewhurst, 2006). 
There is a large body of evidence demonstrating the bioactivity of n-3 FA 
(Fleming & Kris-Etherton, 2014; Pan et al., 2012; Zhao et al., 2004), which has, in turn, 
caused an increase in consumer demand for products enriched in n-3 FA (i.e., functional 
foods). Total n-3 FA were approximately 2-fold higher in a serving of whole milk from 
cows grazing a CSP than cows grazing PM (78.7 vs. 43.0 mg/serving 3.25% milk; 
P<0.001). Consequently, a serving of whole milk from cows on the CSP contained the 
highest contents of ALA (62.8 vs. 29.6 mg/serving 3.25% milk; P<0.001) and 
Eicosapentaenoic acid (EPA) (5.2 vs. 4.5 mg/serving 3.25% milk; P<0.05). Recommended 
intake for n-3 FA is 1.6 g/day for men and 1.1 g/day for women, with 10% of the total as 
EPA and docosahexaenoic acid (DHA) (Institute of Medicine of the National Academies, 
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2005). Three servings of whole milk from cows grazed on CSP would provide 0.24 g/day 
of n-3 FA. This contributes 15-22% of the recommended n-3 FA intake while three 
servings of whole milk from cows grazed on PM would contribute 8-9% of the 
recommended intake. A survey of retail milk samples from conventional and organic 
systems showed that, on average, conventionally produced milks contain 40.0 mg of n-3 
FA per serving, while organically produced milks contain 60.7 mg n-3 FA per serving 
(O’Donnell, Spatny, Vicini, & Bauman, 2010). Consuming organic milk from cows grazed 
on PM would provide a n-3 FA content (43.0 mg/serving) similar to that of conventional 
milk, validating that it is not organic dairy management, but the feeding management that 
can drastically enhance the milk FA profile. Total n-6 FA were lower in a serving of milk 
from cows grazing PM than those grazing CSP (76.6 vs. 96.6 mg/serving 3.25% milk; 
P<0.001). n-6 FA compete with n-3 FA for the same enzymes in the bioconversion to 
eicosanoid products such as prostaglandins, thromboxanes, and leukotrienes. The end 
products have opposing physiological effects, eicosanoids derived from n-6 FA have potent 
inflammatory properties, while eicosanoids produced from n-3 FA are anti-inflammatory 
(Poudyal, Panchal, Diwan, & Brown, 2011). Thus, the ratio of n-6/n-3 FA in the diet should 
be kept under 4:1 to reduce risk of disease (Simopoulos, 2016). Whereas both grazing 
regimes produced low ratios, the n-6/n-3 ratio was lower in milk of cows grazing the CSP 
(1.2) than in those grazing PM (1.8). 
6.6. Conclusion 
The link between diet and health has generated increased demand for functional 
food products that may improve/maintain health without drastic changes to the diet. 
Demand for organic whole-milk is increasing due to its bioactive FA content, and there is 
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potential for dairy producers to optimize milk FA through the dietary feeding regime. This 
study is the first to show that planting diverse CSP can be an important management regime 
for farmers in the northeast U.S. looking to enhance the FA profile in their milk. In contrast, 
we have demonstrated that inclusion of PM, a summer annual, resulted in lower contents 
of CLA and n-3 FA in milk fat, which were similar to that in conventionally produced milk. 
Hence, inclusion of PM in the diet of dairy cows should be limited to maintain levels of 
bioactive FA in organic dairy products. The effects of PM grazed during the vegetative 
stage need to be evaluated, as this may produce a less drastic reduction in milk bioactive 
FA. 
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6.9. Tables 
Table 6.1. Ingredient and chemical composition (mean ± standard deviation) of the 
diet components, cool-season pasture (CSP), pearl millet (PM), and grain. 
 
Diet component 
CSP PM Grain
a 
    %DM 19.3 ± 2.4 19.9 ± 2.6 89.6 ± 0.6 
Chemical composition, % DM    
    aNDFomb 42.5 ± 3.3 53.7 ± 5.0 7.4 ± 1.7 
    ADFc 32.8 ± 2.1 40.5 ± 1.3 10.0 ± 1.4 
    CP (N x 6.25)d 17.4 ± 2.3 14.4 ± 2.3 11.9 ± 1.0 
    Starch 2.1 ± 0.2 1.2 ± 0.2 30.4 ± 1.1 
    NFCd 24.9 ± 0.7 18.4 ± 1.3 64.1 ± 3.3 
    Total fatty acids 2.4 ± 0.2 1.3 ± 0.2 2.4 ± 0.1 
Fatty acid composition (mg/g DM)    
16:0 4.13 ± 0.11 2.93 ± 0.67 4.26 ± 0.41 
18:0 0.41 ± 0.01 0.26 ± 0.05 0.56 ± 0.06 
18:1 c9 0.74 ± 0.10 0.26 ± 0.05 6.63 ± 0.44 
18:2 c9,c12 5.08 ± 0.31 1.83 ± 0.36 10.72 ± 0.96 
18:3 c9,c12,c15 12.04 ± 0.96  6.49 ± 0.93 0.69 ± 0.10 
Ʃ otherf 1.32 ± 0.23 1.16 ± 0.22 0.70 ± 0.09 
Total SFAg 5.57 ± 0.04 4.10 ± 0.84 5.19 ± 0.49 
Total MUFAh 0.93 ± 0.13 0.49 ± 0.18 6.89 ± 0.43 
Total PUFAi 17.17 ± 1.91 8.33 ± 1.26 11.45 ± 1.04 
Total n-3 FA 12.07 ± 0.96  6.51 ± 0.94 0.72 ± 0.08 
Total n-6 FA 5.13 ± 0.35 1.84 ± 0.36 10.76 ± 0.95 
aThe grain consisted of: 47.5% organic corn meal, 16.9% organic whole grain barley, 15.0% 
organic field peas, 12.5% organic wheat middings, 3.75% calcium carbonate, 1.5% sodium 
bicarbonate, 1.5% salt, 0.75% kelpmeal, 0.35% magnesium oxide, and 0.25% concentrated base 
vitamins consisting of: amino acid chelate, manganese amino acid chelate, copper amino acid 
chelate, vitamin E supplement, selenium yeast, zinc sulfate, zinc hydroxychloride, vitamin A 
acetate, vitamin D3 supplement, basic copper chloride, sodium selenite, cobalt carbonate, biotin, 
calcium iodate. baNDFom = Ash-corrected neutral detergent fiber. cADF = Acid detergent fiber. 
dCP = Crude protein. eNFC = Non-fiber carbohydrate = 100 - (NDF + CP + ether extract + ash). 
fƩ other: 12:0; 14:0; 15:0; 16:1 c9; 17:0; 18:1 c11; 20:0; 18:3 c6,c9,c12; 20:2 c11,c14; 22:0; 22:1 
c13; 20:4 c5,c8,c11,c14; 24:0; 24:1 c15. gSFA = Saturated fatty acids. hMUFA = Monounsaturated 
fatty acids. iPUFA = Polyunsaturated fatty acids. 
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Table 6.2. Dry matter intake, milk yield, and components of dairy cowsa 
grazing a cool-season pasture (CSP) and pearl millet (PM). 
 
 Treatment 
P value 
CSP  PM 
Dry matter intake  17.42 ± 0.27  17.22 ± 0.23 0.35 
Milk yield (kg/day)  13.12 ± 1.25  13.76 ± 1.23 0.82 
3.5% FCMb  12.64 ± 1.14  13.13 ± 1.10 0.54 
ECMc  12.57 ± 1.08  13.04 ± 1.04 0.48 
Milk components (kg/day)      
    Fat  0.43 ± 0.04  0.44 ± 0.04 0.39 
    Crude protein  0.40 ± 0.03  0.41 ± 0.03 0.46 
    Organic solids  0.73 ± 0.07  0.76 ± 0.06 0.78 
Milk components (%)       
    Fat  3.38 ± 0.02  3.24 ± 0.02 0.12 
    Crude protein  3.11 ± 0.10  3.01 ± 0.09 0.17 
    Organic solids   5.54 ± 0.04  5.54 ± 0.04 0.66 
a
Least-squares (LS) means ± standard error are based on n = 8 dairy cows. b3.5% Fat-
corrected milk = [0.4324 x milk yield (kg/d)] + [16.216 x fat yield (kg/d)]. cEnergy-
corrected milk = [12.82 x fat yield (kg/d)] + [7.13 x protein yield (kg/d)] + [0.323 x 
milk yield (kg/d)].  
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Table 6.3. Fatty acid contents (mg per serving) in 3.25% milk of dairy 
cowsa grazing a cool-season pasture (CSP) and pearl millet (PM). 
Fatty acid 
 Treatment 
P value 
CSP  PM 
4:0  228.4 ± 7.23  219.8 ± 7.02 0.16 
5:0  4.00 ± 0.33  3.76 ± 0.27 0.60 
6:0  119.0 ± 3.72  125.0 ± 3.39 0.16 
7:0  0.77 ± 0.10  0.99 ± 0.08 0.11 
8:0  60.02 ± 2.63  65.03 ± 2.31 0.14 
9:0  1.14 ± 0.12  1.01 ±0.10 0.32 
10:0  122.7 ± 4.89  137.3 ± 4.78 0.09 
11:0  17.96 ± 1.72  21.28 ± 1.64 0.06 
12:0   150.4 ± 6.54  171.5 ± 6.09 0.06 
iso 13:0  4.50 ± 0.15  3.81 ± 0.12 0.007 
anteiso 13:0  5.86 ± 0.53  6.82 ± 0.50 0.09 
13:0  10.04 ± 0.60  11.58 ± 0.53 0.048 
iso 14:0  13.03 ± 0.52  15.58 ± 0.42 0.007 
14:0  647.2 ± 18.9  726.4 ± 15.5 0.011 
iso 15:0  29.99 ± 1.21  34.49 ± 0.97 0.020 
anteiso 15:0  50.52 ± 1.46  54.03 ± 1.25 0.08 
14:1 c9  69.96 ± 7.59  83.76 ± 7.37 0.045 
15:0  105.3 ± 2.70  109.0 ± 2.13 0.32 
iso 16:0  23.24 ± 0.95  28.61 ± 0.74 0.003 
16:0  1911 ± 74.4  2254 ± 67.7 0.003 
iso 17:0  48.57 ± 1.62  46.41 ± 1.29 0.33 
16:1 t9  2.41 ± 0.60  3.33 ± 0.52 0.23 
16:1 c7  2.36 ± 0.14  1.71 ± 0.10 0.009 
16:1 c8  21.21 ± 0.82  23.40 ± 0.72 0.048 
anteiso 17:0  29.00 ± 1.52  35.46 ± 1.14 0.014 
16:1 c9  96.97 ± 9.98  108.0 ± 9.86 0.10 
16:1 c10/t13  6.51 ± 0.67  5.82 ± 0.64 0.27 
16:1 c11  11.26 ± 0.57  9.06 ± 0.49 0.017 
17:0  58.50 ± 1.21  59.07 ± 1.03 0.70 
17:1 t10  3.66 ± 0.17  4.29 ± 0.13 0.028 
17:1 c8  1.74 ± 0.22  2.49 ± 0.19 0.025 
17:1 c9  20.42 ± 0.50  21.96 ± 0.39 0.047 
18:0  893.3 ± 75.1  765.7 ± 74.2 0.023 
18:1 t6-8  22.30 ± 1.14  19.61 ± 0.96 0.09 
18:1 t9  18.06 ± 0.58  15.29 ± 0.45 0.007 
18:1 t10  17.42 ± 1.32  18.65 ± 1.02 0.49 
18:1 t11  326.5 ± 16.4  201.6 ± 14.6 <0.001 
18:1 t12  16.63 ± 1.15  16.65 ± 0.92 0.95 
18:1 t13/t14  35.40 ± 2.77  32.97 ± 2.15 0.51 
18:1 c9  1536 ± 36.8  1465 ± 30.2 0.16 
18:1 c11  30.43 ± 1.04  28.06 ± 0.84 0.11 
18:1 c12  7.26 ± 0.41  5.65 ± 0.36 0.011 
18:1 c13  4.20 ± 0.21  3.90 ± 0.17 0.32 
18:1 c14/t16  25.63 ± 1.46  21.37 ± 1.23 0.045 
18:1 c15  5.29 ± 1.61  14.07 ± 1.40 0.002 
18:2 t10,t14  9.17 ± 0.81  5.96 ± 0.77 0.004 
18:2 t9,t12  11.16 ± 0.65  7.41 ± 0.49 0.003 
18:2 c9,t13/t8,c12  17.55 ± 0.80  15.18 ± 0.62 0.05 
cyclohexyl-11 11:0  6.19 ± 0.36  6.33 ± 0.27 0.76 
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18:2 c9,t14  7.71 ± 0.51  7.09 ± 0.43 0.35 
18:1 c16  3.62 ± 0.29  3.49 ± 0.24 0.72 
18:2 c12,t16  4.08 ± 0.24  1.78 ± 0.18 <0.001 
18:2 t11,c15  54.89 ± 2.07  37.90 ± 1.52 <0.001 
18:2 c9,c12  83.12 ± 1.91  65.19 ± 1.62 <0.001 
20:0  14.23 ± 0.87  13.40 ± 0.82 0.32 
20:1 c9  10.01 ± 0.38  10.35 ± 0.31 0.50 
18:3 c9,c12,c15  62.76 ± 1.43  29.57 ± 1.11 <0.001 
18:2 c9,t11  150.0 ± 6.50  104.8 ± 5.85 <0.001 
18:2 c9,c11  8.33 ± 0.53  7.55 ± 0.39 0.29 
18:2 t11,t13  2.18 ± 0.19  1.76 ± 0.15 0.15 
18:2 t7,t9/t10,t12  1.70 ± 0.15  1.63 ± 0.12 0.75 
20:2 c11,c14  3.50 ± 0.14  2.99 ± 0.11 0.027 
22:0  7.31 ± 0.45  6.30 ± 0.44 0.026 
20:3 c8,c11,c14  4.44 ± 0.20  3.38 ± 0.16 0.005 
20:4 c5,c8,c11,c14  5.25 ± 0.26  5.22 ± 0.20 0.94 
23:0  5.24 ± 0.38  3.34 ± 0.33 0.003 
20:5 c5,c8,c11,c14,c17  5.17 ± 0.23  4.47 ± 0.19 0.042 
24:0  5.19 ± 0.38  5.82 ± 0.36 0.12 
22:5 c7,c10,c13,c16,c19  8.30 ± 0.39  7.74 ± 0.31 0.29 
Unknown  63.64 ± 1.46  54.13 ± 1.11 0.002 
Total SFAb  4404 ± 49.1  4663 ± 38.5 0.004 
Total MUFAc  2289 ± 42.2  2131 ± 33.9 0.021 
Total PUFA  432.5 ± 8.79  319.1 ± 6.64 <0.001 
Total 18:1 trans  402.9 ± 18.2  273.0 ± 16.0 <0.001 
Total n-6 FAd  96.55 ± 2.13  76.57 ± 1.83 <0.001 
Total n-3 FAe  78.70 ± 1.94  42.98 ± 1.57 <0.001 
n-6:n-3 ratio  1.23 ± 0.04  1.80 ± 0.04 <0.001 
Total CLAf  162.7 ± 6.82  116.3 ± 5.94 <0.001 
Total OBCFAg  442.5 ± 8.13  472.4 ± 6.49 0.022 
a
Least-sqaures (LS) means ± standard error are based on n = 8 cows. bTotal 
SFA: all saturated fatty acid (4:0 to 26:0). cTotal MUFA: all monounsaturated 
fatty acids (14:1 to 24:1). dTotal n-6 FA: all n-6 fatty acids; 18:2 c9,c12; 18:3 
c6,c8,c12; 20:2 c11,c14; 20:3 c8,c11,c14; 20:4 c5,c8,c11,c14; and 22:4 
c7,c10,c13,c16. eTotal n-3 FA: 18:3 c9,c12,c15; 20:3 c11,c14,c17; 20:5 
c5,c8,c11,c14,c17; 22:5 c7,c10,c13,c16,c19; and 22:6 c4,c7,c10,c13,c16,c19. 
fTotal CLA: all detected conjugated linoleic acid isomers: 18:2 c9,t11, 18:2 
t11,t13, and 18:2 t7,t9/18:2 t10,t12. gTotal OBCFA: all odd and branched-chain 
fatty acids (5:0 to 23:0). 
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7.1. Abstract 
Rumen microorganisms are the origin of many unique fatty acids (FA) found in 
ruminant-derived food products. Altering rumen microbial communities through grazing 
regime can potentially enhance the quantity and profile of these bioactive FA that are 
available for incorporation into milk. Thus, the objective of this study was to identify 
rumen bacteria, protozoa, and their cellular FA when cows grazed pearl millet (PM) in 
comparison to a cool-season pasture (CSP). Individual rumen digesta samples were 
obtained from five Holstein dairy cows used in a repeated measures design with 28-day 
periods. DNA was extracted from rumen digesta, sequence reads were produced with the 
Illumina Miseq platform, and bioinformatics were performed using MOTHUR. FA were 
identified in rumen bacteria and protozoa using gas-liquid chromatography/mass 
spectroscopy. Microbial communities shifted in response to grazing regime, bacteria of the 
phylum Bacteriodetes were more abundant during PM than CSP (62.2% vs. 53.1% 
abundance; P=0.004). While protozoa of the genus Eudiplodinium were more abundant 
during CSP than PM (29.2% vs. 7.3% abundance; P=0.004). Consequently, microbial 
membrane FA profiles differed between treatments. Bacteria and protozoa from cows 
grazing CSP contained more n-3 FA and vaccenic acid, but lower contents of odd and 
branched-chain FA. Bacterial and protozoal FA correlated with bacterial and protozoal 
taxa, as well as, levels of vaccenic acid, rumenic acid, and α-linolenic acid in milk. In 
conclusion, grazing regime can be used to alter microbial communities and therefore shift 
the FA profile of microbial cells, and subsequently alter the milk FA profile. 
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7.2. Introduction 
Ruminants play a critical role in our food system, converting forages otherwise 
indigestible to humans, into valuable sources of protein, fat, and nutrients (i.e., meat and 
milk) for human consumption. Ruminants can utilize forages because of their mutualistic 
relationship with bacteria and protozoa that reside within their rumen, fermenting forage 
carbohydrates into volatile fatty acids (VFA), which are usable as an energy source by the 
host animal. Rumen bacteria and protozoa are also an important source of fatty acids (FA) 
to the animal, providing 10-20% of the available lipids to the dairy cow1. The lipids derived 
from rumen microorganisms are incorporated into meat and milk products, thus providing 
a wide array of unique FA with bioactivity.  
Branched-chain FA (BCFA) are unique to the cell membranes of bacteria, because 
bacteria use BCFA to regulate the fluidity of their membranes2. BCFA possess several 
health benefits such as, anti-cancer activity3,4, reducing the risk of necrotizing enterocolitis 
in newborns5, and improving β-cell function6. Odd-chain FA (OCFA) are produced 
through microbial de novo lipogenesis using the fermentation product, propionate, as a 
substrate2. Plasma contents of OCFA in humans have been linked with a decreased risk of 
coronary heart diseases (CVD)7 and type 2 diabetes8. Rumen bacteria biohydrogenate 
forage-derived unsaturated FA producing several biohydrogenation intermediates such 
conjugated linoleic acids (CLA) and vaccenic acid (18:1 t11; VA), that have been shown 
to reduce tumor growth9 and risk for CVD10. n-3 FA are widely known for their anti-
inflammatory, anti-carcinogenic, and cardio-protective effects11,12. Typically, n-3 FA are 
found at low concentrations (<1% of total FA) in dairy products13 because dietary n-3 FA 
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are subject to biohydrogenation by rumen bacteria at a rate of 85-100%14, hence there has 
been interest in discovering ways to increase the content of n-3 FA in dairy products.  
Protozoa are less numerous than bacteria in the rumen (104–106 cells/mL vs. 1010–
1011 cells/mL, respectively)15, but because of their larger size (protozoa; 10-200μm, 
bacteria; 0.5-2μm)16, protozoa make up half of the rumen microbial biomass, and thus, 
supply a large proportion of the microbial FA leaving the rumen17. Protozoa facilitate the 
escape of unsaturated FA from the rumen by engulfing chloroplasts18, as defaunation 
resulted in a 13% and 10% reduction in the flow of monounsaturated FA (MUFA) and 
polyunsaturated FA (PUFA), respectively, to the duodenum19. Therefore, altering the 
number and type of rumen protozoa and bacteria may be a novel way to increase the amount 
of bioactive FA in ruminant products.   
Diet is the main factor driving the shift in rumen microbial communities, and 
many researchers have demonstrated a change in the number and type of rumen bacteria 
and/or protozoa in response to supplemental oils20, high-grain diets21, and a switch from 
total-mixed ration (TMR) to pasture22. In addition, Vlaemick et al.23 demonstrated a shift 
in the FA composition of bacterial cellular membranes with an increasing 
forage:concentrate ratio. Yet, no studies have evaluated the change in cellular FA that could 
accompany the shift in microbial communities when cows graze different pasture regimes.  
The availability and productivity of summer pastures is a concern for grass-based 
dairy producers in the Northeast United States. Summer annuals (C4 species; i.e. 
sudangrass, sorgum, millet) are increasingly popular on grass-based dairy and beef farms, 
as they grow well during the hot summer months when cool-season perennial pastures (C3 
species; i.e. perennial ryegrass, red clover, and orchard grass) experience less growth. 
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Summer annuals generally have more structural carbohydrates (cellulose and 
hemicellulose) and less PUFA than cool-season species due to the differences in plant 
structure and leaf anatomy24, and therefore may favor the proliferation of differing bacteria 
and protozoa in the rumen than a cool-season pasture. We hypothesized that dairy cows 
grazing on the summer annual, pearl millet, in comparison to the native cool-season 
pasture, will shift the rumen microbial community structures (i.e., bacteria and protozoa) 
and alter their cellular membrane FA composition, resulting in an altered milk FA profile. 
The objectives of this study were to i) identify and quantify the rumen bacteria and protozoa 
when cows graze pearl millet in comparison to a cool-season pasture, ii) evaluate the shift 
in microbial membrane FA, and iii) correlate the microbial genera with rumen fermentation 
parameters, cellular FA composition, and FA in milk. 
7.3. Materials and Methods 
7.3.1. Experimental design 
Procedures involving animals were approved under the University of Vermont Animal 
Care and Use Committee. This research is part of a larger study that has been previously 
reported, and a detailed account of the experimental design can be found therein25. Briefly, 
five multiparous (parity: 3.0 ± 0.7 lactations) mid-lactation (171 ± 21 days in milk) Holstein 
dairy cows were used in a repeated measures design with 28-day periods. The treatments 
consisted of two grazing regimes; a diverse cool-season pasture (CSP) and a warm-season 
monoculture of pearl millet (PM) (Table 7.1.). Cows were grazed on CSP and PM in the 
following sequence; PM, CSP, then PM. PM was selected because it is palatable, produces 
high yields, and is drought tolerant. Cows were supplemented grain at 2.4 kg/day (DM 
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basis) during the entirety of the study. After each milking (2x/day) wows were rotated to a 
new paddock. All cows had continuous access to water. 
7.3.2. Forage data and sample collection 
An electronic rising plate meter (Jenquip; Feilding, New Zealand) was used to 
estimate dry matter intake as described previously25. Weekly forage samples for quality 
measurements were collected from the next pasture in the paddock rotation. Each fraction 
was dried at 65°C to determine DM. Forage samples were ground through a Wiley Mill 
(Arthur H. Thomas, Philadelphia, PA) with a 2mm screen and then through an Udy Mill 
(UDY Corporation; Fort Collins, CO) with a 1mm screen. Forage samples were analyzed 
for quality using near-infrared reflectance spectroscopy. 
7.3.3. Rumen sample collection and processing 
On a weekly basis, one L of whole rumen digesta was collected via esophageal 
intubation at 900h starting on day 2 of each period; cows were cut off from feed at 600h. 
Individual samples were thoroughly mixed and pH recorded (Fisher Scienctific Accumet 
Portable Laboratory pH meter, model AP110, Pittsburgh, PA). Two aliquots (50 mL) were 
taken for VFA and microbial identification/quantification, snap frozen in a dry ice and 
ethanol bath, and stored at -80°C until further analyses. The remaining rumen digesta (800 
mL) was used to fractionate rumen bacteria and protozoa by the methods of Or-Rashid et 
al.26 and Lee et al.27 with modification by Bainbridge et al.28. Bacteria and protozoa 
fractions were confirmed under a microscope to contain <5% feed particulate, and were 
subsequently lyophilized (FreeZone Plus 2.5, Labconoco, Kansas City, MO) and stored at 
-20°C.  
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7.3.4. FA analyses 
Forage FA were analyzed by the method of Bainbridge et al.29, VFA were analyzed 
by gas chromatography28, and microbial FA were analyzed by gas-liquid 
chromatography/mass spectroscopy28.  
7.3.5. DNA extraction, PCR amplification, and bioinformatics analyses 
Microbial DNA was extracted from rumen digesta using the method of Yu and 
Morrison28 and modifications by Cersosimo et al.31. Bacteria were identified through 
amplification of the V1-V3 region of the 16S rRNA gene31 and protozoa were identified 
by amplification of the 18S rRNA gene as described prevously32. Molecular Research DNA 
Laboratories (MRDNA; Shallowater, TX) sequenced the PCR products using Illumina 
MiSeq v.3. Real-time PCR was used to asses bacterial and protozoal densities and was 
performed as described by Bainbridge et al.28 and Cersosimo et al.32, respectively. All 
bioinformatics for 16S and 18S rRNA amplicons were performed in-house by the methods 
of Bainbridge et al.28 and Cersosimo et al.32. Briefly, Perl Scripts (courtesy of Dr. Benoit 
St. Pierre, available upon request) were used to screen for quality (>Q30) and remove 
sequences without a forward or reverse primer. The ‘unique.seqs’ command in MOTHUR 
(v. 1.36.1) was used to determine unique sequences. Conserved regions were aligned using 
Perl scripts, and the alignment was manually checked. The ‘chimera.uchime’ command 
was used to remove chimeric sequences and a subsample of 15,000 sequences per sample 
was used in the ‘classify.seqs’ command. Sequences were classified down to genus level 
with an 80% confidence threshold. Sequence data sets are publically available through 
NCBI’s Sequence Read Archive, under accession numbers [SRP080847] and 
[SRP080931]. 
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7.3.6. Statistical Analysis 
The PROC MIXED procedure in SAS 9.4 (SAS Institute, Cary, NC) was used to 
analyze data using a repeated measures ANOVA. The statistical model included the fixed 
effect of diet, the fixed effect of week, and the random effect of cow. The fixed effect of 
diet x period was included in the model and removed if P>0.10, otherwise data were 
presented for each period. The Kenward-Roger approximation was used for computing the 
denominator degrees of freedom for the tests of fixed effects resulting from the model. 
Least-squares (LS) means and standard error (SE) were generated using the 
LSMEANS/DIFF option to display the results. The treatment effect was assessed using 
data from the last week of each period. Correlation matrices were created using the ‘cor’ 
function in RStudio, the statistical computing and graphics software (v. 3.3.0), with default 
parameters (Pearson correlation) and the ‘corrplot’ package. Significance was declared at 
P<0.05 and trends at 0.05≤P<0.10. 
7.4. Results 
7.4.1. Forage quality and FA composition 
The forage quality and FA composition differed between grazing regimes (Table 
7.1.). There was a higher content of neutral detergent fiber (NDF) and acid-detergent fiber 
(ADF) in PM, while CSP contained a higher content of protein, starch, and total FA. The 
FA composition of the grazing regimes varied greatly, CSP contained over 2-fold more 
linoleic acid (LA, 18:2 c9,c12) and almost 2-fold more α-linolenic acid (ALA, 18:2 
c9,c12,c15) than PM. The CSP also contained more MUFA in comparison to PM (Table 
7.1.).   
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7.4.2. Rumen parameters 
The total rumen VFA concentration (mM) differed between grazing regimes; cows 
grazed on PM had a higher molar proportion of VFA than cows grazing a CSP (Table 7.2.). 
There were no differences in VFA profiles. The pH of rumen digesta tended to be lower 
when cows grazed PM vs. CSP (P = 0.052; Table 7.2.).  
7.4.3. Rumen protozoal communities 
Sequences were classified into two orders of ciliate protozoa, Entodiniomorphida 
(62.2% abundance) and Vestibuliferida (37.8% abundance), which did not differ by 
treatment. The most abundant genus within the Vestibuliferida order across all samples 
was Dasytricha (36.4% abundance) followed by Isotricha (11.4% abundance; Table 7.3.). 
The most abundant genera within the Entodiniomorphida order were unclassified species 
of the Ophryoscolecidae family (20.0% abundance), Ostracodinum (13.0% abundance), 
Entodinium (11.6% abundance), Eudiplodinium (10.0% abundance), and Anoplodinium 
(2.4% abundance). Isotricha tended to be more abundant when cows grazed PM (25.8% 
abundance) in comparison to CSP (3.0% abundance; P=0.053). While, unclassified species 
of the Ophryoscolecidae family tended to be more abundant on CSP than PM (28.9% vs. 
15.0% abundance for CSP and PM, respectively; P=0.076). When cows grazed PM, 
protozoa of the genus Entodinium were more abundant within the rumen than when cows 
grazed CSP (14.0% vs. 2.3% abundance for PM and CSP, respectively; P=0.005). 
Eudiplodinium were more abundant in rumen digesta of cows grazing CSP than PM (29.2% 
vs. 7.3% abundance, respectively; P=0.004). Grazing regime altered the densities of 
protozoa within the rumen; cows grazed on CSP had higher protozoal densities than cows 
grazed on PM (4.99 vs. 4.18 log10 cells/mL, respectively; P=0.004).  
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7.4.4. FA composition of rumen protozoa 
The FA composition of rumen protozoal cell membranes was affected by grazing 
regime (Table 7.4.). Total saturated FA (SFA) constituted a higher proportion of protozoal 
membranes when cows grazed CSP in comparison to PM (58.45 vs. 54.80 g/100g FA, 
respectively; P=0.009). Protozoa membranes in cows grazing CSP had a higher content of 
trans-18:1 isomers over cows grazing PM (10.80 vs. 7.38 g/100g FA, respectively; 
P=0.002), while a diet of PM resulted in higher total OBCFA in protozoal membranes 
(10.85 vs. 8.90 g/100g FA for PM and CSP, respectively; P=0.027). The n-6 FA, LA, was 
higher in protozoal membranes when cows grazed PM in comparison to CSP (12.54 vs. 
7.37 g/100g FA, respectively; P<0.001) while the n-3 FA, ALA, was nearly 2-fold higher 
when cows grazed CSP (6.59 vs. 3.54 g/100g FA for CSP and PM, respectively; P<0.001). 
7.4.5. Correlations between protozoal communities, VFA, and protozoal FA 
The only protozoal genus to correlate with rumen VFA was Anoplodinium, which 
was positively correlated with butyric acid (R=0.41; P<0.05; Figure E.1.). Dasytricha was 
negatively correlated with rumen pH (R=-0.39; P<0.05).  
The proportion of VA in protozoal membranes was positively correlated to the 
genera Anoplodinium and Eudiplodinium (R = 0.50 and 0.45, respectively; P<0.01; Figure 
7.1.), while VA in protozoal membranes was negatively correlated to the genus Isotricha 
(R =-0.52; P<0.01). Protozoa of the genus Entodinium were negatively correlated with 
PUFA and n-3 FA in the protozoal cell membranes (R=-0.47 for both; P<0.01), whereas 
Anoplodinium and Eudiplodinium were positively correlated with n-3 FA in protozoal cell 
membranes (R = 0.41; P<0.05 and 0.52; P<0.01), respectively). 
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7.4.6. Rumen bacterial communities 
Rumen bacterial density increased when cows grazed PM in comparison to CSP 
(10.20 vs. 9.30; P = 0.006). The two predominant bacterial phyla observed in the rumen 
were Bacteroidetes (57.6% abundance) and Firmicutes (37.7% abundance). Bacteria from 
the phylum Bacteriodetes were more abundant during PM than CSP (62.2% vs. 53.1% 
abundance, respectively; P=0.004) and Firmicutes were more abundant during CSP than 
PM (41.3% vs. 32.6% abundance, respectively; P<0.05). The only other phylum detected 
at >1% abundance was Proteobacteria (1.2% abundance). The most abundant bacterial 
genus, Prevotella, was higher in cows grazing PM when compared to CSP (53.87 vs. 
41.88% abundance, respectively; P=0.035). Bacterial genera within the Firmicutes phylum 
were more abundant during the CSP treatment (Table 7.5.). The genus Butyrivibrio 
constituted 3.60% of total rumen bacteria when cows grazed CSP, whereas only 1.64% of 
total bacteria were Butyrivibrio when cows grazed PM (P=0.003). Abundance of bacteria 
belonging to the genus Coprococcus and Roseburia were higher on CSP (Coprococcus: 
1.86 vs. 1.32% for CSP and PM, respectively; P=0.034; Roseburia: 1.12 vs. 0.70% for CSP 
and PM, respectively; P=0.034). Unclassified bacteria of the Lachnospiraceae family were 
more abundant in response to grazing CSP than PM (6.68 vs. 4.86%, respectively; 
P=0.029) while unclassified bacteria of the Ruminococcaceae family were less abundant 
when cows grazed PM (4.86 vs. 7.15% for PM and CSP, respectively; P=0.038).  
7.4.7. FA composition of rumen bacteria 
Cows grazing CSP and PM had differing FA profiles of rumen bacterial cell 
membranes (Table 7.6.). Total SFA comprised the largest proportion of bacterial cell 
membranes and were higher when cows grazed PM (78.71 vs. 76.46 g/100g FA for PM 
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and CSP, respectively; P=0.015). MUFA were the next most prevalent class of bacterial 
FA and constituted a higher proportion of cell membranes when cows grazed CSP (16.78 
vs. 15.00 g/100g FA for CSP and PM, respectively; P=0.029). Total trans-18:1 isomers 
were higher in bacterial cell membranes of cows grazing CSP over cows grazing PM (12.02 
vs. 9.25 g/100g FA, respectively; P=0.009). The most notable difference in bacterial FA 
was seen in BCFA; total BCFA constituted a higher proportion of bacterial cell membranes 
in cows grazing PM vs. grazing CSP (13.03 vs. 9.70 g/100g FA for PM and CSP, 
respectively; P=0.021). The individual BCFA; aiso 13:0, iso 14:0, iso 15:0, anteiso 15:0, 
iso 16:0, and iso 17:0 were all higher in bacterial cell membranes of cows grazing PM 
(Table 7.6.).  
7.4.8. Correlations between bacterial communities, VFA, and protozoal FA 
 Bacteria belonging to the genus Prevotella positively correlated with the 
proportion of propionic acid in the rumen (R=0.41) and negatively correlated with rumen 
pH (R=-0.44; P<0.05; Figure E.2.). There were no other significant correlations between 
rumen bacteria and VFA within the rumen.  
 iso 14:0 (R>0.42), aiso 15:0 (R>0.53), 15:0 (R>0.47), and total BCFA (R>0.51) 
were positively correlated with bacteria of the genus Prevotella and the phylum 
Bacteroidetes (P<0.05) (Figure 7.2.). Unclassified bacteria of the Ruminococcaceae 
family were negatively correlated with total BCFA (R=-0.53) and individual OBCFA; iso 
14:0 (R=-0.48), aiso 15:0 (R=-0.57), iso 16:0 (R=-0.53), and 15:0 (R=-0.48) (P<0.01). The 
proportion of VA in bacterial membranes was positively correlated with the abundance of 
unclassified Porphromonadaceae (R=0.40), Butyrivibrio (R=0.44), unclassified 
Ruminococcaceae (R=0.48), and total Firmicutes (R=0.46), but negatively correlated with 
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Prevotella (R=-0.56) and total Bacteroidetes (R=-0.55) (P<0.05). The content of ALA in 
bacterial membranes was positively correlated with the abundance of Butyrivibrio 
(R=0.44) and Pseudobutyrivibrio (R=0.42), and negatively correlated with unclassified 
bacteria of the class Clostridia (R=-0.45) and the order Clostridiales (R=-0.42) (P<0.05). 
Contrarily, unclassified bacteria of the class Clostridia and the order Clostridiales were 
positively correlated with RA in rumen bacterial membranes (R=0.46; P<0.05). OCFA 
were positively correlated with bacteria from the phylum Proteobacteria (R=0.55) and 
negatively correlated with bacteria from the phylum Firmicutes (R=-0.42; P<0.05).  
7.4.9. Correlations between bacterial and protozoal communities, cellular FA, and 
milk FA 
The content of 15:0 and 17:0 in milk was positively correlated with the content of 
15:0 in bacterial cell membranes (R=0.40 and 0.41, respectively; P<0.05) (Figure 7.3.). 
VA in milk fat was positively correlated with levels of VA and ALA in bacterial 
membranes (R=0.42 and 0.40, respectively; P<0.05). The content of milk RA was also 
positively correlated with content of VA in bacterial cell membranes (R=0.56 and 0.58, 
respectively; P<0.01). The level of ALA in milk was positively correlated to the amount 
of ALA in bacterial and protozoal membranes (R=0.43 and 0.62, respectively; P<0.05). 
The content of RA in protozoal cells was correlated to the content of RA, VA, CLA, ALA, 
and total n-3 FA in milk (R=0.61, 0.61, 0.51, 0.62, and 0.46, respectively; P<0.05). 
Furthermore, the content of ALA in protozoal cells was also correlated to the content of 
RA, VA, CLA, ALA, and total n-3 FA in milk (R=0.52, 0.46, 0.62, 0.62, and 0.46, 
respectively; P<0.05). 
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Butyrivibrio species were negatively correlated with content of 17:0 in milk (R=-
0.42; P<0.05) (Figure 7.4.). The protozoal genus, Isotricha, were positively correlated 
with milk contents of 15:0 (R=0.53; P<0.01). Bacteria of the genus Butyrivibrio 
demonstrated a strong positive correlation with the content of VA, RA, and CLA in milk 
(R=0.58, 0.50, 0.47, respectively; P<0.01). The contents of milk ALA and total n-3 FA 
were positively correlated with the bacterial genus Butyrivibrio (R=0.41 and 0.39, 
respectively; P<0.01) and the protozoal genus Eudioplodinium (R= 0.45; P<0.01). 
Unclassified bacteria of the Porphromonadaceae family were negatively correlated with 
the content of OBCFA in milk (R=-0.52; P<0.01), while protozoa of the genus Isotricha 
were positively correlated with milk content of OBCFA (R=0.44; P<0.05).  
7.5. Discussion 
Rumen microorganisms contain unique FA such as OBCFA, and create 
biohydrogenation intermediates (e.g., VA and CLA) that are incorporated into milk fat, 
making it one of the most diverse fats in nature, containing over 400 different FA33. These 
FA also impart bioactive health effects in humans consuming ruminant-derived food 
products. Altering microbial communities and their FA metabolism through diet 
modification can potentially enhance the quantity and profile of these bioactive FA that are 
available for incorporation into milk and meat. Thus, the aim of this study was to examine 
the effect of grazing regime, on the rumen microbial populations and their cellular FA 
composition, and correlate these data with the previously reported milk FA profile25.  
As shown in previous studies28,32,34, the content of SFA was higher in bacterial cell 
membranes than protozoal cell membranes, and UFA were higher in protozoa cells than in 
bacterial cell membranes. The proportions of most FA and the differences in FA 
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proportions between bacteria and protozoa observed in the current study were similar to 
those reported by Or-Rashid et al.34 derived from cows fed a TMR. There were, however, 
a few exceptions; the proportions of ALA and trans-18:1 isomers in bacterial cell 
membranes were 4-fold and 3-fold higher in the current study, and the proportion of ALA 
in rumen protozoal cell membranes was 3-fold higher in this study, presumably as a result 
of the feeding of fresh pasture. Yet, the content of total CLA was over 2-fold higher in 
rumen protozoal cells from cows fed TMR34 than from rumen protozoal cells of the 
pasture-fed cows in the current study. The identity of rumen bacteria and protozoa was not 
determined by Or-Rashid et al.34 and thus, the reason for this discrepancy cannot be 
elucidated.  
VA is the major trans-18:1 isomer formed during the biohydrogenation of dietary 
PUFA. Ruminant fats are the primary source of VA in the human diet and research 
demonstrates VA to possess health benefits11,35. We have previously demonstrated that 
milk content of VA is higher when cows graze a CSP in comparison to PM25, and in the 
current study, have further shown that the VA content of bacterial cell membranes is 
positively correlated with the VA content of milk. The bacterial genus Butyrivirbrio has 
been shown to accumulate VA in the rumen36, confirming the correlation observed in this 
study between Butyrivirbio species and the content of VA in bacterial membranes and milk. 
Research demonstrates that Butyrivibrio species and the Firmicutes genera, Roseburia and 
Ruminococcus, metabolize LA preferentially to VA, rather than to other biohydrogenation 
intermediates37. Thus, the higher content of LA in the CSP diet combined with the 
increased abundance of Butyrivibrio species in the rumen of cows on CSP may have 
contributed to the higher VA content in microbial cell membranes and consequently in 
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milk. This study demonstrated that dietary modification can be used to alter microbial 
populations and therefore modify biohydrogenation processes resulting in changes to the 
milk FA profile. 
Protozoa do not directly participate in the biohydrogenation process38,39, yet, they 
incorporate biohydrogenation intermediates, such as VA and CLA, into their membrane 
lipids38. The quantity and flow rate of protozoa from the rumen is a subject of debate, 
nevertheless, recent research agrees that flow rate is dependent on protozoa type, as 
holorich protozoa migrate to the ventral reticulorumen to prevent being transported out of 
the rumen, while Entodiniomorphids are strongly associated with feed particles, and 
therefore readily leave the rumen with digesta19. Regardless of species, research shows that 
protozoa account for 20-34% of the total VA and 35-43% of RA leaving the rumen40. It 
has been hypothesized that this is because of the preferential incorporation of UFA into 
their cell membranes to maintain cell fluidity and function38. Thus, protozoa appear to play 
an important role in the protection of UFA in the rumen and contribute to the flow of UFA 
to the small intestine18. There was an increased proportion of VA in protozoal cell 
membranes of cows grazing CSP, presumably as a result of the higher amount of LA in the 
pasture and hence, increased subsequent biohydrogenation intermediates in the rumen for 
engulfment by rumen protozoa. Huws et al.41 also described a higher VA content in 
protozoa of steers offered fresh grass in comparison to hay. Our study has shown that 
increasing the content of VA in protozoal cells correlates to increased bioactive FA in milk, 
such as VA and RA. Hence, modification of diet to increase production of VA by rumen 
bacteria, in addition to the engulfment and incorporation of this FA by rumen protozoa to 
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prevent further biohydrogenation, may be an effective strategy to increase the content of 
bioactive FA in milk. 
VA is the primary driver of RA synthesis in the mammary gland through the action 
of delta-9-desaturase42. Therefore, increasing the availability of VA to the mammary gland 
increases the content of RA in milk. Ruminant products are the largest contributor to RA 
intake in the human diet43, and increased evidence suggests that RA imparts health 
benefits10,44. Several bacterial species are known to produce RA and VA, including 
Butyrivibrio45,46 and Roseburia47, which were identified in this study, and several bacteria, 
not reported in this study, such as Bifidobacteria, Lactobacilli, and Propionibacteria48. 
Although multiple bacterial species are involved in the biohydrogenation process, it has 
been suggested that the main bacteria performing biohydrogenation are cellulolytic49, 
potentially explaining the generally higher contents of RA in ruminant products from 
pasture-fed cows. There was no difference between the RA content of rumen bacteria when 
cows grazed CSP and PM, yet, there was an increase in milk total RA when cows grazed 
CSP. Thus, it can be hypothesized that bacteria contribute to milk contents of RA through 
increasing the supply of VA to the mammary gland, which is confirmed by the positive 
correlation between the content of VA in bacterial membranes and the content of total RA 
in milk. 
Protozoa may play an important role in the conservation of RA in the rumen as the 
content of RA in rumen fluid was 2-fold higher in faunated vs. defaunated cattle on a TMR 
diet50. Yet, we observed no significant correlation between RA content in protozoa and RA 
content of milk. Devillard et al.38 analyzed the FA composition of protozoa isolated from 
monofaunated sheep and found Entodinium caudatum to contain high contents of CLA. 
  
194 
 
This is similar to the results of the current study, observing a moderate correlation between 
Entodinium species and the proportion of RA in protozoa. However, this correlation did 
not persist between the abundance of Entodinium and the content of RA in milk, 
presumably because of the overall low abundance of Entodinium observed in the rumen. 
The low concentration of CLA observed in Isotricha species by Devillard et al.38 was also 
supported by the negative correlation found between RA and Isotricha in the current study. 
Cersosimo et al.32 also showed a positive correlation between Entodinium species and the 
content of RA in protozoal cells and a negative correlation between Isotricha species and 
RA in three breeds of dairy cow across a lactation. Thus, future research may focus on 
increasing the abundance of Entodinium species in the rumen to potentially enhance the 
amount of RA in ruminant-derived products. 
The content of ALA in protozoal cells was strongly correlated with the ALA 
content in milk, demonstrating the potential to use protozoa as a tool to increase the 
bioactive FA content of milk. The higher content of ALA in protozoa is purported to be a 
result of their ability to engulf chloroplasts which contain approximately 60% ALA in their 
thylakoid membranes51. Huws et al.18 noted a higher concentration of ALA in protozoal 
cells of steers that were fed fresh perennial ryegrass when compared to straw and 
concentrate. Moreover, the higher content of ALA coincided with an increased ingestion 
of chloroplasts by rumen protozoa18. There is a greater content of chloroplasts in leaf tissue 
than in stem tissue, and as a result of the differences in plant anatomy, cool-season grasses 
generally have a higher leaf to stem ratio than warm-season grasses24. Hence, we 
hypothesize that CSP provided a higher chloroplast content than PM, leading to increased 
ingestion of chloroplasts by rumen protozoa, which contributed to the 2-fold increase in n-
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3 FA observed in protozoal cell membranes and milk from cows grazing CSP in 
comparison to PM. Fluorescence microscopy has revealed chloroplasts to be present in 
39.7% of protozoa in cows on both hay and fresh grass diets, and only 5.5% of those had 
greater than 10 chloroplasts per cell41. In particular, the protozoal genera Epidinium, 
Polyplastron, and Diplodinium contained greater than 10 chloroplasts per cell18,41. These 
genera, however, were observed at lower abundances in the current study than in previous 
research32, highlighting the further enrichments that can be made to the n-3 FA content of 
rumen protozoa from cows grazing CSP if these genera can be made more prolific. A 
correlation between the protozoal genus Eudiplodinium and the content of ALA in 
protozoal cells was observed, which persisted to a correlation between Eudiplodinium and 
the content of ALA in milk fat. 
Bacteria synthesize OCFA de novo through the elongation of propionate in the 
rumen and BCFA through the enlongation of valerate, or alteration and elongation of α-
keto acids, derived from branched-chain amino acids3. As a result, OBCFA are unique to 
dairy products and are often used as biomarkers for dairy intake in humans52. In addition, 
OBCFA are an emerging class of bioactive FA, shown to increase membrane fluidity53, 
reduce tumor growth3, and could be important to neurological function, as levels of OCFA 
were reduced in cerebrospinal fluid of those with Alzheimer’s disease54. In addition, levels 
of 15:0 and 17:0 in plasma appear to correlate with risk for disease, exhibiting an inverse 
relationship with development of type 2 diabetes and CVD53. The OCFA, 15:0, tended 
(P=0.054) to be higher in bacterial cell membranes when cows grazed PM and the content 
of 15:0 and total OCFA correlated with the abundance of bacteria in the phylum 
Bacteroidetes and the genera Prevotella within the Bacteroidetes phylum. Other research 
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has previously shown Prevotella to be enriched with 15:0 (12.1 g/100g FA)55, compared 
to other bacterial genera, exhibiting potential for this bacterium to be targeted for 
modification to enhance the content of OCFA in ruminant products. Indeed, the abundance 
of Prevotella was positively correlated with the content of 15:0 and 17:0 in milk fat. Total 
BCFA and all individual BCFA were higher in the bacterial cell membranes of cows 
grazing PM. Vlaemick et al.23 demonstrated a higher proportion of BCFA in rumen bacteria 
when the forage NDF content of the diet increased. The PM provided more NDF than CSP 
and thus, could presumably be the primary driver of the increased BCFA in bacteria and 
subsequently milk from cows on the PM treatment. Bacteria of the genus Prevotella were 
positively correlated with several individual BCFA, while unclassified bacteria of the 
Ruminococceae family were negatively correlated with BCFA. These correlations were 
not observed when we previously evaluated the relationship between bacterial cell 
membrane FA and bacterial taxa in three breeds of dairy cows consuming a TMR28, 
presumably due to the differing diets. Although it has been previously suggested that the 
OBCFA profile of FA leaving the rumen is more reflective of the abundance of specific 
bacterial taxa than of available substrate56, this study demonstrates the additional 
importance of the diet, in relation with the bacterial taxa, as a factor affecting the bacterial 
FA profile leaving the rumen. 
7.6. Conclusion 
Understanding the contributions of FA derived from rumen microorganism to the 
FA composition of ruminant products is key to establishing novel strategies to optimize 
the bioactive FA content of milk and meat for human health maintenance and promotion. 
This study is the first to evaluate the effect of two different grazing regimes on rumen 
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bacterial and protozoal communities, the subsequent shift in the FA of their cell 
membranes, and their relation to milk FA. We have demonstrated that the interaction 
between dietary lipids and rumen bacteria alters the production of unique bioactive FA and 
that protozoa have a potential role in preserving these key bioactive FA within the rumen 
for incorporation into milk. The higher n-6 and n-3 FA content of the CSP led to a 
substantial increase in n-3 FA and the biohydrogenation intermediate VA in bacterial and 
protozoal cell membranes and subsequently an increase in the milk content of VA and n-3 
FA of cows on the CSP treatment. Furthermore, the interaction of grazing regime and 
bacterial communities resulted in a greater content of OBCFA in microbial membranes of 
cows grazing PM, which lead to an increase in OBCFA in the milk of cows grazing PM. 
In conclusion, there is potential to increase the content of bioactive FA in dairy products 
through management of the diet, shifting rumen microbial communities, resulting in altered 
FA available to the mammary gland. Future research should focus on tailoring the diet to 
induce shifts in the rumen microbial communities to achieve maximal escape of bioactive 
FA from the rumen. 
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7.9. Tables 
Table 7.1. Ingredient and chemical composition (mean ± standard deviation) of the 
diet components, cool-season pasture (CSP), pearl millet (PM), and grain. 
 
Diet component 
CSP PM Graina 
    %DM 19.3 ± 2.4 19.9 ± 2.6 89.6 ± 0.6 
    Dry matter intake 14.8 ± 0.7 15.0 ± 1.0 2.4 ± 0.0 
Chemical composition, % DM    
    aNDFomb 42.5 ± 3.3 53.7 ± 5.0 7.4 ± 1.7 
    ADFc 32.8 ± 2.1 40.5 ± 1.3 10.0 ± 1.4 
    CP (N x 6.25)d 17.4 ± 2.3 14.4 ± 2.3 11.9 ± 1.0 
    Starch 2.1 ± 0.2 1.2 ± 0.2 30.4 ± 1.1 
    NFCd 24.9 ± 0.7 18.4 ± 1.3 64.1 ± 3.3 
    Total fatty acids 2.4 ± 0.2 1.3 ± 0.2 2.4 ± 0.1 
Fatty acid composition (mg/g DM)    
16:0 4.13 ± 0.11 2.93 ± 0.67 4.26 ± 0.41 
18:0 0.41 ± 0.01 0.26 ± 0.05 0.56 ± 0.06 
18:1 c9 0.74 ± 0.10 0.26 ± 0.05 6.63 ± 0.44 
18:2 c9,c12 5.08 ± 0.31 1.83 ± 0.36 10.72 ± 0.96 
18:3 c9,c12,c15 12.04 ± 0.96  6.49 ± 0.93 0.69 ± 0.10 
Ʃ otherf 1.32 ± 0.23 1.16 ± 0.22 0.70 ± 0.09 
Total SFAg 5.57 ± 0.04 4.10 ± 0.84 5.19 ± 0.49 
Total MUFAh 0.93 ± 0.13 0.49 ± 0.18 6.89 ± 0.43 
Total PUFAi 17.17 ± 1.91 8.33 ± 1.26 11.45 ± 1.04 
Total n-3 FA 12.07 ± 0.96  6.51 ± 0.94 0.72 ± 0.08 
Total n-6 FA 5.13 ± 0.35 1.84 ± 0.36 10.76 ± 0.95 
aThe grain consisted of: 47.5% organic corn meal, 16.9% organic whole grain barley, 15.0% 
organic field peas, 12.5% organic wheat middings, 3.75% calcium carbonate, 1.5% sodium 
bicarbonate, 1.5% salt, 0.75% kelpmeal, 0.35% magnesium oxide, and 0.25% concentrated base 
vitamins consisting of: amino acid chelate, manganese amino acid chelate, copper amino acid 
chelate, vitamin E supplement, selenium yeast, zinc sulfate, zinc hydroxychloride, vitamin A 
acetate, vitamin D3 supplement, basic copper chloride, sodium selenite, cobalt carbonate, biotin, 
calcium iodate. baNDFom = Ash-corrected neutral detergent fiber. cADF = Acid detergent fiber. 
dCP = Crude protein. eNFC = Non-fiber carbohydrate = 100 - (NDF + CP + ether extract + ash). 
fƩ other: 12:0; 14:0; 15:0; 16:1 c9; 17:0; 18:1 c11; 20:0; 18:3 c6,c9,c12; 20:2 c11,c14; 22:0; 22:1 
c13; 20:4 c5,c8,c11,c14; 24:0; 24:1 c15. gSFA = Saturated fatty acids. hMUFA = Monounsaturated 
fatty acids. iPUFA = Polyunsaturated fatty acids. 
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Table 7.2. Rumen parameters of dairy cowsa grazing a cool-season 
pasture (CSP) and pearl millet (PM). 
 
 Treatment 
SE P value 
CSP  PM 
Total VFA (mM)  81.56  101.0 4.96 0.029 
VFA, % total       
Acetate  69.58  68.35 0.75 0.39 
Propionate  14.85  16.0 1.00 0.53 
Butyrate  11.53  10.85 0.49 0.32 
Isobutyrate  1.09  1.03 0.02 0.14 
Valerate  0.80  0.79 0.03 0.81 
Isovalerate  0.61  0.60 0.02 0.82 
Lactate  1.41  2.39 1.05 0.22 
A:P ratiob  4.68  4.43 0.26 0.50 
Rumen pH  6.93  6.76 0.05 0.05 
a
Least-squares (LS) means are based on n = 5 dairy cows. bAcetate:propionate 
ratio 
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Table 7.3. Protozoal communities (% of total sequences) in rumen digesta from dairy cowsa grazing a cool-season pasture (CSP) 
and pearl millet (PM). 
Week 
Treatment 
SE 
P value 
PM  CSP  PM 
Tc W(T)d 1 2 3 4  1 2 3 4  1 2 3 4 
Taxa                  
Anaplodinium 0.64 1.12 2.32 0.85  1.68 4.73 2.22 3.50  4.30 1.62 3.42 2.92 0.81 0.15 0.003 
Entodinium 19.3 19.3 10.9 18.2  8.95 14.6 5.11 2.25  12.3 11.0 7.90 9.93 3.03 0.005 <0.001 
Eudiplodinium 4.13 5.35 8.68 5.67  9.77 11.7 14.7 29.2  7.22 9.24 5.77 8.92 4.03 0.004 <0.001 
Ostracodinium 2.53 7.13 8.25 6.01  17.5 4.01 17.2 7.11  12.1 30.4 21.5 22.3 4.83 0.30 0.003 
Un-Ophryoscolecidaeb 37.2 19.6 14.4 15.6  10.9 15.3 19.8 28.9  22.5 16.7 24.6 14.4 6.43 0.076 0.27 
Dasytricha 29.5 34.8 24.9 13.3  30.4 29.4 30.9 14.4  34.0 22.8 30.5 21.8 7.57 0.63 0.30 
Isotricha 4.07 8.56 28.4 36.5  14.1 15.7 6.41 2.97  4.07 1.33 1.92 13.0 6.10 0.053 0.002 
<1% Abundance 2.63 4.08 2.14 3.98  6.63 4.69 3.75 11.7  3.54 6.84 4.39 6.76 2.46 0.21 0.35 
Densitye 3.77 4.28 4.29 3.81  5.13 3.90 5.11 4.99  4.44 4.14 3.54 4.56 0.18 0.004 <0.001 
a
Least-squares (LS) means are based on n = 5 dairy cows. bUn = unclassified. cT = effect of treatment. d W(T) = effect of week within treatment.  
eDensity = log10 cells/mL rumen digestsa
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Table 7.4. Fatty acid composition of rumen protozoa in dairy cowsa 
grazing a cool-season pasture (CSP) and pearl millet (PM). 
Fatty acid 
 
 Treatment 
SE 
P 
value CSP  PM 
12:0  0.16  0.13 0.01 0.21 
13:0  0.12  0.15 0.01 0.15 
iso 14:0  0.32  0.33 0.04 0.84 
14:0  0.83  0.83 0.03 0.91 
iso 15:0   0.50  0.73 0.08 0.15 
14:1 t9  0.24  0.32 0.03 0.15 
anteiso 15:0  0.92  1.17 0.03 0.008 
15:0  1.83  1.98 0.09 0.30 
iso 16:0  1.02  1.59 0.08 0.013 
15:1 t10  0.13  0.22 0.03 0.10 
15:1 c10  0.38  0.54 0.05 0.033 
16:0  30.21  35.93 0.41 0.001 
iso 17:0  0.76  0.98 0.08 0.11 
16:1 c8  0.15  0.12 0.02 0.16 
anteiso 17:0  1.75  2.28 0.09 0.028 
16:1 c9  0.82  0.38 0.06 0.006 
17:0  0.63  0.47 0.03 0.023 
18:0  23.44  14.49 0.57 <0.001 
18:1 t4  0.15  0.13 0.01 0.34 
18:1 t5  0.07  0.07 0.01 0.91 
18:1 t6-8  0.32  0.24 0.03 0.15 
18:1 t9  0.25  0.24 0.01 0.78 
18:1 t10  0.27  0.34 0.04 0.33 
18:1 t11  8.81  5.54 0.38 0.005 
18:1 t12  0.37  0.38 0.03 0.76 
18:1 t13/t14  0.64  0.53 0.07 0.36 
18:1 c9  5.23  9.14 0.29 0.001 
18:1 c11  0.71  1.00 0.07 0.044 
18:1 c12  0.15  0.21 0.01 0.033 
18:1 c14/t16  0.30  0.19 0.03 0.058 
18:2 t10,t14  0.24  0.12 0.01 0.001 
18:2 c9,t13/t8,c12  0.10  0.07 0.01 0.011 
cyclohexyl-11 11:0  0.08  0.15 0.03 0.12 
19:1 t7  0.13  0.12 0.01 0.56 
18:2 t11,c15  0.98  0.41 0.04 <0.001 
18:2 c9,c12  7.37  12.54 0.28 <0.001 
20:0  0.38  0.24 0.02 0.010 
20:1 c5  0.10  0.07 0.00 0.001 
iso 21:0   0.06  0.04 0.01 0.058 
20:1 c11  0.05  0.07 0.00 0.029 
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18:3 c9,c12,c15  6.59  3.54 0.18 <0.001 
18:2 c9,t11  0.43  0.66 0.06 0.082 
18:2 c9,c11  0.17  0.11 0.02 0.14 
18:2 t10,c12  0.11  0.09 0.01 0.18 
18:2 t7,t9/t10,t12  0.06  0.09 0.01 0.16 
22:0  0.36  0.21 0.03 0.015 
23:0  0.29  0.93 0.02 0.003 
24:0  0.39  0.28 0.03 0.093 
Unknown  0.74  0.45 0.04 0.005 
Total SFAb  58.45  54.80 0.49 0.009 
Total MUFAc  19.10  19.85 0.37 0.28 
Total PUFA  16.12  17.63 0.41 0.067 
Total 18:1 trans  10.80  7.48 0.29 0.002 
Total CLAd  0.77  0.95 0.07 0.15 
Total OBCFAe  8.90  10.85 0.36 0.027 
a
Least-sqaures (LS) means are based on n = 5 cows. bTotal SFA: all saturated 
fatty acid (12:0 to 24:0). cTotal MUFA: all monounsaturated fatty acids (14:1 to 
20:1). dTotal CLA: all detected conjugated linoleic acid isomers: 18:2 c9,t11, 
18:2 c9,c11, 18:2 t10,c12, and 18:2 t7,t9/18:2 t10,t12. eTotal OBCFA: all odd 
and branched-chain fatty acids (13:0 to 23:0).  
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Table 7.5. Bacterial communities (% of total sequences) in rumen digesta from dairy cowsa grazing a cool-season pasture (CSP) and pearl 
millet (PM). 
Week 
Treatment 
SE 
P value 
PM  CSP  PM 
Tc W(T)d 
1 2 3 4  1 2 3 4  1 2 3 4    
Taxa                  
Barnesiella 1.15 1.01 1.52 0.94  0.65 1.01 1.48 1.24  1.24 1.32 1.23 0.81 0.24 0.17 0.28 
Un-Porphyromonadaceaeb 0.67 1.48 0.83 0.74  1.94 0.87 2.17 1.83  1.90 1.19 1.81 1.88 0.27 0.41 <0.001 
Prevotella 55.8 49.5 48.2 54.8  50.1 57.9 46.4 41.9  40.6 36.3 41.5 52.9 2.78 0.035 <0.001 
Un-Bacteroidales 3.90 4.11 3.76 2.69  2.07 2.50 3.73 4.59  5.46 7.04 5.26 3.97 0.62 0.20 <0.001 
Bacteroidetes <1% 2.04 2.63 2.04 3.04  1.79 2.44 3.45 3.60  4.05 3.58 3.68 2.68 0.33 0.22 <0.001 
Butyrivibrio 1.82 2.49 2.34 1.99  2.14 3.19 3.16 3.37  2.84 1.65 2.30 1.29 0.28 0.003 <0.001 
Coprococcus 1.95 1.69 1.89 1.31  2.27 1.59 1.66 1.86  1.61 1.09 1.30 1.33 0.17 0.034 0.001 
Pseudobutyrivibrio 2.05 2.21 2.32 2.03  2.40 3.25 2.34 2.45  1.90 0.82 1.72 1.08 0.27 0.10 <0.001 
Roseburia 0.99 1.08 1.37 0.84  1.65 1.52 0.91 1.12  0.92 0.65 0.78 0.57 0.12 0.047 <0.001 
Un-Lachnospiraceae 6.13 6.10 6.24 5.00  6.92 5.55 6.39 6.68  6.31 5.01 5.53 4.73 0.54 0.029 0.068 
Acetivibrio 0.88 0.86 1.26 1.20  1.16 0.63 1.11 1.14  1.32 1.27 1.09 1.05 0.13 0.92 0.011 
Ruminococcus 4.21 3.21 3.56 2.06  3.80 2.26 3.05 3.56  2.42 1.58 2.63 3.35 0.35 0.29 <0.001 
Un-Ruminococcaceae 4.14 5.50 6.16 4.50  5.81 4.03 6.47 7.15  7.57 9.53 7.23 5.23 0.58 0.038 <0.001 
Un-Clostridiales 3.84 4.93 5.48 6.72  3.80 3.29 4.23 4.56  6.45 9.53 7.76 4.10 0.69 0.51 <0.001 
Un-Clostridia 1.90 2.62 2.75 3.73  1.86 1.65 2.25 2.54  3.73 6.28 4.56 2.54 0.50 0.47 <0.001 
Fimicutes <1% 4.96 6.26 6.29 5.53  5.00 5.81 6.08 6.86  6.79 7.70 7.05 4.95 0.35 0.007 <0.001 
Proteobacteria <1% 1.19 0.97 0.41 0.54  1.78 0.61 1.30 1.35  1.72 0.99 0.96 3.14 0.41 0.17 0.002 
Un-Bacteria 0.51 0.19 0.09 0.15  0.29 0.15 0.48 0.47  0.26 0.13 0.18 0.35 0.13 0.079 0.15 
<1% Abundance 1.84 3.20 3.47 2.18  4.55 1.74 3.31 3.76  2.89 4.32 3.47 4.04 0.62 0.57 <0.001 
Densitye 9.60 9.62 9.41 9.56  9.31 9.42 9.30 9.30  9.54 10.5 10.5 10.8 0.12 0.006 <0.001 
a
Least-squares (LS) means are based on n = 5 dairy cows. bUn = unclassified. cT = effect of treatment. d W(T) = effect of week within treatment.  eDensity = log10 
cells/mL rumen digesta
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Table 7.6. Fatty acid composition of rumen bacteria in dairy cowsa 
grazing a cool-season pasture (CSP) and pearl millet (PM). 
Fatty acid 
 Treatment 
SE 
P 
value CSP  PM 
7:0  0.05  0.08 0.01 0.062 
10:0  0.08  0.09 0.01 0.45 
11:0  0.03  0.05 0.05 0.14 
12:0  0.55  0.58 0.04 0.60 
iso 13:0  0.37  0.42 0.03 0.33 
aiso 13:0  0.07  0.11 0.01 0.031 
13:0  0.18  0.22 0.01 0.16 
iso 14:0  0.81  1.11 0.07 0.041 
14:0  1.82  2.13 0.17 0.27 
iso 15:0   1.59  2.54 0.20 0.026 
14:1 t9  0.15  0.24 0.03 0.11 
anteiso 15:0  3.86  5.68 0.27 0.015 
15:0  2.95  3.87 0.38 0.054 
iso 16:0  0.66  0.96 0.06 0.029 
15:1 c10  0.30  0.27 0.03 0.53 
16:0  18.44  22.05 0.32 0.002 
iso 17:0  0.41  0.60 0.04 0.016 
16:1 c8  0.26  0.24 0.03 0.64 
anteiso 17:0  1.51  1.24 0.09 0.13 
16:1 c9  1.20  0.82 0.07 0.018 
17:0  0.91  0.97 0.05 0.44 
iso 18:0  0.06  0.07 0.01 0.73 
18:0  40.72  34.07 1.39 0.025 
18:1 t4  0.10  0.12 0.01 0.13 
18:1 t5  0.13  0.42 0.07 0.038 
18:1 t6-8  0.41  0.39 0.03 0.68 
18:1 t9  0.25  0.24 0.02 0.70 
18:1 t10  0.45  0.56 0.04 0.068 
18:1 t11  9.09  5.84 0.36 0.003 
18:1 t12  0.41  0.51 0.04 0.092 
18:1 t13/t14  1.13  1.18 0.10 0.75 
18:1 c9  1.08  1.99 0.09 0.001 
18:1 c11  0.68  0.92 0.07 0.049 
18:1 c12  0.20  0.36 0.02 0.005 
18:1 c14/t16  0.57  0.64 0.05 0.43 
19:0  0.07  0.07 0.01 0.83 
18:1 c15  0.14  0.10 0.01 0.064 
18:2 t10,t14  0.39  0.25 0.02 0.013 
18:2 c9,t13/t8,c12  0.13  0.09 0.01 0.001 
cyclohexyl-11 11:0  0.28  0.26 0.02 0.44 
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19:1 t7  0.09  0.08 0.01 0.78 
18:2 t11,c15  1.19  0.70 0.07 0.006 
18:2 c9,c12  1.95  2.86 0.15 0.014 
20:0  0.50  0.57 0.03 0.20 
iso 21:0   0.02  0.05 0.01 0.041 
18:3 c9,c12,c15  1.49  0.94 0.05 0.001 
18:2 c9,t11  0.12  0.11 0.02 0.63 
18:2 c9,c11  0.08  0.07 0.01 0.42 
18:2 t10,c12  0.19  0.17 0.01 0.39 
20:2 c11,c14  0.24  0.30 0.05 0.50 
22:0  0.39  0.44 0.03 0.25 
23:0  0.31  0.16 0.01 0.005 
24:0  0.38  0.59 0.04 0.017 
24:1 c15  0.03  0.04 0.01 0.078 
Unknown  0.50  0.52 0.05 0.79 
Total SFAb  76.46  78.71 0.39 0.015 
Total MUFAc  16.78  15.00 0.37 0.029 
Total PUFA  5.78  5.49 0.17 0.33 
Total 18:1 trans  12.02  9.25 0.39 0.009 
Total CLAd  0.36  0.35 0.02 0.78 
Total OCFAe  4.84  5.69 0.31 0.055 
Total BCFAf  9.70  13.03 0.58 0.021 
a
Least-sqaures (LS) means are based on n = 5 cows. bTotal SFA: all saturated 
fatty acid (7:0 to 24:0). cTotal MUFA: all monounsaturated fatty acids (14:1 to 
20:1). dTotal CLA: all detected conjugated linoleic acid isomers: 18:2 c9,t11, 18:2 
c9,c11, and 18:2 t10,c12. eTotal OCFA: all odd-chain fatty acids (7:0 to 23:0). 
fTotal BCFA: all branched-chain fatty acids (iso 13:0 to iso 21:0).  
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7.10. Figures 
 
Figure 7.1. A Pearson correlation matrix between protozoal taxa (>1% abundance) and 
protozoal fatty acids of cows grazing a cool-season pasture and pearl millet. 
The scale of the colors is denoted as follows: the more positive the correlation (closer to 
1), the darker the shade of blue; the more negative the correlation (closer to −1), the darker 
the shade of red. Un = Unclassified, VA = Vaccenic acid, LA = Linoleic acid, ALA = α-
Linolenic acid, MUFA = Monounsaturated fatty acids, RA = Rumenic acid, PUFA = 
Polyunsaturated fatty acids, BCFA = Branched-chain fatty acids, OCFA = Odd-chain fatty 
acids. 
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Figure 7.2. A Pearson correlation matrix between bacterial taxa (>1% abundance) and 
bacterial fatty acids of cows grazing a cool-season pasture and pearl millet. 
The scale of the colors is denoted as follows: the more positive the correlation (closer to 
1), the darker the shade of blue; the more negative the correlation (closer to −1), the darker 
the shade of red. Un = Unclassified, VA = Vaccenic acid, ALA = α-Linolenic acid, RA = 
Rumenic acid, BCFA = Branched-chain fatty acids, OCFA = Odd-chain fatty acids. 
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Figure 7.3. A Pearson correlation matrix between bacterial (Bac), protozoal (Prot), and milk 
fatty acids of cows grazing a cool-season pasture and pearl millet. 
The scale of the colors is denoted as follows: the more positive the correlation (closer to 
1), the darker the shade of blue; the more negative the correlation (closer to −1), the darker 
the shade of red. VA = Vaccenic acid, RA = Rumenic acid, ALA = α-Linolenic acid, CLA 
= Conjugated linoleic acids, PUFA = Polyunsaturated fatty acids, OBCFA = Odd-and-
Branched-chain fatty acids. 
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Figure 7.4. A Pearson correlation matrix between bacterial (Bac) and protozoal (Prot) taxa 
and milk fatty acids (FA) of cows grazing a cool-season pasture and pearl millet. 
The scale of the colors is denoted as follows: the more positive the correlation (closer to 
1), the darker the shade of blue; the more negative the correlation (closer to −1), the darker 
the shade of red. Un = Unclassified, VA = Vaccenic acid, RA = Rumenic acid, CLA = 
Conjugated linoleic acids, ALA = α-Linolenic acid, PUFA = Polyunsaturated fatty acids, 
OBCFA = Odd-and-Branched-chain fatty acids. 
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CHAPTER 8 : SUMMARY, LIMITATIONS, AND CONCLUSIONS 
8.1. Summary 
The research presented in this dissertation evaluated novel strategies to enhance the 
content of bioactive FA in bovine milk. First, the content and profile of bioactive FA in 
three common dairy breeds in the U.S., Holstein, Jersey, and Holstein x Jersey crossbreeds, 
was assessed across their first lactation. Overall, the effect of breed was minimal, but 
Holsteins produced the highest content of bioactive FA per serving of whole milk (3.25% 
fat) (Table 8.1.). The content of bioactive FA varied across the lactation, with the highest 
contents at early lactation and the lowest during late lactation. Because the early stage of 
lactation is rather transitional, and therefore not representative, the mid-lactation period 
should be used for subsequent studies to evaluate and enhance the content of bioactive FA 
in milk.   
The secondary objective of this study was to evaluate rumen bacterial communities 
and their cellular FA composition across a lactation in three breeds of dairy cattle. This 
research demonstrated, for the first time, correlations between bacterial genera and 
bacterial membrane FA obtained from an environmental rumen sample. Positive 
correlations existed between the contents of total anteiso BCFA and total OBCFA in 
bacterial cell membranes and the phylum Proteobacteria and the genus Coprococcus. Total 
trans-18:1 FA in bacterial membranes were positively correlated with the bacterial genera 
Butyrivibrio and Acetivibrio, while Ruminococcus were negatively correlated with total 
trans-18:1 FA. This suggests the ability to identify certain rumen bacteria by their FA 
composition. Overall, the FA composition of rumen bacteria was more affected by lactation 
stage/dietary transition period than breed. Although there was an increased content of RA 
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in bacterial cells of Jerseys when compared to Holsteins and crossbreeds, this did not result 
in a difference in the RA content of milk. This implies that bacterial cells are not a 
significant source of RA to the mammary gland. 
Echium oil is a terrestrial-based source of n-3 FA that has promise as a sustainable 
alternative to fish oil. The objective of our second strategy was to evaluate the impact of 
feeding a lipid-encapsulated echium oil (EEO) supplement rich in bioactive n-3 FA on 
animal performance and the milk FA profile. We demonstrated that EEO increased the 
content of n-3 FA in milk fat by 34% feeding a low EEO amount (1.5% of DM as EEO; 
LEO) and 66% feeding a high EEO amount (3% DM as EEO; HEO) when compared to 
the control, without any detrimental effects on animal production. The content of total n-3 
FA in a serving of whole milk from cows supplemented with HEO was higher than that of 
conventionally produced retail milk and similar to that of organically produced milk (0.81 
g/100g FA HEO-enriched milk, 0.50 g/100g FA conventionally produced milk, and 0.81 
g/100g organically produced milk (O’Donnell et al., 2010)). Despite the observed increase 
in milk n-3 FA, the transfer efficiency of n-3 FA derived from the EEO supplement into 
milk fat was unexpectedly low (<5%). Therefore, in a follow-up study, the ruminal 
protection of EEO and post-ruminal release of EEO-derived FA was examined. The EEO 
was rumen-stable, with less than 5% DM disappearance after 72h in the rumen. Yet, post-
ruminal release was poor, as fecal excretion of EO-derived FA ranged from 7-14% for LEO 
and HEO treatments. In addition, EEO-derived FA were preferentially incorporated into 
plasma lipid fractions unavailable to the mammary gland for milk fat synthesis. VA and 
CLA, the biohydrogenation and metabolism products of dietary n-3 FA, increased in milk 
and feces with EEO supplementation. This increase in biohydrogenation intermediates, 
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however, was minor (0.3% of FA) demonstrating that lipid-encapsulation provided 
insufficient digestibility in the small intestine to achieve adequate transfer efficiency of n-
3 FA into milk.  
The utilization of pastures to enhance the content of bioactive FA in milk has the 
added benefits of being low-cost, with positive consumer perceptions. There is little 
research about the effect of pasture species composition on the milk FA profile, yet pasture 
has shown promise to improve the bioactive FA content of milk due to its high n-3 FA 
content. Hence, the final strategy investigated the impact of two different grazing regimes, 
cool-season pasture (CSP) vs. a warm-season single grass species (pearl millet (PM)) 
pasture, on rumen microorganisms, their metabolism products, and the content and profile 
of bioactive FA in milk. The CSP contained a higher content of total PUFA and n-3 FA, 
which resulted in a 2-fold increase in n-3 FA and RA in milk when compared to cows that 
grazed PM (Table 8.1.). The content of OBCFA was higher when cows grazed PM. The 
higher milk contents of RA and VA were directly related to rumen microbial activities, and 
as a result, we further elucidated the diet-rumen microbiota interaction through 
identification of the FA composition of rumen bacteria and protozoa. Similar to milk, the 
n-3 FA content of rumen protozoa increased by 2-fold when cows grazed CSP. Hence, a 
strong correlation between the content of n-3 FA in rumen protozoa and the content of n-3 
FA in milk was observed. In addition, the content of VA in protozoal and bacterial cells 
strongly correlated with the content of VA and RA in milk fat. Bacterial membrane 
contents of OCFA and 15:0 correlated with the OCFA content of milk. Correlations were 
also identified between specific microbial taxa and the contents of various FA in milk. For 
example, the abundance of Butyrivibrio species strongly correlated with the contents of 
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VA and RA in milk fat, while the abundance of Eudioplodinium correlated to the content 
of n-3 FA in milk. These results demonstrate that diet influences rumen bacteria and their 
cellular FA composition, and that these factors can be utilized to increase the unique 
rumen-derived bioactive FA in milk. In addition, protozoa play a role in preserving key 
bioactive FA (e.g. VA and ALA) within the rumen for incorporation into milk. Overall, 
this research has demonstrated that it is possible to increase the content of bioactive FA in 
dairy products through type of grazing regime, shifting rumen microbial communities and 
their metabolites, resulting in altered FA available to the mammary gland. 
8.2. Research Limitations and Future Perspectives 
Sample size was a limitation in chapters 2 and 3, as utilization of live animals 
requires justification of the number of animals used based on costs, availability, and review 
committees. There is a large amount of individual genetic variation within and among 
breeds and this may explain the few number of bacterial genera and milk FA found 
different between breeds. Although power calculations were performed, non-significant 
results may have reached significance in studies with a greater sample size.  
Individual dry matter intakes (DMI) were not measured in chapters 2 and 3 as 
animals were co-housed in a freestall. DMI affects the energy balance of the animal and 
therefore the source of FA for milk fat synthesis (adipose tissue vs. diet) (Kay et al., 2005). 
Rumen bacterial communities are also affected by the animals’ DMI (McCann et al., 2014). 
DMI has been shown to be a physical characteristic of breed (Kristensen et al., 2015) and 
lactation stage (Devries et al., 2011; Craninx et al., 2008), and future research should utilize 
chromium oxide to estimate DMI while co-housing animals. In respect to chapters 6 and 
7, DMI was estimated using a rising plate meter due to its ease of use in a commercial dairy 
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facility. Research has shown rising plate meter estimates to be accurate (Earle and Mc 
Gowan, 1979), yet future research should utilize chromium oxide or “cut and carry” 
methods for a more accurate DMI measurement. 
As this research was one of the first to investigate lactation stage effects, 
preliminary time points were chosen to be every 3 months. These time points may not 
accurately measure the progression of milk FA or bacterial genera over a lactation, as 
chapter 7 and data presented by Bainbridge et al. (2016d) demonstrated weekly variability 
in the bacterial and protozoal communities within the same animal and among samples. 
Therefore, future research should do a thorough evaluation of weekly changes to the milk 
FA profile and bacterial communities across a lactation from animals on the same diet to 
determine the stability of rumen microbial communities.  
In chapters 2 and 3, the diet of the dairy cattle was switched at parturition from a 
TMR formulated for pre-fresh cows to a TMR formulated for lactating cows, which is 
typical practice on commercial dairy farms. The early lactation stage time point (3/5 DIM) 
was representative of both the transition between diets and lactation stage, future research 
should sample cows after this diet transition to assess true effects of lactation stage on milk 
FA, bacterial FA, and bacterial genera.  
As a result of the limitations in cannulating a large number of dairy cows, rumen 
digesta was obtained via esophageal intubation in chapters 3 and 7. There are reservations 
about the accuracy of this collection method, as some research has shown no statistical 
difference in bacterial diversity or VFA concentrations between samples collected from 
rumen cannula and via esophageal intubation (Lodge-Ivey et al., 2009). There has been no 
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research, however, to demonstrate that this is an accurate method to assess the protozoal 
communities. 
Period length was short (7 days) in chapter 5 and this raises the question as to 
whether there was enough time for adequate adaption to the diet for accurate results. 
Stamey et al.(2012) evaluated the incorporation of n-3 FA from lipid-encapsulated algal 
oil into milk and plasma lipid fractions using 7 day periods, and saw rapid incorporation 
of DHA into milk fat and plasma by day 2 of supplementation. Kitessa et al. (2004 and 
2011) used 10 day periods and concluded milk concentrations of dietary fatty acids 
plateaued from day 7 onwards. Bernal-Santos et al.(2010) infused SDA-enhanced soybean 
oil for 7 days and found levels of milk FA to stabilize by day 3 post-infusion. Therefore, 7 
day periods are long enough to demonstrate the bioavailability, metabolism, and 
incorporation of EO-derived FA into milk fat. 24 hours is also a short period of time for 
fecal collection in chapter 5. Most studies (Harvatine and Allen, 2006; Hristov et al., 2009; 
Bateman and Jenkins, 1998) take grab samples over 2-4 days to represent a 24-hour period. 
With only 7 day periods we concluded that spot sampling over 2-4 days would be 
inaccurate, and thus chose to sample for a full 24 hours. Future studies should extend 
periods by 2-4 days to include longer total fecal collections for the most accurate total-tract 
digestibility results.  
In chapters 6 and 7 the pearl millet treatment was repeated to account for the effect 
of season. However, the cool-season pasture treatment was not repeated and therefore the 
effect of season and environment (i.e. temperature) cannot be delineated from the effect of 
the cool-season pasture treatment. Season has an effect on the FA composition and quality 
of pastures (Glasser et al., 2013), and this must be taken into account when making 
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conclusions and generalizations from this study. Future research should design grazing 
studies to reduce environmental effects on forage quality and composition. In addition, the 
pearl millet was grazed at a mature state due to an unseasonably warm summer that 
provided optimal growing conditions for warm-season grasses. Plant maturity is inversely 
related to forage n-3 FA content, and thus, a different milk FA profile may have resulted if 
pearl millet had been grazed during the vegetative stage. 
The correlations observed between bacterial genera and bacterial FA in chapters 3 
and 7 were inconsistent. Bacteria of the genus Coporococcus were positively correlated to 
total OBCFA in bacterial cells in chapter 3, whereas in chapter 7, no correlation was 
observed. A positive correlation between the abundance of Prevotella in the rumen and 
15:0 in bacterial membranes was observed in chapter 7 that was not corroborated in chapter 
3. The content of trans-18:1 FA was negatively correlated to the abundance of 
Ruminococcus in both studies, although the correlation was stronger in chapter 3 than in 
chapter 7. In both chapters, Butyrivibrio were positively correlated with the content of 
trans-18:1 FA in bacterial membranes. Previous research has shown that the compositon 
of bacterial membranes in more affected by bacterial species than by the available 
substrates in bacterial cultures (VFA and vitamins) (Saluzzi et al., 1993). However, this 
research demonstrates that in environmental samples, the correlations between bacterial 
species and their FA composition is affected by dietary substrates. Hence, future research 
should evaluate the composition of single rumen bacteria speicies in cultures with differing 
substrates, such as FA or amino acids.  
The next steps that need to be taken with this body of research are to determine the 
biologically active concentrations of FA needed to have a positive effect on human health 
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outcomes. This body of research and others have focused solely on increasing the content 
of certain bioactive FA in milk without considering to what extent theses FA should be 
increased. Studies have shown that a dose of 35mg/kg/day of iso 15:0 in mice reduced 
tumor growth (Yang et al., 2000), which would equate to a 2.4g/day dose for a 150lb 
individual. This was the lowest dose tested in this study, thus future research, with 
additional types of BCFA, is needed to determine if lower doses achieve the same effect. 
The Institute of Medicine of the National Academies recommends 1.1g/day of n-3 FA for 
women and 1.6g/day for men. The recommended serving of 3 cups (244g) of whole milk 
per day provides between 7-22% of this recommended intake based on data from these 
experimental chapters, with milk from cows grazing on CSP providing the most n-3 FA. It 
is unknown whether this contribution to the Western diet is enough to affect health 
outcomes. In addition, n-3 FA in milk are mainly ALA and there is conflicting research as 
to whether ALA provides health benefits to the same extent as EPA and DHA (Egert et al., 
2009; Baker et al., 2016; Walker et al., 2013). Therefore, future research needs to 
determine the content of ALA required in milk for human helath maintenance and disease 
prevention.  
8.3. General Conclusions  
The research presented in this dissertation demonstrates the challenge and 
complexity in increasing the content of bioactive FA of bovine milk. We have shown that, 
despite public opinion and perception, milk is naturally rich in several classes of bioactive 
FA. Yet, enriching these bioactive FA in milk to develop a functional food product is a 
challenging research endeavor in ruminants. Supplemental n-3 FA must be protected from 
ruminal biohydrogenation and released in the abomasum or small intestine, then 
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subsequently incorporated into plasma TAG to be available to the mammary gland for 
incorporation into milk. This research has concluded that this cannot be achieved with the 
current rumen-protection technologies, thus further investigation in this area needs focus 
on developing improved rumen-protection methods. Future research should focus on oils 
rich in ALA and SDA, as we have shown that these shorter chain n-3 FA are preferentially 
transported in plasma lipid fractions available to the mammary gland when compared to 
the long-chain n-3 FA EPA and DHA (1.0 and 0.2 g/100g FA for ALA and SDA 
(Bainbridge and Kraft, 2016c) vs. <0.01 g/100g FA for EPA and DHA (Stamey Lanier et 
al., 2013)).  
In pursuing a low-cost approach to enhancing milks’ bioactive FA content, the use 
of fresh forages is a promising strategy, as shown in this dissertation. Grazing fresh-forages 
resulted in the highest contents on bioactive FA in milk (Table 8.1.), regardless of forage 
type (CSP vs. PM). In addition, it was concluded from chapters 3 and 7 that understanding 
the contributions of rumen microorganisms to the FA composition of ruminant products is 
key to discovering novel strategies to enhance the bioactive FA content of milk for human 
health promotion. Therefore, future research may focus on i) evaluating other 
species/specie mixtures of fresh forages in the diet of dairy cattle, ii) enhancing plant 
breeding to increase forage PUFA contents, and iii) increasing the abundance of certain 
microorganisms in the rumen to maximize transfer of bioactive FA from the diet into milk.  
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8.4. Tables 
Table 8.1. The content (mg/serving of 3.25% fat milk) of bioactive fatty acids (FA) in response to experimental strategies used in this 
dissertation. 
Reference Strategy Treatment 
Total n-3 
FA 
RAa VAb OAc BCFAd OCFAe MCFAf 
Total 
Bioactive 
FA 
― mg/serving of whole milk (3.25% fat) ― 
Bainbridge et al., 
2016b Genetics 
HO 44.2 36.9 77.5 1257.2 122.7 307.5 515.6 2361.6 
CB 46.9 35.2 97.7 1195.0 121.9 295.7 476.8 2269.2 
JE 35.1 27.4 72.1 1039.6 119.0 289.2 566.1 2148.5 
Bainbridge et al., 
2015 
Supplementation 
of lipid-
encapsulated 
echium oil 
CON 33.9 20.2 33.5 1031.9 120.1 206.1 714.6 2160.3 
LEO 45.5 23.0 42.9 1109.7 112.8 175.6 667.5 2177.0 
HEO 56.2 27.5 53.9 1164.8 105.9 160.9 592.0 2161.2 
Bainbridge et al., 
2016c 
Supplementation 
of lipid-
encapsulated 
echium oil 
CON 30.2 35.3 70.0 1307.3 120.0 165.9 554.9 2283.6 
LEO 45.0 43.1 82.3 1300.3 108.7 160.9 564.4 2304.7 
HEO 59.9 43.6 89.0 1299.9 112.2 164.4 556.1 2325.1 
Bainbridge et al., 
2017 
Grazing a cool-
season pasture 
(CSP) or pearl 
millet (PM) 
CSP 78.6 156.5 316.9 1528.3 211.7 230.1 337.4 2859.5 
PM 43.2 121.2 209.8 1463.3 233.2 239.5 372.4 2682.6 
aRA: Rumenic acid (18:2 9c,11t). bVA: Vaccenic acid (18:1 11t). cOA: Oleic acid (18:1 9c). dBCFA: Branched-chain fatty acids (13 to 
21 carbon atoms). eOCFA: Odd-chain fatty acids (non-branched; 5 to 23 carbon atoms). fMCFA: Medium-chain fatty acids (8 to 12 
carbon atoms). HO = Holstein, CB = Crossbreed, JE = Jersey, CON = Control, LEO = Low-Echium oil (1.5% DM as lipid-encapsualted 
echium oil), HEO = High-Echium oil (3% DM as lipid-encapsualted echium oil). 
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Appendix A. 
Table A.1. Fatty acid concentrationa (g/100g FA) in milk fat from three breeds of dairy cow over four time points; 5 days in milk (DIM), 95 
DIM, 185 DIM, 275 DIM. 
 
Time Point 
SE 
P Value 
 5 DIM  95 DIM 185 DIM 275 DIM  
Fatty acid HO JE CB HO JE CB HO JE CB HO JE CB Bg Th 
B x 
Ti 
4:0 4.97 5.37 4.69 2.93 3.25 3.11 2.99 3.06 2.97 2.97 3.04 2.90 0.15 NS *** NS 
5:0 0.04 0.03 0.03 0.04 0.03 0.04 0.07 0.08 0.07 0.04 0.05 0.05 0.01 NS *** NS 
6:0 1.95 2.04 1.97 1.86 2.25 2.03 1.98 2.17 2.03 1.92 2.09 1.93 0.10 ƚ NS NS 
7:0 0.02 0.01 0.02 0.04 0.04 0.04 0.03 0.04 0.03 0.03 0.03 0.02 0.00 NS *** NS 
8:0 0.82 0.86 0.90 1.09 1.37 1.20 1.18 1.34 1.21 1.15 1.28 1.17 0.06 ƚ *** NS 
9:0 0.02 0.01 0.02 0.05 0.05 0.05 0.05 0.05 0.04 0.04 0.04 0.03 0.00 NS *** NS 
10:0 1.48 1.56 1.67 2.56 3.38 2.87 2.85 3.31 3.00 2.80 3.17 2.92 0.15 * *** * 
11:0 0.08 0.07 0.08 0.23 0.26 0.25 0.28 0.31 0.30 0.28 0.30 0.29 0.01 NS *** NS 
12:0 1.53 1.56 1.82 3.12 4.15 3.53 3.60 4.20 3.81 3.59 4.05 3.77 0.17 * *** ** 
iso-13:0 0.02 0.02 0.02 0.03 0.03 0.03 0.03 0.03 0.03 0.04 0.04 0.04 0.00 NS *** NS 
anteiso-13:0  0.02 0.02 0.02 0.06 0.08 0.08 0.09 0.10 0.10 0.10 0.11 0.11 0.01 NS *** NS 
13:0 0.06 0.05 0.07 0.22 0.23 0.22 0.23 0.25 0.24 0.22 0.24 0.22 0.01 NS *** NS 
iso-14:0 0.09 0.10 0.08 0.07 0.13 0.12 0.11 0.13 0.12 0.13 0.15 0.15 0.01 * *** ** 
14:0  8.78 8.56 8.57 11.07 12.31 11.64 12.08 12.35 12.20 12.36 12.48 12.57 0.40 NS *** NS 
iso-15:0 0.22 0.20 0.21 0.21 0.21 0.21 0.21 0.20 0.20 0.24 0.23 0.23 0.01 NS *** NS 
14:1 t9 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 NS *** NS 
anteiso-15:0 0.33 0.31 0.34 0.47 0.40 0.43 0.46 0.40 0.45 0.50 0.44 0.49 0.02 NS *** NS 
14:1 c9 0.35 0.24 0.34 0.78 0.74 0.86 0.96 0.96 1.07 1.00 0.93 1.13 0.04 * *** NS 
15:0 0.81 0.72 0.80 1.39 1.28 1.29 1.30 1.28 1.27 1.29 1.29 1.20 0.06 NS *** NS 
iso-16:0 0.27 0.27 0.26 0.20 0.29 0.26 0.27 0.33 0.29 0.34 0.37 0.39 0.02 NS *** * 
16:0 26.33 25.01 26.61 33.03 35.17 34.42 34.62 36.14 35.03 35.12 36.60 35.90 0.83 NS *** NS 
iso-17:0 0.38 0.33 0.40 0.35 0.26 0.30 0.28 0.24 0.27 0.30 0.26 0.29 0.01 ** *** * 
16:1 t9 0.10 0.09 0.09 0.03 0.02 0.02 0.02 0.01 0.02 0.02 0.02 0.02 0.01 NS *** NS 
16:1 isomer 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 NS *** NS 
16:1 c7 0.04 0.03 0.04 0.03 0.02 0.03 0.02 0.02 0.03 0.02 0.02 0.02 0.00 * *** NS 
16:1 c8 0.20 0.20 0.20 0.16 0.11 0.15 0.14 0.11 0.13 0.14 0.11 0.13 0.01 ** *** ƚ 
anteiso-17:0 0.44 0.43 0.35 0.09 0.11 0.10 0.16 0.12 0.11 0.08 0.08 0.09 0.02 NS *** NS 
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16:1 c9 1.63 1.22 1.51 1.59 1.25 1.57 1.52 1.56 1.70 1.64 1.60 1.84 0.10 NS ** * 
16:1 c10/t13 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.01 0.01 0.01 0.00 0.00 NS *** NS 
16:1 c11 0.07 0.05 0.07 0.05 0.03 0.04 0.04 0.04 0.04 0.05 0.05 0.05 0.01 NS *** NS 
17:0 0.97 0.86 0.90 0.76 0.70 0.71 0.71 0.70 0.70 0.71 0.70 0.70 0.02 ƚ *** NS 
iso-18:0 0.01 0.01 0.00 0.01 0.01 0.01 0.01 0.01 0.02 0.01 0.01 0.01 0.00 NS * * 
17:1 t10 0.11 0.09 0.10 0.06 0.05 0.05 0.05 0.05 0.04 0.05 0.05 0.05 0.00 ƚ *** NS 
17:1 c8 0.03 0.02 0.03 0.02 0.01 0.02 0.02 0.01 0.01 0.02 0.01 0.02 0.00 *** *** NS 
17:1 c9 0.46 0.32 0.37 0.24 0.16 0.21 0.19 0.17 0.18 0.19 0.17 0.19 0.02 ** *** * 
18:0 12.93 15.94 13.76 9.45 10.32 8.95 8.52 8.91 8.20 8.40 9.14 7.91 0.50 * *** * 
18:1 t4 0.01 0.01 0.01 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 NS *** NS 
18:1 t5 0.01 0.01 0.01 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 NS *** NS 
18:1 t6-8 0.22 0.22 0.25 0.25 0.23 0.23 0.22 0.20 0.21 0.20 0.18 0.17 0.01 NS *** NS 
18:1 t9 0.15 0.16 0.15 0.21 0.19 0.20 0.18 0.17 0.18 0.16 0.14 0.15 0.01 NS *** NS 
18:1 t10 0.47 0.42 0.42 0.33 0.26 0.30 0.25 0.24 0.26 0.21 0.19 0.22 0.03 NS *** NS 
18:1 t11 1.43 1.38 1.77 1.04 0.96 0.94 0.86 0.77 0.74 0.86 0.79 0.72 0.07 NS *** ** 
18:1 t12 0.24 0.23 0.26 0.33 0.30 0.31 0.28 0.27 0.29 0.26 0.23 0.23 0.01 NS *** NS 
18:1 t13-14 10.01 10.59 8.86 0.43 0.52 0.45 0.40 0.44 0.41 0.42 0.39 0.35 0.50 NS *** NS 
18:1 c9 15.54 14.23 15.25 18.73 13.50 16.71 17.11 14.26 16.47 16.60 14.09 16.18 0.82 ** * * 
18:1 c11 0.94 0.90 0.82 0.80 0.52 0.66 0.65 0.54 0.60 0.53 0.50 0.51 0.05 * *** * 
18:1 c12 0.14 0.16 0.15 0.26 0.26 0.27 0.23 0.24 0.25 0.23 0.20 0.22 0.01 NS *** NS 
18:1 c13 0.13 0.10 0.11 0.08 0.04 0.06 0.05 0.04 0.05 0.05 0.04 0.05 0.01 NS *** NS 
18:1 c14/t16 0.28 0.26 0.30 0.30 0.29 0.29 0.26 0.25 0.25 0.26 0.24 0.23 0.01 NS *** NS 
18:1 c15 0.17 0.16 0.14 0.09 0.08 0.09 0.08 0.06 0.07 0.08 0.06 0.07 0.01 NS *** NS 
18:2 t10,t14 0.03 0.01 0.05 0.09 0.10 0.10 0.07 0.07 0.07 0.08 0.08 0.07 0.01 NS *** NS 
18:2 t9,t12 0.03 0.01 0.03 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 ** *** *** 
18:2 c9,t13/t8,c12 0.14 0.11 0.15 0.18 0.13 0.17 0.16 0.14 0.16 0.16 0.11 0.14 0.01 * *** ƚ 
cyclohexyl-11 11:0 0.07 0.06 0.08 0.15 0.14 0.16 0.17 0.13 0.17 0.17 0.13 0.15 0.01 ** *** NS 
18:2 c9,t14 0.08 0.05 0.07 0.11 0.08 0.09 0.09 0.07 0.09 0.09 0.06 0.08 0.01 ** *** NS 
18:1 c16 0.04 0.05 0.05 0.06 0.06 0.05 0.05 0.04 0.05 0.05 0.04 0.04 0.01 NS ** NS 
18:2 c12,t16 0.00 0.00 0.00 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.00 NS *** NS 
18:2 t9,c12 0.14 0.08 0.19 0.09 0.08 0.10 0.08 0.05 0.07 0.11 0.09 0.07 0.01 ** *** *** 
18:2 t11,c15 0.03 0.02 0.03 0.03 0.03 0.03 0.02 0.03 0.03 0.02 0.03 0.03 0.00 NS NS NS 
18:2 c9,c12 1.49 1.83 1.62 1.59 1.37 1.52 1.56 1.37 1.52 1.38 1.27 1.39 0.10 NS ** * 
18:2 t12,c15 0.05 0.03 0.05 0.08 0.06 0.07 0.06 0.05 0.06 0.07 0.05 0.06 0.01 ** *** NS 
20:0 0.14 0.17 0.14 0.14 0.15 0.13 0.13 0.13 0.13 0.13 0.13 0.12 0.01 NS ** NS 
18:3 t9,t12,c15 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 * *** *** 
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18:3 c6,c9,c12 0.01 0.01 0.01 0.01 0.02 0.02 0.02 0.01 0.01 0.02 0.01 0.02 0.00 NS *** NS 
20:1 c9 0.07 0.06 0.06 0.04 0.03 0.03 0.03 0.02 0.03 0.02 0.03 0.02 0.00 ƚ *** NS 
20:1 c11 0.05 0.06 0.04 0.06 0.04 0.06 0.07 0.06 0.07 0.07 0.05 0.07 0.00 * *** *** 
18:3 c9,c12,c15 0.54 0.40 0.70 0.38 0.33 0.40 0.38 0.32 0.37 0.42 0.35 0.38 0.04 * *** ** 
18:2 c9,t11 0.54 0.41 0.57 0.50 0.33 0.46 0.43 0.33 0.40 0.44 0.33 0.39 0.03 ** *** NS 
21:0 0.02 0.02 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 * *** ** 
18:2 t11,t13 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 NS *** NS 
18:2 t7,t9/t10,t12 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.00 ƚ NS NS 
20:2 c11,c14 0.01 0.02 0.02 0.03 0.03 0.04 0.03 0.03 0.04 0.03 0.04 0.04 0.00 NS *** NS 
22:0 0.05 0.05 0.05 0.06 0.06 0.05 0.05 0.06 0.06 0.06 0.06 0.06 0.00 NS * NS 
20:3 c8,c11,c14 0.07 0.09 0.08 0.09 0.09 0.08 0.10 0.10 0.10 0.10 0.10 0.10 0.01 NS ** NS 
22:1 c13 0.01 0.01 0.01 0.01 0.02 0.01 0.01 0.01 0.00 0.01 0.01 0.01 0.00 NS ** NS 
20:3 c11,c14,c17 0.01 0.01 0.02 0.01 0.01 0.01 0.01 0.01 0.00 0.02 0.01 0.02 0.00 NS * ƚ 
20:4 c5,c8,c11,c14 0.15 0.22 0.16 0.12 0.11 0.11 0.12 0.11 0.11 0.12 0.11 0.11 0.01 NS *** * 
23:0 0.00 0.00 0.01 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.00 NS *** NS 
20:5 c5,c8,c11,c14,c17 0.09 0.05 0.11 0.04 0.03 0.05 0.03 0.03 0.03 0.03 0.03 0.03 0.01 ** *** ** 
24:0 0.03 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.05 0.04 0.05 0.04 0.00 NS NS NS 
24:1 c15 0.01 0.01 0.01 0.03 0.02 0.03 0.00 0.00 0.00 0.01 0.00 0.01 0.00 ƚ *** NS 
22:4 c7,c10,c13,c16 0.01 0.02 0.01 0.01 0.01 0.01 0.02 0.02 0.02 0.02 0.02 0.02 0.00 NS * NS 
22:5 c7,c10,c13,c16,c19 0.16 0.12 0.17 0.09 0.07 0.10 0.07 0.05 0.07 0.06 0.04 0.06 0.01 * *** NS 
22:6 
c4,c7,c10,c13,c16,c19 
0.03 0.02 0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 * *** * 
Unknown 0.55 0.43 0.58 0.68 0.59 0.59 0.45 0.44 0.48 0.51 0.50 0.46 0.03 ** *** ** 
De novo 20.9 21.1 21.0 25.4 29.3 27.2 27.6 29.4 28.3 27.7 29.0 28.2 0.9 NS *** NS 
Mixed 28.38 26.62 28.54 34.91 36.62 36.26 37.90 38.32 36.96 37.00 38.40 37.96 0.82 NS *** NS 
Preformed 49.21 50.95 48.98 37.97 32.31 34.86 34.40 31.03 33.12 33.45 30.77 31.96 1.36 NS *** NS 
Total SFAb 61.02 62.97 62.15 68.11 75.08 70.63 70.73 74.49 71.38 71.17 74.77 71.83 1.28 * *** NS 
Total MUFAc 32.93 31.33 31.44 26.07 19.77 23.72 23.73 20.58 23.21 23.19 20.15 22.74 1.20 * *** NS 
Total PUFA 3.65 3.54 4.08 3.50 2.92 3.38 3.29 2.81 3.17 3.22 2.77 3.04 0.18 NS *** NS 
Total n-6 FAd 1.75 2.18 1.89 1.85 1.62 1.77 1.85 1.63 1.79 1.68 1.54 1.69 0.11 NS ** ** 
Total n-3 FAe 0.83 0.60 1.02 0.53 0.44 0.56 0.49 0.41 0.47 0.54 0.42 0.49 0.05 * *** ** 
n-6:n-3 ratio 2.19 3.75 1.98 3.51 3.69 3.23 3.78 4.03 3.79 3.15 3.74 3.47 0.19 *** *** ** 
Total CLAf 0.57 0.44 0.60 0.52 0.35 0.48 0.45 0.35 0.41 0.46 0.35 0.41 0.03 ** *** NS 
Total 18:1 t 2.54 2.42 2.86 2.19 1.96 2.01 1.81 1.68 1.72 1.71 1.54 1.51 0.12 NS *** NS 
Total branched chain 
FA 
1.76 1.68 1.68 1.50 1.51 1.53 1.63 1.55 1.59 1.74 1.69 1.79 0.07 NS *** NS 
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Total iso FA 0.97 0.92 0.97 0.87 0.92 0.92 0.91 0.94 0.93 1.06 1.06 1.11 0.04 NS *** NS 
Total anteiso FA 0.79 0.76 0.71 0.63 0.59 0.61 0.72 0.62 0.66 0.68 0.63 0.68 0.03 NS *** NS 
Total odd-chain FA 4.02 3.52 3.77 4.28 3.93 4.07 4.18 4.05 4.10 4.15 4.07 4.05 0.11 ƚ *** NS 
aLeast-squares (LS) means are based on n = 7 Holstein (HO), n = 8 Jersey (JE), and n = 7 HO x JE crossbreeds (CB). bTotal SFA: all saturated fatty acid (4:0 to 
26:0). cTotal MUFA: all monounsaturated fatty acids (14:1 to 24:1). dTotal n-6 FA: all n-6 fatty acids; 18:2 n-6, 18:3 n-6, 20:2 n-6, 20:3 n-6, 20:4 n-6, and 22:4 n-
6. eTotal n-3 FA: all n-3 fatty acids; 18:3 n-3, 20:3 n-3, 20:5 n-3, 22:5 n-3, and 22:6 n-3. fTotal CLA: all detected conjugated linoleic acid isomers: 18:2 c9,t11, 
18:2 t11,t13, and 18:2 t7,t9/18:2 t10,t12. gBreed effect. hTime point effect. iBreed x time point interaction. ƚ 0.05≤P<0.10; *P<0.05; **P<0.01; ***P<0.001, NS = 
Not significant. 
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Appendix B. 
Table B.1. Complete fatty acid compositiona (g/100g FA) of milk fat in response to dietary 
treatments of CONb, LEOc, and HEOd. 
fatty acid 
Treatment 
SE P value 
CON LEO HEO 
4:0 2.81 2.90 2.92 0.07 ns 
5:0 0.04a 0.03b 0.03b 0.00 0.008 
6:0 2.14 2.16 2.08 0.04 ns 
7:0 0.04a 0.04b 0.03b 0.00 0.004 
8:0 1.38a 1.36a 1.27b 0.02 0.002 
9:0 0.06a 0.04b 0.04b 0.00 <0.001 
10:0 3.91a 3.70a 3.29b 0.10 <0.001 
11:0 0.43a 0.38b 0.35c 0.02 <0.001 
12:0 4.94a 4.52b 3.94c 0.16 <0.001 
iso 13:0 0.02 0.02 0.02 0.00 ns 
anteiso 13:0 0.11a 0.10b 0.08c 0.00 <0.001 
13:0 0.28a 0.23b 0.20c 0.01 <0.001 
iso 14:0 0.09 0.09 0.09 0.00 ns 
14:0 13.6a 13.1b 12.2c 0.35 <0.001 
iso 15:0 0.20a 0.18b 0.17c 0.00 <0.001 
trans-9 14:1 0.01 0.01 0.01 0.00 ns 
anteiso 15:0 0.42a 0.39b 0.36c 0.01 <0.001 
cis-9 14:1 0.99a 0.92b 0.85c 0.06 <0.001 
15:0 1.28a 1.06b 0.98b 0.06 <0.001 
iso 16:0 0.23 0.23 0.22 0.01 ns 
16:0 34.8a 34.1b 34.5ab 0.62 0.04 
iso 17:0 0.30a 0.28b 0.27b 0.01 <0.001 
trans-9 16:1 0.01 0.02 0.01 0.00 ns 
16:1 isomer 0.01 0.01 0.01 0.00 ns 
cis-7 16:1 0.02a 0.02a 0.03b 0.00 0.008 
cis-8 16:1 0.11a 0.11ab 0.10b 0.00 0.01 
anteiso 17:0 0.34a 0.32a 0.29b 0.01 <0.001 
cis-9 16:1 1.36a 1.27b 1.24b 0.06 0.002 
cis-10 16:1/trans-13 16:1 0.01 0.01 0.01 0.00 ns 
cis-11 16:1 0.02 0.02 0.02 0.00 ns 
17:0 0.65a 0.58b 0.53c 0.02 <0.001 
iso 18:0 0.01 0.01 0.01 0.00 ns 
cis-8 17:1 0.02 0.02 0.02 0.00 ns 
cis-9 17:1 0.15a 0.13b 0.12b 0.01 <0.001 
18:0 6.80a 7.99b 8.58c 0.21 <0.001 
trans-4 18:1 0.01 0.01 0.01 0.00 ns 
trans-5 18:1 0.01 0.01 0.01 0.00 ns 
trans-6–8 18:1 0.15a 0.15a 0.17b 0.01 <0.001 
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trans-9 18:1 0.14a 0.14a 0.16b 0.01 0.02 
trans-10 18:1 0.24 0.27 0.25 0.04 ns 
trans-11 18:1 0.54a 0.62a 0.77b 0.08 <0.001 
trans-12 18:1 0.24a 0.27a 0.31b 0.02 <0.001 
trans-13/14 18:1 0.39a 0.45ab 0.51b 0.04 0.03 
cis-9 18:1 14.8a 15.9b 16.7c 0.28 <0.001 
cis-11 18:1 0.39 0.37 0.36 0.02 ns 
cis-12 18:1 0.26 0.27 0.28 0.02 ns 
cis-13 18:1 0.04 0.04 0.04 0.00 ns 
cis-14 18:1/trans-16 18:1 0.21a 0.24b 0.27c 0.01 <0.001 
cis-15 18:1 0.10a 0.12b 0.14c 0.01 <0.001 
trans-10,trans-14 18:2 0.02 0.01 0.01 0.00 ns 
cis-9,trans-13 18:2/trans-8,cis-12 18:2 0.15a 0.16b 0.19c 0.01 <0.001 
cyclohexyl-11 11:0 0.07a 0.06b 0.06b 0.00 <0.001 
cis-9,trans-14 18:2 0.07a 0.08a 0.09b 0.00 <0.001 
cis-16 18:1 0.04a 0.04ab 0.05b 0.00 0.004 
cis-12,trans-16 18:2 0.01 0.01 0.01 0.00 ns 
trans-10 19:1 0.01 0.01 0.01 0.00 ns 
trans-9,cis-12 18:2 0.03 0.07b 0.15c 0.01 <0.001 
trans-11,cis-15 18:2 0.01 0.01 0.01 0.00 ns 
cis-9,cis-12 18:2  2.46a 2.29b 2.24b 0.07 <0.001 
trans-12,cis-15 18:2 0.02 0.02 0.02 0.00 ns 
20:0 0.08a 0.09b 0.09b 0.00 <0.001 
cis-6,cis-9,cis-12 18:3  0.03a 0.06b 0.08c 0.00 <0.001 
cis-9 20:1 0.07a 0.08b 0.09c 0.00 <0.001 
cis-11 20:1 0.02 0.02 0.03 0.00 ns 
cis-9,cis-12,cis-15 18:3  0.38c 0.47c 0.58c 0.02 <0.001 
cis-9,trans-11 18:2 0.29a 0.30a 0.37b 0.03 <0.001 
cis-9,cis-11 18:2 0.02 0.02 0.02 0.00 ns 
trans-7,trans-9 18:2/trans-10,trans-12 18 :2 0.01 0.01 0.01 0.00 ns 
cis-6,cis-9,cis-12,cis-15 18:4  0.02a 0.06b 0.09c 0.00 <0.001 
cis-11,cis-14 20:2  0.04a 0.03ab 0.03b 0.00 0.005 
22:0 0.04 0.04 0.04 0.00 ns 
cis-8,cis-11,cis-14 20:3  0.13 0.12 0.12 0.01 ns 
cis-11,cis-14,cis-17 20:3  0.00 0.01 0.01 0.00 ns 
cis-5,cis-8,cis-11,cis-14 20:4  0.16a 0.15b 0.15b 0.00 <0.001 
cis-8,cis-11,cis-14,cis-17 20:4  0.02a 0.03b 0.04c 0.00 <0.001 
cis-5,cis-8,cis-11,cis-14,cis-17 20:5  0.03a 0.05b 0.05b 0.00 <0.001 
24:0 0.03 0.03 0.03 0.00 ns 
cis-7,cis-10,cis-13,cis-16 22:4  0.03 0.03 0.03 0.00 ns 
cis-7,cis-10,cis-13,cis-16,cis-19 22:5  0.06a 0.07b 0.06ab 0.00 0.03 
unknown 0.29a 0.30a 0.32b 0.01 <0.001 
a
Means are based on 12 dairy cattle per treatment. Means without a common letter differ significantly (P < 
0.05). bCON: control (0% of DM as lipid-encapsulated echium oil), cLEO: 1.5% of DM as lipid-
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encapsulated echium oil, dHEO: 3% of DM as lipid-encapsulated echium oil. eTotal SFA: sum of saturated 
fatty acids (4:0 to 26:0). fTotal MUFA: sum of monounsaturated fatty acids (14:1 to 24:1).  gTotal PUFA: 
sum of polyunsaturated fatty acids (18:2 to 22:5). hTotal n-6 PUFA: sum of n-6 PUFA: cis-9,cis-12 18:2, cis-6,cis-
9,cis-12 18:3, cis-11,cis-14 20:2, cis-8,cis-11,cis-14 20:3, cis-5,cis-8,cis-11,cis-14 20:4, and cis-7,cis-10,cis-13,cis-16 
22:4. iTotal n-3 PUFA: sum of n-3 PUFA: cis-9,cis-12,cis-15 18:3, cis-6,cis-9,cis-12,cis-15 18:4, cis-11,cis-14,cis-17 
20:3, cis-8,cis-11,cis-14,cis-17 20:4, cis-5,cis-8,cis-11,cis-14,cis-17 20:5, and cis-7,cis-10,cis-13,cis-16,cis-19 22:5. 
jTotal CLA: sum of conjugated linoleic acids: cis-9,trans-11-18:2, cis-9,cis-11-18:2, and trans-7,trans-9-
18:2, and trans-10,trans-12-18:2. 
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Table B.2. Fatty acid compositiona (g/100g FA) of the triacylglycerol plasma lipid fraction in 
response to dietary treatments of CONb, LEOc, and HEOd. 
fatty acid 
Treatment 
SE P value 
CON LEO HEO 
9:0 0.31 0.33 0.26 0.03 ns 
11:0 0.26 0.26 0.23 0.03 ns 
12:0 0.18 0.17 0.18 0.02 ns 
13:0 0.07 0.12 0.06 0.03 ns 
iso 14:0 0.27 0.30 0.24 0.04 ns 
14:0 1.71 1.59 1.47 0.09 ns 
iso 15:0 0.89a 0.75b 0.63c 0.03 <0.001 
anteiso 15:0 1.43a 1.33a 1.06b 0.04 <0.001 
15:0 1.55a 1.39b 1.23c 0.04 <0.001 
iso 16:0 0.74 0.70 0.60 0.05 ns 
trans-10 15:1 0.01 0.00 0.00 0.01 ns 
16:0 19.6a 23.1b 25.3c 0.37 <0.001 
iso 17:0 0.86a 0.63b 0.54b 0.04 <0.001 
trans-9 16:1 0.14 0.09 0.08 0.02 ns 
cis-8 16:1 0.48a 0.40ab 0.30b 0.03 0.005 
anteiso 17:0 0.80 0.81 0.70 0.07 ns 
cis-9 16:1 2.48 2.64 2.24 0.21 ns 
17:0 1.04a 0.89b 0.78b 0.03 <0.001 
18:0 39.5 39.0 39.1 1.25 ns 
trans-6–8 18:1 0.60 0.55 0.47 0.04 ns 
trans-9 18:1 0.42 0.32 0.30 0.04 ns 
trans-10 18:1 0.67 0.64 0.58 0.05 ns 
trans-11 18:1 1.65a 1.83ab 2.02b 0.15 0.03 
trans-12 18:1 0.54 0.55 0.55 0.04 ns 
trans-13/14 18:1/cis-6–8 18:1 2.07 2.10 1.99 0.08 ns 
cis-9 18:1 6.14 5.82 5.33 0.30 ns 
cis-11 18:1 1.18 0.91 0.85 0.09 ns 
cis-12 18:1 0.81 0.70 0.70 0.05 ns 
cis-13 18:1 0.18 0.12 0.11 0.03 ns 
cis-14 18:1/trans-16 18:1 0.90 0.81 0.88 0.06 ns 
cis-15 18:1 0.33 0.30 0.33 0.03 ns 
trans-10,trans-14 18:2 0.34 0.22 0.23 0.04 ns 
cyclohexyl-11 11:0 0.18 0.15 0.19 0.02 ns 
trans-9,cis-12 18:2 0.03a 0.10a 0.30b 0.03 <0.001 
cis-9,cis-12 18:2  6.01a 5.05ab 4.30b 0.30 0.002 
20:0 0.44a 0.36b 0.42ab 0.02 0.03 
trans-9,trans-12,cis-15 18:3 0.05 0.02 0.02 0.01 ns 
cis-6,cis-9,cis-12 18:3  0.20a 0.19a 0.29b 0.03 0.009 
cis-11 20:1  0.07 0.06 0.09 0.01 ns 
cis-9,cis-12,cis-15 18:3  1.15a 1.39b 1.56c 0.08 0.02 
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cis-9,trans-11 18:2 0.08 0.09 0.10 0.02 ns 
trans-7,cis-9 18 :2 /trans-8,cis-10 18 :2 0.12 0.18 0.14 0.03 ns 
trans-10,cis-12 18:2 0.05 0.08 0.07 0.01 ns 
trans-11,trans-13 18:2 0.00a 0.00a 0.03b 0.00 0.001 
cis-6,cis-9,cis-12,cis-15 18:4  0.00a 0.12b 0.23c 0.02 <0.001 
22:0 023 0.18 0.21 0.02 ns 
cis-8,cis-11,cis-14 20:3  0.52a 0.41ab 0.36b 0.05 0.02 
cis-5,cis-8,cis-11,cis-14 20:4  0.21 0.23 0.16 0.02 ns 
23:0 0.21 0.21 0.17 0.02 ns 
cis-8,cis-11,cis-14,cis-17 20:4  0.16a 0.17a 0.25b 0.02 0.005 
cis-5,cis-8,cis-11,cis-14,cis-17 20:5  0.22 0.26 0.31 0.02 ns 
24:0 0.19a 0.05b 0.04b 0.03 0.002 
cis-7,cis-10,cis-13,cis-16,cis-19 22:5  0.13 0.10 0.17 0.03 ns 
unknown 1.64 1.29 1.33 0.01 ns 
total SFAe 65.2a 67.6ab 69.4b 1.08 0.02 
total MUFAf 18.53 17.82 16.83 0.73 ns 
total trans 18:1 5.89 5.98 5.88 0.28 ns 
total PUFAg 9.27 8.60 8.54 0.44 ns 
total  n-6 PUFAh 6.96a 5.87ab 5.10b 0.34 0.003 
total n-3 PUFAi 1.51a 1.87a 2.28b 0.10 0.002 
n-6:n-3 ratio 4.63a 3.12b 2.26c 0.12 <0.001 
total CLAj 0.25 0.35 0.37 0.04 ns 
total odd and branched-chain FA 5.02a 4.51a 3.77b 0.16 <0.001 
aMeans are based on 12 dairy cattle per treatment. Means without a common letter differ significantly (P < 
0.05). bCON: control (0% of DM as lipid-encapsulated echium oil), cLEO: 1.5% of DM as lipid-encapsulated 
echium oil, dHEO: 3% of DM as lipid-encapsulated echium oil. eTotal SFA: sum of saturated fatty acids 
(4:0 to 26:0). fTotal MUFA: sum of monounsaturated fatty acids (14:1 to 24:1). gTotal PUFA: sum of 
polyunsaturated fatty acids (18:2 to 22:5). hTotal n-6 PUFA: sum of n-6 PUFA: cis-9,cis-12 18:2, cis-6,cis-9,cis-
12 18:3, cis-11,cis-14 20:2, cis-8,cis-11,cis-14 20:3, cis-5,cis-8,cis-11,cis-14 20:4, and cis-7,cis-10,cis-13,cis-16 22:4. 
iTotal n-3 PUFA: sum of n-3 PUFA: cis-9,cis-12,cis-15 18:3, cis-6,cis-9,cis-12,cis-15 18:4, cis-11,cis-14,cis-17 20:3, 
cis-8,cis-11,cis-14,cis-17 20:4, cis-5,cis-8,cis-11,cis-14,cis-17 20:5, and cis-7,cis-10,cis-13,cis-16,cis-19 22:5. jTotal 
CLA: sum of conjugated linoleic acids: cis-9,trans-11-18:2, cis-9,cis-11-18:2, and trans-7,trans-9-18:2, and 
trans-10,trans-12-18:2. 
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Table B.3. Fatty acid compositiona (g/100g FA) of plasma free fatty acids in response to 
dietary treatments CONb, LEOc, and HEOd. 
fatty acids 
Treatment 
SE P value 
CON LEO HEO 
9:0 0.05 0.12 0.04 0.03 ns 
10:0 0.08 0.20 0.05 0.07 ns 
11:0 0.21a 0.21a 0.15b 0.01 0.002 
12:0 0.01 0.01 0.05 0.02 ns 
13:0 0.01 0.00 0.04 0.02 ns 
iso 14:0 0.02 0.02 0.03 0.01 ns 
14:0  0.98a 1.26b 1.09a 0.12 <0.001 
iso 15:0 0.31 0.29 0.26 0.02 ns 
anteiso 15:0 038 0.42 0.36 0.03 ns 
cis-9 14:1  0.01 0.01 0.05 0.01 ns 
15:0 0.45 0.43 0.42 0.02 ns 
iso 16:0 0.24 0.23 0.21 0.03 ns 
trans-10 15:1 0.02 0.03 0.02 0.01 ns 
16:0 18.8a 20.7b 20.2b 0.32 0.007 
iso 17:0 0.40 0.34 0.38 0.03 ns 
trans-9 16:1  0.13 0.15 0.09 0.02 ns 
cis-7 16:1  0.03 0.04 0.01 0.002 ns 
cis-8 16:1 0.16 0.13 0.16 0.03 ns 
anteiso 17:0 0.78a 0.76ab 0.61b 0.06 0.034 
cis-9 16:1  1.52 1.43 1.45 0.16 ns 
17:0 0.78 0.82 0.70 004 ns 
iso 18:0 005 0.05 001 0.01 ns 
cis-9 17:1 0.08 0.09 0.08 0.03 ns 
18:0 32.1 32.9 32.7 1.01 ns 
trans-4 18:1 0.14 0.10 0.14 0.03 ns 
trans-5 18:1 0.27 0.18 0.24 0.03 ns 
trans-6–8 18:1 2.03 1.84 1.59 0.15 ns 
trans-9 18:1 0.96 0.67 0.88 0.08 ns 
trans-10 18:1 1.25 1.05 1.11 0.09 ns 
trans-11 18:1 1.36 1.42 1.34 0.09 ns 
trans-12 18:1 0.77 0.58 0.69 0.04 ns 
trans-13/14 18:1 2.07 1.85 1.90 0.09 ns 
cis-9 18:1 13.8 13.8 13.3 1.01 ns 
cis-11 18:1 1.01a 0.92b 0.91b 0.06 0.016 
cis-12 18:1 0.52 0.51 0.55 0.03 ns 
cis-13 18:1 0.27 0.18 0.23 0.03 ns 
cis-14 18:1/trans-16 18:1 0.45 0.40 0.45 0.03 ns 
cis-15 18:1 0.17 0.23 0.23 0.03 ns 
trans-10,trans-14 18:2 0.02 0.01 0.01 0.01 ns 
trans-9,trans-12 18:2 0.01 0.01 0.08 0.05 ns 
cis-9,trans-13 18:2/trans-8,cis-12 18:2 0.05 0.06 0.13 0.04 ns 
cyclohexyl-11 11:0 0.16 0.16 0.16 0.03 ns 
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trans-9,cis-12 18:2 0.00a 0.02a 0.15b 0.02 <0.001 
cis-16 18:1 0.00 0.02 0.00 0.01 ns 
cis-9,cis-12 18:2  9.61 7.60 7.99 0.74 ns 
20:0 0.33 0.31 0.37 0.03 ns 
trans-9,trans-12,cis-15 18:3 0.01 0.02 0.08 0.05 ns 
cis-6,cis-9,cis-12 18:3  0.17a 0.16a 0.23b 0.02 0.034 
cis-11 20:1 0.12 0.09 0.13 0.02 ns 
cis-9,cis-12,cis-15 18:3  3.07 3.14 3.19 0.15 ns 
cis-9,trans-11 18:2 0.07 0.06 0.09 002 ns 
trans-10,cis-12 18:2 0.02 0.01 0.02 0.01 ns 
trans-7,trans-9 18 :2/trans-10,trans-12 18 :2 0.00 0.01 0.01 0.01 ns 
21:0 0.01 0.01 0.02 0.01 ns 
cis-6,cis-9,cis-12,cis-15 18:4  0.01a 0.04a 0.15b 0.02 <0.001 
cis-11,cis-14 20:2  0.07 0.07 0.08 0.02 ns 
22:0 0.34 0.35 0.39 0.03 ns 
cis-8,cis-11,cis-14 20:3  0.59 0.59 0.56 0.04 ns 
cis-5,cis-8,cis-11,cis-14 20:4  0.53 0.46 0.53 0.04 ns 
23:0 0.36 0.30 0.38 0.03 ns 
cis-8,cis-11,cis-14,cis-17 20:4  0.10 0.15 0.18 0.03 ns 
cis-5,cis-8,cis-11,cis-14,cis-17 20:5  0.59 0.55 0.67 0.06 ns 
24:0 0.23 0.31 0.15 0.05 ns 
cis-7,cis-10,cis-13,cis-16 22:4  0.04 0.04 0.04 0.02 ns 
cis-7,cis-10,cis-13,cis-16,cis-19 22:5  0.10 0.09 0.10 0.03 ns 
unknown 0.75 1.16 1.39 0.26 ns 
total SFAe 54.6 57.6 56.8 1.15 ns 
total MUFAf 27.1 25.8 25.6 1.25 ns 
total trans 18:1 8.78 7.71 7.90 0.40 ns 
total PUFAg 15.1 13.1 14.3 0.83 ns 
total n-6 PUFAh 11.00 8.89 9.43 0.75 ns 
total n-3 PUFAi 3.86 3.99 4.28 0.18 ns 
n-6:n-3 ratio 3.41a 2.79ab 2.34b 0.21 0.009 
total CLAj 0.10 0.09 0.13 0.03 ns 
total odd and branched-chain FA 2.16 2.11 1.85 0.12 ns 
aMeans are based on 12 dairy cattle per treatment. Means without a common letter differ significantly (P < 
0.05). bCON: control (0% of DM as lipid-encapsulated echium oil), cLEO: 1.5% of DM as lipid-encapsulated 
echium oil, dHEO: 3% of DM as lipid-encapsulated echium oil. eTotal SFA: sum of saturated fatty acids (4:0 
to 26:0). fTotal MUFA: sum of monounsaturated fatty acids (14:1 to 24:1). gTotal PUFA: sum of 
polyunsaturated fatty acids (18:2 to 22:5). hTotal n-6 PUFA: sum of n-6 PUFA: cis-9,cis-12 18:2, cis-6,cis-9,cis-12 
18:3, cis-11,cis-14 20:2, cis-8,cis-11,cis-14 20:3, cis-5,cis-8,cis-11,cis-14 20:4, and cis-7,cis-10,cis-13,cis-16 22:4. 
iTotal n-3 PUFA: sum of n-3 PUFA: cis-9,cis-12,cis-15 18:3, cis-6,cis-9,cis-12,cis-15 18:4, cis-11,cis-14,cis-17 20:3, 
cis-8,cis-11,cis-14,cis-17 20:4, cis-5,cis-8,cis-11,cis-14,cis-17 20:5, and cis-7,cis-10,cis-13,cis-16,cis-19 22:5.  jTotal 
CLA: sum of conjugated linoleic acids: cis-9,trans-11-18:2, cis-9,cis-11-18:2, and trans-7,trans-9-18:2, and 
trans-10,trans-12-18:2. 
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Table B.4. Fatty acid compositiona (g/100g FA) of cholesterol ester plasma lipid fraction in 
response to dietary treatments CONb, LEOc, and HEOd. 
fatty acid 
Treatment 
SE P value 
CON LEO HEO 
12:0 0.02 0.00 0.01 0.01 ns 
iso 14:0 0.01 0.01 0.02 0.01 ns 
14:0 1.01a 0.92b 0.91b 0.04 0.003 
iso 15:0 0.67a 0.53b 0.53b 0.03 0.002 
anteiso 15:0 0.77a 0.75ab 0.69b 0.03 0.01 
15:0 0.73a 0.64b 0.57c 0.02 <0.001 
iso 16:0 0.36a 0.31ab 0.29b 0.02 0.007 
16:0 4.28 4.27 4.23 0.10 ns 
iso 17:0 0.11 0.01 0.01 0.04 ns 
trans-9 16:1 0.01 0.01 0.00 0.01 ns 
cis-8 16:1 0.48a 0.47ab 0.38b 0.03 0.03 
anteiso 17:0 0.28a 0.21ab 0.18b 0.02 .009 
cis-9 16:1 0.87 0.91 0.82 0.07 ns 
iso 18:0 0.55a 0.46a 0.34b 0.05 ns 
cis-8 17:1 0.01 0.00 0.00 0.00 ns 
cis-9 17:1 0.06 0.10 0.04 0.03 ns 
18:0 0.76 0.58 0.66 0.09 ns 
cis-9 18:1 1.85 1.89 1.71 0.12 ns 
cis-11 18:1 0.12 0.15 0.11 0.02 ns 
cis-12 18:1 0.16 0.15 0.16 0.02 ns 
cyclohexyl-11 11:0 0.19 0.17 0.12 0.03 ns 
cis-9,cis-12 18:2  75.5a 73.7b 72.0c 0.39 <0.001 
cis-6,cis-9,cis-12 18:3  2.31a 2.70b 3.12c 0.09 <0.001 
cis-9,cis-12,cis-15 18:3  5.82a 7.62b 9.09c 0.12 <0.001 
cis-6,cis-9,cis-12,cis-15 18:4  0.27a 0.64b 1.04c 0.02 <0.001 
cis-8,cis-11,cis-14 20:3  0.69 0.67 0.67 0.05 ns 
cis-5,cis-8,cis-11,cis-14 20:4  1.35 1.33 1.30 0.04 ns 
cis-8,cis-11,cis-14,cis-17 20:4  0.17a 0.23a 0.24b 0.03 <0.001 
cis-5,cis-8,cis-11,cis-14,cis-17 20:5  0.29a 0.34ab 0.41b 0.02 0.003 
24:0 0.09a 0.13b 0.12b 0.01 0.04 
unknown 0.19 0.12 0.10 0.07 ns 
total SFAe 6.98 6.55 6.50 0.20 ns 
total MUFAf 3.50ab 3.67a 3.23b 0.21 0.03 
total PUFAg 86.4a 87.2ab 88.0b 0.37 0.001 
total n-6 PUFAh 79.9a 78.4ab 77.1b 0.40 <0.001 
total n-3 PUFAi 6.54a 8.84b 10.88c 0.16 <0.001 
n-6:n-3 ratio 12.2a 8.93b 7.10c 0.21 <0.001 
total odd and branched-chain FA 2.76a 2.29b 2.07b 0.11 <0.001 
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aMeans are based on 12 dairy cattle per treatment Means without a common letter differ significantly (P < 
0.05). bCON: control (0% of DM as lipid-encapsulated echium oil), cLEO: 1.5% of DM as lipid-encapsulated 
echium oil, dHEO: 3% of DM as lipid-encapsulated echium oil. eTotal SFA: sum of saturated fatty acids (4:0 
to 26:0). fTotal MUFA: sum of monounsaturated fatty acids (14:1 to 24:1). gTotal PUFA: sum of 
polyunsaturated fatty acids (18:2 to 22:5). hTotal n-6 PUFA: sum of n-6 PUFA: cis-9,cis-12 18:2, cis-6,cis-9,cis-12 
18:3, cis-11,cis-14 20:2, cis-8,cis-11,cis-14 20:3, cis-5,cis-8,cis-11,cis-14 20:4, and cis-7,cis-10,cis-13,cis-16 22:4. 
iTotal n-3 PUFA: sum of n-3 PUFA: cis-9,cis-12,cis-15 18:3, cis-6,cis-9,cis-12,cis-15 18:4, cis-11,cis-14,cis-17 20:3, 
cis-8,cis-11,cis-14,cis-17 20:4, cis-5,cis-8,cis-11,cis-14,cis-17 20:5, and cis-7,cis-10,cis-13,cis-16,cis-19 22:5. jTotal 
CLA: sum of conjugated linoleic acids: cis-9,trans-11-18:2, cis-9,cis-11-18:2, and trans-7,trans-9-18:2, and 
trans-10,trans-12-18:2. 
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Table B.5. Fatty acid compositiona (g/100g FA) of plasma phospholipids in response to 
dietary treatments of CONb, LEOc, and HEOd. 
fatty acid 
Treatment 
SE P value 
CON LEO HEO 
10:0 0.13 0.12 0.09 0.03 ns 
anteiso 13:0 0.46 0.42 0.43 0.03 ns 
14:0 0.15 0.15 0.13 0.01 ns 
iso 15:0 0.13 0.13 0.10 0.01 ns 
trans-9 14:1 0.42 0.41 0.39 0.05 ns 
anteiso 15:0 0.14 0.14 0.12 0.01 ns 
15:0 0.46a 0.39b 0.40b 0.01 <0.001 
iso 16:0 0.26a 0.25ab 0.21b 0.01 0.026 
trans-10 15:1 0.09 0.07 0.07 0.01 ns 
16:0 13.8a 14.6b 15.0c 0.16 ns 
iso 17:0 0.36 0.30 0.28 0.03 ns 
trans-9 16:1 0.05 0.04 0.04 0.00 ns 
cis-8 16:1 0.08a 0.04ab 0.01b 0.01 0.005 
anteiso 17:0 0.64a 0.56b 0.49b 0.03 <0.001 
cis-9 16:1 2.03 1.98 1.90 0.08 ns 
17:0 1.34a 1.21b 1.12c 0.03 ns 
cis-9 17:1 0.16 0.18 0.15 0.02 ns 
cis-10 17:1 0.13 0.13 0.15 0.02 ns 
18:0 23.8a 24.2ab 24.4b 0.31 0.011 
trans-4 18:1 0.11a 0.11ab 0.05b 0.02 0.030 
trans-6–8 18:1 0.09 0.06 0.08 0.02 ns 
trans-9 18:1 0.10 0.07 0.08 0.02 ns 
trans-10 18:1 0.13 0.15 0.13 0.03 ns 
trans-11 18:1 0.29a 0.9a 0.43b 0.04 0.039 
trans-12 18:1 0.22 0.22 0.24 0.01 ns 
trans-13/14 18:1/cis-6–8 18:1 0.60 0.58 0.57 0.02 ns 
cis-9 18:1 5.40 5.32 4.99 0.23 ns 
cis-11 18:1 0.51a 0.41b 4.40b 0.02 0.001 
cis-12 18:1 0.40 0.44 0.47 0.03 ns 
cis-13 18:1 0.02 0.02 0.01 0.01 ns 
cis-14 18:1/trans-16 18:1 0.18 0.16 0.16 0.01 ns 
cis-15 18:1 0.16 0.15 0.13 0.01 ns 
cyclohexyl-11 11:0 0.09 0.07 0.06 0.02 ns 
cis-9,cis-12 18:2  34.8a 34.1ab 33.4b 0.33 0.003 
cis-6,cis-9,cis-12 18:3  0.33a 0.52b 0.71c 0.02 <0.001 
cis-9,cis-12,cis-15 18:3  1.41a 1.83b 2.21c 0.04 <0.001 
cis-6,cis-9,cis-12,cis-15 18:4  0.00a 0.08b 0.15c 0.01 <0.001 
cis-11,cis-14 20:2  0.14 0.13 0.12 0.01 ns 
cis-8,cis-11,cis-14 20:3  5.05 4.78 4.57 0.25 ns 
cis-5,cis-8,cis-11,cis-14 20:4  2.33 2.33 2.30 0.08 ns 
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cis-8,cis-11,cis-14,cis-17 20:4  0.44a 0.65b 0.83c 0.04 <0.001 
cis-5,cis-8,cis-11,cis-14,cis-17 20:5  0.24a 0.37b 0.46c 0.03 <0.001 
24:0 0.11 0.08 0.08 0.01 ns 
cis-7,cis-10,cis-13,cis-16 22:4  0.56 0.55 0.53 0.03 ns 
cis-7,cis-10,cis-13,cis-16,cis-19 22:5  0.86 0.85 0.85 0.03 ns 
unknown 0.67 0.48 0.53 0.16 ns 
total SFAe 39.9a 40.7b 41.3b 0.26 <0.001 
total MUFAf 11.1 10.8 10.4 0.33 ns 
total trans 18:1 1.55 1.47 1.57 0.08 ns 
total PUFAg 46.2 46.1 46.1 0.35 ns 
total n-6 PUFAh 43.3a 42.4b 41.6b 0.33 <0.001 
total n-3 PUFAi 2.94a 3.77b 4.56c 0.10 <0.001 
n-6:n-3 ratio 14.9a 11.3b 9.33c 0.38 <0.001 
total odd and branched-chain FA 2.00a 1.80b 1.64b 0.05 <0.001 
aMeans are based on 12 dairy cattle per treatment. Means without a common letter differ significantly (P < 
0.05). bCON: control (0% of DM as lipid-encapsulated echium oil), cLEO: 1.5% of DM as lipid-
encapsulated echium oil, dHEO: 3% of DM as lipid-encapsulated echium oil. eTotal SFA: sum of saturated 
fatty acids (4:0 to 26:0). fTotal MUFA: sum of monounsaturated fatty acids (14:1 to 24:1). gTotal PUFA: 
sum of polyunsaturated fatty acids (18:2 to 22:5). hTotal n-6 PUFA: sum of n-6 PUFA: cis-9,cis-12 18:2, cis-6,cis-
9,cis-12 18:3, cis-11,cis-14 20:2, cis-8,cis-11,cis-14 20:3, cis-5,cis-8,cis-11,cis-14 20:4, and cis-7,cis-10,cis-13,cis-16 
22:4. iTotal n-3 PUFA: sum of n-3 PUFA: cis-9,cis-12,cis-15 18:3, cis-6,cis-9,cis-12,cis-15 18:4, cis-11,cis-14,cis-17 
20:3, cis-8,cis-11,cis-14,cis-17 20:4, cis-5,cis-8,cis-11,cis-14,cis-17 20:5, and cis-7,cis-10,cis-13,cis-16,cis-19 22:5. 
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Appendix C. 
 
Figure C.1. Visual evidence of encapsulated echium oil (EEO) and encapsulation matrix [A] 
in feces of cows on baseline diet [B], supplemented with 1.5% of DM as EEO and 1.5% of DM 
as encapsulation matrix [C], and 3% DM as EEO [D]. 
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Table C.1. Daily dry matter intake (DMI), milk yield, milk components, and feed 
efficiency of dairy cowsa on CONb, LEOc, and HEOd diets. 
 Treatment 
SE P-value 
 CON LEO HEO 
DMI, kg/d 27.3 28.0 30.4 1.6 0.09 
      
milk yield, kg/d 41.4 44.8 44.8 2.2 0.07 
3.5% FCMe 42.8 47.2 46.6 1.9 ns 
ECMf 42.2 46.4 46.0 1.9 ns 
milk components      
   fat, kg/d 1.5 1.7 1.7 0.1 ns 
   fat, % 3.7 3.9 3.8 0.2 ns 
   protein, kg/d 1.3 1.4 1.4 0.1 0.06 
   protein, % 3.1 3.1 3.2 0.1 ns 
   lactose, kg/d 2.3 2.5 2.5 0.1 0.07 
   lactose, % 5.6 5.6 5.6 0.1 ns 
      
fecal output (DM, kg/d) 7.4 7.8 8.6 0.6 0.06 
feed efficiencyg 1.5 1.7 1.7 0.2 ns 
aLS means are based on 6 dairy cows per treatment. bCON: control (0% of DM as encapsulated 
echium oil), cLEO: 1.5% of DM as encapsulated echium oil, and 1.5% of DM as encapsulation 
matrix, dHEO: 3% of DM as encapsulated echium oil. e3.5% FCM = [0.43 x milk yield (kg/d)] + 
[16.22 x fat yield (kg/d)]. fECM = [12.82 x fat yield (kg/d)] + [7.13 x protein yield (kg/d)] + [0.32 
x milk yield (kg/d). gFeed efficiency = kg of 3.5% FCM/kg DMI. ns = non-significant.
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Table C.2. Fatty acid compositiona (g/100g FA) of milk fat by day in response to CONb, LEOc, and HEOd diets. 
fatty acid 
Treatment 
SE 
P 
value 
CON LEO HEO 
D-2 D-1 D1 D2 D3 D4 D5 D6 D7 D8 D9 D10 D11 D12 D13 D14 
4:0 3.12 3.13 3.10 3.01 3.09 3.08 3.11 3.12 3.13 3.33 3.06 3.06 3.00 3.08 3.07 3.27 0.10 <0.01 
5:0 0.02 0.01 0.02 0.02 0.01 0.02 0.02 0.02 0.01 0.02 0.02 0.01 0.02 0.02 0.02 0.01 0.00 ns 
6:0 2.00 2.06 2.04 1.98 1.99 1.99 2.01 2.04 2.04 2.06 1.98 2.01 1.95 1.98 1.98 2.09 0.06 <0.01 
7:0 0.01 0.01 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.02 0.02 0.02 0.02 0.03 0.02 0.00 0.057 
8:0 1.20 1.24 1.23 1.18 1.20 1.21 1.21 1.24 1.25 1.19 1.21 1.24 1.20 1.21 1.19 1.26 0.04 <0.01 
9:0 0.02 0.02 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.00 ns 
10:0 2.83 2.93 2.97 2.82 2.79 2.85 2.83 2.89 2.96 2.78 2.89 2.95 2.87 2.88 2.86 2.93 0.09 <0.01 
11:0 0.26 0.28 0.29 0.29 0.28 0.28 0.30 0.30 0.28 0.32 0.28 0.26 0.32 .033 0.31 0.28 0.01 <0.001 
12:0 3.35 3.46 3.51 3.38 3.32 3.38 3.36 3.43 3.50 3.33 3.44 3.51 3.43 3.42 3.37 3.42 0.11 ns 
iso 13:0 0.03 0.03 0.02 0.03 0.03 0.03 0.03 0.03 0.03 0.02 0.02 0.03 0.03 0.03 0.03 0.03 0.00 ns 
anteiso 13:0 0.08 0.09 0.09 0.09 0.08 0.08 0.09 0.09 0.09 0.08 0.08 0.09 0.09 0.09 0.08 0.08 0.01 ns 
13:0 0.17 0.18 0.19 0.19 0.18 0.18 0.18 0.19 0.18 0.18 0.19 0.19 0.19 0.18 0.18 0.18 0.01 ns 
iso 14:0 0.11 0.10 0.10 0.09 0.08 0.09 0.08 0.08 0.09 0.07 0.07 0.07 0.07 0.08 0.09 0.09 0.01 <0.05 
14:0 12.5 12.5 12.4 12.1 12.1 12.1 12.2 12.1 12.4 12.1 12.2 12.0 12.0 12.0 11.9 12.0 0.31 <0.05 
iso 15:0 0.20 0.18 0.18 0.18 0.18 0.18 0.17 0.17 0.17 0.16 0.17 0.17 0.17 0.18 0.19 0.18 0.01 <0.001 
14:1 t9 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 ns 
anteiso 15:0 0.47 0.46 0.45 0.44 0.44 0.43 0.42 0.42 0.41 0.41 0.42 0.42 0.43 0.43 0.43 0.42 0.02 0.053 
14:1 c9 0.93 0.96 1.02 1.03 1.02 1.01 1.05 1.05 1.00 0.97 0.97 0.91 0.91 0.93 0.90 0.91 0.07 ns 
15:0 0.95 0.96 1.01 1.00 0.97 0.96 0.94 0.92 0.91 0.93 0.96 0.96 0.95 0.96 0.96 0.94 0.01 ns 
iso 16:0 0.25 0.25 0.23 0.22 0.19 0.19 0.20 0.21 0.21 0.21 0.18 0.19 0.20 0.21 0.23 0.21 0.01 <0.01 
16:0 32.5 32.8 33.6 33.4 33.5 33.7 33.7 32.6 32.7 32.8 32.5 31.8 31.6 31.2 31.4 31.6 0.89 <0.01 
iso 17:0 0.33 0.34 0.32 0.32 0.33 0.32 0.32 0.32 0.31 0.31 0.31 0.32 0.32 0.31 0.32 0.31 0.02 ns 
16:1 t9 0.02 0.02 0.01 0.02 0.01 0.01 0.02 0.01 0.01 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.00 ns 
16:1 isomer 0.00 0.01 0.00 0.00 0.01 0.00 0.01 0.00 0.01 0.01 0.00 0.01 0.01 0.01 0.01 0.01 0.00 <0.05 
16:1 c7 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.00 ns 
16:1 c8 0.14 0.14 0.14 0.14 0.14 0.13 0.13 0.13 0.12 0.12 0.12 0.12 0.12 0.12 0.12 0.12 0.01 ns 
anteiso 17:0 0.02 0.02 0.01 0.01 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.02 0.00 ns 
16:1 c9 1.78 1.80 1.88 1.92 1.89 1.85 1.88 1.85 1.76 1.75 1.74 1.65 1.64 1.63 1.61 1.60 0.11 <0.05 
16:1 c10/t13 0.01 0.01 0.01 0.01 0.02 0.01 0.01 0.01 0.01 0.03 0.02 0.03 0.03 0.03 0.03 0.01 0.00 <0.001 
16:1 c11 0.09 0.08 0.07 0.06 0.07 0.06 0.06 0.06 0.07 0.02 0.06 0.06 0.03 0.02 0.02 0.06 0.00 <0.001 
17:0 0.62 0.61 0.61 0.60 0.59 0.57 0.57 0.57 0.58 0.57 0.57 0.57 0.57 0.58 0.58 0.57 0.01 ns 
iso 18:0 0.01 0.01 0.01 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 ns 
17:1 c8 0.18 0.17 0.17 0.17 0.16 0.16 0.16 0.15 0.15 0.14 0.15 0.14 0.13 0.14 0.15 0.13 0.01 0.075 
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18:0 9.70 9.34 8.61 8.84 8.93 8.97 8.70 8.97 9.4 9.07 9.28 9.59 9.75 9.89 10.0 9.76 0.34 ns 
18:1 t4 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.01 0.00 ns 
18:1 t5 0.01 0.01 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.02 0.02 0.01 0.00 <0.05 
18:1 t6-8 0.24 0.26 0.26 0.25 0.26 0.25 0.26 0.26 0.27 0.28 0.28 0.28 0.28 0.28 0.25 0.27 0.01 <0.01 
18:1 t9 0.21 0.19 0.22 0.22 0.21 0.21 0.22 0.22 0.23 0.24 0.23 0.24 0.25 0.25 0.24 0.23 0.01 ns 
18:1 t10 0.29 0.29 0.31 0.31 0.32 0.30 0.33 0.33 0.34 0.39 0.36 0.38 0.42 0.37 0.35 0.36 0.02 <0.01 
18:1 t11 0.98 0.92 0.89 0.93 0.99 0.98 1.00 1.09 1.14 1.15 1.17 1.26 1.25 1.24 1.21 1.19 0.09 <0.001 
18:1 t12 0.31 0.32 0.34 0.35 0.36 0.34 0.36 0.38 0.39 0.41 0.41 0.44 0.44 0.42 0.38 0.40 0.02 <0.001 
18:1 t13/14/c6-8 0.40 0.42 0.44 0.47 0.48 0.46 0.49 0.50 0.52 0.63 0.54 0.62 0.66 0.63 0.60 0.54 0.03 <0.001 
18:1 c9 17.7 1.76 17.3 17.9 17.7 17.5 17.4 17.8 17.3 17.5 17.5 17.5 17.5 17.7 17.7 17.4 0.69 0.067 
18:1 c11 0.57 0.57 0.55 0.54 0.51 0.49 0.50 0.48 0.49 0.52 0.50 0.49 0.51 0.51 0.51 0.46 0.03 <0.05 
18:1 c12 0.25 0.26 0.28 0.28 0.29 0.27 0.28 0.28 0.30 0.33 0.31 0.32 0.33 0.33 0.30 0.30 0.02 0.062 
18:1 c13 0.05 0.05 0.05 0.05 0.05 0.05 0.04 0.05 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.03 0.01 ns 
18:1 c14/t16 0.26 0.26 0.27 0.29 0.29 0.28 0.28 0.30 0.29 0.30 0.32 0.34 0.35 0.34 0.33 0.34 0.01 <0.001 
18:1 c15 0.05 0.05 0.06 0.07 0.07 0.07 0.07 0.07 0.07 0.09 0.08 0.11 0.11 0.11 0.11 0.09 0.01 ns 
18:2 t10,t14 0.08 0.08 0.07 0.08 0.08 0.06 0.07 0.07 0.07 0.07 0.07 0.07 0.06 0.07 0.07 0.08 0.01 ns 
18:2 t9,t12 0.16 0.16 0.18 0.20 0.20 0.20 0.21 0.21 0.22 0.23 0.23 0.24 0.24 0.24 0.22 0.22 0.01 ns 
cyclohexyl-11 11:0 0.14 0.14 0.14 0.14 0.13 0.14 0.14 0.13 0.14 0.17 0.15 0.14 0.15 0.16 0.16 0.12 0.01 <0.05 
18:2 c9,t14 0.10 0.10 0.11 0.13 0.11 0.12 0.11 0.12 0.11 0.12 0.12 0.13 0.12 0.13 0.11 0.11 0.01 ns 
18:1 c16 0.05 0.04 0.05 0.05 0.05 0.05 0.06 0.06 0.05 0.06 0.07 0.06 0.08 0.07 0.07 0.06 0.00 ns 
18:2 t9,c12 0.07 0.05 0.06 0.09 0.12 0.13 0.13 0.15 0.15 0.14 0.19 0.24 0.26 0.24 0.23 0.23 0.01 <0.001 
18:2 t11,c15 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.03 0.02 0.02 0.00 ns 
18:2 c9,c12 1.99 1.94 1.94 1.89 1.88 1.88 1.95 2.03 2.02 2.11 2.02 2.05 2.06 2.09 2.05 2.06 0.09 <0.001 
18:2 t12,c15 0.07 0.07 0.06 0.06 0.05 0.06 0.06 0.07 0.06 0.06 0.06 0.06 0.05 0.06 0.05 0.06 0.01 ns 
20 :0 0.13 0.12 0.11 0.12 0.12 0.12 0.11 0.11 0.12 0.10 0.12 0.12 0.11 0.11 0.11 0.12 0.01 0.062 
18:3 c6,c9,c12 0.02 0.02 0.02 0.03 0.04 0.04 0.04 0.05 0.04 0.04 0.06 0.06 0.06 0.07 0.07 0.07 0.01 <0.01 
20:1 c9 0.07 0.08 0.07 0.08 0.02 0.02 0.03 0.02 0.05 0.09 0.03 0.02 0.09 0.09 0.10 0.05 0.01 <0.001 
18:3 c9,c12,c15 0.33 0.33 0.35 0.38 0.46 0.47 0.47 0.49 0.47 0.49 0.53 0.56 0.58 0.58 0.62 0.63 0.02 <0.001 
18:2 c9,t11 0.45 0.44 0.46 0.49 0.50 0.49 0.52 0.55 0.55 0.56 0.57 0.59 0.61 0.58 0.56 0.56 0.04 <0.05 
18:2 c9,c11 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.00 ns 
18:2 t7,t9/t10,t12 0.01 0.01 0.02 0.01 0.01 0.01 0.01 0.02 0.01 0.01 0.02 0.02 0.02 0.02 0.02 0.02 0.00 ns 
18:4 c6,c9,c12,c15 0.00 0.00 0.03 0.04 0.04 0.04 0.05 0.05 0.05 0.06 0.06 0.08 0.08 0.07 0.09 0.09 0.00 <0.001 
20:2 c11,c14 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.03 0.02 0.02 0.04 0.04 0.03 0.02 0.00 <0.01 
20:3 c8,c11,c14 0.16 0.15 0.15 0.14 0.14 0.13 0.14 0.15 0.14 0.11 0.14 0.15 0.10 0.11 0.12 0.03 0.01 <0.001 
22:1 c13 0.01 0.01 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.02 0.02 0.01 0.01 0.02 0.03 0.00 <0.05 
20:3 c11,c14,c17 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.01 0.02 0.00 0.00 <0.05 
20:4 c5,c8,c11,c14 0.14 0.13 0.13 0.13 0.13 0.13 0.12 0.13 0.13 0.12 0.13 0.13 0.11 0.12 0.12 0.13 0.01 <0.05 
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23:0 0.01 0.01 0.01 0.01 0.00 0.01 0.01 0.01 0.01 0.00 0.02 0.02 0.00 0.02 0.02 0.02 0.00 <0.01 
20:5 c5,c8,c11,c14,c17 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.04 0.04 0.05 0.04 0.04 0.00 <0.05 
22:4 c7,c10,c13,c16 0.02 0.03 0.02 0.02 0.02 0.02 0.02 0.03 0.02 0.02 0.03 0.02 0.02 0.03 0.02 0.02 0.00 ns 
22:5 c7,c10,c13,c16,c19 0.05 0.04 0.04 0.04 0.04 0.04 0.05 0.04 0.04 0.04 0.04 0.04 0.04 0.05 0.05 0.05 0.00 ns 
unknown 0.53 0.49 0.50 0.47 0.43 0.44 0.48 0.49 0.46 0.29 0.44 0.51 0.59 0.61 0.62 0.84 0.02 <0.001 
de novoe 27.4 27.8 27.9 27.0 27.0 27.1 27.2 27.4 27.7 27.2 27.2 27.2 26.9 27.0 26.9 27.3 0.46 ns 
mixedf 34.8 35.1 35.9 35.8 35.9 36.0 36.0 34.9 35.0 34.9 34.7 33.9 33.7 33.3 33.5 33.7 0.96 <0.01 
preformedg 35.3 34.8 33.9 34.9 34.9 34.7 34.6 35.5 35.2 35.9 36.0 36.7 37.1 37.4 37.3 36.4 1.21 <0.01 
total SFAh 69.4 69.7 69.7 69.0 69.2 69.5 69.3 68.6 69.1 68.8 68.8 68.4 68.1 68.0 68.2 68.5 0.97 <0.05 
total MUFAi 24.7 24.6 24.5 25.2 25.0 24.7 24.8 25.2 24.7 25.2 25.0 25.1 25.3 25.4 25.1 24.8 0.80 0.056 
total trans 18:1 2.05 2.00 2.05 2.08 2.16 2.10 2.20 2.31 2.40 2.49 2.47 2.63 2.66 2.58 2.46 2.48 0.16 <0.001 
total PUFAj 3.72 3.65 3.73 3.82 3.93 3.89 4.05 4.26 4.19 4.25 4.38 4.55 4.52 4.58 4.52 4.44 0.18 <0.001 
total n-6 PUFAk 2.32 2.27 2.27 2.21 2.22 2.19 2.28 2.39 2.36 2.39 2.38 2.41 2.35 2.41 2.38 2.31 0.10 <0.001 
total n-3 PUFAl 0.41 0.41 0.44 0.50 0.57 0.58 0.60 0.62 0.60 0.62 0.68 0.72 0.74 0.76 0.81 0.81 0.03 <0.001 
total CLAm 0.48 0.47 0.49 0.52 0.53 0.52 0.55 0.58 0.59 0.57 0.61 0.63 0.63 0.60 0.59 0.59 0.04 <0.05 
aMeans are based on 6 dairy cattle per treatment. bCON: control (0% of DM as lipid-encapsulated echium oil), cLEO: 1.5% of DM as lipid-encapsulated echium 
oil, 1.5% of DM as encapsulation, dHEO: 3% of DM as lipid-encapsulated echium oil. eDe novo: sum of fatty acids < 16 carbons. fMixed: sum of 16:0 and 16:1 
c9. gPreformed: sum of fatty acids >16 carbons. hTotal SFA: sum of saturated fatty acids (4:0 to 26:0). iTotal MUFA: sum of monounsaturated fatty acids (14:1 
to 24:1). jTotal PUFA: sum of polyunsaturated fatty acids (18:2 to 22:5). kTotal n-6 PUFA: sum of n-6 PUFA: 18:2 c9,c12, 18:3 c6,c9,c12, 20:2 c11,c14, 20:3 
c8,c11,c14, 20:4 c5,c8,c11,c14and 22:4 c7,c10,c13,c16. lTotal n-3 PUFA: sum of n-3 PUFA: 18:3 c9,c12,c15, 18:4 c6,c9,c12,c15, 20:5 c5,c8,c11,c14,c17, and 
22:5 c7,c10,c13,c16,c19. mTotal CLA: sum of conjugated linoleic acids: 18:2 c9,t11, 18:2 c9,c11, 18:2 t7,t9, and 18:2 t10,t12. 
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Table C.3. Fatty acid compositiona (g/100g FA) of the cholesterol ester plasma lipid fraction by day in response to CONb, LEOc, and HEOd 
diets 
fatty acid 
Treatment 
SE P value CON LEO HEO 
D-1 D2 D3 D4 D7 D9 D10 D11 D14 
10:0 0.00 0.79 0.98 1.31 1.10 1.07 1.80 0.60 0.63 0.33 <0.05 
12:0 0.07 0.05 0.06 0.06 0.06 0.05 0.04 0.05 0.07 0.01 ns 
iso 13:0 0.00 0.01 0.00 0.01 0.00 0.00 0.01 0.01 0.00 0.00 ns 
13:0 0.03 0.03 0.02 0.02 0.03 0.02 0.01 0.01 0.04 0.01 ns 
iso 14:0 0.11 0.08 0.14 0.17 0.09 0.14 0.60 0.10 0.08 0.15 ns 
14:0 1.03 0.97 0.91 0.90 0.90 0.84 0.81 0.88 0.88 0.06 <0.01 
iso 15:0 0.49 0.49 0.47 0.47 0.45 0.43 0.41 0.45 0.42 0.03 <0.01 
anteiso 15:0 0.93 0.87 0.86 0.84 0.82 0.77 0.75 0.78 0.74 0.05 <0.001 
14:1 c9 0.02 0.02 0.02 0.00 0.01 0.01 0.02 0.01 0.01 0.01 ns 
15:0 0.64 0.58 0.56 0.57 0.54 0.50 0.55 0.51 0.46 0.03 <0.01 
iso 16:0 0.30 0.27 0.25 0.24 0.24 0.23 0.23 0.24 0.20 
 
0.01 <0.001 
16:0 4.23 3.48 3.36 3.40 3.20 3.43 3.28 3.41 3.35 0.12 <0.001 
iso 17:0 0.10 0.09 0.09 0.10 0.12 0.10 0.09 0.09 0.08 0.01 ns 
16:1 t9 0.00 0.00 0.01 0.02 0.02 0.02  0.01 0.01 0.02 0.00 <0.05 
16:1 c7 0.02 0.04 0.03 0.04 0.03 0.04 0.03 0.02 0.05 0.01 ns 
16:1 c8 0.58 0.57 0.58 0.58 0.59 0.51 0.49 0.52 0.49 0.04 0.062 
anteiso 17:0 0.01 0.03 0.02 0.03 0.04 0.03 0.02 0.02 0.04 0.02 ns 
16:1 c9 1.26 1.23 1.21 1.21 1.13 1.09 1.02 1.10 1.03 0.05 <0.001 
16:1 c10/t13 0.02 0.04 0.02 0.03 0.02 0.03 0.03 0.04 0.03 0.01 ns 
16:1 c11 0.08 0.09 0.06 0.05 0.07 0.06 0.07 0.06 0.04 0.01 ns 
17:0 0.09 0.05 0.05 0.04 0.08 0.05 0.06 0.05 0.09 0.01 0.068 
iso 18:0 0.76 0.74 0.72 0.70 0.64 0.63 0.65 0.63 0.53 0.08 <0.001 
17:1 c8 0.21 0.18 0.22 0.18 0.21 0.18 0.18 0.17 0.14 0.01 <0.05 
18:0 2.32 0.74 0.51 0.50 2.10 0.72 0.61 0.62 0.58 0.11 <0.001 
18:1 t5 0.00 0.01 0.00 0.01 0.00 0.02 0.00 0.00 0.00 0.01 ns 
18:1 t6-8 0.03 0.05 0.01 0.03 0.06 0.04 0.04 0.01 0.04 0.01 ns 
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18:1 t9 0.03 0.05 0.01 0.04 0.03 0.03 0.02 0.02 0.04 0.01 ns 
18:1 t10 0.07 0.04 0.02 0.07 0.06 0.04 0.03 0.03 0.04 0.01 <0.05 
18:1 t11 0.10 0.05 0.01 0.04 0.13 0.06 0.03 0.03 0.03 0.01 <0.01 
18:1 t12 0.10 0.12 0.05 0.05 0.10 0.08 0.08 0.06 0.08 0.01 ns 
18:1 t13/14/c6-8 0.19 0.16 0.13 0.15 0.22 0.17 0.15 0.11 0.16 0.02 0.069 
18:1 c9 2.80 2.68 2.57 2.60 2.65 2.50 2.32 2.45 2.37 0.08 <0.001 
18:1 c11 0.28 0.25 0.22 0.22 0.20 0.22 0.17 0.20 0.19 0.02 <0.01 
18:1 c12 0.20 0.21 0.20 0.21 0.18 0.22 0.18 0.20 0.20 0.02 ns 
18:2 t10,t14 0.07 0.04 0.06 0.07 0.07 0.07 0.07 0.05 0.08 0.02 ns 
18:2 t9,t12 0.07 0.10 0.08 0.02 0.04 0.47 0.24 0.53 0.26 0.07 <0.01 
cyclohexyl-11 11:0 0.55 0.58 0.55 0.51 0.53 0.51 0.50 0.53 0.44 0.02 <0.05 
18:2 c12,t16 0.00 0.00 0.02 0.03 0.02 0.04 0.06 0.04 0.03 0.01 <0.01 
18:2 c9,c12 71.19 72.02 72.39 71.69 69.09 71.38 71.10 71.83 71.14 0.80 ns 
18:3 c6,c9,c12 1.71 1.93 1.99 2.04 2.06 2.17 2.19 2.34 2.48 0.10  <0.001 
18:3 c9,c12,c15 6.67 6.73 6.91 7.15 7.26 7.45 7.64 8.11 8.82 0.13 <0.001 
18:2 c9,t11 0.05 0.05 0.05 0.06 0.07 0.05 0.08 0.04 0.05 0.01 ns 
18:4 c6,c9,c12,c15 0.00 0.31 0.38 0.44 0.53 0.62 0.68 0.61 0.89 0.05 <0.001 
22:0 0.00 0.00 0.02 0.02 0.01 0.01 0.02 0.00 0.02 0.01 ns 
20:4 c5,c8,c11,c14 1.15 1.16 1.14 1.16 1.11 1.08 1.11 1.07 1.11 0.04 ns 
20:5 c5,c8,c11,c14,c17 0.37 0.39 0.38 0.38 0.39 0.40 0.39 0.40 0.42 0.02 ns 
unknown 1.39 1.10 0.99 0.90 1.12 1.29 0.79 0.77 0.85 0.10 ns 
total SFAe 8.39 6.69 6.46 6.83 9.01 6.72 7.18 6.13 6.08 0.43 <0.01 
total MUFAf 6.01 5.81 5.47 5.54 5.75 5.32 4.88 5.07 4.96 0.20 <0.001 
total trans 18:1 0.51 0.48 0.23 0.39 0.60 0.44 0.34 0.25 0.39 0.04 <0.05 
total PUFAg 80.94 83.27 83.98 83.65 81.20 83.85 83.89 85.19 85.57 0.79 <0.01 
total  n-6 PUFAh 73.79 75.76 76.17 75.52 72.86 75.20 74.97 75.94 75.29 0.80 ns 
total n-3 PUFAi 7.04 7.42 7.67 7.97 8.18 8.48 8.72 9.11 10.13 0.15 <0.001 
aMeans are based on 6 dairy cattle per treatment. bCON: control (0% of DM as lipid-encapsulated echium oil), cLEO: 1.5% of DM as lipid-encapsulated echium 
oil, 1.5% of DM as encapsulation, dHEO: 3% of DM as lipid-encapsulated echium oil. eTotal SFA: sum of saturated fatty acids (4:0 to 26:0). fTotal MUFA: sum 
of monounsaturated fatty acids (14:1 to 24:1). gTotal PUFA: sum of polyunsaturated fatty acids (18:2 to 22:5). hTotal n-6 PUFA: sum of n-6 PUFA: 18:2 c9,c12, 
18:3 c6,c9,c12, 20:2 c11,c14, 20:3 c8,c11,c14, 20:4 c5,c8,c11,c14 and 22:4 c7,c10,c13,c16. iTotal n-3 PUFA: sum of n-3 PUFA: 18:3 c9,c12,c15, 18:4 
c6,c9,c12,c15, 20:5 c5,c8,c11,c14,c17, and 22:5 c7,c10,c13,c16,c19. 
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Table C.4. Fatty acid compositiona (g/100g FA) of the free fatty acid plasma lipid fraction by day in response to CONb, LEOc, and HEOd 
diets. 
fatty acid 
Treatment 
SE P value CON LEO HEO 
D-1 D2 D3 D4 D7 D9 D10 D11 D14 
12:0 0.76 0.71 0.23 0.20 0.33 0.35 0.64 0.41 0.55 0.11 <0.01 
13:0 0.03 0.29 0.25 0.10 0.06 0.24 0.64 0.09 0.18 0.06 <0.01 
iso 14:0 0.09 0.50 0.43 0.13 0.08 0.19 0.16 0.20 0.18 0.07 0.086 
14:0 4.31 4.43 4.23 3.26 2.36 3.54 6.17 2.98 3.93 0.64 ns 
iso 15:0 2.50 1.26 1.78 2.13 2.51 1.05 0.93 0.74 0.69 0.67 ns 
anteiso 15:0 0.47 0.29 0.81 1.16 0.40 1.31 0.80 0.55 0.48 0.12 0.078 
14:1 c9 0.06 0.24 0.21 0.01 0.14 0.24 0.02 0.08 0.03 0.03 <0.05 
15:0 1.80 1.26 0.94 3.75 0.90 0.71 2.90 2.45 1.76 0.56 ns 
iso 16:0 0.39 0.51 0.45 0.45 0.33 0.56 0.50 0.61 
0.73 
0.52 
 
0.07 0.060 
16:0 23.93 25.58 19.64 22.40 24.24 17.98 20.62 19.02 26.88 1.13 0.054 
iso 17:0 0.37 0.69 0.47 0.35 0.56 0.20 0.90 0.92 0.83 0.14 0.086 
16:1 t9 0.03 0.07 0.05 0.09 0.04 0.06 0.31 0.19 0.38 0.04 <0.01 
16:1 c7 0.12 0.20 0.13 0.04 0.07 0.16 0.10 0.31 0.12 0.05 ns 
16:1 c8 0.12 0.15 0.12 0.12 0.14 0.06 0.05 0.13 0.12 0.03 0.073 
anteiso 17:0 0.01 0.08 0.33 0.10 0.10 0.37 0.16 0.17 0.18 0.24 ns 
16:1 c9 1.05 1.69 0.85 0.75 1.70 1.12 0.77 1.19 0.84 0.30 <0.01 
16:1 c11 0.54 0.50 0.63 1.19 0.20 0.22 0.99 0.70 0.25 0.26 ns 
17:0 1.00 1.08 1.05 1.39 1.11 0.88 1.19 1.20 1.16 0.25 ns 
iso 18:0 0.58 0.05 0.13 0.23 0.14 0.14 0.98 0.10 0.10 0.21 ns 
17:1 c8 0.00 0.09 0.04 0.02 0.02 0.06 0.03 0.02 0.02 0.06 ns 
17:1 c10 0.00 0.00 0.00 0.05 0.00 0.05 0.05 0.02 0.02 0.05 ns 
18:0 33.37 34.98 34.28 25.93 36.41 35.27 23.88 32.35 36.59 1.68 ns 
18:1 t4 0.02 0.03 0.00 0.05 0.01 0.00 0.03 0.02 0.00 0.05 ns 
18:1 t5 0.08 0.00 0.02 0.09 0.06 0.00 0.02 0.05 0.02 0.04 ns 
18:1 t6-8 0.14 0.06 0.08 0.13 0.14 0.11 0.14 0.14 0.27 0.03 <0.01 
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18:1 t9 0.10 0.20 0.37 0.28 0.34 0.40 1.21 1.65 1.40 0.18 <0.01 
18:1 t10 0.38 0.47 0.26 0.05 0.42 0.20 0.08 0.45 1.14 0.10 0.80 
18:1 t11 0.47 0.45 0.57 0.35 1.12 0.36 0.52 0.81 0.61 0.13 ns 
18:1 t12 0.19 0.28 0.30 0.31 0.34 0.21 0.28 0.39 0.28 0.04 0.057 
18:1 t13/14/c6-8 0.31 0.33 0.49 0.16 0.96 0.20 0.16 0.49 0.28 0.11 0.070 
18:1 c9 7.59 4.02 6.46 3.86 4.12 2.75 3.09 5.51 4.27 1.63 <0.05 
18:1 c11 0.60 0.32 0.37 0.99 0.95 0.99 1.30 0.83 0.55 0.14 ns 
18:1 c12 0.18 0.20 0.17 0.18 0.37 0.33 0.28 0.42 0.35 0.25 <0.05 
18:1 c13 2.26 0.39 0.33 0.15 0.31 0.17 0.30 0.17 0.46 0.17 <0.01 
18:1 c14/t16 0.96 0.51 0.46 0.54 0.28 0.71 0.13 0.53 0.11 0.15 <0.05 
18:1 c15 0.13 0.46 0.15 0.01 0.07 0.14 0.04 0.29 0.05 0.06 ns 
18:2 t10,t14 0.15 0.14 0.39 0.29 0.09 0.32 0.17 0.43 0.24 0.06 ns 
18:2 t9,t12 0.07 0.10 0.08 0.02 0.04 0.47 0.24 0.53 0.26 0.07 <0.01 
cyclohexyl-11 11:0 0.15 0.09 0.33 0.22 0.44 0.08 0.22 0.44 0.33 0.07 ns 
18:1 c16 0.02 0.02 0.09 0.03 0.04 0.05 0.08 0.11 0.02 0.03 ns 
18:2 c12,t16 0.06 0.07 0.10 0.40 0.02 0.13 0.25 0.24 0.26 0.06 ns 
18:2 c9,c12 6.48 3.66 5.95 6.03 4.24 7.94 6.99 7.90 5.22 0.91 <0.05 
20:0 0.27 0.61 0.32 0.19 0.32 0.23 0.26 0.51 0.50 0.06 ns 
18:3 c6,c9,c12 0.02 0.01 0.05 0.08 0.11 0.10 0.18 0.31 0.46 0.05  <0.001 
18:3 c9,c12,c15 0.51 0.74 0.72 0.89 0.86 1.18 1.09 1.61 1.73 0.16 <0.001 
18:2 c9,t11 0.07 0.04 0.11 0.21 0.20 0.11 0.20 0.24 0.11 0.04 ns 
18:2 c9,c11 0.12 0.02 0.21 0.47 0.35 0.39 0.77 0.29 0.44 0.11 ns 
18:2 t7,t9/t10,t12 0.00 0.00 0.00 0.10 0.09 0.18 0.66 0.57 0.67 0.09 <0.05 
18:4 c6,c9,c12,c15 0.00 0.08 0.12 0.19 0.19 0.25 0.35 0.41 0.65 0.05 <0.001 
20:2 c11,c14 0.04 0.10 
.10 
0.19 0.05 0.06 0.25 0.05 0.23 0.06 0.05 ns 
22:0 0.32 0.24 0.20 0.11 0.07 0.15 0.15 0.29 0.21 0.04 <0.05 
20:3 c8,c11,c14  0.99 0.39 2.08 2.07 0.31 1.69 1.79 0.47 0.24 0.39 ns 
22:1 c13 0.06 0.13 0.08 0.23 0.07 0.03 0.15 0.04 0.04 0.03 0.053 
20:4 c5,c8,c11,c14 0.41 0.59 0.41 0.65 0.30 0.37 0.66 0.62 0.45 0.10 ns 
23:0 0.12 0.05 0.11 0.10 0.05 0.01 0.06 0.24 0.07 0.04 ns 
  
2
7
9
 
20:5 c5,c8,c11,c14,c17 0.08 0.16 0.15 0.22 0.36 0.40 0.46 0.58 0.61 0.09 <0.01 
24:0 0.28 0.44 0.51 0.12 0.16 0.75 0.85 0.57 0.22 0.15 0.069 
22:4 c7,c10,c13,c16 0.04 0.04 0.03 0.06 0.09 0.08 0.03 0.06 0.08 0.05 ns 
22:5 c7,c10,c13,c16,c19  0.03 0.11 0.14 0.23 0.45 0.35 0.28 0.19 0.44 0.09 <0.05 
unknown 2.46 2.97 2.89 2.93 1.26 1.63 3.07 3.23 3.90 0.42 ns 
total SFAe 67.35 70.16 62.34 67.56 65.75 60.33 59.38 65.12 71.84 2.16 ns 
total MUFAf 14.85 14.00 15.36 12.24 12.57 11.79 13.38 13.04 11.22 1.83 ns 
total trans 18:1 1.26 2.68 2.13 1.79 3.34 1.51 2.85 4.13 3.11 0.35 <0.05 
total PUFAg 9.52 7.71 11.35 14.11 7.39 16.48 15.27 15.07 11.19 1.33 <0.01 
total  n-6 PUFAh 8.00 5.23 9.08 10.61 5.07 13.48 9.88 9.41 5.96 1.27 ns 
total n-3 PUFAi 1.03 1.54 2.11 2.34 1.68 1.89 2.44 2.46 2.98 0.28 <0.01 
total CLAj 0.10 0.22 0.25 0.86 0.37 0.28 1.84 1.14 1.33 0.20 <0.01 
aMeans are based on 6 dairy cattle per treatment. bCON: control (0% of DM as lipid-encapsulated echium oil), cLEO: 1.5% of DM as lipid-encapsulated echium 
oil, 1.5% of DM as encapsulation, dHEO: 3% of DM as lipid-encapsulated echium oil. eTotal SFA: sum of saturated fatty acids (4:0 to 26:0). fTotal MUFA: sum 
of monounsaturated fatty acids (14:1 to 24:1). gTotal PUFA: sum of polyunsaturated fatty acids (18:2 to 22:5). hTotal n-6 PUFA: sum of n-6 PUFA: 18:2 c9,c12, 
18:3 c6,c9,c12, 20:2 c11,c14, 20:3 c8,c11,c14, 20:4 c5,c8,c11,c14and 22:4 c7,c10,c13,c16. iTotal n-3 PUFA: sum of n-3 PUFA: 18:3 c9,c12,c15, 18:4 
c6,c9,c12,c15, 20:5 c5,c8,c11,c14,c17, and 22:5 c7,c10,c13,c16,c19. jTotal CLA: sum of conjugated linoleic acids: 18:2 c9,t11, 18:2 c9,c11 and 18:2 t7,t9, and 
18:2 t10,t12. 
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Table C.5. Fatty acid compositiona (g/100g FA) of the phospholipid plasma lipid fraction by day in response to CONb, LEOc, and HEOd 
diets 
fatty acid 
Treatment 
SE P value CON LEO HEO 
D-1 D2 D3 D4 D7 D9 D10 D11 D14 
10:0 0.00 0.32 0.40 0.60 0.37 0.42 0.37 0.37 0.15 0.04 <0.01 
12:0 0.00 0.00 0.01 0.02 0.01 0.02 0.03 0.01 0.02 0.00 <0.01 
13:0 0.00 0.01 0.00 0.01 0.01 0.01 0.01 0.01 0.00 0.00 ns 
iso 14:0 0.00 0.01 0.01 0.01 0.03 0.04 0.04 0.02 0.01 0.01 <0.01 
14:0 0.20 0.18 0.13 0.14 0.15 0.15 0.14 0.14 0.15 0.01 <0.01 
iso 15:0 0.07 0.06 0.07 0.07 0.06 0.06 0.06 0.06 0.07 0.00 0.058 
anteiso 15:0 0.42 0.39 0.39 0.34 0.35 0.35 0.37 0.38 0.36 0.02 ns 
15:0 0.39 0.34 0.34 0.33 0.32 0.34 0.36 0.34 0.32 0.01 <0.01 
iso 16:0 0.21 0.20 0.19 0.19 0.16 0.16 0.16 0.17 0.17 
 
0.01 <0.01 
16:0 13.43 13.18 13.67 13.56 13.85 13.75 13.78 13.98 13.96 0.26 0.075 
iso 17:0 0.34 0.34 0.32 0.32 0.30 0.32 0.30 0.32 0.30 0.02 0.067 
16:1 t9 0.02 0.02 0.02 0.02 0.02 0.03 0.02 0.02 0.01 0.00 ns 
16:1 c7 0.03 0.03 0.02 0.03 0.03 0.03 0.02 0.03 0.03 0.00 ns 
16:1 c8 0.12 0.13 0.13 0.10 0.10 0.08 0.08 0.11 0.08 0.01 <0.01 
anteiso 17:0 0.01 0.01 0.02 0.02 0.01 0.02 0.01 0.02 0.01 0.00 ns 
16:1 c9 0.91 0.89 0.86 0.81 0.76 0.72 0.71 0.75 0.68 0.03 <0.001 
17:0 1.02 1.00 0.97 0.97 0.93 0.92 0.91 0.93 0.89 0.02 <0.01 
iso 18:0 0.07 0.08 0.08 0.06 0.05 0.05 0.06 0.03 0.04 0.01 <0.05 
17:1 c8 0.13 0.12 0.14 0.12 0.11 0.10 0.09 0.09 0.09 0.01 <0.01 
17:1 c10 0.13 0.14 0.13 0.10 0.11 0.10 0.12 0.14 0.11 0.01 ns 
18:0 25.40 25.34 25.52 25.54 25.58 25.58 25.67 25.60 25.70 0.18 ns 
18:1 t5 0.01 0.01 0.01 0.01 0.02 0.01 0.01 0.01 0.00 0.01 ns 
18:1 t6-8 0.05 0.09 0.09 0.09 0.07 0.07 0.06 0.08 0.07 0.01 <0.01 
18:1 t9 0.11 0.12 0.10 0.10 0.10 0.09 0.10 0.10 0.09 0.01 ns 
18:1 t10 0.05 0.07 0.06 0.07 0.07 0.07 0.06 0.07 0.05 0.01 ns 
  
2
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18:1 t11 0.55 0.58 0.57 0.57 0.61 0.67 0.66 0.75 0.68 0.04 <0.01 
18:1 t12 0.19 0.30 0.27 0.27 0.32 0.38 0.35 0.33 0.29 0.32 <0.05 
18:1 t13/14/c6-8 0.53 0.61 0.62 0.72 0.64 0.66 0.65 0.63 0.52 0.02 <0.05 
18:1 c9 8.70 8.32 8.48 8.15 7.26 6.79 6.72 6.80 6.66 0.29 <0.01 
18:1 c11 0.62 0.60 0.59 0.55 0.49 0.50 0.47 0.51 0.45 0.03 <0.01 
18:1 c12 0.48 0.58 0.50 0.48 0.45 0.48 0.48 0.51 0.46 0.02 ns 
18:1 c13 0.01 0.06 0.03 0.03 0.02 0.03 0.02 0.03 0.03 0.01 0.059 
18:1 c14/t16 0.14 0.17 0.17 0.16 0.14 0.15 0.17 0.18 0.17 0.01 <0.05 
18:2 t10,t14 0.20 0.21 0.18 0.15 0.14 0.13 0.17 0.10 0.14 0.02 <0.05 
cyclohexyl-11 11:0 0.25 0.27 0.28 0.26 0.23 0.24 0.23 0.27 0.20 0.03 ns 
18:2 c12,t16 0.00 0.09 0.10 0.07 0.05 0.06 0.05 0.11 0.09 0.02 <0.01 
18:2 c9,c12 32.32 33.09 32.26 32.65 33.96 34.36 34.25 33.97 34.29 0.54 <0.001 
18:3 c6,c9,c12 0.25 0.41 0.45 0.44 0.41 0.51 0.55 0.60 0.61 0.03  <0.001 
18:3 c9,c12,c15 1.58 1.73 1.82 1.91 1.86 2.00 2.08 2.25 2.44 0.04 <0.001 
18:2 c9,t11 0.09 0.09 0.07 0.08 0.07 0.07 0.06 0.06 0.07 0.01 <0.05 
18:4 c6,c9,c12,c15 0.00 0.12 0.13 0.14 0.13 0.16 0.17 0.19 0.18 0.01 <0.001 
20:2 c11,c14 0.17 0.15 
.10 
0.13 0.13 0.12 0.13 0.13 0.13 0.14 0.01 <0.01 
22:0 0.02 0.02 0.01 0.03 0.03 0.04 0.04 0.03 0.04 0.01 ns 
20:3 c8,c11,c14  4.78 4.35 4.44 4.52 4.33 4.14 4.13 3.96 3.97 0.11 <0.001 
20:4 c5,c8,c11,c14 2.24 2.11 2.05 2.09 2.08 1.98 1.95 1.93 1.96 0.08 <0.001 
23:0 0.05 0.04 0.03 0.05 0.06 0.08 0.07 0.04 0.05 0.01 <0.05 
20:5 c5,c8,c11,c14,c17 0.33 0.34 0.32 0.32 0.37 0.35 0.37 0.37 0.42 0.02 <0.01 
24:0 0.06 0.06 0.03 0.04 0.07 0.08 0.07 0.03 0.05 0.01 ns 
cis-5 24 :1 0.02 0.00 0.01 0.01 0.03 0.03 0.02 0.01 0.03 0.01 ns 
22:4 c7,c10,c13,c16 0.53 0.48 0.47 0.49 0.47 0.45 0.46 0.44 0.43 0.03 <0.01 
22:4 c10,c13,c16,c19 0.13 0.10 0.09 0.11 0.09 0.11 0.10 0.11 0.11 0.01 0.051 
22:5 c7,c10,c13,c16,c19  0.84 0.79 0.74 0.76 0.76 0.75 0.75 0.71 0.76 0.04 <0.05 
22:6 c4,c7,c10,c13,c16,c19 0.04 0.03 0.03 0.03 0.03 0.03 0.04 0.03 0.03 0.01 ns 
unknown 1.60 1.32 1.22 1.04 1.22 1.15 1.26 1.82 1.38 0.09 <0.01 
total SFAe 40.58 40.46 41.13 41.31 41.37 41.38 41.44 41.52 41.34 0.30 <0.01 
  
2
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total MUFAf 12.95 12.80 13.00 12.45 11.34 11.01 10.82 11.40 10.53 0.38 <0.001 
total trans 18:1 1.20 1.18 1.09 1.11 1.19 1.30 1.25 1.34 1.18 0.08 ns 
total PUFAg 43.45 44.09 43.30 43.89 44.87 45.22 45.25 44.99 45.64 0.54 <0.001 
total  n-6 PUFAh 40.28 40.63 39.81 40.31 41.37 41.58 41.46 41.02 41.39 0.58 <0.01 
total n-3 PUFAi 2.91 3.08 3.13 3.28 3.24 3.39 3.51 3.65 3.95 0.05 <0.001 
aMeans are based on 6 dairy cattle per treatment. bCON: control (0% of DM as lipid-encapsulated echium oil), cLEO: 1.5% of DM as lipid-encapsulated echium 
oil, 1.5% of DM as encapsulation, dHEO: 3% of DM as lipid-encapsulated echium oil. eTotal SFA: sum of saturated fatty acids (4:0 to 26:0). fTotal MUFA: sum 
of monounsaturated fatty acids (14:1 to 24:1). gTotal PUFA: sum of polyunsaturated fatty acids (18:2 to 22:5). hTotal n-6 PUFA: sum of n-6 PUFA: 18:2 c9,c12, 
18:3 c6,c9,c12, 20:2 c11,c14, 20:3 c8,c11,c14, 20:4 c5,c8,c11,c14and 22:4 c7,c10,c13,c16. iTotal n-3 PUFA: sum of n-3 PUFA: 18:3 c9,c12,c15, 18:4 
c6,c9,c12,c15, 20:5 c5,c8,c11,c14,c17, and 22:5 c7,c10,c13,c16,c19.  
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Table C.6. Fatty acid compositiona (g/100g FA) of the triacylglycerol plasma lipid fraction by day in response to CONb, LEOc, and HEOd 
diets. 
fatty acid 
Treatment 
SE P value CON
 
LEO HEO 
D-1 D2 D3 D4 D7 D9 D10 D11 D14 
10:0 0.00 0.09 0.10 0.07 0.00 0.12 0.09 0.16 0.22 0.03 <0.001 
12:0 0.21 0.20 0.19 0.20 0.19 0.23 0.30 0.29 0.29 0.03 0.007 
iso 13:0 0.07 0.05 0.04 0.06 0.06 0.05 0.05 0.05 0.05 0.01 ns 
13:0 0.13 0.12 0.09 0.10 0.11 0.08 0.08 0.08 0.10 0.02 0.068 
iso 14:0 0.27 0.23 0.20 0.20 0.24 0.17 0.18 0.18 0.18 0.03 <0.05 
14:0 2.02 1.70 1.60 1.70 1.61 1.66 1.74 1.77 2.02 0.16 ns 
iso 15:0 0.73 0.63 0.53 0.56 0.61 0.57 0.55 0.51 0.47 0.04 <0.01 
anteiso 15:0 1.44 1.22 1.09 1.13 1.13 1.22 1.15 1.05 1.10 0.09 <0.05 
14:1 c9 0.04 0.03 0.06 0.07 0.03 0.02 0.03 0.04 0.09 0.02 ns 
15:0 1.44 1.28 1.10 1.16 1.21 1.21 1.16 1.15 1.14 0.06 <0.01 
iso 16:0 1.05 1.03 0.94 1.03 0.82 0.99 0.90 0.84 0.73 0.10 ns 
16:0 20.83 24.36 24.53 24.90 23.68 24.48 24.40 24.32 24.03 0.64 <0.01 
iso 17:0 0.60 0.67 0.59 0.61 0.54 0.65 0.59 0.54 0.64 0.06 ns 
16:1 t9 0.05 0.04 0.04 0.06 0.06 0.05 0.05 0.04 0.09 0.02 ns 
16:1 c7 0.12 0.07 0.05 0.06 0.08 0.08 0.08 0.05 0.18 0.04 ns 
16:1 c8 1.01 0.58 0.46 0.54 0.42 0.48 0.43 0.37 0.52 0.10 <0.01 
anteiso 17:0 0.19 0.04 0.02 0.32 0.18 0.24 0.16 0.08 0.05 0.05 ns 
16:1 c9 1.46 1.44 1.59 1.19 1.00 1.10 1.03 1.01 1.11 0.10 <0.01 
17:0 1.01 0.91 0.92 0.91 0.86 0.87 0.85 0.85 1.00 0.07 ns 
iso 18:0 0.16 0.15 0.15 0.14 0.11 0.10 0.07 0.04 0.08 0.02 <0.01 
17:1 c8 0.00 0.07 0.11 0.17 0.13 0.06 0.06 0.06 0.07 0.03 ns 
18:0 41.35 40.13 37.79 39.64 39.42 39.73 40.44 41.08 37.90 1.55 ns 
18:1 t4 0.04 0.04 0.02 0.01 0.03 0.04 0.04 0.04 0.11 0.03 ns 
18:1 t5 0.03 0.07 0.03 0.02 0.05 0.04 0.04 0.05 0.19 0.03 ns 
  
2
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18:1 t6-8 0.54 0.51 0.44 0.53 0.58 0.56 0.56 0.55 0.43 0.04 ns 
18:1 t9 0.29 0.35 0.33 0.30 0.36 0.41 0.42 0.43 0.29 0.04 <0.05 
18:1 t10 0.62 0.63 0.79 0.54 0.69 0.69 0.72 0.72 0.59 0.07 ns 
18:1 t11 2.46 2.60 2.34 2.16 2.28 3.00 3.05 3.08 2.71 0.20 <0.05 
18:1 t12 0.64 0.71 0.61 0.63 0.78 0.80 0.79 0.76 0.99 0.11 ns 
18:1 t13/14/c6-8 1.77 1.90 1.84 1.92 1.97 2.30 2.30 2.12 1.76 0.12 <0.05 
18:1 c9 7.40 6.89 10.98 6.45 6.45 5.96 5.56 6.33 6.71 1.28 ns 
18:1 c11 1.10 0.94 1.05 0.73 0.86 0.74 0.86 0.74 0.69 0.07 <0.01 
18:1 c12 0.51 0.50 0.48 0.96 0.49 0.88 0.82 0.79 0.45 0.07 <0.05 
18:1 c13 0.19 0.12 0.13 0.42 0.24 0.67 0.52 0.35 0.91 0.27 ns 
18:1 c14/t16 0.55 0.71 0.64 0.24 0.67 0.26 0.47 0.67 0.71 0.07 ns 
18:1 c15 0.42 0.13 0.13 0.51 0.56 0.67 0.51 0.29 0.20 0.09 ns 
18:2 t10,t14 0.00 0.57 0.51 0.44 0.48 0.55 0.54 0.48 0.36 0.06 <0.001 
cyclohexyl-11 11:0 0.51 0.48 0.50 0.49 0.53 0.56 0.47 0.43 0.36 0.05 ns 
18:2 t9,c12 0.00 0.18 0.18 0.16 0.24 0.33 0.31 0.42 0.30 0.03 <0.001 
18:2 c9,c12 3.18 3.03 2.77 2.86 3.38 2.93 3.05 2.73 4.46 0.54 ns 
20:0 0.38 0.36 0.33 0.31 0.36 0.38 0.39 0.38 0.43 0.03 0.065 
18:3 c6,c9,c12 0.00 0.02 0.07 0.10 0.12 0.12 0.12 0.13 0.14 0.02 <0.001 
18:3 c9,c12,c15 0.68 0.80 0.89 0.94 0.98 1.04 1.06 1.16 1.19 0.07 <0.01 
18:2 c9,t11 0.08 0.14 0.18 0.11 0.11 0.13 0.12 0.17 0.49 0.12 ns 
18:2 t7,t9/t10,t1218 :2 0.00 0.02 0.02 0.02 0.06 0.06 0.08 0.06 0.04 0.01 <0.01 
18:4 c6,c9,c12,c15 0.00 0.11 0.12 0.16 0.19 0.20 0.20 0.20 0.22 0.02 <0.001 
22:0 0.25 0.18 0.18 0.19 0.18 0.19 0.19 0.20 0.30 0.04 ns 
20:3 c8,c11,c14  0.00 0.30 0.28 0.27 0.25 0.24 0.26 0.24 0.80 0.20 ns 
20:4 c5,c8,c11,c14 0.16 0.26 0.24 0.14 0.15 0.13 0.14 0.13 0.10 0.04 0.074 
23:0 0.17 0.17 0.12 0.18 0.18 0.21 0.18 0.19 0.15 0.02 ns 
20:5 c5,c8,c11,c14,c17 0.00 0.01 0.02 0.03 0.04 0.05 0.04 0.07 0.05 0.01 <0.01 
24:0 0.23 0.24 0.18 0.23 0.22 0.29 0.30 0.25 0.40 0.05 0.057 
22:5 c7,c10,c13,c16,c19  0.00 0.00 0.07 0.07 0.08 0.11 0.13 0.13 0.11 0.02 <0.01 
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unknown 1.25 1.15 1.28 1.46 1.62 1.20 1.27 1.18 1.26 0.15 ns 
total SFAe 68.02 70.30 67.11 69.58 67.91 69.44 70.12 70.72 67.99 1.54 ns 
total MUFAf 21.62 18.73 22.21 17.59 20.71 18.96 18.41 18.55 18.91 1.35 ns 
total trans 18:1 6.40 6.79 6.41 6.10 7.76 7.86 7.92 7.74 7.07 0.36 <0.01 
total PUFAg 4.10 5.61 5.32 5.33 5.34 5.88 6.07 5.83 5.84 0.29 <0.01 
total  n-6 PUFAh 3.34 3.65 3.44 3.41 3.64 3.44 3.59 3.24 5.52 0.72 ns 
total n-3 PUFAi 0.68 1.00 1.13 1.18 1.42 1.36 1.41 1.46 1.51 0.07 <0.001 
total CLAj 0.08 0.16 0.20 0.13 0.18 0.19 0.20 0.22 0.53 0.12 ns 
aMeans are based on 6 dairy cattle per treatment. bCON: control (0% of DM as lipid-encapsulated echium oil), cLEO: 1.5% of DM as lipid-encapsulated echium 
oil, 1.5% of DM as encapsulation, dHEO: 3% of DM as lipid-encapsulated echium oil. eTotal SFA: sum of saturated fatty acids (4:0 to 26:0). fTotal MUFA: sum 
of monounsaturated fatty acids (14:1 to 24:1). gTotal PUFA: sum of polyunsaturated fatty acids (18:2 to 22:5). hTotal n-6 PUFA: sum of n-6 PUFA: 18:2 c9,c12, 
18:3 c6,c9,c12, 20:3 c8,c11,c14, and cis-5,cis-8,cis-11,cis-14 20:4. iTotal n-3 PUFA: sum of n-3 PUFA: 18:3 c9,c12,c15, 18:4 c6,c9,c12,c15, 20:5 
c5,c8,c11,c14,c17, and 22:5 c7,c10,c13,c16,c19. jTotal CLA: sum of conjugated linoleic acids: 18:2 c9,t11, and 18:2 t7,t9, and 18:2 t10,t12. 
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Table C.7. Fatty acid content of fecal matter (mg/g DM) from dairy cowsa on CONb, 
LEOc, and HEOd diets. 
 Treatment 
SE P-value 
 CON
 LEO HEO 
total fatty acids 21.09c 65.63a 55.21b 2.59 <0.001 
   14:0 0.27c 0.75a 0.61b 0.04 <0.001 
   iso-15:0 0.13 0.11 0.12 0.01 ns 
   anteiso-15:0 0.38a 0.31b 0.34b 0.02 0.029 
   15:0 0.42 0.35 0.37 0.02 ns 
   iso-16:0 0.15a 0.09b 0.11b 0.01 0.002 
   16:0 3.45c 28.60a 22.20b 1.04 <0.001 
   iso-17:0 0.22 0.17 0.19 0.02 ns 
   17:0 0.30 0.30 0.32 0.03 ns 
   18:0 5.67c 26.61a 22.21b 1.63 <0.001 
   18:1 t11 0.64b 0.71b 0.92a 0.04 <0.001 
   18:1 c9 1.14c 1.56b 2.06a 0.07 <0.001 
   18:1 c11 0.42a 0.35b 0.38b 0.02 0.023 
   18:2 t9,c12 0.07c 0.23b 0.50a 0.02 <0.001 
   18:2 c9,c12 1.38b 1.90a 2.10a 0.16 0.009 
   20:0 0.21b 0.40a 0.41a 0.02 <0.001 
   18:3 c6,c9,c12 0.00a 0.14b 0.30c 0.01 <0.001 
   18:3 c9,c12,c15 0.30c 0.73b 1.29a 0.04 <0.001 
   18:2 c9,t11 0.04b 0.07a 0.08b 0.01 0.023 
   18:4 c6,c9,c12,c15 0.00c 0.18b 0.38c 0.01 <0.001 
   22:0 0.20b 0.22ab 0.22a 0.01 0.038 
   20:5 c5,c8,c11,c14,c17 0.13c 0.16b 0.21a 0.01 <0.001 
   24:0 0.25 0.25 0.26 0.01 ns 
   unknown 0.08 0.06 0.07 0.01 ns 
   total otherd 1.58 1.39 1.57 0.09 ns 
   total SFAe 14.53c 57.67a 44.73b 2.48 <0.001 
   total MUFAf 3.07b 3.38b 4.30a 0.11 <0.001 
   total trans 18:1 1.04b 1.07b 1.35 0.08 0.003 
   total PUFAg 1.94c 3.42b 4.88c 0.19 <0.001 
   total n-6 1.39b 2.03a 2.40a 0.16 0.002 
   total n-3 0.44c 1.09b 1.91a 0.05 <0.001 
aCON: control (0% of DM as encapsulated echium oil),bLEO: 1.5% of DM as encapsulated echium oil, 
and 1.5% of DM as encapsulation matrix. cHEO: 3% of DM as encapsulated echium oil. dƩ Other: 12:0, 
iso-13:0, iso-14:0, 16:1 t9, 16:1 c7, 16:1 c8, 16:1 c9, 16:1 c11, 17:1 c10, 18:1 t4, 18:1 t5, 18:1 t6-8, 
18:1 t9, 18:1 t10, 18:1 t12, 18:1 c6-8/t13-14, 18:1 c12, 18:1 c13, 18:1 c14/t16, 18:1 c15, cyclohexyl-
11:0, 20:0, 20:3 c11,c14,c17, 20:4 c5,c8,c11,c14, 23:0, 24:1 c15. eTotal SFA: sum of saturated fatty 
acids (4:0 to 26:0). fTotal MUFA: sum of monounsaturated fatty acids (14:1 to 24:1). gTotal PUFA: 
sum of polyunsaturated fatty acids (18:2 to 22:5). 
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Appendix D. 
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Figure D.1. A typical chromatograph produced by analysis of milk fat via gas-liquid chromatography from cows grazing a cool-season 
pasture.
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Appendix E. 
 
Figure E.1. A Pearson correlation matrix between protozoal taxa (>1% abundance) and 
volatile fatty acids (VFA) of cows grazing a cool-season pasture and pearl millet. 
The scale of the colors is denoted as follows: the more positive the correlation (closer to 
1), the darker the shade of blue; the more negative the correlation (closer to −1), the darker 
the shade of red. Un = Unclassified, A:P ratio = Acetate: propionate ratio. 
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Figure E.2. A Pearson correlation matrix between bacterial taxa (>1% abundance) and 
volatile fatty acids (VFA) of cows grazing a cool-season pasture and pearl millet. 
The scale of the colors is denoted as follows: the more positive the correlation (closer to 
1), the darker the shade of blue; the more negative the correlation (closer to −1), the darker 
the shade of red. Un = Unclassified. 
